UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 20-F

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number: 001-37381

 

Xylo Technologies Ltd.

(Exact name of Registrant as specified in its charter)

 

Israel

(Jurisdiction of incorporation or organization)

 

10 Hanechoshet, Tel-Aviv 6971072, Israel

(Address of principal executive offices)

 

Tali Dinar

10 Hanechoshet, Tel-Aviv 6971072, Israel Tel: +972-3-689-9124

 

Fax: +972-8-853-8194

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of class   Trading Symbol(s)   Name of each exchange on which registered
American Depositary Shares, each representing forty (40) Ordinary Shares(1)   XYLO   Nasdaq Capital Market
Ordinary Shares, no-par value (2)        

 

(1)Evidenced by American Depositary Receipts.

 

(2)Not for trading, but only in connection with the registration of the American Depositary Shares.

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None 

 

 

 

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of December 31, 2024: 32,258,663 Ordinary Shares, no par value per share.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act:

 

Yes No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934:

 

Yes No

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “accelerated filer and large accelerated filer” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large Accelerated filer Accelerated filer Non-accelerated filer
          Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).

 

Indicate by check mark the basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP

 

International Financial Reporting Standards as issued by the International Accounting Standards Board

 

Other

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

 

Item 17 Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):

 

Yes No

 

 

 

 

 

 

TABLE OF CONTENTS

 

        Page
Introduction    iii
Cautionary Note Regarding Forward-Looking Statements   iv
Summary Risk Factors   iv
         
    Part I   1
         
Item 1.   Identity of Directors, Senior Management and Advisors   1
Item 2.   Offer Statistics and Expected Timetable   1
Item 3.   Key Information   1
A.   Reserved   1
B.   Capitalization and Indebtedness   1
C.   Reasons for the Offer and Use of Proceeds   1
D.   Risk Factors   1
Item 4.   Information on the Company   30
A.   History and Development of the Company   30
B.   Business Overview   31
C.   Organizational Structure   37
D.   Property, Plant and Equipment   38
Item 4a.   Unresolved staff Comments   38
Item 5.   Operating and Financial Review and Prospects   38
A.   Operating Results   39
B.   Liquidity and Capital Resources   43
C.   Research and Development, Patents and Licenses, etc.   45
D.   Trend Information   45
E.   Critical Accounting Estimates   45
Item 6.   Directors, Senior Management and Employees   46
A.   Directors and Senior Management   46
B.   Compensation   48
C.   Board Practices   51
D.   Employees   64
E.   Share Ownership   66
F.   Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation   67
Item 7.   Major Shareholders and Related Party Transactions   67
A.   Major Shareholders   67
B.   Related Party Transactions   69
C.   Interests of Experts and Counsel   70
Item 8.   Financial Information   70
A.   Consolidated Statements and Other Financial Information   70
B.   Significant Changes   71
Item 9.   The Offer and Listing   72
A.   Offer and Listing Details   72
B.   Plan of Distribution   72
C   Markets   72
D   Selling Shareholders   72
E   Dilution   72
F   Expenses of the Issue   72

 

i

 

 

Item 10.   Additional Information   72
A.   Share Capital   72
B.   Memorandum and Articles of Association   72
C.   Material Contracts   73
D.   Exchange Controls   73
E.   Taxation   74
F.   Dividends and Paying Agents   87
G.   Statements by Experts   87
H.   Documents on Display   87
I.   Subsidiary Information   88
J.   Annual Report to Security Holders   88
Item 11.   Quantitative and Qualitative Disclosures About Market Risk   88
Item 12.   Description of Securities Other Than Equity Securities   89
A.   Debt Securities   89
B.   Warrants and Rights   89
C.   Other Securities   89
D.   American Depositary Shares   89
         
    Part II   90
         
Item 13.   Defaults, Dividend Arrearages and Delinquencies   90
Item 14.   Material Modifications to the Rights of Security Holders and Use of proceeds   90
Item 15.   Controls and Procedures   90
Item 16   Reserved   91
Item 16A.   Audit Committee Financial Expert   91
Item 16B.   Code of Ethics   91
Item 16C.   Principal Accountant Fees and Services   91
Item 16D.   Exemptions from the Listing Standards for Audit Committees   92
Item 16E.   Purchases of Equity Securities by the Issuer and Affiliated Purchasers   92
Item 16F.   Change in Registrant’s Certifying Accountant   92
Item 16G.   Corporate Governance   92
Item 16H.   Mine Safety Disclosure   93
Item 16I.   Disclosure regarding foreign jurisdictions that prevent inspections   93
Item 16J.   Insider Trading Policies   93
Item 16K.   Cybersecurity   93
         
    Part III   94
         
Item 17.   Financial Statements   94
Item 18.   Financial Statements   94
Item 19.   Exhibits   94
Signatures   96

 

ii

 

 

INTRODUCTION

 

Certain Definitions

 

In this annual report, unless the context otherwise requires:

 

  references to “ADS” refer to American Depositary Shares, each representing forty (40) Ordinary Shares.
     
  references to “Charging Robotics” refer to Charging Robotics, Inc., formerly known as Fuel Doctor Holdings, Inc., a company incorporated under the laws of the State of Delaware, a majority owned subsidiary of the Company.
     
  references to the “Companies Law” refer to the Israeli Companies Law, 5759-1999, as amended.
     
  references to “endoscopy” refer to a medical procedure which is used to diagnose or treat various diseases using an endoscope (a flexible tube which contains lighting features, imaging features and a system used to direct the endoscope within bodily systems).
     
     
  references to “Eventer” refer to Eventer Technologies Ltd., a company incorporated under the laws of the State of Israel, a majority subsidiary of the Company.
     
  references to “GERD IP” refer to GERD IP, Inc., a corporation incorporated under the laws of the State of Delaware, a majority owned subsidiary of the Company
     
  references to “Gix Internet” refer to Gix Internet Ltd. (formerly known as Algomizer Ltd.), a public company incorporated under the laws of the State of Israel, a subsidiary of the Company.
     
  references to “Group” refer to the Company and its consolidated subsidiaries, which are Charging Robotics, GERD IP, Gix Internet and Eventer.
     
  references to “Jeffs’ Brands” refer to Jeffs’ Brands Ltd., a company incorporated under the laws of the State of Israel.
     
  references to “Xylo Technologies,” the “Company,” the “Registrant,” “us,” “we” and “our” refer to Xylo Technologies Ltd. (formerly known as Medigus Ltd.), an Israeli company.
     
  references to “MUSE” refer to the Medigus Ultrasonic Surgical Endostapler, the trade name of an endoscopy system developed by the Company which is intended as a minimally invasive treatment for Gastroesophageal Reflux Disease, or GERD.
     
  references to “NIS” refer to New Israeli Shekels, the Israeli currency.
     
  references to “Ordinary Shares,” “our shares” and similar expressions refer to the Company’s Ordinary Shares, of no par value per share.
     
  references to “Polyrizon” refer to Polyrizon Ltd., a company incorporated under the laws of the State of Israel, a minority owned entity of the Company.
     
     
  references to the “SEC” refer to the United States Securities and Exchange Commission.
     
  references to “Odysight.ai” (formerly known as “ScoutCam Inc.”) refer to Odysight.ai Inc., a company incorporated under the laws of State of Nevada, a previously minority owned subsidiary of the Company.
     
  References to “Viewbix” refer to Viewbix Ltd., a company incorporated under the law of the State of Israel, a subsidiary of Gix Internet.

 

iii

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND A SUMMARY OF RISK FACTORS

 

Certain information included or incorporated by reference in this annual report on Form 20-F may be deemed to be “forward-looking statements”. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.

 

These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition, statements relating to the research, development and use of our products, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.

 

Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate.

 

Important factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements include, among other things:

 

  recent material changes in our strategy;
     
  we have a history of operating losses, we may incur additional losses in the future and our ability to grow sales and achieve profitability are unpredictable;

 

  we will need additional funding. If we are unable to raise capital, we will be forced to reduce or eliminate our operations;

 

  the overall global economic and macroeconomic environment;

 

  certain of our subsidiaries’ dependencies on key employees;

 

  changing laws, regulations, standards and contractual obligations related to privacy, data protection and data security and our and our subsidiaries’ ability to comply with them;

 

  Gix Internet’s performance;

 

  Eventer’s commercial success;

 

  our ability to secure and maintain intellectual property protections;

 

  our ability to secure and maintain intellectual property protections;

 

iv

 

 

  patent and other intellectual property litigation that could be costly, result in the diversion of management’s attention, require us to pay damages and force us to discontinue selling our products;

 

  conditions in Israel, including the ongoing war between Israel and Hamas, and other conflicts in the region;

 

  raising additional capital by issuing securities may cause dilution to existing shareholders;

 

  if the proposed acquisition of all issued and outstanding share capital by a single shareholder is not approved at the upcoming special shareholder meetings, , there may be significant uncertainty regarding the our future direction;

 

  those factors referred to in “Item 3. Key Information - D. Risk Factors,” “Item 4. Information on the Company,” and “Item 5. Operating and Financial Review and Prospects”, as well as in this annual report on Form 20-F generally.

 

Readers are urged to carefully review and consider the various disclosures made throughout this annual report on Form 20-F, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

In addition, the section of this Annual Report on Form 20-F entitled “Item 4. Information on the Company” contains information obtained from independent industry and other sources that we have not independently verified. You should not put undue reliance on any forward-looking statements. The forward-looking statements made in this Annual Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Annual Report to reflect events or circumstances after the date of this Annual Report or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

 

v

 

 

PART I

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISORS

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

You should carefully consider the risks described below, together with all of the other information in this annual report on Form 20-F. The risks described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs, our business and financial condition could suffer, and the price of our shares could decline.

 

Risks Related to Our Business

 

Starting in 2019, we made material changes to our business strategy. We cannot guarantee that any of these changes will result in any value to our shareholders.

 

Since 2019, we have materially changed our business model, adjusted our exclusive focus on the medical device industry to include other industries, abandoned our strategy to commercialize the MUSE system, sold our holdings in Odysight.ai. and diversified our investments into new markets and industries. In addition to the medical field, we entered the electric vehicle field. We also invested in the online advertising field. Additionally, we have begun investing in real estate. As a result of these changes, we have acquired substantial stakes in a number of ventures, including but not limited to online business activities such as ad-tech, electric vehicles and online event management. We cannot guarantee that these strategic decisions will derive the anticipated value to our shareholders, or any value at all.

 

We have a history of operating losses, we may incur additional losses in the future and our ability to grow sales and achieve profitability is unpredictable.

 

As of December 31, 2024, we had an accumulated deficit of $107.6 million and incurred total operating loss of approximately $8 million in the year ended on December 31, 2024, and total operating losses of approximately $23.3 million in the year ended December 31, 2023. Our losses have had, and will continue to have, an adverse effect on our shareholders’ equity and working capital. Any failure to achieve and maintain profitability would continue to have an adverse effect on our shareholders’ equity and working capital and could result in a decline in our share price or cause us to cease operations.

 

1

 

 

Our ability to reach profitability depends on many factors, which include:

 

  successfully implementing our business strategy;

 

  increasing revenues; and

 

  controlling costs.

 

There can be no assurance that we will be able to successfully implement our business plan, meet our challenges and become profitable in the future.

 

We will need additional funding. If we are unable to raise capital, we will be forced to reduce or eliminate our operations.

 

During the year ended December 31, 2024, the Group incurred loss of $12 million mainly due to operating loss from our consolidated financial reports of approximately $8 million and a negative cash flow from operating activities of approximately $1.8 million. Furthermore, in recent years, the Group has suffered recurring losses from operations, negative cash flows from operating activities and has an accumulated deficit of $107.6 million as of December 31, 2024.

 

As of December 31, 2024, we had a total cash and cash equivalents balance and short term deposits of approximately $8.7 million. Our management expects that we will continue to generate operating losses. Our management plans to continue to fund its operations primarily through utilization of its financial resources. In addition, we may raise additional capital or realize some of our investments in other entities in order to fund our operating needs. Our management is of the opinion that based on our current operating plan it will be able to carry out its plan for more than a year after the issuance date of this Annual Report on Form 20-F. However, we anticipate that we are likely to continue to incur significant losses for at least the next year. There is no assurance however, that we will be successful in obtaining the level of financing needed for our operations. If we are unable to obtain additional sufficient financing our business and results of operations will be materially harmed.

 

Even if we are able to continue to finance our business, the sale of additional equity or debt securities could result in dilution to our current shareholders and could require us to grant a security interest in our assets. If we raise additional funds through the issuance of debt securities, these securities may have rights senior to those of our Ordinary Shares and could contain covenants that could restrict our operations. In addition, we may require additional capital beyond our currently forecasted amounts to achieve profitability. Any such required additional capital may not be available on reasonable terms, or at all.

 

Global economic and macroeconomic conditions may adversely affect our operating results in a material manner.

 

Our operating businesses are subject to normal economic cycles affecting the general economy or the specific industries in which they operate. Negative conditions in the general economy, including significant inflation, rising interest rates, financial and credit market fluctuations, international trade relations, political turmoil, geopolitical conflicts such as the military conflict between Russia and Ukraine, natural catastrophes, regional or global outbreaks of contagious diseases, warfare and terrorist attacks, could cause a decrease in business investments and could produce a material adverse effect on one or more of our subsidiaries. Extreme volatility in financial markets, has adversely impacted and may continue to adversely impact our share price and our ability to access capital markets. To the extent that access to the capital markets is restricted or the cost of funding increases, our operations could be adversely affected.

 

2

 

 

Certain of our subsidiaries rely on key employees and highly skilled personnel, and, if they are unable to attract, retain or motivate qualified personnel, they may not be able to operate their business effectively.

 

The success of certain of our subsidiaries depends largely on the continued employment of their senior management and key personnel who can effectively operate its business and its ability to attract and retain skilled employees. Competition for highly skilled management, technical, research and development, and other employees is intense, and our subsidiaries may not be able to attract or retain highly qualified personnel in the future. If any of the key employees of these subsidiaries leave or are terminated, and such companies fail to manage a transition to new personnel effectively, or if they fail to attract and retain qualified and experienced professionals on acceptable terms, the business, financial condition and results of operations of these subsidiaries could be adversely affected.

 

We, and our subsidiaries, are subject to stringent and changing laws, regulations, standards, and contractual obligations related to privacy, data protection, and data security. The actual or perceived failure to comply with such obligations could harm our business.

 

Our business and our subsidiaries are or could be conducted through the internet and therefore, among other things, we are subject to the laws and regulations that apply to online businesses and platform around the world. These laws and regulations are becoming more prevalent in the United States, Europe, Israel and elsewhere and may impede the growth of the internet and consequently our services. These regulations and laws may cover privacy, data collection and protection, location of data storage and processing, cybersecurity, e-commerce, content, use of “cookies,” access changes, “net neutrality,” pricing, advertising, distribution of “spam” copyright and other intellectual property, libel, marketing, distribution of products, protection of minors, consumer protection, taxation and online payment services. Many areas of the law affecting the internet remain largely unsettled, even in areas where there has been some legislative action.

 

Our subsidiaries and we receive, collect, store, process, transfer, and use personal information and other data relating to users of our products, our employees and contractors, and other persons. We have legal and contractual obligations regarding the protection of confidentiality and appropriate use of certain data, including personal information. We are subject to numerous federal, state, local, and international laws, directives, and regulations regarding privacy, data protection, and data security and the collection, storing, sharing, use, processing, transfer, disclosure, and protection of personal information and other data, the scope of which are changing, subject to differing interpretations, and may be inconsistent among jurisdictions or conflict with other legal and regulatory requirements. We are also subject to certain contractual obligations to third parties related to privacy, data protection and data security. We strive to comply with our applicable policies and applicable laws, regulations, contractual obligations, and other legal obligations relating to privacy, data protection, and data security to the extent possible. However, the regulatory framework for privacy, data protection and data security worldwide is, and is likely to remain for the foreseeable future, uncertain and complex, and it is possible that these or other actual or alleged obligations may be interpreted and applied in a manner that we do not anticipate or that is inconsistent from one jurisdiction to another and may conflict with other legal obligations or our practices. Further, any significant change to applicable laws, regulations or industry practices regarding the collection, use, retention, security or disclosure of data, or their interpretation, or any changes regarding the manner in which the consent of users or other data subjects for the collection, use, retention or disclosure of such data must be obtained, could increase our costs and require us to modify our services and features, possibly in a material manner, which we may be unable to complete, and may limit our ability to store and process user data or develop new services and features.

 

If our subsidiaries or we were found in violation of any applicable laws or regulations relating to privacy, data protection, or security, our business may be materially and adversely affected, and we would likely have to change our business practices and potentially the services and features available through our platform. In addition, these laws and regulations could impose significant costs on us and could constrain our ability to use and process data in manners that may be commercially desirable. In addition, if a breach of data security were to occur or to be alleged to have occurred, if any violation of laws and regulations relating to privacy, data protection or data security were to be alleged, or if we had any actual or alleged defect in our safeguards or practices relating to privacy, data protection, or data security, our solutions may be perceived as less desirable, and our business, prospects, financial condition, and results of operations could be materially and adversely affected.

 

3

 

 

We also expect that there will continue to be new laws, regulations, and industry standards concerning privacy, data protection, and information security proposed and enacted in various jurisdictions. For example, the data protection landscape in the European Union (“EU”) is currently evolving, resulting in possible significant operational costs for internal compliance and risks to our business. The EU adopted the General Data Protection Regulation or GDPR, which contains numerous requirements and changes from previously existing EU laws, including more robust obligations on data controllers and processors and heavier documentation requirements for data protection compliance programs by companies. Among other requirements, the GDPR regulates the transfer of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States.

 

In addition to the GDPR, we are also subject to evolving laws and regulations on cookies, tracking technologies, including the Directive 2002/58 on Privacy and Electronic Communications Regulation, “PECR” and the Privacy and Electronic Communications (EC Directive) Regulations 2003, “ePrivacy Directive”. Informed and freely given consent is required for the placement of non- essential cookies and similar technologies on devices and website users. The GDPR and UK regime also impose conditions on obtaining valid consent for cookies, such as a prohibition on pre-checked consents and a requirement to ensure separate consents are sought for each type of cookie or similar technology. Recent European court and regulatory decisions are driving increased attention to cookies and tracking technologies, which could lead to substantial costs, require significant system changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities.

 

In addition, the U.K.’s General Data Protection Regulation (the “UK GDPR”), imposes robust obligations for the collection, control, use, sharing, disclosure and other processing of personal data and contains documentation and accountability requirements for data protection compliance. . Both the GDPR and the UK GDPR expose us to similar regimes, each of which includes similar fines and may subject us to increased compliance risk based on differing, and potentially inconsistent or conflicting interpretation and enforcement by regulators and authorities (particularly, if the laws are amended in the future in divergent ways). Failure to comply with these obligations can result in significant fines and other liability under applicable law. In particular, under the GDPR, fines of up to EUR 20 million (or GBP 17.5 million under the UK GDPR) or up to 4% of the annual global revenue of the noncompliant company, whichever is greater, could be imposed for violations of certain of the GDPR’s requirements. The GDPR and UK GDPR requirements apply not only to third-party transactions, but also to transfers of data between us and our subsidiaries, including employee data. Because our services are accessible worldwide, certain foreign jurisdictions may claim that we are required to comply with their laws, including in jurisdictions where we have no presence, local entity, employees or infrastructure.

 

On November 1, 2022, the Digital Markets Act, (the “DMA”), entered into force and on November 16, 2022, the Digital Services Act (the “DSA”), followed. For the DSA, most provisions became applicable on February 17, 2024. The DSA and the DMA focus on creating a safer digital space, protecting fundamental rights of all users of digital services, and establishing a level playing field for businesses and consumers with regards to online platforms. As further guidance is issued and interpretation of both the DSA and the DMA evolves, it is difficult to assess the impact of the DSA and DMA on our and our subsidiaries’ business or operations, but, to the extent applicable, it may require us to modify our practices and policies and we could incur substantial costs as a result.

 

Additionally, legal developments in Europe in recent years, have created complexity and uncertainty regarding transfers of personal data from the EEA to the United States. On June 27, 2021, following a decision by the Court of Justice of the European Union (“CJEU”),the European Commission published a new set of modular standard contractual clauses (the “New SCCs”). The New SCCs must be used for all relevant transfers of personal data outside the EEA (since December 27, 2022) and organizations must ensure that all new and existing contracts involving the transfer of personal data outside the EEA contain New SCCs and, for transfers out of the UK, the International Data Transfer Agreement (“IDTA”) or the UK Addendum to the New SCCs. Contracts involving data processing which are based on the old EU SCCs and concluded on or before September 21, 2022, continued to provide appropriate safeguards under the UK GDPR until March 21, 2024. In addition to the use of a valid data transfer mechanism, transfer impact assessments to evaluate the legal regime applicable in the destination country, in particular applicable surveillance laws and rights of individuals may have to be carried out in respect of planned transfers of personal data from the EEA/UK to third countries including the U.S., and failure to do so may expose us to further compliance risk. However, the nature of these additional measures is currently uncertain. Additionally, recent legal developments in the EU have created complexity and uncertainty regarding transfers of personal data from the EU to the United States and other non-adequate jurisdictions. The EU-U.S. Data Privacy Framework (EU-U.S. DPF), the UK Extension to the EU-U.S. Data Privacy Framework (UK Extension to the EU-U.S. DPF), and the Swiss-U.S. Data Privacy Framework (Swiss-U.S. DPF) were implemented to facilitate cross-border transfers to the United States from the European Union / European Economic Area, the United Kingdom (and Gibraltar), and Switzerland that are consistent with EU, UK, and Swiss law. On July 10, 2023, the European Commission adopted its adequacy decision for the EU-U.S. DPF. The adequacy decision means that participating organizations are deemed to provide “adequate” data protection (i.e., privacy protection), a requirement (subject to limited derogations) for the transfer of personal data from the EU to US companies participating in the EU-U.S. DPF. On October 12, 2023, the UK Extension to the EU-U.S. DPF, known as the UK-US Data Bridge, took effect, allowing the transfers of personal data from the United Kingdom (UK) to the US without the need of having additional mechanism or safeguards in place.

 

4

 

 

Further, the European Commission regularly re-examines its adequacy decisions, including its Decision 2011/61/EU regarding the adequacy of Israeli law. On January 15, 2024, the European Commission successfully concluded its review of 11 existing adequacy decisions. These decisions had been adopted under the EU data protection legislation that preceded the GDPR. The European Commission finds that personal data transferred from the European Union to Andorra, Argentina, Canada, Faroe Islands, Guernsey, the Isle of Man, Israel, Jersey, New Zealand, Switzerland and Uruguay, continues to benefit from adequate data protection safeguards. Therefore, the adequacy decisions adopted for these eleven countries and territories remain in place and data can continue to flow freely to these jurisdictions. In addition, while the European Commission adopted an adequacy decision for the UK on June 28, 2021, allowing the continued flow of personal data from the EEA to the UK, this decision will automatically expire in June 2025 unless the European Commission re-assesses and renews or extends that decision. The decision will be regularly reviewed by the European Commission going forward and may be revoked if the UK diverges from its current data protection laws and the European Commission deems the UK to no longer provide adequate protection of personal data. Additionally, on January 15, 2024, the European Commission announced its decision according to which Israel continues to provide an adequate level of protection for personal data transferred from the EU.

 

Additionally, in June 2018, California passed the California Consumer Privacy Act, or CCPA, which provides new data privacy rights for California consumers and new operational requirements for covered companies. Specifically, the CCPA provides that covered companies must provide new disclosures to California consumers and afford such consumers new data privacy rights that include the right to request a copy from a covered company of the personal information collected about them, the right to request deletion of such personal information, and the right to request to opt-out of certain sales of such personal information. The California Attorney General can enforce the CCPA, including seeking an injunction and civil penalties for violations. The CCPA also provides a private right of action for certain data breaches expected to increase data breach litigation. The CCPA may require us to modify our data practices and policies and to incur substantial costs and expenses in order to comply. On November 3, 2020, California voters passed the California Privacy Rights Act into law, which took effect in January 2023 and significantly expands the CCPA, including by introducing additional obligations such as data minimization and storage limitations, granting additional rights to consumers. The CCPA may increase our compliance costs and potential liability. More generally, some observers have noted that the CCPA could mark the beginning of a trend toward more stringent United States state and federal privacy legislations as observed with the subsequent adoption of state-level comprehensive consumer privacy legislation, which could increase our potential liability and adversely affect our business. For example, Connecticut, Virginia, Colorado and Utah each has enacted legislation similar to the CCPA that took effect in 2023; Florida, Montana, Oregon, and Texas each has enacted similar legislation that took effect in 2024; Tennessee, Iowa, Delaware, New Hampshire, New Jersey, Maryland, Minnesota, and Nebraska each has enacted similar legislation that have taken, or will take, effect in 2025; and Indiana, Kentucky, and Rhode Island each has enacted similar legislation that will become effective in 2026

 

In many respects, these state laws focus on advertising activities, mandating that businesses that engage in certain advertising uses of consumer personal data to offer and honor an opt-out of such activities, including, in some states, through browser or device-based preference signals. These state privacy laws also provide consumers other rights, such as to access, correct or delete their personal data (subject to certain limitations), opt out of certain processing of their personal data, and impose special rules on the collection of data from minors, as well as transparency and data governance obligations. Four US states (Vermont, California, Texas, and Oregon) have enacted data broker laws and regulations imposing certain requirements on data brokers, including, without limitation, regarding registration, consent requirements, disclosure limitations, and/or data security Additionally, new state privacy laws (including, privacy laws, social media regulations, children online data laws and data broker laws) are expected to become effective in 2025, including privacy laws in Tennessee, Minnesota and Maryland , and additional states are expected to follow in future years. There are also a number of legislative proposals pending before the U.S. Congress and various state legislative bodies concerning various data protection topics, including, privacy, children data, data brokers, which could affect us. Moreover, several federal laws have been enacted, for example, the Children’s Online Privacy Protection Rule (“COPPA”) that restricts online service providers’ collection of user data on minors as well as distribution of materials deemed harmful to minors. Furthermore, the Controlling the Assault of Non-Solicited Pornography and Marketing (“CAN-SPAM”) Act and the Federal Trade Commission (“FTC”) Act could also be applicable to some of our activities. In addition, the FTC has increasingly issued orders restricting data brokers from selling certain location data obtained by tracking individual’s mobile devices. Other countries and jurisdictions may enact similar or related laws or regulations, and/or their authorities may reach similar decisions. These laws, regulations and decisions could impact our services, business operations, practices, products, or our ability to receive information necessary to conduct our business.

 

5

 

 

The abovementioned laws, regulations and decisions could impact our services, business operations, practices, products, or our ability to receive information necessary to conduct our business.

 

In addition, failure to comply with the Israeli Privacy Protection Law 5741-1981, and its regulations as well as the guidelines of the Israeli Privacy Protection Authority, may expose us to administrative fines, civil claims (including class actions), and in certain cases, criminal liability. Furthermore, on August 5, 2024, the Israeli parliament approved Amendment 13 to the Israeli Privacy Protection Law 1981, which will come into effect on August 14, 2025 (“Amendment”). This Amendment enhances data security requirements, expands enforcement powers for the Privacy Protection Authority, introduces guidance for data transfers and imposes additional obligations on organizations handling personal data. The consequences of implementing the requirements under the Amendment could lead to substantial costs, require significant system changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities.

 

In addition, there have also been privacy bills enacted in other countries around the world, such as Brazil, which have introduced new or expanded privacy requirements and we expect that privacy legislation will continue to evolve in the coming years. Therefore, it is difficult to determine whether and how such existing laws and regulations will apply to and impact the internet and our business.

 

We rely on information technology systems to operate and manage our business and to process, maintain, and safeguard information, including information related to our customers, partners, and personnel. This information is stored and managed within our internal information technology infrastructure or, in certain instances, on platforms maintained by third-party service providers. These systems, whether operated internally or externally, may be subject to breaches, failures, or disruptions as a result of, among other things, cyber-attacks, computer viruses, physical security breaches, natural disasters, accidents, power disruptions, telecommunications failures, new system implementations, or acts of terrorism or war. In the current environment, there are numerous and evolving risks to cybersecurity, data and privacy, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, employee malfeasance and human or technological error. High-profile security breaches at other companies and in government agencies have increased in frequency and sophistication in recent years. Moreover, geopolitical tensions, particularly the Hamas-Israel and the Russia-Ukraine conflicts, have contributed to a surge in cyber-attacks targeting Israeli companies and products globally, posing a threat to critical infrastructure. We have experienced and expect to continue to experience actual and attempted cyber-attacks of our IT networks and systems, such as through phishing scams and ransomware. Although none of these actual or attempted cyber-attacks has yet had a material adverse impact on our operations, financial condition, or reputation, we cannot guarantee that such incidents will not have such an impact in the future.

 

Any failure or perceived failure by our subsidiaries or by us to comply with our posted privacy policies, our privacy-related obligations to users or other third parties, or any other legal obligations or regulatory requirements relating to privacy, data protection, or data security may result in governmental investigations or enforcement actions, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, other obligations, and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for, our platform. Additionally, if third parties we work with violate applicable laws, regulations, or contractual obligations, such violations may put our users’ data at risk, could result in governmental investigations or enforcement actions, fines, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect our reputation and business. Further, public scrutiny of, or complaints about, technology companies or their data handling or data protection practices, even if unrelated to our business, industry, or operations, may lead to increased scrutiny of technology companies, including us, and may cause government agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.

 

6

 

 

While it is generally the laws of the jurisdiction in which our business is located apply, there is a risk that data protection regulators of other countries may seek jurisdiction over our remote activities in locations in which we process data of our customers, but do not have an operating entity. Where the local data protection and privacy laws of a jurisdiction apply, we may be required to register our operations in that jurisdiction or make changes to our business so that personal data is only collected and processed in accordance with applicable local law. In addition, because our services are accessible worldwide, certain foreign jurisdictions may claim that we are required to comply with their privacy and data protection laws, including in jurisdictions where we have no local entity, employees, or infrastructure. In such cases, we may require additional legal review and resources to ensure compliance with any applicable privacy or data protection laws and regulations. In addition, in many jurisdictions there may in the future be new legislation that may affect our business and require additional legal review. Additionally, if third parties we work with violate applicable laws, regulations, or contractual obligations, such violations may put our users’ data at risk, could result in governmental investigations or enforcement actions, fines, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect our reputation and business. Further, public scrutiny of, or complaints about, technology companies or their data handling or data protection practices, even if unrelated to our business, industry, or operations, may lead to increased scrutiny of technology companies, including us, and may cause government agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.

 

Due to rapid changes in technology and the inconsistent interpretations of privacy and data collection and protection laws and regulations, we may be required to materially change the way we conduct business. The challenges imposed by the ongoing need to remain compliant with such laws and regulations, as well the need to implement any changes required based on newly introduced laws and regulations, may slow our growth, and if we are not able to cope with these challenges as effectively as other companies, we will be competitively disadvantaged. Any limitation on our ability to collect and utilize data, including personal data, would make it more difficult for us to be able to optimize sales, which could render our solutions less valuable and potentially result in loss of revenue.

 

Risks Related to Gix Internet’s Business and Industry

 

Gix Internet’s success depends, in part, upon the continued demand of digital advertising as an integral part of corporate marketing and internal communications plans and the continued growth and acceptance of digital content as effective alternatives to traditional offline marketing products and services.

 

Gix Internet provides digital advertising platforms. Its revenues are derived from the sale of its platforms. If the demand for digital advertising does not continue to grow or customers do not embrace its platforms, this could have a material adverse effect on its business and financial condition.

 

Gix Internet’s success also depends, in part, on its ability to compete for a share of available advertising/marketing expenditures as more traditional offline and emerging media companies continue to enter the digital advertising market, as well as on the continued growth and acceptance of digital advertising generally. If for any reason digital advertising is not perceived as effective (relative to traditional advertising), web browsers, software programs and/or other applications that limit or prevent advertising from being displayed become commonplace and/or the industry fails to effectively manage click fraud, the market for digital advertising will be negatively impacted. Any lack of growth in the market for digital advertising could adversely affect its business, financial condition, and results of operations.

 

Online platform updates, including operating systems, search engines, browsers and social media might affect Gix Internet’s ability to generate revenues, temporarily or permanently.

 

Gix Internet complies with certain guidelines promulgated by online platforms for the use of the respective brands and services. Online platforms may unilaterally update their policies and guidelines, which could, in turn, require modifications to, or prohibit and/or render obsolete certain of its advertising solutions, products, services and practices, which could be costly to address or otherwise have an adverse effect on its business, its financial condition and results of operations. Noncompliance with platforms’ guidelines, whether by it or by third parties it works with, if not cured, could result in such online platforms’ suspension of some or all of their services to it, or to the websites of third parties it works with, or the reimbursement of funds paid to it, or the imposition of additional restrictions on our advertising abilities or the termination of certain advertising agreements with its customers.

 

7

 

 

Should the providers of internet browsers, advertisement platforms and Search Engines further regulate, constrain or limit Gix Internet’s ability to offer advertising services, or materially change their guidelines, technology or the way they operate, its ability to generate revenue from advertising could be significantly reduced.

 

As Gix Internet provides its services through the internet, it’s reliant on its ability to work with the different internet browsers, search engines and advertisement platforms. If Microsoft, Google, Apple, Meta or other companies that provide internet browsers, advertisement platforms and search engines, effectively further restrict, discourage or otherwise hamper companies, like Gix Internet, from offering or advertising services, this would continue to cause a material adverse effect on its revenue and its financial results.

 

Large and established internet and technology companies, such as Google and Meta, play a substantial role in the digital advertising market and may significantly impair Gix Internet’s ability to operate in this industry.

 

Google and Meta are substantial players in the digital advertising market and account for a large portion of the digital advertising budgets, along with other smaller players. Such high concentration subjects Gix Internet to unilateral changes with respect to advertising on their respective platforms, which may be more lucrative than alternative methods of advertising or partnerships with other publishers that are not subject to such changes. Furthermore, Gix Internet could have limited ability to respond to, and adjust for, changes implemented by such players.

 

These companies, along with other large and established Internet and technology companies, may also leverage their power to make changes to their web browsers, operating systems, platforms, networks or other products or services in a way that impacts the entire digital advertising marketplace.

 

The use of third-party software solutions for the purpose of blocking ads and / or alerts may cause Gix Internet’s business to suffer.

 

Digital advertising may be blocked by third-party providers. As a result, Gix Internet may lose both existing and potential new customers and its ability to generate revenue will be negatively impacted.

 

Gix Internet depends on supply sources to provide it with an advertising inventory in order for it to deliver advertising campaigns in a cost-effective manner.

 

Gix Internet relies on a diverse set of publishers including direct publishers, advertising exchange platforms, social networks and other platforms, that aggregate advertising inventory, to provide it with high-quality digital advertising inventory on which it delivers ads, collectively referred to as “supply sources”. The future growth of Gix Internet’s advertising business will depend, in part, on its ability to maintain, expand and further develop successful business relationships in order to increase the network of its supply sources.

 

Gix Internet’s supply sources typically make their advertising inventory available to it on a non-exclusive basis and are not required to provide any minimum amounts of advertising inventory to it or to provide it with a consistent supply of advertising inventory, at any predetermined price or through real time bidding. Supply sources often maintain relationships with various sources of demand that compete with Gix Internet, and it is easy for supply sources to quickly shift their advertising inventory among these demand sources, or to shift inventory to new demand sources, without notice or accountability. Supply sources may also seek to change the terms at which they offer inventory to Gix Internet, or they may allocate their advertising inventory to its competitors who offer more favorable economic terms, better solutions and advanced technology. Supply sources may also elect to sell all, or a portion, of their advertising inventory directly to advertisers and agencies, or they may develop their own competitive offerings, which could diminish the demand for Gix Internet’s solutions. In addition, significant supply sources within the industry may enter into exclusivity arrangements with Gix Internet’s competitors, which could limit its access to a meaningful supply of inventory. As a result of all of these factors, Gix Internet’s supply sources may not supply it with sufficient amounts of high-quality digital advertising inventory in order for it to fulfill the demands of its advertising customers.

 

Because of these factors, Gix Internet seeks to expand and diversify its supply sources; nonetheless, if its supply sources terminate or reduce its access to their advertising inventory, increase the price of inventory or place significant restrictions on the sale of their advertising inventory, or if platforms or exchanges terminate its access to them and it is unsuccessful in establishing or maintaining its relationships with supply sources on commercially reasonable terms, it may not be able to replace this with inventory from other supply sources that satisfy its requirements in a timely and cost-effective manner. If any of these happens, Gix Internet’s revenue could decline or its cost of acquiring inventory could increase, which, in turn, could lower its operating margins and materially adversely affect its advertising business.

 

8

 

 

Reliance upon Gix Internet’s top customers may adversely affect its revenue and operating results.

 

Gix Internet’s main customers represented approximately 36% and 28% of its consolidated revenue for the years ended December 31, 2024, and 2023, respectively on a pro forma basis. It is likely that Gix Internet will depend on a relatively small number of customers for a significant portion of its revenue in the future. If a top customer fails to pay Gix Internet, cash flow from operations would be impacted and its operating results and financial condition could be harmed. Additionally, if Gix Internet were to lose a material customer, it may not be able to offer its services at similar utilization or pricing levels and such loss could have an adverse effect on its business until the services are offered at similar utilization or pricing levels.

 

Reliance upon material suppliers may adversely affect Gix Internet’s revenue and operating results.

 

Gix Internet is dependent on certain material suppliers and service providers for some of the services it renders. In certain cases, Gix Internet relies on a single supplier and/or service provider for the services it offers its customers. In most cases Gix Internet does not have long term contracts with these suppliers, and even in the cases where it does, the contracts include significant qualifications that would make it extremely difficult for it to force the supplier or service provider to provide it with their services, should they choose not to do so. Gix Internet is therefore subject to the risk that these third-parties it works with will not be able or willing to continue to provide it with services that meet its specifications, quality standards and delivery schedules. Factors that could impact these third parties’ willingness and ability to continue to provide Gix Internet with the required services include disruption at or affecting their facilities, such as work stoppages or natural disasters, adverse weather or other conditions that affect their supply, their financial conditions and/or deterioration in its relationships with these third parties. In addition, Gix Internet cannot be sure that it will be able procure the services its needs on satisfactory terms. Any increase in costs could reduce Gix Internet’s revenues and harm its gross margins. In addition, any loss of a material supplier and / or service provider may permanently cause a change in one or more of Gix Internet’s services that may not be accepted by its customers or cause it to eliminate that product altogether.

 

Gix Internet may not be able to receive credit facility to fund its operations on favorable terms, if at all.

 

Gix Internet generally finances its operations primarily through a combination of cash flow generated from operations and borrowings under its credit facilities, loans, and through credit with its vendors. Gix Internet’s ability to access capital through its existing credit facilities and raise additional capital by expanding its credit facilities on economically favorable terms (including available borrowing line and the rate of interest charged thereunder) or at all, or if it is in violation of its financial covenants in the future and does not receive a waiver, depends on its ability to stay in compliance with a financing agreement, which imposes certain limitations. In addition, and as a result of the decrease in its revenues, Gix Internet’s financial performance has been negatively impacted, which may affect the terms on which it is able to obtain credit facilities and loans.

 

If adequate capital is not available at the time Gix Internet needs it, it may have to curtail future growth or change its expansion plans, which could have a material adverse effect on it.

 

If borrowing under Gix Internet’s existing credit facilities is reduced, or otherwise becomes unavailable, or it is unable to arrange substitute financing facilities or other sources of capital, its ability to fund its operations would be impaired, which would have a material adverse effect on its results of operations.

 

9

 

 

Gix Internet may be unable to pay its obligations when they become due

 

Gix Internet has financed its acquisitions principally through the raising of debt, credit facilities, and its operations through credit with our vendors. Its ability to continue its operations and to pay its obligations, including under a financing agreement with Bank Leumi Le Israel Ltd  (the “Financing Agreement”) and credit facilities, when they become due is contingent upon obtaining additional financing.

 

In addition, during August 2024, Gix Internet renegotiated the terms of the Financing Agreement and entered into the Fourth Addendum to the Financing Agreement. The availability of the credit facilities is subject to Gix Internet successfully raising additional capital and depositing at least $2,000,000 with Gix Media. If Gix Internet and certain of its subsidiaries cannot maintain compliance with the terms and covenant of the Financing Agreement, or if we are unable to obtain sufficient amounts of additional capital, we may be required to reduce the scope of our planned operations, and/or consider reductions in personnel costs or other operating costs, in addition to the measures currently contemplated pursuant to the Financing Agreement.

 

Certain of Gix Internet’s subsidiaries have signed amendments to the existing loan agreements with a banking corporation (the “Banking Corporation”), according to which the current loan payments of Gix Media Ltd. (“Gix Media”) will be deferred and the short-term credit lines with the banking corporation will be extended. If the Banking Corporation does not agree to a further update of the repayment schedule, and in addition, Gix Media fails to raise additional capital and, as a result, is unable to repay the loans according to the revised schedule, the Banking Corporation may demand immediate repayment of all loans it has provided to Gix Media. Furthermore, failure by certain subsidiaries to meet financial covenants related to loan agreements, some of which are beyond the Gix Internet’s control, may lead to the loans being called for immediate repayment and/or the realization of securities provided by the subsidiaries. In addition, Gix Internet and its subsidiaries have cash flow obligations to various suppliers, and a lack of sufficient funding sources may result in non-compliance with these obligations. In the event of payment defaults to suppliers, additional financial pressure may arise, which could adversely affect Gix Internet’s ongoing business operations. This situation could lead to demands for immediate payments, restrictions on credit lines, and even legal proceedings by suppliers with whom Gix Internet is unable to meet payment terms.

 

Gix Internet and its subsidiaries finance their operations primarily through cash flows from ongoing activities, credit facilities, private placements, loans, and supplier credit. The ability to raise additional capital or expand credit facilities depends on compliance with the terms of the financing agreements, which impose certain restrictions. In addition, the decline in Gix Internet’s and it subsidiaries’ revenues has affected their financial performance, which may impact the terms for obtaining credit and loans. If sufficient capital is not available, Gix Internet and its subsidiaries may be unable to meet their obligations to banking corporations and suppliers, and may also need to reduce its future growth or alter its expansion plans, which could adversely affect its results. Furthermore, Gix Internet and its subsidiaries plan to raise capital during 2025 in order to meet the conditions of a share purchase transaction and to strengthen the Gix Internet’s financial structure, including by reducing debt to the banking system and complying with the loan agreements with the banking system.

 

Gix Internet’s success is dependent on the preferences of consumers, internet users and advertisers.

 

Gix Internet’s services rely on the digital devices used by consumers and users. To the extent that users change their consumption habits, or to the extent that traffic does not grow, its activities may decrease and its business operations could be harmed.

 

A change in advertisers’ preferences could also affect Gix Internet’s operations. Advertisers may change their preferences relating to their willingness to work with certain technologies and certain advertising platforms, which could reduce Gix Internet’s activities and harm its business operations.

 

Gix Internet may not be able to retain and attract programmatic advertisers, and the associated payments received from such programmatic advertisers’ ads on websites which have been categorized as “Made for Advertising” may be adversely affected.

 

Certain recent developments relating to publishers that are categorized by a number of programmatic advertisers as “Made for Advertising” (MFA) sites, including decisions made by leading media programmatic advertisers to prioritize different media categories and implement publishing restrictions in connection with MFA, have negatively impacted one of Gix Internet’s subsidiaries (the “Subsidiary”) business and operations. In connection with the foregoing, a significant customer of the Subsidiary has decided to stop advertising on the Subsidiary’s sites. Additional advertising customers of the Subsidiary may opt to stop advertising on the Subsidiary’s sites, which will impact the Subsidiary’s, and as a result thereof, the Gix Internet’s current and future revenue streams and results of operations. The foregoing issues could lead to decreased advertiser interest in the Subsidiary’s sites, potentially resulting in lower bids for ad space, and as a result thereof, lower revenues from the Subsidiary’s business, and decrease in the Subsidiary’s results of operations.

 

A loss of the services of Gix Internet’s technology vendors could adversely affect the execution of its business strategy.

 

Should some of Gix Internet’s technology vendors terminate their relationship with Gix Internet, Gix Internet’s ability to continue the development of some of its platforms could be adversely affected, until such time that Gix Internet finds adequate replacement for these vendors, or until such time that it can continue the development on its own.

 

10

 

 

The report of Gix Internet’s independent registered public accounting firm contains an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern, which could prevent it from obtaining new financing on reasonable terms or at all.

 

The report of Gix Internet’s independent registered public accounting firm on its audited consolidated financial statements for the year ended December 31, 2024, contains an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern. Gix Internet’s audited consolidated financial statements do not include any adjustments that might result from the outcome of the uncertainty regarding its ability to continue as a going concern. This going concern opinion could materially limit Gix Internet’s ability to raise additional funds through the issuance of equity or debt securities or otherwise. Further reports on Gix Internet’s consolidated financial statements may include an explanatory paragraph with respect to its ability to continue as a going concern. Until Gix Internet’s can generate significant recurring cash flow, Gix Internet expects to satisfy its future cash needs through debt or equity financing. Gix Internet cannot be certain that additional funding will be available to it on acceptable terms, if at all. If funds are not available, Gix Internet may be required to delay or reduce the scope of its operations.

 

Risks Related to Gix Internet’s Competition

 

Gix Internet’s implementation and use of artificial intelligence technologies may not be successful, which may impair its ability to compete effectively, result in reputational harm and have an adverse effect on its business.

 

Gix Internet uses artificial intelligence technologies (“AI”) throughout its business and continuously attempts to improve its use of such technologies. For example, Gix Internet uses AI to translate articles from English into multiple languages on its content platform. As with many technological innovations, there are significant risks and challenges involved in developing, maintaining, and deploying these technologies and there can be no assurance that the usage of such technologies will always enhance Gix Internet’s products or services or be beneficial to its business, including to its efficiency or profitability. In addition, the market for AI is rapidly evolving and remains unproven in many industries, including Gix Internet’s own. Gix Internet cannot ensure that the market will continue to grow or that it will grow in the manner it anticipates.

 

Gix Internet is currently in various stages of development of its AI systems, and it may not be successful in such development in the face of novel and evolving technical, reputational and market factors. The development, maintenance and operation of Gix Internet’s artificial intelligence technologies are expensive and complex, and may involve unforeseen difficulties including material performance problems, undetected defects, or errors. Furthermore, Gix Internet uses third-party AI technologies or software, which may introduce significant risks to its cybersecurity as these could spread vulnerabilities, defects viruses, ransomware, or malware through our products and/or services across its supply chain and operations. Gix Internet may encounter technical obstacles, and it is possible that it may discover additional problems that may prevent its technologies from operating properly, which could adversely affect its business, customer relationships and reputation.

 

Gix Internet faces significant competition from other companies in its industry in relation to the development and deployment of AI. Those other companies may develop AI technologies that are similar or superior to Gix Internet’s and/or are more cost-effective and/or quicker to develop and deploy. If Gix Internet cannot develop, offer, or deploy new AI technologies as effectively, as quickly and/or as cost-efficiently as its competitors, Gix Internet could experience a material adverse effect on its operating results of operation, customer relationships and growth.

 

11

 

 

Gix Internet may not be able to protect its systems, technology, and infrastructure from cyberattacks.

 

Gix Internet relies on information technology systems to operate and manage its business and to process, maintain, and safeguard information, including information related to its customers, partners, and personnel. This information is stored and managed within its internal information technology infrastructure or, in certain instances, on platforms maintained by third-party service providers. These systems, whether operated internally or externally, may be subject to attacks by perpetrators of malicious technology-related events, such as the use of botnets, malware or other destructive or disruptive software, distributed denial of service attacks, phishing, attempts to misappropriate user information and other similar malicious activities. The incidence of events of this nature (or any combination thereof) is on the rise worldwide. Since the beginning of the war between Israel and Hamas which began on October 7, 2023, Israeli and Israeli associated companies have become more frequent targets of cyberattacks. As such, the risk of a cyberattack against Gix Internet’s platforms may become heightened. While Gix Internet continuously develops and maintains systems designed to detect and prevent events of this nature from impacting its platforms, Gix Internet has invested and continues to invest in these efforts. These efforts are costly and require ongoing monitoring and updating as technologies change and efforts to overcome preventative security measures become more sophisticated.

 

Any event of this nature that Gix Internet experiences could damage its systems, technology, or infrastructure, prevent Gix Internet from providing its services, compromise the integrity of its services, damage its reputation and/or be costly to remedy, as well as subject Gix Internet to investigations by regulatory authorities, fines and/or litigation that could result in liability to third parties.

 

As the regulatory framework for AI evolves, including with respect to unintentional bias and discrimination, Gix Internet’s business, financial condition, and results of operations may be adversely affected.

 

Gix Internet’s business increasingly relies on artificial intelligence technologies. The regulatory framework for this technology is rapidly evolving, and Gix Internet may not always be able to anticipate how to respond to these laws or regulations. Many federal, state, and foreign government bodies and agencies have introduced or are currently considering additional laws and regulations governing the use of such technologies. There is also an increase in litigation in a number of jurisdictions, including the United States, relating to the development, security and use of artificial intelligence.

 

For example, in October 2023, President Biden issued the Executive Order on Safe, Secure and Trustworthy Artificial Intelligence (“The Order”) with the goal of promoting the “safe, secure, and trustworthy development and use of artificial intelligence in the United States.” The Order has established certain new standards for the training, testing and cybersecurity of sophisticated artificial intelligence models, and the Order has also instructed other federal agencies to promulgate additional regulations within certain timeframes from the date of the Order. Federal artificial intelligence legislation has also been introduced in the U.S. Senate. Such additional regulations may impact Gix Internet’s ability to develop, use and commercialize artificial intelligence and machine learning technologies in the future.

 

It is possible that the US artificial intelligence framework, along with the adoption of new laws and regulations in other jurisdictions, or the interpretation of existing laws and regulations, may affect the operation of Gix Internet’s platforms and services and the way in which it uses artificial intelligence, including with respect to how it trains its models, unintentional bias and discrimination. Failure to comply with such laws or regulations could subject Gix Internet to legal or regulatory liability. Further, the cost of complying with such laws or regulations could be significant and would increase Gix Internet operating expenses, which could adversely affect its business, financial condition and results of operations.

 

12

 

 

Risks Related to Eventer’s Business

 

If Eventer is unable to maintain and enhance the quality of its platform and user experience, its business, financial condition, and results of operations could be adversely affected.

 

Eventer’s success depends on its ability to maintain and enhance its platform to attract clients managing online and offline events or facilitating ticket sales. To meet evolving user expectations, Eventer must continuously improve user experience, innovate, and introduce features that resonate with event managers and ticket purchasers alike. This requires significant investment in research and development, along with rapid adaptation to shifting user preferences. In addition, the usability, performance, and reliability of Eventer’s platform are critical to ensuring user satisfaction. Should Eventer encounter difficulties in implementing new technologies or integrating emerging trends in event management, it could adversely affect its competitive position. The complexity of maintaining and updating the platform, combined with the challenge of timely feature releases, makes it difficult to predict and address potential technical issues. Prolonged downtimes, bugs, or security vulnerabilities could damage user trust and brand reputation, leading to reduced engagement and financial losses. Additionally, if Eventer fails to anticipate industry changes or user demands, it may lose market relevance, impacting its growth and profitability. As the market continues to evolve, Eventer must proactively innovate to differentiate itself from competitors by offering unique functionalities and superior user experiences. Failure to achieve this may result in diminished brand value and customer loyalty, leading to a potential decline in revenue.

 

If Eventer is unable to respond to changing public preferences and secure a consistent supply of popular events, its business, growth, and financial results could be negatively impacted.

 

Eventer operates in an industry highly sensitive to public tastes and preferences. Its success hinges on securing popular artists and live events that resonate with consumers. As Eventer relies on third parties for event creation and performance, any shortage of popular artists or events could limit revenue opportunities. The platform’s effectiveness also depends on its ability to adapt to shifting entertainment trends, such as the rise of virtual events or hybrid experiences. If Eventer fails to incorporate these trends into its service offerings, it risks losing audience engagement. Changes in public preferences, economic conditions, or reduced touring frequency by artists may also impact attendance and revenue, thereby affecting Eventer’s financial performance. Furthermore, social media influence and digital marketing dynamics play a pivotal role in shaping event demand. If Eventer is unable to leverage digital channels effectively, it could hinder its growth prospects. Additionally, consumer behaviors and preferences are increasingly influenced by technological advancements, including virtual reality, augmented reality, and personalized event experiences. Eventer must stay at the forefront of these trends to remain relevant.

 

If Eventer is unable to compete effectively in the highly competitive event management and ticketing industry, its market share, revenue, and profitability could be adversely affected

 

Eventer faces intense competition in both online and offline event management and ticketing. Competitors compete for artist relationships, technological advancements, and market share. Some competitors may engage in aggressive pricing, extensive marketing, or rapid technological development, potentially impacting Eventer’s revenue. Additionally, competition from self-ticketing systems poses a threat as clients may choose to integrate these solutions into their operations, impacting Eventer’s market share and financial results. The emergence of new entrants with innovative solutions or superior technology could further intensify competition. To remain competitive, Eventer must invest in advanced technologies, including data analytics, AI-driven marketing, and seamless user experiences. Failure to do so could result in Eventer losing competitive ground. The competitive landscape is also influenced by strategic alliances and partnerships, which competitors may leverage to expand their reach and market dominance. Eventer must remain vigilant in monitoring these market dynamics to sustain its competitive position.

 

13

 

 

If Eventer fails to provide high-quality customer service and maintain a strong brand reputation, its ability to attract and retain users, as well as its financial performance, could be adversely affected

 

High-quality customer service is crucial for Eventer to maintain its brand reputation and client satisfaction. Inadequate support or platform issues could lead to negative user experiences, harming brand loyalty and impacting financial outcomes. Failure to provide reliable customer support could make the platform less attractive to potential users. Eventer’s ability to respond to customer feedback, resolve technical issues promptly, and offer personalized assistance is vital for retaining user trust. Poor customer experiences could result in negative reviews, diminishing Eventer’s brand value and influencing user acquisition and retention rates. In addition, as customer expectations continue to evolve, Eventer must ensure that its customer service capabilities are scalable and adaptable to different cultural and geographical preferences.

 

If Eventer experiences technological failures, system vulnerabilities, or disruptions in third-party infrastructure, its operations, reputation, and financial results could be negatively impacted

 

Eventer relies on complex systems and third-party infrastructure to deliver its services. System interruptions, security breaches, or technological failures, whether due to natural disasters, cyberattacks, or human error, could disrupt operations, resulting in financial loss and reputational damage. Although Eventer invests in security measures and disaster recovery planning, unforeseen disruptions could adversely affect its business operations and customer trust. Moreover, as technology evolves, Eventer must consistently upgrade its infrastructure to ensure compatibility, scalability, and security. Failure to do so could result in system inefficiencies, slow performance, or security vulnerabilities. Additionally, reliance on third-party technology providers poses risks related to vendor reliability and service continuity, which Eventer must carefully manage.

 

If adverse economic conditions reduce consumer and corporate spending, Eventer’s revenue, profitability, and financial stability could be adversely affected

 

Eventer’s business relies heavily on discretionary consumer and corporate spending. Economic downturns, inflation, unemployment, and geopolitical instability, including the ongoing conflicts in the Middle East, could reduce demand for events, negatively impacting Eventer’s revenue. Additionally, changes in tax rates, interest rates, and other economic variables can influence consumer behavior, impacting ticket sales and overall business performance. Eventer must continually assess economic indicators to adjust its marketing strategies and pricing models accordingly. Additionally, shifts in global economic trends, including changes in foreign exchange rates, could influence Eventer’s profitability and financial stability.

 

If Eventer’s platform experiences errors, defects, or disruptions, its reputation, user confidence, and financial performance could be materially and adversely affected

 

Errors, defects, or disruptions within Eventer’s platform could negatively impact its brand, subject it to liability, and materially affect its business, financial condition, and operational results. Any system performance issues, including bugs or glitches, could harm Eventer’s reputation and disrupt the activities of artists and clients using its platform. Eventer’s online systems, including its website and mobile applications, may contain undetected errors that adversely affect functionality. Furthermore, as Eventer regularly updates its website, platform, and other systems, newly introduced versions may contain undetected issues that cause service disruptions. These disruptions could diminish user confidence, lead to market share loss, and negatively impact Eventer’s financial performance. Continued investment in robust quality assurance processes and comprehensive testing is essential to mitigate these risks.

 

14

 

 

If Eventer fails to comply with escrow, payment services, and money transmitter regulations, its operations, financial condition, and reputation could be adversely affected

 

Eventer relies on third-party providers to collect funds from ticket purchasers, remit payments to event organizers, and hold funds related to ticket transactions. Despite its belief in regulatory compliance, changes in existing laws or reinterpretations of regulations concerning escrow, money transmission, or financial transactions could impact Eventer’s operations. As a result, Eventer may be required to obtain licenses as an escrow agent, money transmitter, or similar financial entity in its active jurisdictions. Additionally, Eventer may face regulatory enforcement actions, requiring significant legal and administrative resources to resolve. Increased scrutiny and evolving regulations could lead to higher compliance costs, affecting Eventer’s profitability.

 

If Eventer is unable to effectively manage payment and fraud risks, it could face financial losses, legal liability, and reputational harm

 

Eventer is exposed to payment and fraud risks, including unauthorized transactions, identity theft, and sophisticated cyber-fraud schemes. Despite implementing advanced security measures, there is no guarantee that Eventer can prevent all fraudulent activities. Possible consequences include liability for unauthorized transactions, chargebacks, or financial penalties from payment processors. Moreover, fraud incidents could result in reputational damage, diminished user trust, and adverse effects on Eventer’s financial performance. Continuous investment in fraud detection technologies, user authentication mechanisms, and secure payment processing systems is crucial to mitigate these risks.

 

If Eventer fails to properly manage the use of open source software, it could face legal, operational, and security risks that may adversely affect its business and competitive position

 

Eventer incorporates substantial open-source software in its platform, which poses risks related to intellectual property disputes, licensing compliance, and potential security vulnerabilities. Misuse or non-compliance with open source licenses could expose Eventer to legal disputes, requiring costly platform modifications. Additionally, if Eventer’s proprietary software inadvertently integrates with open source code under restrictive licenses, it may be required to disclose its source code, compromising its competitive advantage. Eventer must maintain stringent compliance protocols and regularly review its open-source usage to minimize legal and operational risks.

 

If Eventer experiences data security breaches or cybersecurity threats, it could suffer legal liability, regulatory penalties, reputational harm, and loss of user trust

 

Eventer’s platform stores sensitive user information, including payment details and personal data. As cyber threats evolve, Eventer faces risks of unauthorized access, data breaches, and security incidents that could compromise user privacy and financial data integrity. If Eventer’s security measures are compromised, it could face legal liabilities, regulatory penalties, and reputational damage. Additionally, reliance on third-party cloud infrastructure necessitates stringent security standards to protect against cyberattacks and data theft. Proactive investment in cybersecurity solutions, comprehensive threat monitoring, and regular security audits are critical to safeguarding user data and maintaining operational integrity.

 

15

 

 

Risks Related to Our Intellectual Property

 

If we are unable to secure and maintain patent or other intellectual property protection for the intellectual property used in our products, our ability to compete will be harmed.

 

Our commercial success depends, in part, on obtaining and maintaining patent and other intellectual property protection for the technologies used in our products. If we, or the other parties from whom we may license intellectual property, fail to obtain and maintain adequate patent or other intellectual property protection for intellectual property used in our products, or if any protection is reduced or eliminated, others could use the intellectual property used in our products, resulting in harm to our competitive business position. In addition, patent and other intellectual property protection may not provide us with a competitive advantage against competitors that devise ways of making competitive products without infringing any patents that we own.

 

U.S. patents and patent applications may be subject to interference proceedings, and U.S. patents may be subject to re-examination proceedings in the U.S. Patent and Trademark Office and the Federal courts. Foreign patents may be subject to opposition or comparable proceedings in the corresponding foreign patent offices and courts. Any of these proceedings could result in loss of the patent or denial of the patent application, or loss or reduction in the scope of one or more of the claims of the patent or patent application. Changes in either patent laws or in interpretations of patent laws may also diminish the value of our intellectual property or narrow the scope of our protection. Interference, re-examination and opposition proceedings may be costly and time consuming, and we, or the other parties from whom we might potentially license intellectual property, may be unsuccessful in defending against such proceedings. Thus, any patents that we own or might license may provide limited or no protection against competitors. In addition, our pending patent applications and those we may file in the future may have claims narrowed during prosecution or may not result in patents being issued. Even if any of our pending or future applications are issued, they may not provide us with adequate protection or any competitive advantages. Our ability to develop additional patentable technology is also uncertain.

 

Non-payment or delay in payment of patent fees or annuities, whether intentional or unintentional, may also result in the loss of patents or patent rights important to our business. Many countries, including certain countries in Europe, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. In addition, many countries limit the enforceability of patents against other parties, including government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of the patent. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States, particularly in the field of medical products and procedures.

 

If we are unable to prevent unauthorized use or disclosure of our proprietary trade secrets and unpatented know-how, our ability to compete will be harmed.

 

Proprietary trade secrets, copyrights, trademarks and unpatented know-how are also very important to our business. We rely on a combination of trade secrets, copyrights, trademarks, confidentiality agreements and other contractual provisions and technical security measures to protect certain aspects of our technology, especially where we do not believe that patent protection is appropriate or obtainable. We require our office holders, employees, consultants and distributors of our products and most third parties (such as contractors or clinical collaborators) to execute confidentiality agreements in connection with their relationships with us. However, these measures may not be adequate to safeguard our proprietary intellectual property and conflicts may, nonetheless, arise regarding ownership of inventions. Such conflicts may lead to the loss or impairment of our intellectual property or to expensive litigation to defend our rights against competitors who may be better funded and have superior resources. Our office holders, employees, consultants and other advisors may unintentionally or willfully disclose our confidential information to competitors. In addition, confidentiality agreements may be unenforceable or may not provide an adequate remedy in the event of unauthorized disclosure. Enforcing a claim that a third party illegally obtained and is using our trade secrets is expensive and time consuming, and the outcome is unpredictable. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products that we consider proprietary. As a result, other parties may be able to use our proprietary technology or information, and our ability to compete in the market would be harmed.

 

16

 

 

We could become subject to patent and other intellectual property litigation that could be costly, result in the diversion of management’s attention, require us to pay damages and force us to discontinue selling our products.

 

Our industry is characterized by competing intellectual property and a substantial amount of litigation over patent and other intellectual property rights. Determining whether a product infringes a patent involves complex legal and factual issues, and the outcome of a patent litigation action is often uncertain. No assurance can be given that patents containing claims covering our products, parts of our products, technology or methods do not exist, have not been filed or could not be filed or issued. Furthermore, our competitors or other parties may assert that our products and the methods we employ in the use of our products are covered by U.S. or foreign patents held by them. In addition, because patent applications can take many years to issue and because publication schedules for pending applications vary by jurisdiction, there may be applications now pending of which we are unaware and which may result in issued patents which our current or future products infringe. Also, because the claims of published patent applications can change between publication and patent grant, there may be published patent applications with claims that we infringe. There could also be existing patents that one or more of our products or parts may infringe and of which we are unaware.

 

Infringement actions and other intellectual property claims and proceedings brought against or by us, whether with or without merit, may cause us to incur substantial costs and could place a significant strain on our financial resources, divert the attention of management from our business and harm our reputation. Some of our competitors may be able to sustain the costs of complex patent or intellectual property litigation more effectively than we can because they have substantially greater resources. Part of our patent portfolio may be infringed by a third party. After initial discussions with such third party we are evaluating our next steps including possibly conducting further discussions with such third party.

 

We cannot be certain that we will successfully defend against allegations of infringement of patents and intellectual property rights of others. In the event that we become subject to a patent infringement or other intellectual property lawsuit and if the other party’s patents or other intellectual property were upheld as valid and enforceable and we were found to infringe the other party’s patents or violate the terms of a license to which we are a party, we could be required to pay damages. We could also be prevented from selling our products unless we could obtain a license to use technology or processes covered by such patents or will be able to redesign the product to avoid infringement. A license may not be available at all or on commercially reasonable terms or we may not be able to redesign our products to avoid infringement. In these circumstances, we may be unable to sell our products at competitive prices or at all, our business and operating results could be harmed.

 

We may be subject to claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties or, that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.

 

Certain of our current or former employees, consultants and personnel were previously employed at universities, medical institutions, or other biotechnology or pharmaceutical companies. Although we try to ensure that our employees, consultants, and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our current or former employees, consultants, or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee’s former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Furthermore, universities or medical institutions who employ or employed some of our key employees and personnel in parallel to their engagement by us may claim that intellectual property developed by such person is owned by the respective academic or medical institution under the respective institution intellectual property policy or applicable law.

 

17

 

 

We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.

 

We may be subject to claims that former employees, collaborators, or other third parties have an ownership interest in our patents or other intellectual property. Ownership disputes may arise in the future, for example, from conflicting obligations of consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.  

 

Disruptions to the Group’s information technology systems due to cyber-attacks or the Group’s failure to upgrade and adjust our information technology systems, may materially impair the Group’s operations, hinder our growth and materially and adversely affect our business and results of operations.

 

We believe that an appropriate information technology, or IT, infrastructure is important in order to support the Group’s daily operations and the growth of our business. If we experience difficulties in implementing new or upgraded information systems or experience significant system failures, or if we are unable to successfully modify the Group’s management information systems or respond to changes in our business needs, we may not be able to effectively manage the Group’s business, and we may fail to meet our reporting obligations. Additionally, if our current back-up storage arrangements and our disaster recovery plan are not operated as planned, we may not be able to effectively recover our information system in the event of a crisis, which may materially and adversely affect our business and results of operations.

 

In the current environment, there are numerous and evolving risks to cybersecurity and privacy, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, employee malfeasance and human or technological error. High-profile security breaches at other companies and in government agencies have increased in recent years, and security industry experts and government officials have warned about the risks of hackers and cyber-attacks targeting businesses such as ours. Computer hackers and others routinely attempt to breach the security of technology products, services and systems, and to fraudulently induce employees, customers, or others to disclose information or unwittingly provide access to systems or data. We can provide no assurance that the Group’s current IT system or any updates or upgrades thereto and the current or future IT systems of our distributors use or may use in the future, are fully protected against third-party intrusions, viruses, hacker attacks, information or data theft or other similar threats. Legislative or regulatory action in these areas is also evolving, and we may be unable to adapt the Group’s IT systems or to manage the IT systems of third parties to accommodate these changes. In the current environment, there are numerous and evolving risks to cybersecurity, data and privacy, including criminal hackers, hacktivists, state-sponsored intrusions, industrial espionage, employee malfeasance and human or technological error. High-profile security breaches at other companies and in government agencies have increased in frequency and sophistication in recent years. Moreover, geopolitical tensions, particularly the Hamas-Israel and the Russia-Ukraine conflicts, have contributed to a surge in cyber-attacks targeting Israeli companies and products globally, posing a threat to critical infrastructure. We have experienced and expect to continue to experience actual or attempted cyber-attacks of our IT networks. Although none of these actual or attempted cyber-attacks has had a material adverse impact on our operations or financial condition, we cannot guarantee that any such incidents will not have such an impact in the future.

 

18

 

 

Risks Related to Our Operations in Israel

 

Conditions in Israel, including the ongoing war between Israel and Hamas, and other conflicts in the region, may adversely affect our operations and limit our ability to market our products, which would lead to a decrease in revenues.

 

We are incorporated under the laws of the State of Israel, and our employees, including management members, operate from our offices that are located in Tel Aviv, Israel. In addition, a number our officers and directors are residents of Israel. Accordingly, our business and operations are directly affected by economic, political, geopolitical and military conditions in Israel. Since the establishment of the State of Israel in 1948, a number of armed conflicts have occurred between Israel and its neighboring countries and terrorist organizations active in the region. These conflicts have involved missile strikes, hostile infiltrations and terrorism against civilian targets in various parts of Israel, which have negatively affected business conditions in Israel.

 

Following the October 7th attacks by Hamas terrorists in Israel’s southern border, Israel declared war against Hamas and since then, Israel has been involved in military conflicts with Hamas, Hezbollah, a terrorist organization based in Lebanon, and Iran, both directly and through proxies like the Houthi movement in Yemen and armed groups in Iraq and other terrorist organizations. Additionally, following the fall of the Assad regime in Syria, Israel has conducted limited military operations targeting the Syrian army, Iranian military assets and infrastructure linked to Hezbollah and other Iran-supported groups. Although certain ceasefire agreements have been reached with Hamas and Lebanon (with respect to Hezbollah), and some Iranian proxies have declared a halt to their attacks, there is no assurance that these agreements will be upheld, military activity and hostilities continue to exist at varying levels of intensity, and the situation remains volatile, with the potential for escalation into a broader regional conflict involving additional terrorist organizations and possibly other countries. Also, the fall of the Assad regime in Syria may create geopolitical instability in the region.

 

While our facilities have not been damaged during the current war, the hostilities with Hamas, Hezbollah, Iran and its proxies and others have caused and may continue to cause damage to private and public facilities, infrastructure, utilities, and telecommunication networks, and potentially disrupting our operations and supply chains. In addition, Israeli organizations, government agencies and companies have been subject to extensive cyberattacks. This could lead to increased costs, risks to employee safety, and challenges to business continuity, with potential financial losses.

 

The continuation of the war has also led to a deterioration of certain indicators of Israel’s economic standing, for instance, a downgrade in Israel’s credit rating by rating agencies (such as by Moody’s, S&P Global, and Fitch).

 

In connection with the ongoing war, several hundred thousand Israeli military reservists were drafted to perform immediate military service, and military reservists are expected to perform long reserve duty service in the coming years. As of the date of this annual report, only several of our employees are called to active military duty. The absence of our employees due to their military service in the current or future wars or other armed conflicts may materially and adversely affect our ability to conduct our operations.

 

Although the Israeli government currently covers the reinstatement value of certain direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that such government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse effect on our business.

 

The global perception of Israel and Israeli companies, influenced by actions by international judicial bodies, may lead to increased sanctions and other negative measures against Israel, as well as Israeli companies and academic institutions. There is also a growing movement among countries, activists, and organizations to boycott Israeli goods, services and academic research or restrict business with Israel, which could affect business operations. If these efforts become widespread, along with any future rulings from international tribunals against Israel, they could significantly and negatively impact business operations.

 

19

 

 

Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.

 

Our reporting and functional currency is the U.S. dollar. Gix Internet’s revenues are currently primarily payable in U.S. dollars, and we expect our future revenues to be denominated primarily in U.S. dollars. However, Eventer’s revenues and certain amount of our and Gix Internet’s expenses and investments are in NIS and as a result, we are exposed to the currency fluctuation risks relating to the recording of our expenses and Eventer’s revenues in U.S. dollars. We may, in the future, decide to enter into currency hedging transactions. These measures, however, may not adequately protect us from material adverse effects.

 

The government tax benefits that we currently are entitled to receive require us to meet several conditions and may be terminated or reduced in the future.

 

Some of our operations in Israel may entitle us to certain tax benefits under the Law for the Encouragement of Capital Investments, 5719-1959, or the Investments Law once we begin to produce taxable income. From time to time, the government of Israel has considered reducing or eliminating the tax benefits available to Benefitted Enterprise programs such as ours. If we do not meet the requirements for maintaining these benefits, they may be reduced or cancelled and the relevant operations would be subject to Israeli corporate tax at the standard rate, which was set at 23% in 2018 and thereafter. In addition to being subject to the standard corporate tax rate, we could be required to refund any tax benefits that we have already received, plus interest and penalties thereon. Even if we continue to meet the relevant requirements, the tax benefits that our current “Benefitted Enterprise” is entitled to may not be continued in the future at their current levels, or at all. If these tax benefits were reduced or eliminated, the amount of taxes that we will have to pay if we produce revenues would likely increase, as all of our operations would consequently be subject to corporate tax at the standard rate, which could adversely affect our results of operations. Additionally, if we increase our activities outside of Israel, for example, by way of acquisitions, our increased activities may not be eligible for inclusion in Israeli tax benefits programs. See Item 10. “Additional Information - E. Taxation.” 

 

Provisions of Israeli law and our amended and restated articles of association may delay, prevent or otherwise impede a merger with, or an acquisition of, our Company, which could prevent a change of control, even when the terms of such a transaction are favorable to us and our shareholders.

 

Provisions of Israeli law and our amended and restated articles of association could have the effect of delaying or preventing a change in control and may make it more difficult for a third party to acquire us or our shareholders to elect different individuals to our board of directors, even if doing so would be considered to be beneficial by some of our shareholders, and may limit the price that investors may be willing to pay in the future for our Ordinary Shares. Among other things:

 

  Israeli corporate law regulates mergers, requires tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors, officers or significant shareholders and regulates other matters that may be relevant to such types of transactions. For example, a merger may not be consummated unless at least 50 days have passed from the date on which a merger proposal is filed by each merging company with the Israel Registrar of Companies and at least 30 days have passed from the date on which the shareholders of both merging companies have approved the merger. In addition, a majority of each class of securities of the target company must approve a merger. Moreover, a tender offer for all of a company’s issued and outstanding shares can only be completed if the acquirer receives positive responses from the holders of at least 95% of the issued share capital. Completion of the tender offer also requires approval of a majority of the offerees that do not have a personal interest in the tender offer, unless, following consummation of the tender offer, the acquirer would hold at least 98% of the Company’s outstanding shares. Furthermore, the shareholders, including those who indicated their acceptance of the tender offer, may, at any time within six months following the completion of the tender offer, claim that the consideration for the acquisition of the shares does not reflect their fair market value, and petition an Israeli court to alter the consideration for the acquisition accordingly, unless the acquirer stipulated in its tender offer that a shareholder that accepts the offer may not seek such appraisal rights, and the acquirer or the company published all required information with respect to the tender offer prior to the tender offer’s response date;

 

20

 

 

  our amended and restated articles of association divide our directors into three classes, each of which is elected once every three years;

 

  our amended and restated articles of association require a vote of the holders of a majority of our outstanding Ordinary Shares entitled to vote present and voting on the matter at a general meeting of shareholders (referred to as simple majority). The affirmative vote of at least three-quarters (3/4) of the directors, in addition to the approval of our shareholders, is required in order to amend our amended and restated articles of association;

 

  our amended and restated articles of association provide that director vacancies may be filled by our board of directors;

 

  subject to certain exceptions, our amended and restated articles of association restrict us from engaging in certain business combination transactions with any shareholder and/or its affiliates and/or investors for a period of three years following (i) any shareholder who holds 15% or more of our voting power, and (ii) with respect to all shareholders of the Company, each time as such shareholder and/or any of its affiliates and/or investors become(s) (other than due to a buyback, redemption or cancellation of shares by the Company) the holder(s) (beneficially or of record) of fifteen percent (15%) or more of the issued and outstanding voting power of our Ordinary Shares. The transactions subject to such restrictions include mergers, consolidations and dispositions of our assets with an aggregate market value of 10% or more of our assets or outstanding shares; and

 

  our amended and restated articles of association require an affirmative vote of at least three-quarters (3/4) of the then serving directors, to approve certain transactions which may have a significant effect on the Company’s structure, assets or business, including mergers acquisitions, consolidations and issuance of equity securities or debt securities convertible into equity in each case that would reasonably be expected to result in change of beneficial ownership of above than fifteen percent (15%) in the Company, material changes to the principal business of the Company and any resolution to transfer the headquarters of the Company outside of Israel.

 

Furthermore, Israeli tax considerations may make potential transactions unappealing to us or to our shareholders whose country of residence does not have a tax treaty with Israel exempting such shareholders from Israeli tax.

 

These and other similar provisions could delay, prevent or impede an acquisition of us or our merger with another company, even if such an acquisition or merger would be beneficial to us or to our shareholders.

 

21

 

 

It may be difficult to enforce a judgment of a U.S. court against us and our officers and directors and the Israeli experts named in this annual report on Form 20-F in Israel or the United States, to assert United States securities laws claims in Israel or to serve process on our officers and directors and these experts.

 

We are incorporated in Israel. Certain of our executive officers and directors reside in Israel and most of our assets and most of the assets of these persons are located outside of the United States. Therefore, a judgment obtained against us, or any of these persons in the United States, including one based on the civil liability provisions of the U.S. federal securities laws, may not be collectible in the United States and may not necessarily be enforced by an Israeli court. It may also be difficult to affect service of process on these persons in the United States or to assert United States securities law claims in original actions instituted in Israel.

 

Even if an Israeli court agrees to hear such claim, it may determine that Israeli law, and not U.S. law is applicable to the claim. Under Israeli law, if U.S. law is found to be applicable to such claim, the content of applicable U.S. law must be proven as a fact by expert witnesses, which can be a time consuming and costly process, and certain matters of procedure would also be governed by Israeli law. There is little binding case law in Israel that addresses the matters.

 

Our amended and restated articles of association provide that unless the Company consents otherwise, the competent courts of Tel Aviv, Israel shall be the sole and exclusive forum for substantially all disputes between the Company and its shareholders under the Companies Law and the Israeli Securities Law, which could limit its shareholders ability to brings claims and proceedings against, as well as obtain favorable judicial forum for disputes with the Company, its directors, officers and other employees.

 

The competent courts of Tel Aviv, Israel shall be the exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s shareholders, or (iii) any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law. This exclusive forum provision is intended to apply to claims arising under Israeli Law and would not apply to claims brought pursuant to the Securities Act or the Exchange Act or any other claim for which federal courts would have exclusive jurisdiction. Such exclusive forum provision in our amended and restated articles of association will not relieve the Company of its duties to comply with federal securities laws and the rules and regulations thereunder, and shareholders of the Company will not be deemed to have waived the Company’s compliance with these laws, rules and regulations. This exclusive forum provision may limit a shareholder’s ability to bring a claim in a judicial forum of its choosing for disputes with the Company or its directors or other employees which may discourage lawsuits against the Company, its directors, officers and employees.

 

The rights and responsibilities of a shareholder will be governed by Israeli law which differs in some material respects from the rights and responsibilities of shareholders of U.S. companies.

 

The rights and responsibilities of the holders of our Ordinary Shares are governed by our amended and restated articles of association and by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities of shareholders in typical U.S.-registered corporations. In particular, a shareholder of an Israeli company has certain duties to act in good faith and fairness towards the company and other shareholders, and to refrain from abusing its power in the company. There is limited case law available to assist us in understanding the nature of this duty or the implications of these provisions. These provisions may be interpreted to impose additional obligations and liabilities on holders of our Ordinary Shares that are not typically imposed on shareholders of U.S. corporations.

 

22

 

 

The ability of any Israeli company to pay dividends is subject to Israeli law and the amount of cash dividends payable may be subject to devaluation in the Israeli currency.

 

We paid cash dividends in an amount of $1.6 million on December 28, 2022. We do not anticipate that we will pay any cash dividends on our securities in the foreseeable future. The ability of an Israeli company to pay dividends is governed by Israeli law, which provides that cash dividends may be paid only out of retained earnings or earnings derived over the two most recent fiscal years, whichever is higher, as determined for statutory purposes in Israeli currency, provided that there is no reasonable concern that payment of a dividend will prevent a company from satisfying its existing and foreseeable obligations as they become due. In the event of a devaluation of the Israeli currency against the U.S. dollar, the amount in U.S. dollars available for payment of cash dividends out of prior years’ earnings will decrease.

 

The termination or reduction of tax and other incentives that the Israeli Government provides to domestic companies may increase the costs involved in operating a company in Israel.

 

The Israeli government currently provides major tax and capital investment incentives to domestic companies, as well as grant and loan programs relating to research and development and marketing and export activities. In recent years, the Israeli Government has reduced the benefits available under these programs and the Israeli Governmental authorities have indicated that the government may in the future further reduce or eliminate the benefits of those programs. We currently take advantage of these programs. There is no assurance that such benefits and programs would continue to be available in the future to us. If such benefits and programs were terminated or further reduced, it could have an adverse effect on our business, operating results and financial condition.

 

We may become subject to claims for remuneration or royalties for assigned service invention rights by our employees, which could result in litigation and adversely affect our business.

 

A significant portion of our intellectual property has been developed by our employees in the course of their employment for us. Under the Israeli Patent Law, 5727-1967, or the Patent Law, inventions conceived by an employee in the course and as a result of or arising from his or her employment with a company are regarded as “service inventions,” which belong to the employer, absent a specific agreement between the employee and employer giving the employee service invention rights. The Patent Law also provides that if there is no such agreement between an employer and an employee, the Israeli Compensation and Royalties Committee, or the Committee, a body constituted under the Patent Law, will determine whether the employee is entitled to remuneration for his inventions. Recent case law clarifies that the right to receive consideration for “service inventions” can be waived by the employee and that in certain circumstances, such waiver does not necessarily have to be explicit. The Committee will examine, on a case-by-case basis, the general contractual framework between the parties, using interpretation rules of the general Israeli contract laws. Further, the Committee has not yet determined one specific formula for calculating this remuneration (but rather uses the criteria specified in the Patent Law). Although we generally enter into assignment-of-invention agreements with our employees pursuant to which such individuals assign to us all rights to any inventions created in the scope of their employment or engagement with us, we may face claims demanding remuneration in consideration for assigned inventions. As a consequence of such claims, we could be required to pay additional remuneration or royalties to our current and/or former employees, or be forced to litigate such claims, which could negatively affect our business.

 

23

 

 

Risks Related to an Investment Our Securities

 

There can be no assurance that we will not be a passive foreign investment company, or PFIC, for U.S. federal income tax purposes in 2025 or in any subsequent year. If we are a PFIC, this may result in adverse U.S. federal income tax consequences for U.S. taxpayers that are holders of our securities. 

 

We will generally be treated as a PFIC for U.S. federal income tax purposes in any taxable year in which either (1) at least 75% of our gross income is “passive income” or (2) on average at least 50% of our assets by value (generally determined on the basis of a quarterly average) produce passive income or are held for the production of passive income. Passive income for this purpose generally includes, among other things, certain dividends, interest, royalties, rents and gains from commodities and securities transactions and from the sale or exchange of property that gives rise to passive income. Passive income also includes amounts derived by reason of the temporary investment of funds, including those raised in a public offering. In determining whether a non-U.S. corporation is a PFIC, a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25% interest (by value) is taken into account. Based on our anticipated income and the composition of our income and assets, we do not believe we were a PFIC for our 2024 taxable year . Because the PFIC determination is highly fact intensive, there can be no assurance that we were not a PFIC in 2024 and will not be a PFIC in 2025 or any other year, as our operating results for any such years may cause us to be a PFIC. If we were a PFIC in 2024, or are a PFIC in any subsequent year, and a U.S. shareholder does not make an election to treat us as a “qualified electing fund,” or QEF, or make a “mark-to-market” election, then “excess distributions” to a U.S. shareholder, and any gain realized on the sale or other disposition of our securities will be subject to special rules. Under these rules: (1) the excess distribution or gain would be allocated ratably over the U.S. shareholder’s holding period for the securities; (2) the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3) the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting tax attributable to each such other taxable year. In addition, if the U.S. Internal Revenue Service, or the IRS, determines that we are a PFIC for a year with respect to which we have determined that we were not a PFIC, it may be too late for a U.S. shareholder to make a timely QEF or mark-to-market election. You may make a QEF election with respect to your Ordinary Shares or ADSs only if we furnish you annually with certain tax information, and we currently do not intend to prepare or provide such information. U.S. shareholders who hold or have held our securities during a period when we were or are a PFIC will generally be subject to the foregoing rules unless we cease to be a PFIC and you make a “deemed sale” election with respect to our Ordinary Shares. If we are a PFIC in any year, U.S. shareholders may be subject to additional IRS filing requirements, including the filing of IRS Form 8621, as a result of directly or indirectly owning stock of a PFIC. U.S. shareholders are urged to consult their own tax advisors regarding the application of the PFIC rules. For more information, see Item 10. “Additional Information - Taxation - Certain Material U.S. Federal Income Tax Consequences.”

 

If a United States person is treated as owning at least 10% of our Ordinary Shares, such holder may be subject to adverse U.S. federal income tax consequences.

 

If a United States person is treated as owning (directly, indirectly, or constructively) at least 10% of the value or voting power of our Ordinary Shares, such person may be treated as a “United States shareholder” with respect to each controlled foreign corporation, or CFC, in our group (if any). Because our group includes a U.S. subsidiary, certain of our non-U.S. subsidiaries will be treated as CFCs (regardless of whether or not we are treated as a CFC). A United States shareholder of a CFC may be required to report annually and include in its U.S. taxable income its pro rata share of “Subpart F income,” “global intangible low-taxed income,” and investments in U.S. property by CFCs, regardless of whether we make any distributions. An individual that is a United States shareholder with respect to a CFC generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder that is a U.S. corporation. Failure to comply with these reporting obligations may subject a United States shareholder to significant monetary penalties and may prevent the statute of limitations with respect to such shareholder’s U.S. federal income tax return for the year for which reporting was due from starting. We cannot provide any assurances that we will assist investors in determining whether we are or any of our non-U.S. subsidiaries is treated as CFC or whether any investor is treated as a United States shareholder with respect to any such CFC or furnish to  any United States shareholders information that may be necessary to comply with the aforementioned reporting and tax paying obligations. The IRS has provided limited guidance on situations in which investors may rely on publicly available information to comply with their reporting and tax paying obligations with respect to foreign-controlled CFCs. A United States investor should consult its advisors regarding the potential application of these rules to an investment in our Ordinary Shares or ADSs.

 

24

 

 

Changes in U.S. and foreign tax laws could have a material adverse effect on our business, cash flow, results of operations or financial conditions.

 

We are subject to taxation in several countries, including the United States and Israel; changes in tax laws or challenges to our tax positions could adversely affect our business, results of operations, and financial condition. As such, we are subject to tax laws, regulations, and policies of the U.S. federal, state, and local governments and of comparable taxing authorities in foreign jurisdictions. Changes in tax laws, including proposed legislation currently being discussed in the U.S. Congress, as well as other factors, could cause us to experience fluctuations in our tax obligations and effective tax rates in the future and otherwise adversely affect our tax positions and/or our tax liabilities. There can be no assurance that our effective tax rates, tax payments, tax credits, or incentives will not be adversely affected by changes in tax laws in various jurisdictions.

 

The market prices of our securities are subject to fluctuation, which could result in substantial losses by our investors.

 

The stock market in general and the market prices of our ADSs on Nasdaq, in particular, are or will be subject to fluctuation, and changes in these prices may be unrelated to our operating performance. We anticipate that the market prices of our securities will continue to be subject to wide fluctuations. The market price of our securities is, and will be, subject to a number of factors, including:

 

announcements of technological innovations or new products by us or others;

 

announcements by us of significant acquisitions, strategic partnerships, in-licensing, out-licensing, ventures or capital commitments;

 

expiration or terminations of licenses, research contracts or other collaboration agreements;

 

public concern as to the safety of the equipment we sell;

 

the volatility of market prices for shares of medical devices companies generally;

 

developments concerning intellectual property rights or regulatory approvals;

 

variations in our and our competitors’ results of operations;

 

changes in revenues, gross profits and earnings announced by the Company;

 

changes in estimates or recommendations by securities analysts, if our Ordinary Shares or the ADSs are covered by analysts;

 

fluctuations in the stock price of our publicly traded subsidiaries;

 

changes in government regulations or patent decisions; and

 

general market conditions and other factors, including factors unrelated to our operating performance.

 

These factors may materially and adversely affect the market price of our securities s and result in substantial losses by our investors.

 

We do not know whether a market for the ADSs will be sustained or what the trading price of the ADSs will be and as a result it may be difficult for you to sell your ADSs.

 

Although our ADSs trade on Nasdaq, an active trading market for the ADSs may not be sustained. It may be difficult for you to sell your ADSs without depressing the market price for the ADSs. As a result of these and other factors, you may not be able to sell your ADSs. Further, an inactive market may also impair our ability to raise capital by selling ADSs and may impair our ability to enter into strategic partnerships or acquire companies or products by using our ADSs as consideration.

 

25

 

 

Future sales of our securities could reduce their market price.

 

Substantial sales of our securities on Nasdaq, may cause the market price of our securities to decline. Sales by us or our security holders of substantial amounts of our securities, or the perception that these sales may occur in the future, could cause a reduction in the market price of our securities.

 

The issuance of any additional Ordinary Shares, ADSs, warrants or any securities that are exercisable for or convertible into our Ordinary Shares or ADSs, may have an adverse effect on the market price of our securities and will have a dilutive effect on our existing shareholders and holders of ADSs.

 

Holders of ADSs may not receive the same distributions or dividends as those we make to the holders of our Ordinary Shares, and, in some limited circumstances, you may not receive dividends or other distributions on our Ordinary Shares and you may not receive any value for them, if it is illegal or impractical to make them available to you.

 

The depositary for the ADSs has agreed to pay to you the cash dividends or other distributions it or the custodian receives on Ordinary Shares or other deposited securities underlying the ADSs, after deducting its fees and expenses. You will receive these distributions in proportion to the number of Ordinary Shares your ADSs represent. However, the depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any holders of ADSs. For example, it would be unlawful to make a distribution to a holder of ADSs if it consists of securities that require registration under the Securities Act of 1933, as amended, or the Securities Act, but that are not properly registered or distributed under an applicable exemption from registration. In addition, conversion into U.S. dollars from foreign currency that was part of a dividend made in respect of deposited Ordinary Shares may require the approval or license of, or a filing with, any government or agency thereof, which may be unobtainable. In these cases, the depositary may determine not to distribute such property and hold it as “deposited securities” or may seek to affect a substitute dividend or distribution, including net cash proceeds from the sale of the dividends that the depositary deems an equitable and practicable substitute. We have no obligation to register under U.S. securities laws any ADSs, Ordinary Shares, rights or other securities received through such distributions. We also have no obligation to take any other action to permit the distribution of ADSs, Ordinary Shares, rights or anything else to holders of ADSs. In addition, the depositary may withhold from such dividends or distributions its fees and an amount on account of taxes or other governmental charges to the extent the depositary believes it is required to make such withholding. This means that you may not receive the same distributions or dividends as those we make to the holders of our Ordinary Shares, and, in some limited circumstances, you may not receive any value for such distributions or dividends if it is illegal or impractical for us to make them available to you. These restrictions may cause a material decline in the value of the ADSs.

 

Holders of ADSs must act through the depositary to exercise their rights as shareholders of our Company.

 

Holders of our ADSs do not have the same rights as our shareholders and may only exercise the voting rights with respect to the underlying Ordinary Shares in accordance with the provisions of the Deposit Agreement. Under Israeli law and our amended and restated articles of association, the minimum notice period required to convene a shareholders meeting is no less than 21 or 35 calendar days, depending on the proposals on the agenda for the shareholders meeting. When a shareholder meeting is convened, holders of ADSs may not receive sufficient notice of a shareholders’ meeting to permit them to withdraw their Ordinary Shares to allow them to cast their vote with respect to any specific matter. In addition, the Depositary and its agents may not be able to send voting instructions to holders of ADSs or carry out their voting instructions in a timely manner. We will make all reasonable efforts to cause the Depositary to extend voting rights to holders of the ADSs in a timely manner, but we cannot assure holders that they will receive the voting materials in time to ensure that they can instruct the Depositary to vote their Ordinary Shares underlying the ADSs. Furthermore, the Depositary and its agents will not be responsible for any failure to carry out any instructions to vote, for the manner in which any vote is cast or for the effect of any such vote. As a result, holders of ADSs may not be able to exercise their right to vote and they may lack recourse if their Ordinary Shares underlying the ADSs are not voted as they requested. In addition, in the capacity as a holder of ADSs, they will not be able to call a shareholders’ meeting.

 

26

 

 

We incur additional increased costs as a result of the listing of the ADSs for trading on Nasdaq, and our management is required to devote substantial time to new compliance initiatives and reporting requirements.

 

As a public company in the United States, we incur significant accounting, legal and other expenses as a result of the listing of the ADSs on Nasdaq. These include costs associated with corporate governance requirements of the Securities Exchange Commission, or the SEC, and the Marketplace Rules of the Nasdaq, as well as requirements under Section 404 and other provisions of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act. These rules and regulations increase our legal and financial compliance costs, introduce costs such as investor relations, stock exchange listing fees and shareholder reporting, and make some activities more time consuming and costly. Any future changes in the laws and regulations affecting public companies in the United States and Israel, including Section 404 and other provisions of the Sarbanes-Oxley Act, the rules and regulations adopted by the SEC and the rules of the Nasdaq Stock Market may result in increased costs to us as we respond to such changes. These laws, rules and regulations could make it more difficult or more costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.

 

As a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to investors under rules applicable to domestic issuers.

 

As a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of those otherwise required under the rules of the Nasdaq for domestic issuers. Following our home country governance practices as opposed to the requirements that would otherwise apply to a U.S. company listed on the Nasdaq, may provide less protection than is accorded to investors under the rules of the Nasdaq applicable to domestic issuers. For more information, see “Item 16G. Corporate Governance - Nasdaq Stock Market Listing Rules and Home Country Practices.”

 

In addition, as a foreign private issuer, we are exempt from the rules and regulations under the Securities Exchange Act of 1934, as amended, or the Exchange Act, related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as domestic companies whose securities are registered under the Exchange Act.

 

We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

We are a foreign private issuer, as such term is defined in Rule 405 under the Securities Act, and therefore, we are not required to comply with all the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. Under Rule 405, the determination of foreign private issuer status is made annually on the last business day of an issuer’s most recently completed second fiscal quarter and, accordingly, the next determination will be made with respect to us on June 30, 2024.

 

In the future, we would lose our foreign private issuer status if a majority of our shareholders, directors or management are U.S. citizens or residents, and we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. Although we have elected to comply with certain U.S. regulatory provisions, our loss of foreign private issuer status would make such provisions mandatory. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly higher. If we are not a foreign private issuer, we will be required to file periodic reports and registration statements on U.S. domestic issuer forms with the U.S. Securities and Exchange Commission, or the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. For example, the annual report on Form 10-K requires domestic issuers to disclose executive compensation information on an individual basis with specific disclosure regarding the domestic compensation philosophy, objectives, annual total compensation (base salary, bonus, equity compensation) and potential payments in connection with change in control, retirement, death or disability, while the SEC forms applicable to foreign private issuers permit them to disclose compensation information on an aggregate basis if executive compensation disclosure on an individual basis is not required or otherwise has not been provided in the issuer’s home jurisdiction. We disclose individual compensation information, but this disclosure is not as comprehensive as that required of U.S. domestic issuers since we are not required to disclose more detailed information in Israel. We intend to continue this practice as long as it is permitted under the SEC’s rules and Israel’s rules do not require more detailed disclosure. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act. We may also be required to modify certain of our policies to comply with good governance practices associated with U.S. domestic issuers. Such conversion and modifications will involve additional costs. In addition, we may lose our ability to rely upon exemptions from certain corporate governance requirements on U.S. stock exchanges that are available to foreign private issuers.

 

27

 

 

If we fail to develop and maintain proper and effective internal controls over financial reporting, our ability to produce timely and accurate financial statements, comply with applicable laws and regulations, or access the capital markets could be impaired.

 

As a public company, we are actively evaluating our internal control over financial reporting in a manner that meets the standards of publicly traded companies required by Section 404(a) of the Sarbanes-Oxley Act, or Section 404. As disclosed in Item 15, our management concluded that, as of December 31, 2024, the Company’s internal controls over financial reporting were effective.

 

The process of designing and implementing effective internal control over financial reporting is a continuous effort. If our management cannot favorably assess the effectiveness of our internal controls over financial reporting, or if our independent registered public accounting firm identifies material weaknesses in our internal control, investor confidence in our financial results may weaken, and the market price of our securities may suffer.

 

Our amended and restated articles of association provide that unless we consent to an alternate forum, the federal district courts of the United States shall be the exclusive forum of resolution of any claims arising under the Securities Act which may impose additional litigation costs on our shareholders.

 

Our amended and restated articles of association provide that the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause or causes of action arising under the Securities Act, including all causes of action asserted against any defendant to such complaint. Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. This choice of forum provision may limit a shareholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees and may increase the costs associated with such lawsuits, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our amended and restated articles of association inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition. Any person or entity purchasing or otherwise acquiring any interest in our share capital shall be deemed to have notice of and to have consented to the choice of forum provisions of our amended and restated articles of association described above. This provision would not apply to shall not apply to causes of action arising under the Exchange Act.

 

28

 

 

Risks Related to the Arrangement

 

Consummation of the Arrangement is subject to court approval. If the Arrangement is not approved, our business and operations could be materially harmed.

 

Pursuant to Section 350 of the Israeli Companies Law, even if the proposed arrangement whereby L.I.A Pure Capital Ltd. (“Pure Capital”) will acquire the entirety of issued and outstanding share capital (the “Arrangement”) is approved by our shareholders, it is still subject to the court’s approval. Neither us nor Pure Capital can guarantee whether the Tel Aviv District Court (Economic Division) (the “Court”) will approve the Arrangement, or its conditions will be satisfied. Moreover, even if our shareholders approve the Arrangement, the Court retains broad discretion to reject it if it believes the terms are unfair to minority shareholders or if statutory requirements are not satisfied. Objecting shareholders have the right to submit objections to the court, which could lead to delays or prevent the Arrangement from being consummated.

 

If the Arrangement is not consummated, we may be subject to the following material risks, among others:

 

third parties may be reluctant to enter into or renew relationships with us due to uncertainties relating to our continuing as an public and/or independent company;

 

if the Arrangement is not finalized and our board of directors determines to seek another buyer, we may not be able to find a party willing to pay an equivalent or more attractive price than that which would be paid pursuant to the Arrangement; and

 

our ability to raise capital to fund its business needs or pursue strategic opportunities may be impaired.

 

If some or all of these risks were to occur, we may not be able to continue our present level of operations, we may need to scale back our business and may not be able to take advantage of future opportunities or effectively respond to competitive pressures, any of which could have a material adverse effect on our business and results of our operations.

 

Xylo’s directors and executive officers have personal interests in the Arrangement.

 

Our directors and executive officers have personal interests in the Arrangement that are different from, or in addition to, those of our shareholders generally. These interests include the following:

 

Current executive officers of us are expected to continue their employment with us following the consummation of the Arrangement;

 

We agreed to provide customary “run-off” insurance benefits to present and former directors and executive officers of ours and in our subsidiaries for a period of seven years following the consummation of the Arrangement; and

 

Our directors and executive officers hold restricted shares units to purchase shares of us, which, if unvested, are subject to acceleration upon finalization of the Arrangement. Assuming the Arrangement was finalized on April 17, 2025, the aggregate benefit to all executive officers and directors as a group (6 persons) as a result of the acceleration of RSUs at the finalization of the Arrangement would have been $127,893.

 

In the event that the Second Meeting is adjourned or postponed for any reason, it may be more difficult to secure shareholder approval for the Arrangement.

 

At the second special general meeting to be held on May 27, 2025 (the “Second Meeting”), which our shareholders (other than Pure Capital or its controlling shareholder and persons having an ongoing business relationship with Pure Capital or its controlling shareholder) will be asked to approve the Arrangement. Under the Israeli Companies Law as currently in effect, the Arrangement cannot be consummated unless a majority of our shareholders present (in person or by proxy) and voting (not including abstentions) who hold together at least 75% of the Ordinary Shares represented at the Second Meeting approves the Arrangement. Failure to obtain such 75% approval will prevent the consummation of the Arrangement. For more information on the Arrangement see section “4.B – Business Overview”.

 

29

 

 

General Risk Factors

 

We do not intend to pay any cash dividends on our Ordinary Shares in the foreseeable future and, therefore, any return on your investment in our securities must come from increases in the value and trading price of our securities.

 

We paid cash dividends in an amount of $1.6 million on December 28, 2022. We do not anticipate that we will pay any cash dividends on our securities in the foreseeable future, therefore, any return on your investment in our securities must come from increases in the value and trading price of our securities.

 

We intend to retain our earnings to finance the development and expenses of our business. Any future determination relating to our dividend policy will be at the discretion of our board of directors and will depend on a number of factors, including future earnings, our financial condition, operating results, contractual restrictions, capital requirements, business prospects, applicable Israeli law and other factors our board of directors may deem relevant.

 

Raising additional capital by issuing securities may cause dilution to existing shareholders.

 

We may seek additional capital through a combination of private and public equity offerings, debt financings and collaborations and strategic and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest will be diluted, and the terms of any such offerings may include liquidation or other preferences that may adversely affect the then existing shareholders rights. Debt financing, if available, would result in increased fixed payment obligations and may involve agreements that include covenants limiting or restricting our ability to take specific actions such as incurring debt or making capital expenditures. If we raise additional funds through collaboration, strategic alliance or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates, or grant licenses on terms that are not favorable to us.

 

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our share price and trading volume could decline.

 

The trading market for our securities will depend on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. There can be no assurance that analysts will cover us or provide favorable coverage. If one or more analysts downgrade our shares or change their opinion of our securities, the price of our securities would likely decline. In addition, if one or more analysts cease coverage of our Company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of the Company

 

We were incorporated in the State of Israel on December 9, 1999, as a private company pursuant to the Israeli Companies Ordinance (New Version), 1983. In February 2006, we completed our initial public offering in Israel, and our Ordinary Shares traded on the TASE until January 25, 2021. In May 2015, we listed the ADSs on Nasdaq and since August 2015 the ADSs have been traded on Nasdaq under the symbol “MDGS”. Following a 20:1 reverse share split of our ordinary shares effected on July 7, 2022, together with a 1:15 ratio change of the ADSs on November 14, 2022 (the “Ratio Change”), each ADS represents fifteen (15) Ordinary Shares. On March 6, 2024, our shareholders approved an amendment to our Articles of Association for our board of directors to implement a name change of our company to Xylo Technologies Ltd., or any other name as will be approved by the Registrar of Companies, which our board of directors believes may better reflect future business expansion. The name change became effective on April 1, 2024, and symbol change became effective on April 18, 2024. On August 5, 2024, we executed a ratio change in our American Depositary Receipts (ADRs) resulting in a reverse split of our ADR program on the basis of one (1) new ADS for every 2.666666 old ADSs held. As a result, the number of Ordinary Shares represented by each ADS was changed from fifteen (15) Ordinary Shares to forty (40) Ordinary Shares.

 

30

 

 

On November 15, 2024, we entered into a Warrants Purchase Agreement with an institutional investor, whereby the investor purchased $1,000,000 worth of pre-funded warrants.

 

Principal Capital Expenditures

 

Our Group had capital expenditures of approximately $12,000, $51,000 and $74,000 in the years ended on December 31, 2024, 2023 and 2022, respectively. Our capital expenditures are primarily for network infrastructure, computer hardware, purchase of machinery and software and leasehold improvements of our facilities. We have financed our capital expenditures from our available cash. We expect to maintain our capital expenditures in 2025 with a consistent volume.

 

There are no significant capital expenditures or divestitures currently in progress by the Company.

 

B. Business Overview

 

Overview

 

The activities carried out by us and our subsidiaries are focused on internet and other online-related technologies, real estate and the electric vehicle (EV) sector.

 

Our internet-related activities include ad-tech operations through our stake in Gix Internet in which as of December 31, 2024, we held 45.74% of its outstanding share capital. Our internet related activities also include our investment in Eventer, an online - event management and ticketing platform in which we held, as of December 31, 2024, 58.44% of its outstanding share capital.

 

Our medical related activities include: innovative surgical devices with direct visualization capabilities for the treatment of Gastroesophageal Reflux Disease using Ultrasonic Surgical Endostapler, or MUSE.  

 

Our activity in the EV sector includes our ownership of Charging Robotics Inc. (“Charging Robotics”) and its 19.99% subsidiary Revoltz, developing both wireless vehicle battery charging technology and three modular EVs. On April 7, 2023, Charging Robotics Ltd. consummated a share exchange transaction, whereby it became a wholly owned subsidiary of Charging Robotics Inc. (previously known as “Fuel Doctor”). As of December 31, 2024 we held 63.75% of the outstanding share capital of Fuel Doctor, with an option to increase our holdings to 73.35% of the outstanding share capital based on predetermined milestones.

 

Our activity in the drone products and safety field is conducted through our stake in Parazero Technologies Ltd. (“Parazero”) in which we held, as of December 31, 2024, 5.7% of its outstanding share capital.

 

Our interests in real estate include our ownership of 60% of Zig Miami 54 LLC’s issued and outstanding share capital

 

On December 24, 2024, L.I.A Pure Capital Ltd. (“Pure Capital”), through its legal representatives, submitted a request to the district court of Tel Aviv to call a general meeting of our shareholders, pursuant to Section 350 of the Israeli Companies Law (the “Request”), to approve a proposal whereby Pure Capital would acquire the entirety of our issued and outstanding share capital (the “Arrangement”). On February 19, 2025, after negotiations between us and Pure Capital, Pure Capital proposed setting the purchase price pursuant to the Request at $5.25 per ADS, as opposed to the original purchase price of $3.70 per ADS, to which we agreed. On March 20, 2025, the court ordered us to call a shareholders meeting (or meetings), in order to discuss and approve the Arrangement, and on April 21, 2025, we published proxy materials in preparation for such shareholders meetings.

  

31

 

 

On February 13, 2025, we, together with Pure Capital’s agreement, requested an additional extension to further analyze the Request until March 6, 2025, which the court granted. On February 16, 2025, in order to facilitate further discussion regarding the Request, we, together with Pure Capital signed a mutual non-disclosure agreement.

 

On February 19, 2025, following deliberations between our and Pure Capital’s legal representatives, we noted that according to the Initial Economic Analysis conducted on our behalf, the ADS price was close to $6.5 per ADS. Pure Capital stated that given the above valuation and the trading price of the ADSs on Nasdaq was then $4.48 per ADS (with an average price-per-ADS over the past six months of $3.73 per ADS), it proposed setting the purchase price pursuant to the Request on $5.25 per ADS.

 

On February 27, 2025, our board of directors convened to discuss the initial Economic Analysis prepared by IFS Consulting and Investments (2009) Ltd. (“IFS”). Following the discussions, our board of directors requested that IFS conduct further analysis on the possible alternatives to Pure Capital’s proposition.

 

On March 3, 2025, our legal counsel informed Pure Capital’s legal counsel that (i) unvested restricted share units granted to our officers, directors and employees pursuant to the our share incentive plan would undergo acceleration assuming the Arrangement was finalized (pursuant to the grant letters signed by us and the grantees of such restricted share units); and (ii) we intended to acquire “run-off” insurance, as is customary in change-of-control transactions.

 

On March 3, 2025, our board of directors met to discuss IFS’ further analysis. Following a discussion of our alternatives, our board of directors resolved after thoroughly considering relevant factors, including several alternatives, that we should not object to the Arrangement, which is fair.

 

On March 4, 2025, Pure Capital submitted an amendment to the Request (the “Amended Request”). The Amended Request increased Pure Capital’s proposal for the acquisition of the remaining of our issued and outstanding share capital to an updated purchase price of $0.13125 per Ordinary Share of Xylo (or $5.25 per ADS) as opposed to the previous proposed purchase price of $0.0925 per Ordinary Share of Xylo (or $3.70 per ADS). The Amended Request further clarified, subject to shareholder approval of the Arrangement, that (i) Pure Capital commits to purchase RSUs granted to our employees, officers and directors that are subject to acceleration upon a change of control; and (ii) we will purchase customary run-off insurance as of the date the Arrangement becomes effective.

 

On March 12, 2025, we filed a response to the Request (the “Response”) with the court, stating that following our engagement with an independent valuation expert, and after due consideration of the Amended Request, our board of directors does not oppose the convention of a general meeting and intends to present its position that the proposed Arrangement terms are fair. Furthermore, due to the fact that certain confidential information regarding the Arrangement and the Amended Request (the “Classified Information”) was attached to the Response, we requested permission from the court to submit the Classified Information in a closed session and under a temporary confidentiality order, accessible only to the court, Pure Capital, and any other respondent as determined by the court (subject to confidentiality assurances). This measure was sought to prevent selective information disclosure until the filing date of the notice and proxy statement for the general meeting of our shareholders, at which point the information would be made public. On March 13, 2025, the court approved the Amended Request as submitted.

 

On March 20, 2025, the court ordered us to call a shareholders meeting (or meetings), in order to discuss and approve the Arrangement.

 

32

 

 

On March 27, 2025, we, in agreement with Pure Capital, submitted a request to the court to order the convening of two shareholders meetings, in accordance with Section 350 of the Israeli Companies Law, as follows: the first meeting shall include all of our shareholders and ADS holders; the second meeting shall be considered a “pure” meeting, including our shareholders and ADS holders, except for (i) Pure Capital; (ii) Pure Capital’s controlling shareholder; and (iii) holders of Ordinary Shares or ADSs who have an ongoing business relationship with Pure Capital or its controlling shareholder. The court has approved the joint request as submitted.

 

On April 21, 2025, we published proxy materials in preparation for the upcoming shareholders meetings. These materials included detailed information about the proposed Arrangement, the Amended Request, and the rationale behind our board of directors’ decision not to oppose the Arrangement. The proxy materials also provided instructions for shareholders and ADS holders on how to participate in the meetings, vote on the proposed Arrangement, and submit any questions or comments they may have.

 

Internet and other online related Activity Overview

 

Gix Internet - Ad-Tech and Online Advertising

 

Gix Internet is the parent of Viewbix Inc. a publicly traded company (OTC: VBIX) (“Viewbix”) which is the majority shareholder of Gix Media Ltd. following a corporate reorganization that was consummated on September 19, 2022 (the “Reorganization Transaction”). Gix Media Ltd., is the majority holder of Cortex Media Group Ltd., a digital advertising platform that develops and markets a variety of technological platforms that automate, optimize and monetize digital online campaigns.

 

We consolidated Gix Internet’s financial statements as of February 28, 2022.

 

As of December 31, 2024, we held 45.74% of Gix Internet’s outstanding share capital.

 

Eventer Technologies Ltd. - Online Event Management

 

Eventer is a technology company engaged in the development of unique tools for automatic creation, management, promotion, and billing of events and ticketing sales. Eventer seeks to tap the growing demand for enterprise and private online communication. As such, Eventer’s systems offer and enable advanced, user-friendly solutions for online events such as online concerts, enterprise events and online conferences, in addition to management and ticket sales for events carried out in offline venues. In addition, Eventer’s platform provides individuals with the ability to create and sell tickets to custom small-scale private or public events. Eventer’s revenues are derived from commissions from sales of tickets for online and offline events planned and managed through its platform.

 

On December 6, 2023, we signed a share purchase agreement with Keshet Holdings LP to purchase its entire stake in Eventer for consideration of USD 250K which was paid in our shares. The closing of the transaction occurred on August 28, 2024. Following this transaction, our holdings in Eventer increased to 58.44% of Eventer’s issued and outstanding common stock. As of December 31, 2024, we held 58.44% of Eventer’s outstanding share capital.

 

Medical Activity Overview 

 

Our MUSE‎™‎ System  

 

We have been engaged in the development, production and marketing of innovative surgical devices with direct visualization capabilities for the treatment of Gastroesophageal Reflux Disease, a common ailment, which is predominantly treated by medical therapy (e.g. proton pump inhibitors) or in chronic cases, conventional open or laparoscopic surgery. Our product, the MUSE™ system for transoral fundoplication is a single use innovative device for the treatment of GERD disorder. The MUSE™ system is an endoscopic, incisionless solution that is used to perform a procedure as an alternative to a surgical fundoplication.

 

On June 3, 2019, we entered into the Golden Grand Agreement for the know-how licensing and sale of good relating to the MUSE™ system in China, Hong Kong, Taiwan and Macao. Four out of five predetermined milestones in the Golden Grand Agreement were completed during 2020 and 2021, and consequently 80% of the agreed payments were already transferred to us. The parties are having difficulty completing the last milestone and are currently discussing how to resolve the issue.

 

33

 

 

Electric Vehicle Activity Overview

 

Charging Robotics Inc.

 

We invested in Charging Robotics Ltd., which was previously our wholly owned subsidiary. Charging Robotics is developing an autonomous wireless charging system for electric vehicles. On March 28, 2023, the Company entered into a securities exchange agreement (the “Exchange Agreement”) with Fuel Doctor Holdings, Inc. (“Fuel Doctor”). Pursuant to the Exchange Agreement, at the closing, which occurred on April 7, 2023, Fuel Doctor acquired 100% of the issued and outstanding share capital of Charging Robotics, making Charging Robotics a wholly-owned subsidiary of Fuel Doctor, in exchange for the issuance of shares of the Fuel Doctor’s common stock. As a result, Charging Robotics became a subsidiary of Fuel Doctor and as of December 31, 2024, we held 63.75% of Fuel Doctor’s outstanding share capital, with an option to increase our holdings to up to 73.35% of its outstanding share capital based on pre-set milestones. Fuel Doctor later changed its name to Charging Robotics, Inc.

 

Revoltz Ltd.

 

On February 19, 2021, Charging Robotics entered into a joint venture agreement with Amir Zaid, Weijian Zhou and Charging Robotics, for the purpose of developing and commercializing three modular electric vehicle (EV) micro mobility vehicles for urban individual use and “last mile” cargo delivery, through a new subsidiary, Revoltz Ltd. (“Revoltz”) Pursuant to the terms of such agreement, Charging Robotics was issued 19.99% of the issued and outstanding share capital of Revoltz.

 

Other Activities 

 

Parazero Ltd.

 

In 2022 we made multiple investments in Parazero, a company specializing in drone safety systems, through various transactions. As of December 31, 2024, we held 5.7% of Parazero’s issued and outstanding share capital. Parazero develops and provides drone safety solutions designed to protect people and payloads, providing a solution to reduce the risk of a drone’s malfunction in an urban environment.

 

Zig Miami 54 LLC

 

On September 13, 2023, we signed an operating agreement with Zig Investment Group LLC (“Zig Investment Group”), a Florida limited liability company, pursuant to which they formed a company, under the name Zig Miami 54 LLC (“Zig Miami 54”), a Florida limited liability company. The purpose of Zig Miami 54 is to acquire, improve, renovate, develop, manage, sell and otherwise deal with a commercial property located in Miami, Florida. The rights of Zig Miami 54 are exercised by Zig Investment Group, and the business and affairs of Zig Miami 54 are managed under the direction of Zig Investment Group (the “Manager”). As of December 31, 2024, we held 60% of Zig Miami 54’s issued and outstanding share capital.

 

34

 

 

Our Strategy

 

Our primary goal is to generate revenues through the activities of our consolidated subsidiaries, each in their respective market and field. In addition, we seek to generate revenues by pursuing potential opportunities to sell our MUSE technology, or alternatively grant a license or licenses for the use of the MUSE technology. Our strategy includes the following key elements:

 

Commercialization of the products and services provided by our consolidated subsidiaries as well as achieving organic growth and profitability. Our board of directors has determined to support the growth, development and expansion of our consolidated subsidiaries businesses. 

 

Sell or License MUSE‎ technology. Our board of directors has determined to examine potential opportunities to sell our MUSE technology, or alternatively grant a license or licenses for the use of the MUSEtechnology.

 

General Pursuit of Opportunities. Our board of directors and management are constantly seeking and pursuing opportunities through which to leverage our assets and capabilities.

 

A substantial material portion of our revenues in 2024 and 2023 derived from Gix Internet, Jeffs’ Brands and Eventer. In 2022 revenues derived from Jeffs’ Brands, Eventer and from the licensing and sale agreement. The following data reflects our total revenue arising from the following services:

 

  Revenues 
  Year Ended December 31, 
  2024  2023   2022 
  (Thousands of U.S. dollars)
Revenues from sale of products (from Jeffs’ Brands) (**)1,002   10,008    5,861 
Revenues from internet services (from Gix Internet) 26,941   79,613    (*)83,532
Revenues from commissions (from Eventer Technologies) 1,551   2,103    2,465 
Management fees and others (from Xylo Technologies)(***)     364       -    - 
Total 29,858   91,724    91,858 

 

  (*) The revenues from Gix Internet are presented for the period from February 28, 2022, to December 31, 2022.
  (**) The revenues from Jeffs’ Brands are presented for the period from January 1, 2024, to January 28, 2024.
  (***) Revenues from consulting services to Jeffs’ Brands and Parazero.

 

35

 

 

The following data reflects our total revenue broken down by geographic region:

 

   Revenues 
   Year Ended December 31, 
   2024   2023   2022 
   (Thousands of U.S. dollars) 
United States   15,785    49,954    52,129 
Europe   8,419    19,285    21,731 
Great Britain   662    5,628    166 
Israel   4,864    15,653    15,266 
Canada   117    944    385 
Asia   10    254    2,108 
Other   1    6    73 
Total   29,858    91,724    91,858 

 

Seasonality of Business

 

During the last few years, we have not seen any seasonality in our sales. However, our subsidiaries experience certain effects of seasonality in their operations.

 

In connection with our subsidiary, Eventer, there is an increase in events scheduled during the holiday season in Israel, which typically occurs in September and October, and which corresponds to an increase in ticket sales.

 

In connection with our subsidiary, Gix Internet, the digital advertising industry is not affected by much seasonality. However, there is a seasonal trend such that the fourth quarter is characterized by higher activity compared to average, while the first quarter is characterized in lower activity than average. This seasonality results from, among other things, changes in large advertising budgets, usually towards the end of each quarter and effective towards the end of each year. In addition, the last quarter of the year includes many leading events and an increase in advertising budgets and the volume of traffic on the network.

 

Marketing and Distribution

 

Sale or License of MUSE System

 

As part of our board of directors’ decision to examine potential opportunities to sell our MUSE™ technology, or alternatively grant a license or licenses for the use of the MUSE™ technology, our board of directors has reexamined the efforts and resources previously invested by us in our MUSE™ technology distribution agreements as well as the revenues obtained through such agreements in order to assess their financial viability. As a result of this analysis, our board of directors resolved to terminate our distribution agreements in order to redirect our resources to securing licensing agreements, which may in turn generate significant income in the short term, reduce operating expenses and lower our Company’s burn rate. On May 5, 2021, the Company engaged with a contractor into service agreement, which the contractor seek, develop, evaluate, filter and recommend suitable business opportunities for the Company in the fields of the Muse products and technology, and also Communicate and meet potential customers and introduce the Company and the Company’s products thereto, and, to the extent required by the Company from time to time, assistance and support with respect to negotiations with potential customers.

 

Intellectual Property  

 

Our commercial success depends, in part, on obtaining and maintaining patent and other intellectual property protection, in the United States and internationally, for the technologies used in our products. We cannot be sure that any of our patents will be commercially useful in protecting our technology. Our commercial success also depends in part on our non-infringement of the patents or proprietary rights of third parties. The patent positions of medical device companies and companies in the automotive space, can be highly uncertain and involve complex and evolving legal and factual questions. For additional information see “Item 3. Key information-D. Risk Factors-Risks Related to Our Intellectual Property.”

 

We and Charging Robotics (hereinafter in this paragraph: “We” or “Us”) own 13 U.S. patents and have two additional pending patent applications in the U.S. In addition, we own 5 patents that were granted in other countries, including European patents, which are not valid on their own unless validated in specific European countries as indeed were validated or requested the protection of the Unified Patent System and 2 pending patent applications in such other countries. We also own two pending Paris Convention Treaty (PCT) patent applications.

 

36

 

 

We have nine (9) registered trademarks, tradenames and service marks.

 

We cannot be sure that any patents will be granted with respect to any the pending patent applications or with respect to any patent applications filed by us in the future. There is also a significant risk that any issued patents will have substantially narrower claims than those that are currently sought.

 

Competition

 

Competition related to our subsidiary Eventer

 

Eventer competes with traditional ticketing offices and digital platforms offering event management and ticketing solutions. In Israel, major competitors include Eventbuzz, TickChak Ltd., Kupat, Leaan Tickets Ltd., CTS Eventim New Co, and Kupot Tel-Aviv Tickets and Shows Ltd. Additionally, Eventer faces competition from platforms like BUYME and Groupon for events and activities. Maintaining competitive advantages through innovation and strategic marketing is essential for sustaining growth and market share.

 

Competition related to our subsidiary Gix Internet

 

There are companies that develop various types of software and digital content that partially enable some of the operations performed by Gix Internet. As of the date of the report, Gix Internet is unable to assess its size and position compared to its other competitors and its size in the digital advertising market. The main competitors in the field are Perion, FireArc, Spigot, IAC AOL, System One, Tonic, Aporia, Kueez, Spike Media, Front Story and Predicto. Additionally, there are hundreds of smaller competitors.

 

Government Regulation

 

The healthcare industry, and, therefore, our business, is subject to extensive federal, state, local and foreign regulation. Some of the pertinent laws have not been definitively interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. In addition, these laws and their interpretations are subject to change.

 

Both federal and state governmental agencies continue to subject the healthcare industry to intense regulatory scrutiny, including heightened civil and criminal enforcement efforts. As indicated by work plans and reports issued by these agencies, the federal government will continue to scrutinize, among other things, the billing practices of healthcare providers and the marketing of healthcare products.

 

We believe that we have structured our business operations and relationships with our customers to comply with all applicable legal requirements. However, it is possible that governmental entities or other third parties could interpret these laws differently and assert otherwise. In addition, because there is a risk that our products could be used off label, we believe we are subject to increased risk of prosecution under these laws and by these entities even if we believe we are acting appropriately. We discuss below the statutes and regulations that are most relevant to our business and most frequently cited in enforcement actions.

 

C. Organizational Structure

 

As of December 31, 2024, we had three significant subsidiaries, (i) Eventer Technologies, a company incorporated under the laws of the State of Israel in which held, as of December 31, 2024, 58.44% of its outstanding share capital, (ii) Charging Robotics Inc., a Delaware corporation, in which we held, as of December 31, 2024, 63.75% of its outstanding share capital, (iii) Gix Internet a company incorporated under the laws of the State of Israel in which we held, as of December 31, 2024, 45.74% of its outstanding share capital.

 

37

 

 

D. Property, Plant and Equipment

 

Our offices are located at 10 HaNechoshet Street, Tel Aviv, Israel, 6971072, where we occupy approximately 102 square meters. We believe our facilities sufficiently meet our current needs.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes to those statements included elsewhere in this annual report on Form 20-F. In addition to historical consolidated financial information, the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those discussed under “Item 3. Key Information-D. Risk Factors” and elsewhere in this annual report.

 

Certain information called for by this Item 5, including a discussion of the year ended December 31, 2023, compared to the year ended December 31, 2022, has been reported previously in our annual report on April 22, 2024, under Item 5 “Operating and Financial Review and Prospects”.

 

For the purpose of this Item 5., references to “Xylo Technologies”, the “Company”, “us”, “we” and “our” refer to Xylo Technologies and its consolidated subsidiaries.

 

Overview  

 

Our legal and commercial name is Xylo Technologies Ltd. We were incorporated in the State of Israel on December 9, 1999, as a private company pursuant to the Israeli Companies Ordinance (New Version), 1983. In February 2006, we completed our initial public offering in Israel, and until January 25, 2021, our Ordinary Shares were traded on the TASE, under the symbol “MDGS”. On January 25, 2021, we delisted our Ordinary Shares from trading on TASE. In May 2015, we listed our ADSs on Nasdaq, and from August 2015 until April 17, 2024, our ADSs were traded on the Nasdaq under the symbol “MDGS”. Following a 1:15 ratio change of the ADSs on November 14, 2022 (the “Ratio Change”), each ADS represents fifteen (15) Ordinary Shares. In connection with our name change our ADSs began trading on Nasdaq under the symbol “XYLO” as of April 18, 2024. On August 5, 2024, we executed a ratio change in our American Depositary Receipts (ADRs) resulting in a reverse split of our ADR program on the basis of one (1) new ADS for every 2.666666 old ADSs held. As a result, the number of Ordinary Shares represented by each ADS was changed from fifteen (15) Ordinary Shares to forty (40) Ordinary Shares.

 

On October 14, 2020, we signed a share purchase agreement and a revolving loan agreement with Eventer. The Eventer transaction closed on October 26, 2020. Pursuant to the share purchase agreement, we invested $750,000 and were issued 325,270 ordinary shares of Eventer, representing 58.7% of Eventer’s then issued and outstanding share capital. On April 8, 2021, Eventer consummated an additional share purchase agreement with certain investors in connection with the sale and issuance its ordinary shares for an aggregate amount of $2.25 million (the “Purchase Agreement”). According to the Purchase Agreement, if during the twelve months following the closing of the Purchase Agreement, or March 25, 2022, Eventer shall not consummate an IPO, then the price per share shall be adjusted by issuance of additional shares. By March 25, 2022, Eventer had not consummated an IPO, therefore, on May 25, 2022, Eventer issued additional shares to the Company and additional investors. As a result of such share issuance, our holding in Eventer decreased to 46.21% of Eventer’s outstanding share capital. On December 6, 2023, we signed a share purchase agreement with Keshet Holdings LP to purchase its entire stake in Eventer for consideration of USD 250K which will be paid as our ordinary shares. The closing of the transaction occurred on August 28, 2024. Following this transaction, our holdings in Eventer increased to 58.44% of Eventer’s issued and outstanding common stock. As of December 31, 2024, we held 58.44% of Eventer’s outstanding share capital.

 

As of December 31, 2021, we held 34.58% of Gix Internet’s outstanding share capital. On February 14, 2022, we purchased 500,000 additional shares, increasing our holdings to 35.78% of Gix Internet’s outstanding share capital. On February 28, 2022, we purchased additional shares following which our holdings in Gix Internet increased to 38.03% of its outstanding share capital. As a result of this increase, and the fulfillment of additional conditions we consolidated Gix Internet’s financial statements as of February 28, 2023. On June 19, 2022, we purchased an additional 3,171,160 shares of Gix Internet. On December 11, 2023, we signed an agreement for an additional investment of NIS 1.3 million (approximately USD 350 thousand). As of December 31, 2024, we held 45.74% of Gix Internet’s outstanding share capital.

 

38

 

 

A. Operating results:

 

The following table sets forth a summary of our operating results:

 

   Year ended
December 31,
 
   2024   2023 
   U.S. Dollars, in thousands,
except per share and
weighted average
shares data
 
Revenues        
Products   1,002    10,008 
Services   28,856    81,716 
    29,858    91,724 
Cost of revenues          
Products   927    9,019 
Services   22,248    70,864 
    23,175    79,883 
           
Gross profit   6,683    11,841 
Research and development expenses   4,917    5,888 
Sales and marketing expenses   3,038    4,660 
General and administrative expenses   7,222    12,108 
Loss (Gain) from changes in fair value of financial assets at fair value through profit or loss   (3,623)   3,830 
Equity losses   367    4,107 
Net loss (gain) from derecognition of investments accounted for using the equity method   (140)   2,227 
Impairment of goodwill and other intangible assets   2,919    1,812 
Amortization of excess purchase price of associates   -    530 
Operating loss   (8,017)   (23,321)
           
Loss from deconsolidation of Jeffs’ Brands   1,318    - 
Gain from sale of investments in financial assets at fair value through profit or loss and investments accounted for using the equity method   (10)   - 
Other income, net   -    (329)
Gain from changes in fair value of warrants issued to investors   -    (396)
Changes in fair value of warrants issued to third party investors by subsidiaries   53    (2,322)
Loss in connection with issuance of warrants by Viewbix Inc,   1,833    - 
Financial loss, net   1,051    1,532 
Loss before taxes on income   (12,262)   (21,806)
Tax benefit   (257)   (74)
Net loss for the year   (12,005)   (21,732)
           
Other comprehensive loss          
Items that may be reclassified to profit or loss          
Share of other comprehensive loss of consolidated subsidiaries and associates accounted for using the equity method   (118)   (121)
Other comprehensive loss for the year   (118)   (121)
Total comprehensive loss for the year   (12,123)   (21,853)
Net loss for the year is attributable to:          
Owners of Xylo Technologies Ltd.   (6,027)   (16,025)
Non-controlling interests   (5,978)   (5,707)
    (12,005)   (21,732)
Total comprehensive loss for the year is attributable to:          
Owners of Xylo Technologies Ltd.   (6,015)   (16,210)
Non-controlling interests   (6,108)   (5,643)
    (12,123)   (21,853)
Loss per ordinary share attributed to Xylo Technologies Ltd.          
Basic   (0.20)   (0.63)
Diluted   (0.20)   (0.63)
           
Weighted average ordinary shares outstanding (in thousands)   29,756    25,292 
Basic   29,756    25,292 

 

39

 

 

Year ended December 31, 2024, compared to year ended December 31, 2023

 

Revenues

 

Revenues for the year ended December 31, 2024, were $29,858 thousand representing a decrease of $61,866 thousand or 67% compared to total revenues of $91,724 thousand for the year ended December 31, 2023.

 

The decrease in revenues was primarily due to: (1) the decrease in Gix Internet’s revenues from internet services, mainly as a result of technological changes and changes in content policy in the advertising platforms.

 

(2) deconsolidation of Jeffs’ Brands as of January 28, 2024.

 

The tables below set forth our revenues, by region and by product for the periods presented:

 

U.S. dollars; in thousand

 

   Year Ended December 31, 
   2024   2023 
United States   15,785    53%   49,954    54%
Europe   8,419    28%   19,285    21%
Great Britain   662    2%   5,628    6%
Israel   4,864    16%   15,653    17%
Canada   117    0.4%   944    1%
Asia   10    -%   254    0.3%
Other   1    -%   6    1.7%
Total   29,858    100%   91,724    100%

 

U.S. dollars; in thousand

 

   Year Ended December 31, 
   2024   2023 
Revenues from commissions (from Eventer Technologies)   1,551    5%   2,103    2%
Revenues from sale of products (from Jeffs’ Brands) *   1,022    4%   10,008    11%
Management fees and others (from Xylo Technologies)**   364    1%   -    - 
Revenues from internet services (from Gix Internet)   26,941    90%   79,613    87%
Total   29,858    100%   91,724    100%

 

* The revenues from Jeffs’ Brands are presented for the period from January 1, 2024, to January 28, 2024.
** Revenues from consulting services to Jeffs’ Brands and Parazero and other revenues from Jeffs’ Brands

 

40

 

 

Cost of revenues 

 

Cost of revenues for the year ended December 31, 2024, were $23,175 thousand representing a decrease of $56,708 thousand, or 71%, compared to cost of revenues and of $79,883 thousand for the year ended December 31, 2023. The decrease is primarily due to the decrease in cost of revenues of Gix Internet as a result of the decrease in revenues and the deconsolidation of Jeffs’ Brands as of January 28, 2024.

 

Gross Profit 

 

Gross profit for the year ended December 31, 2024, was $6,683 thousand, representing a decrease of $5,158 thousand compared to gross profit of $11,841 thousand for the year ended December 31, 2023. The decrease in gross profit was primarily due to decrease of sales related to Gix Internet and the deconsolidation of Jeffs’ Brands as of January 28, 2024.

 

Research and Development Expenses 

 

Research and development expenses for the year ended December 31, 2024, were $4,917 thousand, representing a decrease of $971 thousand, or 16.5%, compared to $5,888 thousand for the year ended December 31, 2023. The decrease was primarily due to the reduction of expenses primarily in manpower and technological services in Gix Internet as part of a reduction costs program in Gix following the revenues decrease.

 

Sales and Marketing Expenses 

 

Sales and marketing expenses for the year ended December 31, 2024, were $3,038 thousand, representing a decrease of 1,622 thousand, or 35%, compared to $4,660 thousand for the year ended December 31, 2023. The decrease was primarily due to the reduction of expenses in the Search and Content Platform, primarily in manpower and salaries in Gix as part of cost reduction program following revenues decrease. It was additionally affected by the deconsolidation of Jeffs’ Brands starting January 28, 2024.

 

General and Administrative Expenses 

 

General and Administrative expenses for the year ended December 31, 2024, were $7,222 thousand, representing a decrease of $4,886 thousand, or 40%, compared to $12,108 thousand, for the year ended December 31, 2023.

 

The majority of the decrease was due to: (1) The deconsolidation of Jeffs’ Brands starting January 28, 2024; (2) decrease in the company's professional services expenses mainly due to decrease in costs related to the sale of odysight.ai in 2023 and decrease in granted options benefit expenses.

 

Net change in fair value of financial assets at fair value through profit or loss 

 

During 2024 we recognized a gain of $3,623 thousand from net change in the fair value of financial assets derived mainly from income of $2,339 from Parazero, $806 thousand from Polyrizon and $781 thousand from Metagramm, offsets mainly by the expenses of $1,311 from the change in the fair value of the shares of Jeffs’ Brands.

 

During 2023 we recognized a loss of $3,830 thousand from net change in the fair value of financial assets derived mainly due to expenses of $1,806 from Parazero, $703 thousand from Clearmind Medicine Inc. and $793 thousand from Automax Ltd.

 

Equity losses  

 

The investments in each of Revoltz, SciSparc (as part of Jeffs’ Brands until January 28, 2024), Solterra Energy (formerly known as A.I. Conversation Systems) until November 28,2024 , Polyrizon until July 2,2024 and Zig Miami 54 are accounted for using the equity method. The share net loss accounted for using the equity method for the year ended December 31, 2024, amounted to $367 thousand representing a decrease of $3,740 thousand, or 91% compared to $4,107 thousand, for the year ended December 31, 2023.

 

The majority of the decrease was due to: (1) the decrease in equity losses in SciSparc due to the deconsolidation of Jeffs’ Brands starting January 28, 2024; (2) transition of method from equity to fair value in Solterra Energy and Polyrizon due to diluted cause by issue and mergers (3) an impairment loss of USD 1,176 thousand following the impairment of the entire amount of the investment in Laminera in 2023.

 

41

 

 

Net gain from derecognition of investments accounted for using the equity method 

 

During 2024 we recorded $140 thousand net gain from derecognition of investments accounted for using the equity method mainly due to a gain of $138 thousand from transition of Solterra Energy (formerly known as A.I. Conversation Systems) investment to a fair value method.

 

During 2023 we recorded $2,227 thousand net loss from derecognition of investments accounted for using the equity method upon loss of significant influence mainly due to a gain of $714 thousand from transition of Parazero investment to a fair value method and a loss of $2,941 thousand from Odysight.ai as a result of transition of the investment to a fair value method prior to its sale.

 

Impairment of goodwill and other intangible assets

 

During 2024 we recognized an impairment loss of goodwill and other intangible assets of $2,919 thousand due to an impairment loss for the online advertising & internet traffic routing reporting unit’s goodwill.

 

During 2023 we recognized an impairment loss of goodwill and other intangible assets of $1,812 thousand mainly due to an impairment loss of $508 thousand for the online advertising & internet traffic routing reporting unit’s goodwill and of $1,304 thousand related to Eventer’s software license.

 

Operating loss 

 

We incurred an operating loss of $8,017 thousand for the year ended December 31, 2024, representing a decrease of $15,304 thousand, or 66% compared to operating loss of $23,321 thousand for the year ended December 31, 2023. The decrease was primarily due to a gain from changes in fair value of financial assets at fair value through profit or loss and decrease in Operating loss due to the deconsolidation of Jeffs’ Brands starting January 28, 2024.

 

Change in Fair Value of Warrants Issued to Investors 

 

There is no gain or loss from the change in fair value of the company’s warrants issued to investors for the year ended December 31, 2024 due to the expiration of the warrants on July 19, 2023.

 

During the year ended December 31, 2023 the Company recognized gain from change in the fair value of warrants issued to third party investors of $396 thousand for the year ended December 31, 2023.

 

Loss in connection with issuance of warrant by subsidiaries

 

The Company incurred a loss in connection with the issuance of warrants by subsidiaries of USD 1,833 thousand for the year ended December 31, 2024. The loss is due to the cost of warrants granted in Viewbix Inc. as part of certain loan agreements to which it is party.

 

Loss (Gain) from changes in fair value of warrants issued to third party investors by subsidiaries 

 

Loss from change in the fair value of warrants issued to third party investors by a consolidated subsidiary for the year ended December 31, 2024, was USD 53 thousand compared to a gain of USD 2,322 thousand for the year ended December 31, 2023.

 

Warrants issued to investors are classified as either liabilities or as part of the shareholders’ equity based on the accounting guidance established in connection with the rights attached to the warrants. The warrants that were classified as liabilities due to a cashless exercise mechanism are subject to adjustment to fair value each statement of financial position cut-off date. This adjustment is presented separately within the consolidated statement of loss and other comprehensive loss.

 

Financial expenses net 

 

Finance expenses, net for the year ended December 31, 2024, were $1,051 thousand, representing a decrease of $481 thousand, compared to finance expenses of $1,532 thousand for the year ended December 31, 2023, primarily due to the deconsolidation of Jeffs’ Brands as of January 28, 2024.

 

Loss for the year

 

We incurred net loss of $12,005 thousand for the year ended December 31, 2024, representing a decrease of $9,727 thousand, or 45%, compared to loss of $21,732 thousand for the year ended December 31, 2023. This decrease was primarily due to: (i) a decrease in operating expenses of Gix Internet and Jeffs’ Brands due to the deconsolidation of Jeffs’ Brands as of January 28, 2024; (ii) a gain from changes in fair value of financial assets at fair value through profit or loss.

 

42

 

 

Year ended December 31, 2023, compared to year ended December 31, 2022

 

The discussion and analysis regarding the results of operations from the fiscal years ended December 31, 2023, and December 31, 2022, is contained in our annual report on Form 20-F, filed with the SEC, on April 22, 2024.

 

Effective Corporate Tax Rate

 

Our effective consolidated tax rate for the year ended December 31, 2024 was 2%, and for the year ended December 31, 2023 was almost zero percent (0%), primarily due to the fact that the Company, Gix Internet, Jeffs’ Brands and Eventer did not record a deferred tax asset in connection with the losses incurred in Israel, since it is not probable that we will be able to utilize such losses in the foreseeable future against taxable income.

 

Impact of Inflation, Devaluation and Fluctuation in Currencies on Results of Operations, Liabilities and Assets

 

We generate part of our revenues in different currencies than our functional currency (U.S. dollars), such as NIS and Euro. As a result, some of our financial assets are denominated in these currencies, and fluctuations in these currencies could adversely affect our financial results. A considerable amount of our expenses are generated in U.S. dollars, but a significant portion of our expenses such as salaries are generated in other currencies such as NIS. Accordingly, we incur and expect to continue incurring additional expenses in non-U.S. dollar currencies, such as described above. Due to the mentioned, our results could be adversely affected as a result of a strengthening or weakening of the U.S. Dollar compared to these other currencies.

 

The inflation in Israel during the last several years was relatively immaterial and, therefore, had immaterial effect on our results of operations.

 

Effective January 1, 2016, we changed our functional currency to the U.S. dollar from NIS. This change was based on management’s assessment that the U.S. dollar is the primary currency of the economic environment in which we operate. Accordingly, the functional and reporting currency of our consolidated financial statements is the U.S. dollar.

 

B. Liquidity and Capital Resources

 

Liquidity

 

During the year ended December 31, 2024, we incurred a total comprehensive loss of approximately $ 12.1 million and a negative cash flow used in operating activities of approximately $ 1.8 million. As of December 31, 2024, we incurred accumulated deficit of approximately $ 107.6 million.

 

We will need to seek additional sources of funds, including selling additional equity, debt or other securities or entering into a credit facility, take costs reduction steps or modify our current business plan to achieve profitability. If we raise additional funds through the issuance of debt securities, these securities may have rights senior to those of our Ordinary Shares and could contain covenants that could restrict our operations and ability to issue dividends. We may also require additional capital beyond our currently forecasted amounts. Any required additional capital, whether forecasted or not, may not be available on reasonable terms, or at all. If we are unable to obtain additional financing, we may be required to reduce the scope of, delay or eliminate some or all of our planned research, development and commercialization activities, which could materially harm our business and results of operations.

 

43

 

 

Because of the numerous risks and uncertainties associated with the development of our products and the current economic situation, we are unable to estimate the exact amounts of capital outlays and operating expenditures necessary to complete the development of our products and successfully deliver commercial products to the market. Our future capital requirements will depend on many factors, including but not limited to the following:

 

the revenue generated by sales of our current and future products;

 

the expenses we incur in selling and marketing our products and supporting our growth;

 

the costs and timing of regulatory clearance or approvals for new products or upgrades or changes to our products;

 

  the expenses we incur in complying with domestic or foreign regulatory requirements imposed on medical device companies;

 

  the rate of progress, cost and success or failure of on-going development activities;

 

  the emergence of competing or complementary technological developments;

 

  the costs of filing, prosecuting, defending and enforcing any patent or license claims and other intellectual property rights;

 

  the terms and timing of any collaborative, licensing, or other arrangements that we may establish;

 

  the future unknown impact of recently enacted healthcare legislation;

 

  the acquisition of businesses, products and technologies; and

 

  general economic conditions and interest rates.

 

Cash Flows

 

Net cash used in operating activities for the year ended December 31, 2024, was $1,824 thousand, compared to $6,247 thousand for the year ended December 31, 2023. For the year ended December 31, 2024, the Company had net cash from investing activities of $2,384 thousand compared to net cash used in investing activities of $1,438 thousand for the year ended December 31, 2023. For the year ended December 31, 2024, the Company had net cash used in financing activities of $998 thousand compared to $3,149 thousand of net cash flow from financing activity for the year ended December 31, 2023.

 

The change in our liquidity for the year ended December 31, 2024, resulted from several factors, including but not limited to:

 

  net cash used in operating activities consists primarily of $6,833 thousand decrease in trade accounts payable, $3,623 thousand gain from changes in fair value of financial assets at fair value, $1,431 thousand decrease in accrued expenses and other current liabilities, $690 thousand interest paid, offset by $10,206 thousand decrease in trade accounts receivable, $2,919 thousand impairment of goodwill and other intangible assets.

 

  net cash from investing activities consists mainly of $3,324 thousand proceeds from sale of financial assets at fair value through profit or loss offset by $564 thousand acquisitions and investments in associates and $330 thousand acquisitions of investments at fair value through profit or loss.

 

  net generated used in financing activities consists mainly of $4,477 thousand repayment of short-term and long-term loans and offset by $1,932 thousand receipt of short-term loans, $932 proceeds from issuance of prefunded shares by the company, net of issuances costs, $ 410 proceeds from issuance of common stock in a private placement offering by Charging Robotics Inc. and $246 issuance of shares and warrants in connection with a private placement issued by Viewbix Inc.    

 

44

 

 

C. Research and Development, Patents and Licenses, etc.

 

Our research and development efforts are focused on continuous improvement of our products. We conduct all of our research activities in Israel.

 

As of December 31, 2024, our research and development team consisted of 6 employees and subcontractors for the development of our products in Gix Internet, and Eventer as needed. We have assembled an experienced team with recognized expertise in software, control algorithms and systems integration.

 

The table below set forth our research and development expenses for the periods presented:

 

   Year Ended December 31, 
   2024   2023 
   (U.S. Dollars, in thousands) 
Research and development expenses  $4,917   $5,888 

 

From time to time, we file applications for patent registration in certain countries, some in which we are active and some which we consider as potential markets in order to protect our developed intellectual property.

 

D. Trend Information

 

Other than as disclosed elsewhere in this Annual Report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2024 to December 31, 2024 that are reasonably likely to have a material adverse effect on our revenue, profitability, liquidity or capital resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial condition.

 

E. Critical Accounting Estimates

 

Our significant accounting policies and their effect on our financial condition and results of operations are more fully described in our audited consolidated financial statements included elsewhere in this Annual Report. We have prepared our financial statements in conformity with International Financial Reporting Standards or IFRS, which requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. These estimates are prepared using our best judgment, after considering past and current events and various other assumptions. While management believes the factors evaluated provide a meaningful basis for establishing and applying sound accounting policies, management cannot guarantee that the estimates will always be consistent with actual results. In addition, certain information relied upon by us in preparing such estimates includes internally generated financial and operating information, external market information, when available, and when necessary, information obtained from consultations with third parties. Actual results may differ from these estimates. We believe that the accounting policies discussed below are critical to our financial results and to the understanding of our past and future performance, as these policies relate to the more significant areas involving management’s estimates and assumptions. We consider an accounting estimate to be critical if: (1) it requires us to make assumptions because it included matters that were highly uncertain at the time, we were making our estimate or the assumption is material due to the levels of subjectivity and judgment involved, and (2) changes in the estimate could have a material impact on our financial condition or results of operations.

 

45

 

 

Fair value measurements and valuation process of financial assets and liabilities measured at fair value through profit or loss (FVTPL)

 

Some of the Group’s financial assets and financial liabilities are measured at fair value for financial reporting purposes.

 

In estimating the fair value of such assets or liabilities, the Group uses market-observable data. Where Level 1 or 2 inputs are not available, the Group determines the fair value of the financial instrument using acceptable valuation techniques and, as applicable, engages third party qualified valuation specialists to perform the valuation.

 

Impairment of Intangible Assets

 

During 2024, the Company recognized an impairment loss of USD 2,919 thousand for the online advertising & internet traffic routing reporting unit’s goodwill, reducing the book value of goodwill to USD 4.8 million as of December 31, 2024. The Company’s quantitative goodwill impairment test involves the comparison of the fair value of each reporting unit to its carrying value. In estimating the fair value of the online advertising & internet traffic routing reporting unit (Gix Internet) the Company used the income approach method, which requires management to make significant estimates and assumptions related to future cash flows and discount rates.

 

Recent Accounting Pronouncements

 

Please see Note 2 to our audited consolidated financial statements included elsewhere in this annual report for information regarding recent accounting pronouncements.

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Senior Management

 

The following table lists the names and ages of our directors and senior management as of April 29, 2024:

 

Name   Age   Position(s)
Liron Carmel   41   Chief Executive Officer
Eliyahu Yoresh(1)(3)(4)   55   Chairman of the Board of Directors
Ronen Rosenbloom(1)(2)(4)   53   Director
Eli Cohen(1)(2)(3)(4)   56   Director
Kineret Tzedef(2)(4)   45   Director
Tali Dinar   53   Chief Financial Officer

 

(1) Member of the audit committee.
   
(2) Member of the compensation committee.
   
(3) Member of the investment committee.
   
(4) Indicates independent director under Nasdaq Stock Market rules.

 

Liron Carmel has served as our Chief Executive Officer since April 2019. Mr. Carmel has vast experience in business and leadership across multiple industries, including bio pharma, internet technology, oil & gas exploration & production, real estate and financial services. In addition, he serves as chairman of the Israel Table Tennis Association. Mr. Carmel also currently serves as a member of the board of directors of several of our subsidiaries including Gix Internet (TASE: GIX), beginning April 2021, Polyrizon Ltd., beginning July 2020 until September 2024 and since January 2025, Jeffs’ Brands Ltd. (Nasdaq: JFBR) beginning September 2021, Viewbix Inc. (OTC: VBIX) beginning September 2022 and as the chairman of the board of directors of Eventer Technologies Ltd. beginning October 2020. Mr. Carmel holds a B.A in economics and management from the College of Management.

 

46

 

 

Eliyahu Yoresh has served as a member of our Board since September 2018 and as Chairman of the board since February 2020. Mr. Yoresh serves as Chief Financial Officer of Foresight Autonomous Holdings Ltd. (Nasdaq, TASE: FRSX). In addition, Mr. Yoresh serves as Chairman of Rail Vision (Nasdaq: RVSN) and Gix (TASE: GIX) and serves as a director of Viewbix Inc. (OTC: VBIX), Charging Robotics Inc (OTC:CHEV) and Elbit Imaging (TASE: EMITF). Mr. Yoresh served as the Chief Executive Officer of Tomcar Global Holdings Ltd., a global manufacturer of off-road vehicles, from 2005 to 2008. Mr. Yoresh is an Israeli Certified Public Accountant. Mr. Yoresh holds a B.A. in business administration from the College of Management, Israel and an M.A. in Law Study from Bar-Ilan University, Israel.

 

Ronen Rosenbloom has served as a member of our Board since September 2018. Mr. Rosenbloom is an independent lawyer and has been working for a self-owned law firm specializing in white collar offences since 2004. Mr. Rosenbloom served as chairman of the Israeli Money Laundering Prohibition committee and the Prohibition of Money Laundering Committee of the Tel Aviv District, both of the Israel Bar Association from November 2015 until December 2019. Mr. Rosenbloom holds an LL.B. from the Ono Academic College, an Israeli branch of University of Manchester.

 

Eli Cohen has served as a member of our Board since September 2018. Mr. Cohen is an independent lawyer working for a self-owned firm. He serves as chairman of Univo Pharmaceuticals Ltd., as director of Europe Hagag Ltd., and previously served as director of Hagag Group Ltd., Multimatrixs Ltd., Matrat Mizug Ltd. and User Trend-M Ltd. Mr. Cohen also serves as a director of several private companies. Mr. Cohen holds a B.A. in economics, an LL.B. and an LL.M. in Commercial Law from Tel-Aviv University, as well as an MBA from the Northwestern University and Tel-Aviv University joint program.

 

Kineret Tzedef has served as member of our Board since June 2019. Ms. Tzedef also serves as a director of sports division and served in other positions at Hapoel Organization (Israeli Sport Federation) since 2007. Ms. Tzedef serves as an external director at Upsellon Brands Holdings Ltd. (TASE: UPSL), and as an external director of Augwind Energy Tech Storage Ltd. (TASE: AUGN). Ms. Tzedef is admitted to the Israel Bar Association since 2014. Ms. Tzedef holds a LL.B. from the Academic Center for Law and Science, Israel and a B.Ed. in Law Study from the Academic College at Wingate, Israel.

 

Tali Dinar has served as our Chief Financial Officer since June 8, 2021. Mrs. Dinar served as Chief Financial Officer of Novomic Ltd., a private company between January 2019 and January 2023. Mrs. Dinar also currently serves as a member of the board of directors of Jeffs’ Brands, beginning September 30, 2021, Parazero. beginning February 13, 2022, a director in Charging Robotics Ltd. since November 2021, a director in Charing Robotics Inc. since April 4, 2023. She has also served as a member of the board of directors of Micronet Ltd. (TASE: MCRNT) between July 2016 and February 2023. In addition, she has also served as a director of Canzon Israel Ltd. (TASE: CNZN) since August 2020 until March 2022. Between 2019 and 2020, Mrs. Dinar served as the Chief Financial Officer of TechCare Corp. (currently Citrine Global Corp.) (OTCQB: CTGL). Between 2009 and 2019, Mrs. Dinar worked at the MICT group and served in various positions, including as Chief Financial Officer of MICT Inc. (Nasdaq: MICT) and as Chief Financial Officer of MICT Telematics Ltd. From 2002 until 2006, Mrs. Dinar served as the chief controller of I.T.L. Optronics Ltd. From 1997 until 2000, Mrs. Dinar worked in the audit department of Ernst & Young Global. Mrs. Dinar is a certified public accountant in Israel and holds a B.A. degree in Accounting and Business Management from The College of Management, Israel.

 

47

 

 

Family Relationships

 

There are no family relationships between any members of our executive management and our directors.

 

Arrangements for Election of Directions and Members of Management

 

There are no arrangements or understandings with major shareholders, customers, suppliers or others pursuant to which any of our executive management or our directors were appointed.

 

B. Compensation

 

Compensation of Directors and Executive Officers

 

In accordance with the provisions of the Companies Law, the compensation of our directors and officer holders must generally comply with the terms and conditions of our compensation policy, as approved by our compensation committee, board of directors and general meetings of our shareholders, subject to certain exceptions under the Companies Law.

 

The table below reflects the compensation granted to our six most highly compensated directors and officers during or with respect to the year ended December 31, 2024.

 

Name and Position  Salary   Bonus   Equity-Based
Compensation(1)
   Total 
   U.S. Dollars in thousands 
Liron Carmel, Chief Executive Officer   195    54    96    345 
Eliyahu Yoresh(2), Chairman of the Board of Directors   146    44    97    287 
Tali Dinar(3), Chief Financial Officer   134    28    40    202 
Kineret Tzedef, Director   36    -    22    58 
Eli Cohen, Director   36    -    27    63 
Ronen Rosenbloom, Director   36    -    22    58 

 

(1) Represents the equity-based compensation expenses, including expenses related to RSUs, recorded in the Company’s consolidated financial statements for the year ended December 31, 2024, based on the fair value, calculated in accordance with accounting guidance for equity-based compensation.

 

(2) Mr. Yoresh has been serving as a member of our board of directors since September 2018 and as Chairman of the board of directors since February 2020.

 

(3) Salary includes gross salary plus payment of social benefits made by us on behalf of such office holder. Such benefits may include, to the extent applicable to the office holder, payments, contributions and/or allocations for savings funds (such as managers’ life insurance policy), education funds (referred to in Hebrew as “keren hishtalmut”), pension, severance, risk insurances (e.g., life, or work disability insurance), payments for social security and tax gross-up payments, vacation, medical insurance and benefits, convalescence or recreation pay and other benefits and perquisites consistent with our policies.

 

The aggregate compensation paid by us to our office holders, as defined in the Companies Law, for the year ended December 31, 2024, was approximately $1.01 million, which includes six persons. This amount includes, when applicable, set aside or accrued to provide pension, severance, retirement or similar benefits or expenses, car expenses and value of the Ordinary Shares underlying the options representing accounting expenses, but does not include business travel, relocation, professional and business association dues and expenses reimbursed to officers, and other benefits commonly reimbursed or paid by companies in Israel.

 

48

 

 

Compensation of Directors

 

Under the Companies Law and the rules and regulations promulgated thereunder, our directors are entitled to a fixed annual compensation, up to the limits set forth in the compensation policy. We currently pay each of Mr. Ronen Rosenbloom, Ms. Kineret Tzedef and Mr. Eli Cohen an annual fee of NIS 132,000.

 

Each of our non-executive directors were also granted options to purchase   100,000 Ordinary Shares under the Plan (as defined herein). Such options were granted on June 29, 2021. The options vest over a period of three (3) years commencing on April 1, 2021, with 1/12 of such options vesting at the end of each subsequent three-month period following the grant, (ii) the term of the options is of six (6) years from the grant date, unless they have been exercised or cancelled in accordance with the terms of and conditions of the applicable incentive plan of the Company, (iii) unless previously exercised or cancelled, the options may be exercised until 180 days from the termination of the tenure of a director, (iv) the exercise price per share of the options is equal to the average share price of the 30 days prior to the date of grant, $1.783 (v) the options grant is in accordance and pursuant to Section 102 of the Income Tax Ordinance [New Version] (“Tax Ordinance”), if applicable, and (vi) the options will be accelerated upon the closing of a material transaction, resulting in change of control of the Company.

 

On April 25, 2021, and on May 4, 2021, our compensation committee and board of directors approved new compensation terms for Mr. Eliyahu Yoresh in connection with his services as an active chairman of the board of directors. For his services, Mr. Yoresh is entitled to receive a monthly payment of NIS 45,000 plus VAT, which constitutes the sole and complete compensation. In addition, Mr. Yoresh is entitled to an annual, target-based bonus and an additional overachievement bonus of up to 6 monthly salaries, each. The weight afforded to each target and overachievement component, is to be decided by our board of directors and compensation committee in accordance with the following weights: (a) 35% Company performance measures of strategic goals and related objectives; (b) 25% Company performance measures of material transaction or material profitability/revenues; (c) 20% Company performance measures of revenues and/or loss reduction; and (d) 20% Company performance measures of achieving commercialization of Company’s technology. The aforementioned compensation terms are consistent with our current compensation policy.

 

Following the approval of the annual general meeting of our shareholders held on August 30, 2021, Mr. Yoresh was granted a one-time grant of options to purchase 300,000 Ordinary Shares in accordance with the terms of the Plan. The options vest over a period of three (3) years commencing on April 1,2021, with 1/12 of such options vesting at the end of each subsequent three-month period following the grant, (ii) the term of the options is of six (6) years from the grant date, unless they have been exercised or cancelled in accordance with the terms of and conditions of the applicable incentive plan of the Company, (iii) unless previously exercised or cancelled, the options may be exercised until 180 days from the termination of Mr. Yoresh’ tenure as a chairman, (iv) the exercise price per share of the options is equal to the average share price of the 30 days prior to the date of grant, $1.783 (v) the options grant will be in accordance and pursuant to Section 102 of the Tax Ordinance, if applicable, and (vi) the options will be accelerated upon the closing of a material transaction, resulting in change of control of the Company.

 

As a result of market conditions, in June 2023, Mr. Yoresh and Mr. Carmel elected to reduce their compensation by 20%, effective June 2023 through December 2023. Similarly, the Board voted to reduce the directors’ compensation by 20% for the second, third and fourth quarters of 2023. As of January 2024, Mr. Yoresh’s, Mr. Carmel’s and Board’s respective compensation were reinstated to their full amounts.

 

Equity Based Compensation of our Executive Officers and Directors 

 

As of April 17, 2025, options to purchase 1,037,500 of our Ordinary Shares were outstanding and held by current executive officers and directors consisting of 6 persons with an average exercise price of NIS 5.93 per ordinary share. As of December 31, 2024, 2,273,645 restricted share units, or RSUs, had been granted to our executive officers and directors See “Item 6. Directors, Senior Management and Employees-E. Share Ownership” in this annual report on Form 20-F.

 

49

 

 

Agreements with our Executive Officers

 

We have entered into written agreements with each of our executive officers. All of these agreements contain customary provisions regarding non-competition, confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited under applicable law. In addition, we have entered into agreements with each executive officer and director pursuant to which we have agreed to indemnify each of them to the fullest extent permitted by law to the extent that these liabilities are not covered by directors and officers insurance.

  

Our office holders are generally eligible for bonuses each year. The bonuses are established and granted in accordance with our compensation policy and are generally payable upon meeting objectives and targets that are approved by our compensation committee and board of directors (and if required by our shareholders).

 

Consulting Agreement with Mr. Carmel

 

On July 25, 2019, our shareholders approved that as of April 2, 2019, our Company would enter into a consulting agreement with Mr. Carmel, who serves as our Chief Executive Officer. The term is for an indefinite period, however the agreement may be terminated by either party by giving 60 days advance notice, or shorter periods in some cases, such as termination for “cause.” During the notice period, Mr. Carmel will be entitled to consulting fees only to the extent that he provides services to the Company during the notice period. The agreement also includes customary covenants regarding confidentiality, IP assignment, non-competition and non-solicitation.

 

Mr. Carmel’s monthly consulting fee is NIS 60,000 plus VAT, effective as of May 2021, as approved by our shareholders at our annual general meeting held on August 30, 2021. In addition, Mr. Carmel is entitled to an annual target based bonus and an additional overachievement bonus of up to 6 monthly salaries each, subject to a performance matrix to be approved by the Company’s compensation committee and board of directors on an annual basis, while up to 30% of such annual bonus may be discretionary and not subject to measurable performance indexes. The annual target bonus may be reduced by our board of directors according to our financial position and Mr. Carmel’s performance, and must be returned by Mr. Carmel if it is later shown to be granted in error which shall be restated in our financial statements.

 

In addition, Mr. Carmel was granted with options to purchase up to 62,500 Ordinary Shares of the Company (the “Options”), in accordance with the following terms: (i) the Options vest over a period of four (4) years commencing April 1, 2019, 25% of the Options vest on the first anniversary (i.e., April 1, 2020), and 75% of the Options vest on a quarterly basis over a period of three (3) years thereafter; (ii) the term of the Options is of six (6) years from the date of grant, unless they have been exercised or cancelled in accordance with the terms of and conditions of the applicable incentive plan of the Company, (iii) unless previously exercised or cancelled, the Options may be exercised until 180 days from the date of termination of the service, (iv) the exercise price per share of the Options shall be NIS 11.8, (v) the Options’ grant shall be in accordance and pursuant to Section 102 of the Income Tax Ordinance [New Version], and (vi) the Options shall be accelerated upon the closing of a material transaction, resulting in change of control of the Company.

 

At the annual general meeting of our shareholders held on August 30, 2021, Mr. Carmel was granted with additional grant of options to purchase 300,000 Ordinary Shares. The options vest over a period of three (3) years commencing on April 1, 2021, with 1/12 of such options vesting at the end of each subsequent three-month period following the grant, (ii) the term of the options is of six (6) years from the grant date, unless they have been exercised or cancelled in accordance with the terms of and conditions of the applicable incentive plan of the Company, (iii) unless previously exercised or cancelled, the options may be exercised until 180 days following the termination of the engagement, (iv) the exercise price per share of the options is equal to the average share price of the 30 days prior to the date of grant, $1.783 (v) the options grant will be in accordance and pursuant to Section 102 of the Tax Ordinance, if applicable, and (vi) the options will be accelerated upon the closing of a material transaction, resulting in change of control of the Company.

 

Following the SEC approval of Nasdaq’s proposed clawback listing standards, under Rule 10D-1 (the “Clawback Listing Rules”), which directed companies to adopt and comply with a written clawback policy, to disclose and file the policy as an exhibit to its annual report, we have adopted as of September 28, 2023, a clawback policy as contemplated pursuant to the Clawback Listing Rules, as filed as an exhibit to this Annual Report as Exhibit 97.

 

50

 

 

C. Board Practices

 

Introduction

 

Under the Companies Law and our amended and restated articles of association, the management of our business is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible for our day-to-day management and have individual responsibilities established by our board of directors.

 

Under our amended and restated articles of association, our board of directors must consist of at least three and not more than six directors, including two external directors appointed as required under the Companies Law. Our board of directors currently consists of four members, none of which are external directors, including our chairman of the board of directors, which is also appointed by the general meeting of our shareholders.

 

Our directors are divided into three classes with staggered three-year terms. At each annual general meeting of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors of that class of directors is for a term of office that expires on the third annual general meeting following such election or re-election, such that at each annual general meeting the term of office only one class of directors will expire. Each director holds office until the annual general meeting of our shareholders for the year in which his or her term expires and until his or her successor is duly appointed, unless the tenure of such director expires earlier pursuant to the Companies Law upon the occurrence of certain events or unless removed from office by a vote of the holders of at least 65% of the total voting power of our shareholders at a general meeting of our shareholders in accordance with our amended and restated articles of association.

 

Our directors are divided among the three classes as follows:

 

the Class I directors consist of Mr. Eli Cohen, and his term will expire at our annual general meeting of shareholders to be held in 2026;

 

the Class II directors consist of Ms. Kineret Tzedef and her term will expire at our annual general meeting of shareholders to be held in 2027; and

 

the Class III directors consist of Mr. Eliyahu Yoresh and Mr. Ronen Rosenbloom and their terms will expire at our annual general meeting of shareholders to be held in 2025.

 

In addition, our amended and restated articles of association allow our Board of Directors to appoint directors to fill vacancies on our Board of Directors or in addition to the acting directors (subject to the limitation on the number of directors and their qualifications), until the next general meeting in which directors may be appointed or such appointment terminated.

 

The board of directors (and, if so determined by the board of directors, the general meeting) may at any time and from time to time appoint any person as a director to fill a vacancy (whether such vacancy is due to a director no longer serving or due to the number of directors serving being less than the maximum number of six directors. In the event of one or more such vacancies in the board of directors, the continuing directors may continue to act in every matter, provided, however, that if the number of directors serving is less than three, than our board of directors may only act in an emergency or to fill the office of a director which has become vacant up to three directors, or for the purpose of convening a general meeting of the Company’s shareholders for the purpose of electing directors to fill any or all vacancies. The office of a director that was appointed by the board of directors to fill any vacancy shall only be for the remaining period of time during which the director whose service has ended was filled would have held office, or in case of a vacancy due to the number of directors serving being less than six, the board of directors shall determine at the time of appointment the class to which the additional director shall be assigned.

 

51

 

 

Pursuant to the Companies Law and our amended and restated articles of association, a resolution proposed at any meeting of our board of directors at which a quorum is present is adopted if approved by a vote of a majority of the directors present and eligible to vote. A quorum of the board of directors requires at least a majority of the directors then in office who are lawfully entitled to participate in the meeting.

 

According to the Companies Law, the board of directors of a public company must determine the minimum number of board members that should have financial and accounting expertise while considering, among other, the nature of the company, its size, the scope and complexity of its operations and the number of directors stated in the articles of association. Our board of directors resolved that the minimum number of board members that need to have financial and accounting expertise is one, and that Mr. Eliyahu Yoresh has accounting and financial expertise as required under the Companies Law.

 

External Directors

 

Under the Companies Law, companies incorporated under the laws of the State of Israel that are “public companies,” including companies with shares listed on the Nasdaq Capital Market, are required to appoint at least two external directors. External directors must meet certain independence criteria to ensure that they are unaffiliated with the company and its controlling shareholder, as well as certain other criteria. External directors are elected for three-year terms in accordance with specific rules set forth in the Companies Law and the regulations promulgated thereunder and may be removed from office only under limited circumstances. Under the Companies Law, each committee of a company’s board of directors that is authorized to exercise powers of the board of directors is required to include at least one external director, and all external directors must be members of the company’s audit committee and compensation committee.

 

Pursuant to regulations promulgated under the Companies Law, companies with shares traded on a U.S. stock exchange, including the Nasdaq Capital Market, may, subject to certain conditions, “opt out” from the Companies Law requirements to appoint external directors and related Companies Law rules concerning the composition of the audit committee and compensation committee of the board of directors. In accordance with these regulations, effective as of June 28, 2017, we have “opted out” from the Companies Law requirements to appoint external directors and related Companies Law rules concerning the composition of the audit committee and compensation committee of the board of directors.

 

Under these regulations, the exemptions from such Companies Law requirements will continue to be available to us so long as: (i) we do not have a “controlling shareholder” (as such term is defined under the Companies Law), (ii) our shares are traded on a U.S. stock exchange, including the Nasdaq Capital Market, and (iii) we comply with the director independence requirements, the audit committee and the compensation committee composition requirements, under U.S. laws (including applicable Nasdaq Rules) applicable to U.S. domestic issuers. We believe that Mr. Eli Cohen, Mr. Eliyahu Yoresh, Mr. Ronen Rosenbloom and Ms. Kineret Tzedef are “independent” for purposes of the Nasdaq Stock Market rules.

 

Alternate directors

 

Our amended and restated articles of association provide, as allowed by the Companies Law, that any director may, by written notice to us, appoint another person who is qualified to serve as a director to serve as an alternate director and to terminate such appointment. Under the Companies Law, a person who is not qualified to be appointed as a director, a person who is already serving as a director or a person who is already serving as an alternate director for another director, may not be appointed as an alternate director. Nevertheless, a director who is already serving as a director may be appointed as an alternate director for a member of a committee of the board of directors as long as he or she is not already serving as a member of such committee.

 

52

 

 

Board committees

 

The board of directors may, subject to the provisions of the Companies Law, delegate any or all of its powers to committees, each consisting of one or more directors (except the audit and compensation committees, as described below), and it may, from time to time, revoke such delegation or alter the composition of any such committees. Unless otherwise expressly provided by the board of directors, the committees will not be empowered to further delegate such powers. The composition and duties of our audit committee and compensation committee are described below.

 

Audit committee

 

Our audit committee is currently comprised of Mr. Eli Cohen, Mr. Eliyahu Yoresh, and Mr. Ronen Rosenbloom. Mr. Eliyahu Yoresh acts as the chairperson of our audit committee.

 

Companies Law Requirements

 

Under the Companies Law, our board of directors is required to appoint an audit committee, which is responsible, among others, for:

 

  (i) determining whether there are deficiencies in the business management practices of our Company, including in consultation with our internal auditor or the independent auditor, and making recommendations to our board of directors to improve such practices;

 

  (ii) determining the approval process for transactions that are ‘non-negligible’ (i.e., transactions with a controlling shareholder that are classified by the audit committee as non-negligible, even though they are not deemed extraordinary transactions), as well as determining which types of transactions would require the approval of the audit committee, optionally based on criteria which may be determined annually in advance by the audit committee;

 

  (iii) determining whether to approve certain related party transactions (including transactions in which an office holder has a personal interest and whether such transaction is extraordinary or material under Companies Law. See “Fiduciary duties and approval of specified related party transactions and compensation under Israeli law.”;

 

  (iv) where the board of directors approves the working plan of the internal auditor, to examine such working plan before its submission to our board of directors and proposing amendments thereto;

 

  (v) examining our internal controls and internal auditor’s performance, including whether the internal auditor has sufficient resources and tools to dispose of its responsibilities;

 

  (vi) examining the scope of our auditor’s work and compensation and submitting a recommendation with respect thereto to our board of directors or shareholders, depending on which of them is considering the appointment of our auditor; and

 

  (vii) establishing procedures for the handling of employees’ complaints as to the management of our business and the protection to be provided to such employees.

 

Nasdaq requirements

 

Under the Nasdaq corporate governance rules, we are required to maintain an audit committee consisting of at least three independent directors, all of whom are financially literate and one of whom has accounting or related financial management expertise. All members of our audit committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and the Nasdaq corporate governance rules. Our board of directors has determined that Mr. Eliyahu Yoresh is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq Marketplace Rules.

 

Each of the members of the audit committee is required to be “independent” as such term is defined in Rule 10A-3(b)(1) under the Exchange Act, which is different from the general test for independence of board and committee members. Our board of directors has determined that each member of our audit committee is independent as such term is defined in Rule 10A-3(b)(1) of the Exchange Act.

 

53

 

 

Audit committee role

 

Our board of directors has adopted an audit committee charter setting forth the responsibilities of the audit committee consistent with the rules of the SEC and the Nasdaq Rules, which include, among others:

 

  retaining and terminating our independent auditors, subject to the ratification of the board of directors, and in the case of retention, to that of the shareholders;

 

  pre-approving of audit and non-audit services and related fees and terms, to be provided by the independent auditors;

 

  overseeing the accounting and financial reporting processes of our Company and audits of our financial statements, the effectiveness of our internal control over financial reporting and making such reports as may be required of an audit committee under the rules and regulations promulgated under the Exchange Act;

 

  reviewing with management and our independent auditor our annual and quarterly financial statements prior to publication or filing (or submission, as the case may be) to the SEC;

 

  recommending to the board of directors the retention and termination of the internal auditor, and the internal auditor’s engagement fees and terms, in accordance with the Companies Law as well as approving the yearly or periodic work plan proposed by the internal auditor;

 

  reviewing with our general counsel and/or external counsel, as deem necessary, legal and regulatory matters that could have a material impact on the financial statements;

 

  identifying irregularities in our business administration, inter alia, by consulting with the internal auditor or with the independent auditor, and suggesting corrective measures to the board of directors; and

 

  reviewing policies and procedures with respect to transactions (other than transactions related to the compensation or terms of services) between the Company and officers and directors, or affiliates of officers or directors, or transactions that are not in the ordinary course of the Company’s business and deciding whether to approve such acts and transactions if so required under the Companies Law.

 

The audit committee charter states that in fulfilling its obligations, the committee is entitled to demand from the Company any document, file, report or any other information that is required for the fulfillment of its roles and duties and to interview any of our employees or any employees of our subsidiaries in order to receive more details about his or her line of work or other issues that are connected to the roles and duties of the audit committee.

 

Compensation Committee

 

Our compensation committee is currently comprised of Mr. Ronen Rosenbloom, Mr. Eli Cohen and Ms. Kineret Tzedef. Mr. Eli Cohen acts as the chairperson of our compensation committee.

 

54

 

 

Companies Law requirements

 

Under the Companies Law, the board of directors of a public company must appoint a compensation committee which roles are, among others, as follows:

 

to recommend to the board of directors the approval of compensation policy for directors and officers in accordance with the requirements of the Companies Law;

 

to oversee the development and implementation of such compensation policy and recommending to the board of directors regarding any amendments or modifications that the compensation committee deems appropriate;

 

to determine whether to approve transactions concerning the terms of engagement and employment of office holders that require approval of the compensation committee; and

 

to resolve whether to exempt a transaction with a candidate for Chief Executive Officer from shareholder’s approval.

 

Nasdaq requirements

 

Our board of directors has adopted a compensation committee charter setting forth the responsibilities of the committee consistent with the Nasdaq Rules, which include among others:

 

recommending to our board of directors for its approval a compensation policy in accordance with the requirements of the Companies Law as well as other compensation policies, incentive-based compensation plans and equity-based compensation plans, and overseeing the development and implementation of such policies and recommending to our board of directors any amendments or modifications to the committee deems appropriate, including as required under the Companies Law;

 

reviewing and approving the granting of options and other incentive awards to our Chief Executive Officer and other executive officers, including reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive Officer and other executive officers, including evaluating their performance in light of such goals and objectives;

 

approving and exempting certain transactions regarding office holders’ compensation pursuant to the Companies Law; and

 

administer our equity-based compensation plans, including without limitation to approve the adoption of such plans, to amend and interpret such plans and the awards and agreements issued pursuant thereto, and to make awards to eligible persons under the plans and determine the terms of such awards.

 

The compensation committee is also authorized to retain and terminate compensation consultants, legal counsel or other advisors to the committee and to approve the engagement of any such consultant, counsel or advisor, to the extent it deems necessary or advisable.

 

Our board of directors has determined that each member of our compensation committee is independent under the Nasdaq Rules, including the additional independence requirements applicable to the members of a compensation committee.

 

55

 

 

Compensation policy

 

Under the Companies Law, companies incorporated under the laws of the State of Israel, whose shares are listed for trading on a stock exchange or have been offered to the public in or outside of Israel, such as us, are required to adopt a policy governing the compensation of “office holders” (as defined in the Companies Law). Following the recommendation of our compensation committee and approval by our board of directors, our shareholders approved a compensation policy for directors and officers on October 30, 2024, which was identical to the compensation policy approved by our shareholders on August 30, 2021. Our compensation policy must be approved at least once every three years, first, by our board of directors, upon recommendation of our compensation committee, and second, by a simple majority of the Ordinary Shares present, in person or by proxy, and voting at a shareholders meeting, provided that either:

 

such majority includes at least a majority of the shares held by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in such compensation policy; or

 

the total number of shares of non-controlling shareholders and shareholders who do not have a personal interest in the compensation policy and who vote against the policy, does not exceed 2% of the company’s aggregate voting rights.

 

Such majority determined in accordance with the majority requirement described above is hereinafter referred to as the Compensation Special Majority Requirement.

 

To the extent a compensation policy is not approved by shareholders at a duly convened shareholders meeting or by the Compensation Special Majority Requirement, the board of directors of a company may override the resolution of the shareholders following a re-discussion of the matter by the board of directors and the compensation committee and for specified reasons, and after determining that despite the rejection by the shareholders, the adoption of the compensation policy is in the best interest of the company. A compensation policy that is for a period of more than three years must be approved in accordance with the above procedure once every three years.

 

The compensation policy must serve as the basis for decisions concerning the financial terms of employment or engagement of office holders, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy must relate to certain factors, including advancement of the company’s objectives, the company’s business plan and its long-term strategy, and creation of appropriate incentives for office holders. It must also consider, among other things, the company’s risk management, size and the nature of its operations; and with respect to variable compensation, the contribution of the office holder towards the achievement of the company’s long-term goals and the maximization of its profits, all with a long-term objective and according to the position of the office holder. The compensation policy must furthermore consider the following additional factors:

 

the education, skills, experience, expertise and accomplishments of the relevant office holder;

 

the office holder’s position and responsibilities;

 

prior compensation agreements with the office holder;

 

the ratio between the cost of the terms of employment of an office holder and the cost of the employment of other employees of the company, including employees employed through contractors who provide services to the company, in particular the ratio between such cost to the average and median salary of such employees of the company, as well as the impact of disparities between them on the work relationships in the company;

 

the terms of employment include variable components - the possibility of reducing variable components at the discretion of the board of directors and the possibility of setting a limit on the value of non-cash variable equity-based components; and

 

if the terms of employment include severance compensation - the term of employment or office of the office holder, the terms of the office holder’s compensation during such period, the company’s performance during such period, the office holder’s individual contribution to the achievement of the company goals and the maximization of its profits and the circumstances under which he or she is leaving the company.

 

56

 

 

The compensation policy must also include the following principles:

 

with regards to variable components;

 

with the exception of office holders who report to the Chief Executive Officer, a means of determining the variable components on the basis of long-term performance and measurable criteria; provided that the company may determine that an immaterial part of the variable components of the compensation package of an office holder shall be awarded based on non-measurable criteria, or if such amount is not higher than three months’ salary per annum, taking into account such office holder’s contribution to the company;

 

the ratio between variable and fixed components, as well as the limit of the values of variable components at the time of their payment, or in the case of equity-based compensation, at the time of grant;

 

a condition under which the office holder will return to the company, according to conditions to be set forth in the compensation policy, any amounts paid as part of the office holder’s terms of employment, if such amounts were paid based on information later to be discovered to be wrong, and such information was restated in the company’s financial statements;

 

  the minimum holding or vesting period of variable equity-based components to be set in the terms of office or employment, as applicable, while taking into consideration long-term incentives; and

 

  a limit to retirement grants.

 

Our compensation policy is designed to promote retention and motivation of directors and executive officers, incentivize superior individual excellence, align the interests of our directors and executive officers with our long-term performance and provide a risk management tool. To that end, a portion of our executive officer compensation package is targeted to reflect our short and long-term goals, as well as the executive officer’s individual performance. On the other hand, our compensation policy includes measures designed to reduce the executive officer’s incentives to take excessive risks that may harm us in the long-term, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and the total compensation of an executive officer and minimum vesting periods and performance-based vesting for equity-based compensation.

 

Our compensation policy also addresses our executive officers’ individual characteristics (such as their respective position, education, scope of responsibilities and contribution to the attainment of our goals) as the basis for compensation variation among our executive officers and considers the internal ratios between compensation of our executive officers and directors and other employees. Pursuant to our compensation policy, the compensation that may be granted to an executive officer may include: base salary, annual bonuses and other cash bonuses (such as a signing bonus and special bonuses with respect to any special achievements, such as outstanding personal achievement, outstanding personal effort or outstanding Company performance), equity-based compensation, benefits and retirement and termination of service arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer’s base salary.

 

An annual cash bonus may be awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may be granted to our executive officers other than our Chief Executive Officer will be based on performance objectives and a discretionary evaluation of the executive officer’s overall performance by our Chief Executive Officer and subject to minimum thresholds. The annual cash bonus that may be granted to executive officers other than our Chief Executive Officer may alternatively be based entirely on a discretionary evaluation. Furthermore, our Chief Executive Officer will be entitled to approve performance objectives for executive officers who report to him.

 

The measurable performance objectives of our Chief Executive Officer will be determined annually by our compensation committee and board of directors. A non-material portion of the Chief Executive Officer’s annual cash bonus, as provided in our compensation policy, may be based on a discretionary evaluation of the Chief Executive Officer’s overall performance by the compensation committee and the board of directors.

 

57

 

 

The equity-based compensation under our compensation policy for our executive officers (including members of our board of directors) is designed in a manner consistent with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the executive officers’ interests with our long-term interests and those of our shareholders and to strengthen the retention and the motivation of executive officers in the long term. Our compensation policy provides for executive officer compensation in the form of share options or other equity-based awards, such as restricted shares and restricted share units, in accordance with our equity incentive plan then in place. The equity-based compensation shall be granted from time to time and be individually determined and awarded according to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities of the executive officer.

 

In addition, our compensation policy contains compensation recovery provisions which allow us under certain conditions to recover bonuses paid in excess, enable our Chief Executive Officer to approve an immaterial change in the terms of employment of an executive officer who reports directly him (provided that the changes of the terms of employment are in accordance with our compensation policy) and allow us to exculpate, indemnify and insure our executive officers and directors to the maximum extent permitted by Israeli law subject to certain limitations set forth therein.

 

Our compensation policy also provides for compensation to the members of our board of directors either (i) in accordance with the amounts provided in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director) of 2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel) of 2000, as such regulations may be amended from time to time, or (ii) in accordance with the amounts determined in our compensation policy.

 

Investment Committee

 

Our investment committee is comprised of Mr. Eli Yoresh and Mr. Eli Cohen. The investment committee is authorized to approve certain investments in accordance with the Company’s investment policy approved by the board of directors. The investment committee monitors the management of the portfolio for compliance with the investment policies and guidelines and considers the merits of time sensitive investments that could be beneficial to the Company.

 

Internal auditor

 

Under the Companies Law, the board of directors of a public company must appoint an internal auditor based on the recommendation of the audit committee. Under the Companies Law, each of the following may not be appointed as internal auditor:

 

a person (or a relative of a person) who holds more than 5% of the company’s outstanding shares or voting rights;

 

a person (or a relative of a person) who has the power to appoint a director or the general manager of the company;

 

an office holder (including a director) of the company (or a relative thereof); or

 

a member of the company’s independent accounting firm, or anyone on his or her behalf.

 

The role of the internal auditor is, among other things, to examine whether a company’s actions comply with applicable law and orderly business procedure. The audit committee is required to oversee the activities and to assess the performance of the internal auditor as well as to review the internal auditor’s work plan. Our internal auditor is Daniel Spira, Certified Public Accountant (Isr.).

 

58

 

 

Fiduciary duties and approval of specified related party transactions and compensation under Israeli law

 

Fiduciary duties of office holders

 

The Companies Law imposes fiduciary duties on all office holders of a company comprised of a duty of care and a duty of loyalty.

 

The duty of care requires an office holder to act in the same degree of proficiency with which a reasonable office holder in the same position would have acted under the same circumstances. The duty of care includes, among other things, a duty to use reasonable means, in light of the circumstances, to obtain:

 

information on the business advisability of a given action brought for his or her approval or performed by virtue of his or her position; and

 

all other important information pertaining to such action.

 

The duty of loyalty requires an office holder to act in good faith and for the benefit of the company, and includes, among other things, the duty to:

 

refrain from any act involving a conflict of interest between the performance of his or her duties in the company and his or her other duties or personal affairs;

 

refrain from any activity that is competitive with the business of the company;

 

refrain from exploiting any business opportunity of the company for the purpose of gaining a personal advantage for himself or herself or others; and

 

disclose to the company any information or documents relating to the company’s affairs which the office holder received as a result of his or her position as an office holder.

 

Under the Companies Law, we may approve an act specified above, provided that the office holder acted in good faith, the act or its approval does not harm the company’s best interest, and the office holder discloses his or her personal interest a sufficient time before the approval of such act, including any relevant document.

 

Disclosure of personal interests of an office holder and approval of transactions

 

The Companies Law requires that an office holder promptly disclose to the company any personal interest that he or she may have and all related material information or documents relating to any existing or proposed transaction by the company. An interested office holder’s disclosure must be made promptly and, in any event, no later than the first meeting of the board of directors at which the transaction is considered. Under the Companies Law, once an office holder complies with the above disclosure requirement, the board of directors at which the transaction is considered. An office holder is not obliged to disclose such information if the personal interest of the office holder derives solely from the personal interest of his or her relative in a transaction that is not considered an extraordinary transaction.

 

Under the Companies Law, a company may approve a transaction between the company and the office holder or a third party in which the office holder has a personal interest only if the office holder has complied with the above disclosure requirement, provided, however, that a company may not approve a transaction or action that is not to the company’s benefit.

 

Under the Companies Law, unless the articles of association of a company provide otherwise, a transaction with an office holder or with a third party in which the office holder has a personal interest, which is not an extraordinary transaction, requires approval by the board of directors. Our amended and restated articles of association do not state otherwise. If the transaction considered with an office holder or third party in which the office holder has a personal interest is an extraordinary transaction, then the audit committee’s approval is required prior to approval by the board of directors. For the approval of compensation arrangements with directors and executive officers, see “Item 6. Directors, Senior Management and Employees -C. Board Practices-Compensation of directors and executive officers.”

 

59

 

 

Any person who has a personal interest in the approval of a transaction that is brought before a meeting of the board of directors or the audit committee may not be present at the meeting or vote on the matter. However, if the chairperson of the board of directors or the chairperson of the audit committee has determined that the presence of an office holder with a personal interest is required, such office holder may be present at the meeting for the purpose of presenting the matter. Notwithstanding the foregoing, a director who has a personal interest may be present at the meeting and vote on the matter if a majority of the directors or members of the audit committee have a personal interest in the approval of such transaction’ provided, however, that if a majority of the directors at a board of directors meeting have a personal interest in the approval of the transaction, such transaction also requires the approval of the shareholders of the company.

 

A “personal interest” is defined under the Companies Law as the personal interest of a person in an action or in a transaction of the company, including the personal interest of such person’s relative or the interest of any other corporate body in which such person and/or such person’s relative is a director or general manager, a 5% shareholder or holds 5% or more of the voting rights, or has the right to appoint at least one director or the general manager, but excluding a personal interest stemming solely from the fact of holding shares in the company. A personal interest also includes (1) a personal interest of a person who votes according to a proxy of another person, including in the event that the other person has no personal interest, and (2) a personal interest of a person who gave a proxy to another person to vote on his or her behalf regardless of whether the discretion of how to vote lies with the person voting or not.

 

An “extraordinary transaction” is defined under the Companies Law as any of the following:

 

a transaction other than in the ordinary course of business;

 

a transaction that is not on market terms; or

 

a transaction that may have a material impact on the company’s profitability, assets or liabilities.

 

An extraordinary transaction in which an office holder has a personal interest requires approval of the company’s audit committee followed by the approval of the board of directors.

 

Disclosure of personal interests of a controlling shareholder and approval of transactions

 

The Companies Law also requires that a controlling shareholder promptly disclose to the company any personal interest that he or she may have and all related material information or documents relating to any existing or proposed transaction by the company. A controlling shareholder’s disclosure must be made promptly and, in any event, no later than the first meeting of the board of directors at which the transaction is considered. The following require the approval of each of (i) the audit committee (or the compensation committee with respect to the terms of engagement of the controlling shareholder or relative thereof with the company related for the provision of service, including among others as an office holder or employee of the company), (ii) the board of directors and (iii) the shareholders (in that order): (a) extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest (including a private placement in which a controlling shareholder has a personal interest), (b) the engagement with a controlling shareholder or his or her relative, directly or indirectly, for the provision of services to the company, (c) the terms of engagement and compensation of a controlling shareholder or his or her relative as an office holder, and (d) the employment of a controlling shareholder or his or her relative by the company, other than as an office holder (collectively referred as Transaction with a Controlling Shareholder). In addition, the shareholder approval must fulfill one of the following requirements:

 

  at least a majority of the shares held by shareholders who have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding abstentions; or
     
  the shares voted by shareholders who have no personal interest in the transaction who vote against the transaction represent no more than two percent (2%) of the voting rights in the company.

 

60

 

 

In addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest with a term of more than three years requires the abovementioned approval every three years, however, unless, with respect to certain transactions the audit committee determines that such longer term is reasonable under the circumstances.

 

Pursuant to regulations promulgated under the Companies Law, certain transactions with a controlling shareholder, a relative thereof, or with a director, that would otherwise require approval of a company’s shareholders may be exempt from shareholder approval upon certain determinations of the audit committee and board of directors.

 

The Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question. Failure to so indicate will result in the invalidation of that shareholder’s vote.

 

Approval of the compensation of directors and executive officers

 

The compensation of, or an undertaking to indemnify, insure or exculpate, an office holder who is not a director requires the approval of the company’s compensation committee, followed by the approval of the company’s board of directors, and, if such compensation arrangement or an undertaking to indemnify or insure is inconsistent with the company’s stated compensation policy, or if the said office holder is the Chief Executive Officer of the company (apart from a number of specific exceptions), then such arrangement is subject to the approval of our shareholders, subject to the Compensation Special Majority Requirement.

 

Directors. Under the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of the board of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general meeting of our shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided that those provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation committee and board of directors, shareholder approval will also be required to be approved by the Compensation Special Majority Requirement.

 

Executive officers other than the Chief Executive Officer. The Companies Law requires the approval of the compensation of a public company’s executive officers (other than the Chief Executive Officer) in the following order: (i) the compensation committee, (ii) the company’s board of directors, and (iii) if such compensation arrangement is inconsistent with the company’s stated compensation policy, the company’s shareholders by the Compensation Special Majority Requirement. However, if the shareholders of the company do not approve a compensation arrangement with an executive officer that is inconsistent with the company’s stated compensation policy, the compensation committee and board of directors may override the shareholders’ decision if each of the compensation committee and the board of directors provide detailed reasons for their decision.

 

Chief Executive Officer. Under the Companies Law, the compensation of a public company’s Chief Executive Officer is required to be approved by: (i) the company’s compensation committee; (ii) the company’s board of directors, and (iii) the company’s shareholders by the Compensation Special Majority Requirement. However, if the shareholders of the company do not approve the compensation arrangement with the Chief Executive Officer, the compensation committee and board of directors may override the shareholders’ decision if each of the compensation committee and the board of directors provide a detailed reasoning for their decision. The approval of each of the compensation committee and the board of directors must be in accordance with the company’s stated compensation policy; however, under special circumstances, the compensation committee and the board of directors may approve compensation terms of a Chief Executive Officer that are inconsistent with the company’s compensation policy provided that they have considered those provisions that must be included in the compensation policy according to the Companies Law and that shareholder approval was obtained by the Compensation Special Majority Requirement. In addition, the compensation committee may resolve that the shareholder approval is not required for the approval of the engagement terms of a candidate to serve as the Chief Executive Officer, if the compensation committee determines that the compensation arrangement is consistent with the company’s stated compensation policy, that the Chief Executive Officer did not have a prior business relationship with the company or a controlling shareholder of the company, and that subjecting the approval to a shareholder vote would impede the company’s ability to attain the candidate to serve as the company’s Chief Executive Officer.

 

61

 

 

Duties of shareholders

 

Under the Companies Law, a shareholder has a duty to refrain from abusing its power in the company and to act in good faith and in an acceptable manner in exercising its rights and performing its obligations to the company and other shareholders, including, among other things, when voting at meetings of shareholders on the following matters:

 

an amendment to the articles of association;

 

an increase in the company’s authorized share capital;

 

a merger; and

 

the approval of related party transactions and acts of office holders that require shareholder approval.

 

A shareholder also has a general duty to refrain from discriminating against other shareholders.

 

The remedies generally available upon a breach of contract will also apply to a breach of the shareholder duties mentioned above, and in the event of discrimination against other shareholders, additional remedies are available to the injured shareholder.

 

In addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any shareholder that, under a company’s articles of association, has the power to appoint or prevent the appointment of an office holder, or any other power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with fairness, taking each shareholder’s position in the company into account.

 

Approval of private placements

 

Under the Companies Law and the regulations promulgated thereunder, a private placement of securities does not require approval at a general meeting of the shareholders of a company; provided however, that in special circumstances, such as a private placement completed in lieu of a special tender offer or a private placement which qualifies as a related party transaction (See “Item 6. Directors, Senior Management and Employees -C. Board Practices-Fiduciary duties and approval of specified related party transactions and compensation under Israeli law”), for which approval at a general meeting of the shareholders of a company is required.

 

Exemption, Insurance and Indemnification of Directors and Officers 

 

Under the Companies Law, a company may not exculpate an office holder from liability for a breach of a fiduciary duty. An Israeli company may exculpate an office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our amended and restated articles of association include such a provision. The company may not exculpate in advance a director from liability arising out of a prohibited dividend or distribution to shareholders.

 

62

 

 

Under the Companies Law and the Securities Law, 5738-1968, or the Securities Law, a company may indemnify an office holder in respect of the following liabilities, payments and expenses incurred for acts performed by him or her as an office holder, either in advance of an event or following an event, provided its articles of association include a provision authorizing such indemnification:

 

a monetary liability incurred by or imposed on the office holder in favor of another person pursuant to a court judgment, including pursuant to a settlement confirmed as judgment or arbitrator’s decision approved by a competent court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company’s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking will detail the abovementioned foreseen events and amount or criteria;

 

reasonable litigation expenses, including reasonable attorneys’ fees, which were incurred by the office holder as a result of an investigation or proceeding filed against the office holder by an authority authorized to conduct such investigation or proceeding, provided that such investigation or proceeding was either (i) concluded without the filing of an indictment against such office holder and without the imposition on him of any monetary obligation in lieu of a criminal proceeding; (ii) concluded without the filing of an indictment against the office holder but with the imposition of a monetary obligation on the office holder in lieu of criminal proceedings for an offense that does not require proof of criminal intent; or (iii) in connection with a monetary sanction;

 

reasonable litigation expenses, including attorneys’ fees, incurred by the office holder or which were imposed on the office holder by a court (i) in a proceeding instituted against him or her by the company, on its behalf, or by a third party, (ii) in connection with criminal indictment of which the office holder was acquitted, or (iii) in a criminal indictment which the office holder was convicted of an offense that does not require proof of criminal intent;

 

a monetary liability imposed on the office holder in favor of a payment for a breach offended at an Administrative Procedure (as defined below) as set forth in Section 52(54)(a)(1)(a) to the Securities Law;

 

expenses incurred by an office holder or certain compensation payments made to an injured party that were instituted against an office holder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys’ fees; and

 

any other obligation or expense in respect of which it is permitted or will be permitted under applicable law to indemnify an office holder, including, without limitation, matters referenced in Section 56H(b)(1) of the Securities Law.

 

An “Administrative Procedure” is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law.

 

Under the Companies Law and the Securities Law, a company may insure an office holder against the following liabilities incurred for acts performed by him or her as an office holder if and to the extent provided in the company’s articles of association:

 

a breach of a fiduciary duty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company;

 

63

 

 

a breach of duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder;

 

a monetary liability imposed on the office holder in favor of a third party;

 

a monetary liability imposed on the office holder in favor of an injured party at an Administrative Procedure pursuant to Section 52(54)(a)(1)(a) of the Securities Law; and

 

expenses incurred by an office holder in connection with an Administrative Procedure, including reasonable litigation expenses and reasonable attorneys’ fees.

 

Under the Companies Law, a company may not indemnify, exculpate or insure an office holder against any of the following:

 

a breach of fiduciary duty, except for indemnification and insurance for a breach of the fiduciary duty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;

 

a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;

 

an act or omission committed with intent to derive illegal personal benefit; or

 

a civil or administrative fine, monetary sanction or forfeit levied against the office holder.

 

Under the Companies Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee and the board of directors and, with respect to directors or controlling shareholders, their relatives and third parties in which such controlling shareholders have a personal interest, also by the shareholders.

 

Our amended and restated articles of association permit us to exculpate, indemnify and insure our office holders to the fullest extent permitted or to be permitted by law. On February 18, 2021, our board of directors approved a new directors’ and officers’ liability insurance policy, following the recent amended of our compensation policy approved by our shareholders on February 12, 2021.

 

Employment and consulting agreements with executive officers

 

We have entered into written employment or service agreements with each of our executive officers. See “Item 7. Major Shareholders and Related Party Transactions - B. Related Party Transactions - Employment Agreements” for additional information.

 

Directors’ service contracts

 

There are no arrangements or understandings between us, on the one hand, and any of our directors, on the other hand, providing for benefits upon termination of their employment or service as directors of our Company.

 

D. Employees

 

Number of Employees

 

As of December 31, 2024, the Group employed 38 employees, which includes our Chief Executive Officer and other executive officers that are engaged by the Company as consultants.

 

As of December 31, 2023, the Group employed 84 employees, which included our Chief Executive Officer and other executive officers that are engaged by the Company as consultants.

 

As of December 31, 2022, we employed 77 employees in Israel including those employed by our subsidiaries Jeffs’ Brands, Charging Robotics and Eventer, which included our Chief Executive Officer and other executive officers that are engaged by the Company as consultants.

 

64

 

 

Distribution of Employees

 

The breakdown of our employees, by areas of engagement and geographic location, as of the end of each of the past three fiscal years is as follows:

 

   As of December 31, 
   2024   2023   2022 
Numbers of employees by category of activity            
Management and administrative   17    32    32 
Research and development   6    14    16 
Sales and marketing   15    36    29 
Production   -    2    - 
Total workforce   38    84    77 
                
Numbers of employees by geographic location               
Israel   38    79    75 
Europe   -    4    1 
Other   -    1    1 
Total workforce   38    84    77 
                
Numbers of employees by employer               
Xylo Technologies Ltd.   5    5    5 
Eventer   10    16    16 
Jeff Brands   -    15    4 
Gix Internet   21    46    51 
Charging Robotics   2    2    1 
    38    84    77 

 

During the years covered by the above table, we did not employ a significant number of temporary employees. We consider our relations with our employees excellent and have never experienced a strike or work stoppage. None of our employees are represented by a labor union.

 

In Israel we are subject to certain labor statutes and national labor court precedent rulings, as well as to certain provisions of the collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic Organizations including the Industrialists’ Associations. These provisions of collective bargaining agreements are applicable to our Israeli employees by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Ministry of Economy and Industry, and which apply such agreement provisions to our employees even though they are not directly part of a union that has signed a collective bargaining agreement. The laws and labor court rulings that apply to our employees principally concern the minimum wage laws, length of the workday and workweek, overtime payment, procedures for dismissing employees, determination of severance pay, leaves of absence (such as annual vacation or maternity leave), sick pay and other conditions for employment. The general extension orders which apply to our employees principally concern mandatory contributions to a pension fund or managers’ insurance, annual recreation allowance, travel expenses payment and other conditions of employment. We generally provide our employees with benefits and working conditions beyond the required minimums.

 

65

 

 

Israeli law generally requires severance pay upon a dismissal of an employee by the employer without “cause” (as defined in the law), which equal to the employee’s latest monthly salary multiplied by the number of years of continuous employment with the same employer or at the same employment facilities (the “Statutory Severance Pay”). The severance pay is usually funded by the employer allocating monthly payments to employees’ managers’ insurance and/or pension fund described below, on account of the Statutory Severance Pay. The monthly payments to the managers’ insurance and/or pension fund in respect of severance pay usually amount to 8.33% or 6% of an employee’s monthly wages. Upon an event that entitles an employee to severance pay, the employer will generally release in favor of the employee the amounts accrued in the severance fund, as described above and will complete any shortfall amount between the Statutory Severance Pay and the amounts accrued in the severance fund. An alternative, and commonly used, pension and severance contribution scheme is known as the Section 14 Arrangement under the General Approval issued under the Severance Pay Law (the “Section 14 Arrangement”). Where the Section 14 Arrangement is properly applied, the amounts accrued in the severance fund are in lieu of the Statutory Severance Pay and the employer’s sole obligation with respect to severance pay would be to release the amounts accrued in the severance and pension funds in any event of termination of employment (dismissal or resignation), without the need to complete any amounts on account the Statutory Severance Pay. Furthermore, Israeli employees and employers are required to pay predetermined sums to the National Insurance Institute, which is similar to the United States Social Security Administration. Such amounts also include payments for national health insurance.

 

E. Share Ownership

 

Share ownership by Directors and Executive Officers

 

For information regarding ownership of our Ordinary Shares by our directors and executive officers, see Item 7. “Major Shareholders and Related Party Transactions - A. Major Shareholders.”

 

2013 Share Option and Incentive Plan

 

In August 2013, our board of directors approved and adopted our 2013 Share Option and Incentive Plan, or the Plan, which expired in August 2023. The Plan provided for the issuance of shares and the granting of options, restricted shares, restricted share units and other share-based awards to employees, directors, officers, consultants, advisors, and our service providers. Following adoption of the 2023 Share Incentive Plan, as detailed herein, we have ceased granting equity under the 2013 Share Option and Incentive Plan.

 

Options granted under the Plan which are currently outstanding generally may not expire later than six years from the date of grant, unless otherwise specified. Unvested awards that are cancelled and/or forfeited go back into the plan.

 

2023 Share Incentive Plan

 

In September 2023, our board of directors approved and adopted our 2023 Share Incentive Plan, or the 2023 Plan, which expires in September 2033. The 2023 Plan provides for the issuance of shares and the granting of options, restricted shares, restricted share units and other share-based awards to employees, directors, officers, consultants, advisors, and our service providers. The 2023 Plan provides for awards to be issued at the determination of our board of directors in accordance with applicable law.

 

The 2023 Plan provides for the grant to residents of Israel of options that qualify under the provisions of Section 102 Tax Ordinance, as well as for the grant of options that do not qualify under such provisions. The 2023 Plan was submitted to the ITA, as required by applicable law. The 2023 Plan also provides for the grant of options to U.S. resident employees that are “qualified”, i.e., incentive stock options, under the U.S. Internal Revenue Code of 1986, as amended, or the Code, and options that are not qualified. In addition to the grant of awards under the relevant tax regimes of the United States and Israel, the 2023 Plan allows for the grant of awards to grantees in other jurisdictions, with respect to which our board of directors is empowered to make the requisite adjustments in the plan.

 

Options granted under the 2023 Plan which are currently outstanding generally may not expire later than six years from the date of grant, unless otherwise specified. Unvested awards that are cancelled and/or forfeited go back into the plan.

 

66

 

 

F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation

 

Not applicable.

 

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

The following table sets forth information with respect to the beneficial ownership of our Ordinary Shares as of April 17, 2025 (unless otherwise noted below), the beneficial ownership of our Ordinary Shares by:

 

  each person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our voting securities;
     
  each of our directors and executive officers individually; and

 

all of our executive officers and directors as a group.

 

The beneficial ownership of our Ordinary Shares is determined in accordance with the rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes the power to dispose of or to direct the disposition of the security. For purposes of the table below, we deem Ordinary Shares issuable pursuant to options that are currently exercisable or exercisable within 60 days as of April 17, 2025, if any, to be outstanding and to be beneficially owned by the person holding the options or warrants for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. The percentage of Ordinary Shares beneficially owned is based on 51,241,661Ordinary Shares outstanding as of April 17, 2025.

 

Except where otherwise indicated, we believe, based on information furnished to us by such owners, that the beneficial owners of the Ordinary Shares listed below have sole investment and voting power with respect to such shares. In addition, none of our shareholders will have different voting rights from other shareholders. To the best of our knowledge, we are not owned or controlled, directly or indirectly, by another corporation or by any foreign government. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our Company.

 

As of April 17, 2025, there was one shareholder of record of our Ordinary Shares. The number of record holders is not representative of the number of beneficial holders of our Ordinary Shares, as the shares of all shareholders for a publicly traded company such as our Ordinary Shares underlying our ADSs are recorded in the name of our transfer agent, Computershare Trust Company, N.A.

 

Unless otherwise noted below, each beneficial owner’s address is Xylo Technologies Ltd., 10 Hanechoshet Street, Tel Aviv, Israel, 6971072.

 

Our principal shareholders do not have different or special voting rights.

 

67

 

 

Holders of more than 5% of our voting securities  Number
of Shares
Beneficially
Owned(1)
   
   Percentage
of Shares
Beneficially
Owned(2)
 
 
         
L.I.A. Pure Capital Ltd.(3)   2,900,000    5.66%
Directors and executive officers          
Kineret Tzedef(4)     222,378     * 
Liron Carmel(5)     825,170    1.6%
Ronen Rosenbloom(6)     307,958     * 
Eliyahu Yoresh(7)     1,049,520    2.04%
Eli Cohen(8)     157,778     * 
Tali Dinar(9)     306,973     * 
           
All directors and executive officers as a group (six persons)   2,869,777    5.49%

 

*

less than 1%.

 

(1) Beneficial ownership is determined in accordance with the rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a security if that person, even if not the record owner, has or shares the underlying benefits of ownership. These benefits include the power to direct the voting or the disposition of the securities or to receive the economic benefit of ownership of the securities. A person also is considered to be the “beneficial owner” of securities that the person has the right to acquire within 60 days by option or other agreement. Beneficial owners include persons who hold their securities through one or more trustees, brokers, agents, legal representatives or other intermediaries, or through companies in which they have a “controlling interest,” which means the direct or indirect power to direct the management and policies of the entity.

 

(2) The percentages shown are based on 51,241,661 Ordinary Shares issued and outstanding as of April 17, 2025.

 

(3)

Pursuant to a Schedule 13D/A filed by Pure Capital on April 17, 2025. 

 

(4) Includes options to purchase 37,500 Ordinary Shares at an exercise price of NIS 8.96 per share that are exercisable within 60 days of April 14, 2025, and options to purchase 100,000 Ordinary Shares at an exercise price of NIS 5.81 per share that are exercisable within 60 days as of April 17, 2025.

 

(5) Includes options to purchase 300,000 Ordinary Shares at an exercise price of NIS 5.81 per share that are exercisable within 60 days as of April 17, 2025.

 

(6) Includes options to purchase 100,000 Ordinary Shares at an exercise price of NIS 5.81 per share that are exercisable within 60 days as of April 17, 2025.

 

(7) Includes options to purchase 300,000 Ordinary Shares at an exercise price of NIS 5.81 per share that are exercisable within 60 days of April 17, 2025.

 

(8) Includes options to purchase 100,000 Ordinary Shares at an exercise price of NIS 5.81 per share that are exercisable within 60 days as of April 17, 2025.

 

(9) Includes options to purchase 100,000 Ordinary Shares at an exercise price of NIS 5.81 per share that are exercisable within 60 days as of April 17, 2025.

 

68

 

 

Significant Changes in Percentage Ownership by Major Shareholders

 

Over the course of 2024 and as of April 19, 2024, Pure Capital, based on its filings of Schedule 13Ds with the SEC, held up to 8.87% of our issued and outstanding share capital. As of the date of this Annual Report, pursuant to a Schedule 13D/A filed with the SEC on April 22, 2025, Pure Capital holds 5.66% of our issued and outstanding share capital.

 

Over the course of 2023, there were no changes in the percentage ownership of our major shareholders.

 

Over the course of 2022 there were no changes in the percentage ownership of our major shareholders.

 

B. Related Party Transactions

 

Agreements with our Executive Officers

 

We have entered into written agreements with each of our executive officers. All of these agreements contain customary provisions regarding non-competition, confidentiality of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable law. In addition, we have entered into agreements with each executive officer and director pursuant to which we have agreed to indemnify each of them to the fullest extent permitted by law to the extent that these liabilities are not covered by directors and officers insurance.

 

Our office holders are generally eligible for bonuses each year. The bonuses are established and granted in accordance with our compensation policy and, are generally payable upon meeting objectives and targets that are approved by our compensation committee and board of directors (and if required by our shareholders).

 

Directors and Officers Insurance Policy and Indemnification Agreements

 

Our amended and restated articles of association permit us to exculpate, indemnify and insure our directors and officeholders to the fullest extent permitted by the Companies Law.

 

We have entered into agreements with each of our current director and officers exculpating them from a breach of their duty of care to us to the fullest extent permitted by law, subject to limited exceptions, and undertaking to indemnify them to the fullest extent permitted by law, to the extent that these liabilities are not covered by insurance. This indemnification is limited, with respect to any monetary liability imposed in favor of a third party, to events determined as foreseeable by the board of directors based on our activities. The maximum aggregate amount of indemnification that we may pay to our directors and officers based on such indemnification agreement is equal to 25% of our shareholders’ equity pursuant to our latest audited or unaudited consolidated financial statements, as applicable, as of the date of the indemnification payment. Such indemnification amounts are in addition to any insurance amounts. Each director or officer who agrees to receive this letter of indemnification also gives his approval to the termination of all previous letters of indemnification that we have provided to him or her in the past, if any.

 

Our current compensation policy determines, among others, that we may provide our directors and officers, including those serving in any of our subsidiaries from time or time and those who are controlling shareholders, with liability insurance policies provided that the engagement is in the ordinary course of business, in market terms and is not expected to materially influence our profits, properties and undertakings. The coverage limit is up to the greater of $50 million or 50% of the Company’s shareholders equity based on the most recent financial statements of the Company at the time of approval of the insurance policy by our compensation committee.

 

On March 2, 2023, our compensation committee approved a new directors’ and officers’ liability insurance policy. The new directors’ and officers’ liability insurance policy provides total coverage of $4 million in the aggregate, for the benefit of all of our directors and officers, in respect of which we are charged a twelve-month premium of $195,000, and which includes a deductible of $300,000 per claim, other than securities related claims filed in the United States or Canada, for which the deductible will not exceed $1 million.

 

69

 

 

Agreements with our Subsidiaries

  

On October 14, 2020, we signed a share purchase agreement and a revolving loan agreement with Eventer (the “Revolving Loan Agreement”). As part of the share purchase agreement and the revolving loan agreement, we invested $750,000, and following the completion thereof we held 58.7% of Eventer’s issued and outstanding share capital.

 

On April 8, 2021, Eventer consummated a share purchase agreement for an aggregate amount of $2.25 million out of which we invested $300,000. We currently hold approximately 46.21% of Eventer’s outstanding share capital.

 

In November 2021 we agreed with Eventer that the repayment of the initial advance under the Revolving Loan Agreement will occur on the earlier of (i) six months following the maturity date of the initial advance; or (ii) immediately following an initial public offering of Eventer.

 

On April 12, 2022, we amended the Revolving Loan Agreement, such that the repayment of the initial advance will occur at the earlier of (i) twelve months following the Maturity Date of the Initial Advance; or (ii) immediately following an initial public offering of Eventer.

 

On May 20, 2021, we entered into a sublease agreement with Jeffs’ Brands pursuant to which we subleased office space of approximately 97 square meters to Jeffs’ Brands, which terminated on October 30, 2022.

 

On October 12, 2021, we entered into a loan agreement with Gix Internet (the “Gix Loan Agreement”), pursuant to which we lent to Gix Internet NIS 4 million. On August 25, 2022, we entered into an amendment to the Gix Loan Agreement, effective as of July 1, 2022 (the “First Amendment to the Gix Loan Agreement), pursuant to which, on November 2, 2022, the Company received a total of NIS 1 million as repayment of the original loan and the accrued interest thereon up to such date. The Repayment of the balance of the loan fund, in the amount of NIS 3 million, was postponed until June 30, 2023. On August 29, 2023, we entered into a second amendment to the to the Gix Loan Agreement (“Amendment No. 2 to the Gix Loan Agreement”) effective as of July 1, 2023, pursuant to which the repayment of the balance of the original remaining loan amount and accrued interest was deferred to January 1, 2024. On November 8, 2023, we entered into a third amendment to the Gix Loan Agreement (“Amendment No. 3 to the Gix Loan Agreement”) pursuant to which the Company lent an additional NIS 100,000 to Gix Internet. On January 1, 2024, we entered into a fourth amendment to the Gix Loan Agreement (“Amendment No. 4 to the Gix Loan Agreement”). On August 22, 2024, we entered into a fifth amendment to the Gix Loan Agreement (Amendment No. 5 to the Gix Loan Agreement”). On October 6, 2024, we entered into a sixth amendment to the Gix Loan Agreement (“Amendment No. 6 to the Gix Loan Agreement”). On January 26, 2025 we entered into a seventh amendment to the Gix Loan Agreement (“Amendment No. 7 to the Gix Loan Agreement”). In addition, the Company is entitled to convert all or part of the balance of the extended loan into shares of Gix Internet. The Gix Loan Agreement and, the First Amendment to the Gix Loan Agreement were filed as Exhibits 4.6 and 4.7, respectively, to our annual report on Form 20-F filed on May 3, 2023. Amendment No. 2 to the Gix Loan Agreement, Amendment No. 3 to the Gix Loan Agreement and Amendment No. 4 to the Gix Loan Agreement were filed as Exhibits 4.9, 4.10 and 4.11 respectively, to our annual report on Form 20-F filed on April 22, 2024. Amendment No. 5 to the Gix Loan Agreement, Amendment No. 6 to the Gix Loan Agreement and Amendment No. 7 to the Gix Loan Agreement are filed as Exhibits 4.17, 4.18 and 4.19 to the this annual report on Form 20-F.

 

On November 15, 2023, we entered into a loan agreement (the “Viewbix Loan Agreement”) with Viewbix Ltd, pursuant to which we lent Viewbix Ltd. (“Viewbix”) $200,000. The Viewbix Loan Agreement is filed as Exhibit 4.17 to this annual report on Form 20-F. On April 16. 2025 we entered into an additional loan agreement with Viewbix pursuant to which we lent Viewbix

 

On April 7, 2023, our formerly wholly owned subsidiary Charging Robotics consummated a share exchange transaction with Fuel Doctor and became its wholly owned subsidiary. As a result of the transaction, held, as of December 31, 2023, 67% of Fuel Doctor’s outstanding share capital, with options to acquire up to 71% of its outstanding share capital based on predetermined milestones.

 

C. Interests of Experts and Counsel

 

Not applicable.

 

ITEM 8. FINANCIAL INFORMATION

 

A. Consolidated Statements and Other Financial Information.

 

See “Item 18. Financial Statements.”

 

70

 

 

Export Sales

 

The following table presents total export sales for each of the fiscal years indicated ($, in thousands):

 

   For the year ended December 31, 
   2024   2023   2022 
Total export sales*   24,994    76,071    89,393 
as a percentage of total revenues   85%   83%   97%

 

* Export sales, as presented, are defined as sales to customers located outside of Israel.

 

Legal Proceedings

 

From time to time, we may assert or be subject to various asserted or unasserted legal proceedings and claims. Any such claims, regardless of merit, could be time-consuming and expensive to defend and could divert management’s attention and resources from our operations. While the management believes that we have adequate insurance coverage and we accrue loss contingencies for all known matters that are probable and can be reasonably estimated, we cannot assure that the outcome of all current or future litigation will not have a material adverse effect on us and our results of operations.

 

On April 1, 2024, a lawsuit seeking declaratory judgement was filed in the District Court of Tel Aviv-Jaffa in Israel by minority shareholders Eventer, a subsidiary of the Company (together, the “Defendants”). The minority shareholders of Eventer (the “Plaintiffs”), hold in aggregate 31.86% of the Outstanding Ordinary Shares of Eventer. The Plaintiffs allege, among others, that Defendants violated the agreement whereby the Company acquired control of Eventer (the “Purchase Agreement”), which established a “separation” mechanism, within which certain Plaintiffs were granted an option to convert their shares in Eventer into shares of the Company. The claim alleges that the Company has violated the terms of the Purchase Agreement by refusing to negotiate Eventer’s valuation to enable certain of the Plaintiffs to exercise their option to convert their shares of Eventer into shares of the Company. The Plaintiffs seek an aggregate of NIS 2,259,000 from Eventer (approximately $600,000) and seek to convert their shares held in Eventer into Company shares for an aggregate value of NIS 8,602,200 (approximately $2,348,200) following which all shares held by the Plaintiffs in Eventer would be transferred to the Company. The Company has not yet submitted its response to the District Court of Tel Aviv - Jaffa. The Company’s position is that the lawsuit has no merit, and it intends to defend its position vigorously. As of the date of this annual report, the Company is unable to estimate a loss or range of loss of this claim.

 

Dividends

 

On December 28, 2022, we paid cash dividends on our Ordinary Shares and our Series C Warrants. We do not anticipate that we will further pay any cash dividends on our Ordinary Shares or ADSs in the foreseeable future.

 

We intend to retain our earnings to finance the development and expenses of our business. Any future determination relating to our dividend policy will be at the discretion of our board of directors and will depend on a number of factors, including future earnings, our financial condition, operating results, contractual restrictions, capital requirements, business prospects, applicable Israeli law and other factors our board of directors may deem relevant.

 

B. Significant Changes

 

No significant change, other than as otherwise described in this annual report, has occurred in our operations since the date of our consolidated financial statements included in this annual report.

 

71

 

 

ITEM 9. THE OFFER AND LISTING 

 

A. Offer and Listing Details

 

Our Ordinary Shares were traded on the TASE under the symbol “MDGS” from February 2006 to January 25, 2021, when we delisted our Ordinary Shares from TASE. Our ADSs were traded on Nasdaq under the symbol “MDGS.” In connection with our name change our ADSs began trading under the symbol “XYLO” on April 18, 2024. Each ADS currently represents 40 Ordinary Shares.

 

For a description of the ADSs, see “Item 12. Description of Securities Other Than Equity Securities - D. American Depositary Shares.”

 

Our Series C Warrants traded on Nasdaq under the symbol “MDGSW” beginning in July 2018 until July 2023. Each Series C Warrant was exercisable into one/fifteen ADSs for an exercise price of $52.50 and expired in July 2023.

 

B. Plan of Distribution

 

Not Applicable.

 

C. Markets

 

Our Ordinary Shares are no longer listed on TASE. Our ADSs were traded on Nasdaq under the symbol “MDGS” until April 17, 2024. In connection with our name change, our ADSs began trading under the symbol “XYLO” as of April 18, 2024.

 

D. Selling Shareholders

 

Not Applicable.

 

E. Dilution

 

Not Applicable.

 

F. Expenses of the Issue

 

Not Applicable.

 

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

Not Applicable.

 

B. Memorandum and Articles of Association

 

A copy of our amended and restated articles of association is attached as Exhibit 1.1 to this annual report on Form 20-F.

 

72

 

 

C. Material Contracts 

 

The following is a summary of each material contract, other than material contracts entered into in the ordinary course of business, to which we are or have been a party, for the two years immediately preceding the date of this annual report on Form 20-F:

 

  Loan Agreement by and between the Company and Gix Internet dated October 12, 2021 (the “Loan Agreement”), filed as Exhibit 4.6 to our annual report on Form 20-F filed on May 3, 2023.
     
  Amendments to the Loan Agreement by and between the Company and Gix Internet dated (i) August 25, 2022, and effective as of July 1, 2022, filed as Exhibit 4.7 to our annual report on Form 20-F filed May 3, 2023; (ii) August 29, 2023 and effective as of July 1, 2023, filed as Exhibit 4.9 to our annual report on Form 20-F filed on April 22, 2024; (iii) November 8, 2023, filed as Exhibit 4.10 to our annual report on Form 20-F filed on April 22, 2024; (iv) January 1, 2024, filed as Exhibit 4.11 to our annual report on Form 20-F filed on April 22, 2024, (v) August 22, 2024, filed as Exhibit 4.17 to this annual report on Form 20-F and incorporated herein by reference, (vi) October 6, 2024, filed as Exhibit 4.18 to this annual report on Form 20-F and (vi) January 26, 2025 and incorporated herein by reference, filed as Exhibit 4.19 to this annual report on Form 20-F and incorporated herein by reference.
     
  Share Purchase Agreement, by and among the Company, Parazero, Delta Drone International Ltd., L.I.A Pure Capital Ltd. and other entities listed therein, dated January 28, 2022, filed as Exhibit 4.8 to our annual report on Form 20-F filed on May 3, 2023.
     
  Securities Exchange Agreement by and between Medigus Ltd., the additional shareholders of Charging Robotics Ltd. and Fuel Doctor Holdings, Inc. dated March 28, 2023, filed as Exhibit 4.9 to our annual report on Form 20-F filed on May 3, 2023.
     
  Share Purchase Agreement, by and among the Company and Metagramm, dated April 13, 2023, a summary of which is filed as Exhibit 4.14 to our annual report on Form 20-F filed on April 22, 2024.
     
  Share Purchase Agreement, by and between the Company, Parazero and other investors, dated June 20, 2023, filed as Exhibit 4.15 to our annual report on Form 20-F filed on April 22, 2024.

 

  Operating agreement by and between the Company and Zig Investment Group LLC, dated September 13, 2023, filed as Exhibit 4.16 to our annual report on Form 20-F filed April 22, 2024.
     
  Loan Agreement by and between Viewbix Ltd. and the Lenders listed therein, dated November 15, 2023, filed as exhibit 4.17 to our annual report on Form 20-F filed on April 22, 2024.
     
  Investment Agreement by and between the Company and Gix Internet, dated December 11, 2023, filed as exhibit 4.18 to our annual report on Form 20-F filed on April 22, 2024.
     
  Warrants Purchase Agreement by and between the Company and an institutional investor, dated November 15, 2024, filed as exhibit 10.1 to our report of foreign private issuer on Form 6-K, filed on November 15, 2024.

 

D. Exchange Controls

 

There are currently no Israeli currency control restrictions on payments of dividends or other distributions with respect to our securities or the proceeds from the sale of our securities, except or otherwise as set forth in this section and under “Item 10E. Additional Information - Taxation.” However, legislation remains in effect pursuant to which currency controls can be imposed by administrative action at any time.

 

The ownership or voting of our Ordinary Shares by non-residents of Israel, except with respect to citizens of countries that are in a state of war with Israel, is not restricted in any way by our amended and restated articles or by the laws of the State of Israel.

 

73

 

 

E. Taxation

 

The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of our Ordinary Shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.

 

Israeli Tax Considerations and Government Programs

 

The following is a summary of the material Israeli tax laws applicable to us, and some Israeli Government programs benefiting us. This section also contains a discussion of some Israeli tax consequences to persons owning our Ordinary Shares. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of this kind of investor include traders in securities or persons that own, directly or indirectly, 10% or more of our outstanding means of control, all of whom are subject to special tax regimes not covered in this discussion. Some parts of this discussion are based on a new tax legislation which has not been subject to judicial or administrative interpretation. The discussion should not be construed as legal or professional tax advice and does not cover all possible tax considerations.

 

SHAREHOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS AS TO THE ISRAELI OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES, INCLUDING, IN PARTICULAR, THE EFFECT OF ANY FOREIGN, STATE OR LOCAL TAXES.

 

General Corporate Tax Structure in Israel

 

Israeli resident companies are generally subject to corporate tax on their taxable income at the rate of 23% of a company’s taxable income. However, the effective tax rate payable by a company that derives income from a Benefited Enterprise, a Preferred Enterprise, a Special Preferred Enterprise, a Preferred Technological Enterprise or a Special Preferred Technological Enterprise (as discussed below) may be considerably less. Capital gains derived by an Israeli resident company are generally subject to tax at the prevailing corporate tax rate.

 

Law for the Encouragement of Industry (Taxes), 5729-1969

 

The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for “Industrial Companies.”

 

The Industry Encouragement Law defines an “Industrial Company” as an Israeli resident company incorporated in Israel, of which 90% or more of its income in the tax year, other than income from certain government loans, derived from an “Industrial Enterprise” owned by it and located in Israel or in the “Area”, in accordance with the definition under section 3A of Tax Ordinance (New Version) 1961 (the “Tax Ordinance”). An “Industrial Enterprise” is defined as an enterprise which is held by an Industrial Company whose principal activity in any given tax year is industrial production.

 

The following corporate tax benefits, among others, are available to Industrial Companies:

 

  Amortization over an eight-year period commencing on the year in which such rights were first exercised, of the cost of purchased patents, rights to use a patent and know-how which are used for the development or advancement of the Industrial Enterprise;
     
  Under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies controlled by it; and
     
  Under certain conditions, expenses related to a public offering are deductible in equal amounts over a three years period commencing on the year of the offering.

 

We may qualify as an Industrial Company and may be eligible for the benefits described above.

 

Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.

 

74

 

 

Tax Benefits and Grants for Research and Development

 

Israeli tax law allows, under certain conditions, a tax deduction for research and development expenditures, including capital expenditures, for the year in which they are incurred. Expenditures are deemed related to scientific research and development projects, if:

 

  The expenditures are approved by the relevant Israeli government ministry, determined by the field of research;
     
  The research and development must be for the promotion of the company; and
     
  The research and development is carried out by or on behalf of the company seeking such tax deduction.

 

The amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is related to an expense invested in an asset depreciable under the general depreciation rules of the Tax Ordinance. Expenditures not so approved are deductible in equal amounts over a three-year period.

 

From time to time, we may apply the Israel Innovation Authority (previously known as the Israeli Office of the Chief Scientist) (the “IIA”) for approval to allow a tax deduction for all research and development expenses during the year incurred. There can be no assurance that such application will be accepted.

 

Law for the Encouragement of Capital Investments, 5719-1959

 

The Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets) by “Industrial Enterprises” (as defined under the Investment Law).

 

The Investment Law has been amended several times over the recent years, with the three most significant changes effective as of April 1, 2005 (referred to as the 2005 Amendment), as of January 1, 2011 (referred to as the 2011 Amendment) and as of January 1, 2017 (referred to as the 2017 Amendment).

 

Tax Benefits Subsequent to the 2005 Amendment

 

The 2005 Amendment applies to investment programs commencing after 2004, but does not apply to investment programs approved prior to April 1, 2005. The 2005 Amendment provides that terms and benefits included in any certificate of approval that was granted before the 2005 Amendment became effective (April 1, 2005) will remain subject to the provisions of the Investment Law as in effect on the date of such approval. Pursuant to the 2005 Amendment, the Israeli Authority for Investments and Development of the Israeli Ministry of Economy (referred to as the Investment Center) will continue to grant Approved Enterprise status to qualifying investments. The 2005 Amendment, however, limits the scope of enterprises that may be approved by the Investment Center by setting criteria for the approval of a facility as an Approved Enterprise, such as provisions generally requiring that at least 25% of the Approved Enterprise’s income be derived from exports. An enterprise that qualifies under the new provisions is referred to as a “Benefited Enterprise”, rather than “Approved Enterprise”. The 2005 Amendment provides that Approved Enterprise status will only be necessary for receiving cash grants. As a result, it was no longer necessary for a company to obtain Approved Enterprise status in order to receive the tax benefits previously available under the alternative benefits track. Rather, a company may claim the tax benefits offered by the Investment Law directly in its tax returns, provided that its facilities meet the criteria for tax benefits set forth in the 2005 Amendment. Such a position may be subject to a future tax audit. Companies are entitled to approach the Israeli Tax Authority for a pre-ruling regarding their eligibility for benefits under the Investment Law, as amended.

 

75

 

 

Tax benefits are available under the 2005 Amendment to production facilities (or other eligible facilities) which are generally required to derive 25% or more of their business income from export to specific markets with a population of at least 14 million in 2012 (such export criteria will further be increased in the future by 1.4% per annum). In order to receive the tax benefits, the 2005 Amendment states that a company must make an investment which meets all of the conditions, including exceeding a minimum investment amount specified in the Investment Law. Such investment allows a company to receive “Benefited Enterprise” status, and may be made over a period of no more than three years that will end at the year in which the company requested to have the tax benefits apply to its Benefited Enterprise. The benefits period under the Benefited Enterprise status is limited to 12 years from the year the company chose to have its tax benefits apply. Where the company requests to apply the tax benefits to an expansion of existing facilities, only the expansion will be considered to be a Benefited Enterprise and the company’s effective tax rate will be the weighted average of the applicable rates. In this case, the minimum investment required in order to qualify as a Benefited Enterprise is required to exceed a certain percentage of the value of the company’s production assets before the expansion.

 

The extent of the tax benefits available under the 2005 Amendment to qualifying income of a Benefited Enterprise depend on, among other things, the geographic location in Israel of the Benefited Enterprise. The location will also determine the period for which tax benefits are available. Such tax benefits include an exemption from corporate tax on undistributed income for a period of between two to ten years, depending on the geographic location of the Benefited Enterprise in Israel, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year. The benefits period is limited to 12 or 14 years from the year the company first chose to have the tax benefits apply, depending on the location of the company within Israel.

 

A company qualifying for tax benefits under the 2005 Amendment which pays a dividend out of income derived by its Benefited Enterprise during the tax exemption period will be subject to corporate tax in respect of the gross amount of the dividend, or a lower rate in the case of a qualified Foreign Investors’ Company, to which we refer as a FIC, which is at least 49% owned by non-Israeli residents. Dividends paid to Israeli shareholders out of income attributed to a Benefited Enterprise (or out of dividends received from a company whose income is attributed to a Benefited Enterprise) are generally subject to withholding tax at source at the rate of 15% (in the case of non-Israeli shareholders - subject to the receipt in advance of a valid certificate from the ITA allowing the reduced 15% tax rate, or such lower rate as may be provided in an applicable tax treaty). The reduced rate of 15% is limited to dividends and distributions out of income attributed to a Benefited Enterprise during the benefits period and actually paid at any time up to 12 years thereafter except with respect to a FIC (as such term is defined in the Investment Law), in which case the 12-year limit does not apply.

 

The benefits available to a Benefited Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions, it may be required to refund the amount of tax benefits, as adjusted by the Israeli consumer price index, and interest, or other monetary penalties.

 

Tax Benefits under the 2011 Amendment

 

The Investment Law was significantly amended as of January 1, 2011 (the “2011 Amendment”). The 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment.

 

The 2011 Amendment introduced new tax benefits for income generated by a “Preferred Company” through its “Preferred Enterprise” in accordance with the definition of such term in the Investments Law. A “Preferred Company” is defined as either: (i) a company incorporated in Israel which is not wholly owned by a governmental entity, or (ii) a limited partnership that: (a) was registered under the Israeli Partnerships Ordinance and; (b) all of its limited partners are companies incorporated in Israel, but not all of them are governmental entities; which has, among other things, Preferred Enterprise status and is controlled and managed from Israel.

 

76

 

 

A Preferred Company is entitled to a reduced flat tax rate with respect to the income attributed to the Preferred Enterprise, at the following rates:

 

Tax Year  Development
Region “A”
   Other Areas
within Israel
 
2011 - 2012    10%   15%
2013    7%   12.5%
2014    9%   16%
2017 onwards(1)     7.5%   16%

  

(1) In December 2016, the Israeli Parliament (the Knesset) approved an amendment to the Investment Law pursuant to which the tax rate applicable to Preferred Enterprises in Development Region “A” would be reduced to 7.5% as of 2017.

 

In addition, Income derived by a Preferred Company from a “Special Preferred Enterprise” (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or to 5% if the Special Preferred Enterprise is located in a Development Region “A”. Since January 1, 2017, the definition for “Special Preferred Enterprise” includes less stringent conditions.

 

Dividends distributed from income which is attributed to a “Preferred Enterprise” or to a “Special Preferred Enterprise” will be subject to withholding tax at source at the following rates: (i) Israeli resident corporations - 0%, (ii) Israeli resident individuals - 20%, and (iii) non-Israeli residents - 20% or a reduced tax rate under the provisions of an applicable double tax treaty, subject to the receipt in advance of a valid certificate from the Israel Tax Authority (“ITA”) allowing for a reduced tax rate.

 

Under the 2011 Amendment, a company located in Development Region “A” may be entitled to cash grants and the provision of loans under certain conditions, if approved. The rates for grants and loans shall not be fixed, but up to 20% of the amount of the approved investment (may be increased with additional 4%). In addition, a company owning a Preferred Enterprise under the Grant Track may be entitled also to the tax benefits which are prescribed for a Preferred Company.

 

The 2011 Amendment also provided transitional provisions to address companies already enjoying current benefits under the Investment Law. These transitional provisions provide, among other things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to be derived as of January 1, 2011: (i) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, which chose to receive grants, before the 2011 Amendment became effective, will remain subject to the provisions of the Investment Law as in effect on the date of such approval, and subject to certain conditions; (ii) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, that had participated in an alternative benefits program, before the 2011 Amendment became effective will remain subject to the provisions of the Investment Law as in effect on the date of such approval, provided that certain conditions are met; and (iii) a Benefited Enterprise can elect to continue to benefit from the benefits provided to it before the 2011 Amendment came into effect, provided that certain conditions are met.

 

The tax benefits under the 2011 Amendment also include accelerated depreciation and amortization for tax purposes.

 

The termination or substantial reduction of any of the benefits available under the Investment Law could materially increase our tax liabilities.

 

As the Company does not have taxable income as of today, it does not use tax benefits under the said regime.

 

77

 

 

New Tax benefits under the 2017 Amendment that became effective on January 1, 2017

 

The 2017 Amendment provides new tax benefits for two types of Technology Enterprises, as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.

 

The 2017 Amendment provides that a technology company satisfying certain conditions will qualify as a Preferred Technology Enterprise and will thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as Preferred Technology Income, as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technology Enterprise located in development zone “A”. In addition, a Preferred Technology Company will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain Benefited Intangible Assets (as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January 1, 2017, for at least NIS 200 million, and the sale receives prior approval from the IIA.

 

The 2017 Amendment further provides that a technology company satisfying certain conditions will qualify as a “Special Preferred Technology Enterprise” (an enterprise for which, among others, total consolidated revenues of its parent company and all subsidiaries is at least NIS 10 billion) and will thereby enjoy a reduced corporate tax rate of 6% on Preferred Technology Income regardless of the company’s geographic location within Israel. In addition, a Special Preferred Technology Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain “Benefited Intangible Assets” to a related foreign company if the Benefited Intangible Assets were either developed by the Special Preferred Technology Enterprise or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from IIA. A Special Preferred Technology Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500 million will be eligible for these benefits for at least ten years, subject to certain approvals as specified in the Investment Law.

 

Dividends distributed to Israeli shareholders by a Preferred Technology Enterprise or a Special Preferred Technology Enterprise, paid out of Preferred Technology Income, are generally subject to withholding tax at source at the rate of 20% (in the case of non-Israeli shareholders - subject to the receipt in advance of a valid certificate from the ITA allowing the reduced 20% tax rate, or such lower rate as may be provided in an applicable tax treaty). However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, the aforesaid will apply). If such dividends are distributed to a foreign company that holds solely or together with other foreign companies 90% or more in the Israeli company and other conditions are met, the withholding tax rate will be 4% or a lower rate under a tax treaty, if applicable subject to the receipt in advance of a valid certificate from the ITA.

 

Taxation of Our Shareholders

 

Capital Gains

 

Capital gain tax is imposed on the disposition of capital assets by an Israeli resident, and on the disposition of such assets by a non-Israeli resident if those assets are either (i) located in Israel; (ii) are shares or a right to a share in an Israeli resident corporation, or (iii) represent, directly or indirectly, rights to assets located in Israel, unless a tax treaty between Israel and the seller’s country of residence provides otherwise. The Tax Ordinance distinguishes between “Real Capital Gain” and the “Inflationary Surplus”. Real Capital Gain is the excess of the total capital gain over Inflationary Surplus computed generally on the basis of the increase in the Israeli Consumer Price Index or, in certain circumstances, a foreign currency exchange rate between the date of purchase and the date of disposition. Inflationary Surplus is not subject to tax in Israel if accrued after 1993.

 

Generally, Real Capital Gain accrued by individuals on the sale of our Ordinary Shares will be taxed at the rate of 25%. However, if the individual shareholder is a “Substantial Shareholder” (i.e., a person who holds, directly or indirectly, alone or together with such person’s relative or another person who collaborates with such person on a permanent basis, 10% or more of one of the Israeli resident company’s means of control (including, among other things, the right to receive profits of the company, voting rights, the right to receive the company’s liquidation proceeds, the right to appoint a director or an executive officer and order someone who holds any of the aforesaid rights how to act, regardless of the source of such right) at the time of sale or at any time during the preceding 12 months period, such gain will be taxed at the rate of 30%.

 

78

 

 

Real Capital Gain derived by corporations will be generally subject to a corporate tax rate of 23% (in 2024).

 

Individuals and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income – 23% for corporations in 2024 and a marginal tax rate of up to 47% in 2024 for individuals (excluding excess tax as discussed below), unless the benefiting provisions of an applicable treaty applies.

 

Notwithstanding the foregoing, capital gains derived from the sale of our Ordinary Shares by a non-Israeli shareholder may be exempt under the Tax Ordinance from Israeli taxation provided that the following cumulative conditions are met: (i) the shares were purchased upon or after the registration of the securities on the stock exchange (ii) the seller does not have a permanent establishment in Israel to which the derived capital gain is attributed, (iii) neither the shareholder nor the particular capital gain is otherwise subject to the Israeli Income Tax Law (Inflationary Adjustments) 5745-1985), (iv) if the seller is a corporation, no more than 25% of its means of control are held, directly and indirectly, by an Israeli resident shareholders, and there is no Israeli Resident that is entitled to 25% or more of the revenues or profits of the corporation directly or indirectly. In addition, such an exemption would not be available to a person whose gains from selling or otherwise disposing of the securities are deemed to be business income.

 

In addition, the sale of shares may be exempt from Israeli capital gain tax under the provisions of an applicable tax treaty. For example, the U.S.-Israel Double Tax Treaty exempts a U.S. resident from Israeli capital gain tax in connection with such sale, provided that (i) the U.S. resident owned, directly or indirectly, less than 10% of an Israeli resident company’s voting power at any time within the 12 month period preceding such sale; (ii) the seller, being an individual, is present in Israel for a period or periods of less than 183 days in the aggregate at the taxable year; and (iii) the capital gain from the sale was not derived through a permanent establishment of the U.S. resident in Israel; (iv) the capital gain arising from such sale, exchange or disposition is not attributed to real estate located in Israel; (v) the capital gains arising from such sale, exchange or disposition is not attributed to royalties; and (vi) the shareholder is a U.S. resident (for purposes of the U.S.-Israel Treaty) is holding the shares as a capital asset. Under the U.S.-Israel Double Tax Treaty, a U.S. resident would be permitted to claim a credit for the Israeli tax against the U.S. federal income tax imposed with respect to the sale, exchange or disposition, subject to the limitations in U.S. laws applicable to foreign tax credits. The U.S-Israel Double Tax Treaty does not provide such credit against any U.S. state or local taxes.

 

Regardless of whether our shareholders (including non-Israeli shareholders) may be liable for Israeli tax on the sale of their Ordinary Shares, the payment of the consideration may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, the ITA may require shareholders who are not liable for Israeli tax to sign declarations in forms specified by this authority, provide documentation (including, for example, a certificate of residency) or to obtain a specific exemption from the ITA to confirm their status as non-Israeli resident, and, in the absence of such declarations or exemptions, may require the purchaser of the shares to withhold taxes at source.

 

At the sale of securities traded on a stock exchange a detailed return, including a computation of the tax due, must be filed and an advanced payment must be paid on January 31 and July 31 of every tax year in respect of sales of securities made within the previous six months. However, if all tax due was withheld at source according to applicable provisions of the Tax Ordinance and regulations promulgated thereunder the aforementioned return need not be filed and no advance payment must be paid provided that (i) such income was not generated from business conducted in Israel by the taxpayer, (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed and an advance payment does not need to be made, and (iii) the taxpayer is not obligated to pay excess tax (as further explained below). Capital gain is also reportable on the annual income tax return.

 

79

 

 

Dividend Income

 

Generally, a distribution of a dividend to Israeli shareholders by our Company from income attributed to a Benefited Enterprise will be subject to withholding tax in Israel at a rate of 15% (in the case of non-Israeli shareholders - subject to the receipt in advance of a valid certificate from the ITA allowing the reduced 15% tax rate or such a reduced tax rate as may be provided under an applicable tax treaty). A distribution of dividend by our Company from income attributed to a Preferred Enterprise or Preferred Technology Enterprise (if the Company will be entitled to tax benefits of a Preferred Enterprise or Preferred Technology Enterprise) will generally be subject to withholding tax in Israel at the following tax rates: Israeli resident individuals - 20%; Israeli resident companies - 0%; Non-Israeli residents - 20% (subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate, 20% , or such lower rate as may be provided in an applicable tax treaty).

 

A distribution of dividends from income, which is not attributed to a Preferred Enterprise or a Benefited Enterprise to an Israeli resident individual, will generally be subject to withholding tax at a rate of 25%. However, a 30% tax rate will apply if the dividend recipient is a “Substantial Shareholder” (as defined above) at the time of distribution or at any time during the preceding 12 months period. If the recipient of the dividend is an Israeli resident corporation, such dividend will be exempt from withholding tax provided the income from which such dividend is distributed was derived or accrued within Israel and was subject to tax in Israel. An average rate will be set in case the dividend is distributed from mixed types of income (regular and preferred income).

 

The Tax Ordinance provides that a non-Israeli resident (either individual or corporation) is generally subject to an Israeli income tax on the receipt of dividends at the rate of 25% (30% if the dividends recipient is a “Substantial Shareholder” (as defined above), at the time of distribution or at any time during the preceding 12 months period). Dividends paid on publicly traded shares, like our Ordinary Shares, to non-Israeli residents, are generally subject to Israeli withholding tax at a rate of 25%, so long as the shares are registered with a nominee company (whether or not the recipient is a substantial shareholder); those rates are subject to a reduced tax rate under the provisions of an applicable double tax treaty (subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate). Thus, under the U.S.-Israel Double Tax Treaty the following rates will apply in respect of dividends not attributed to a Benefited Enterprise or Preferred Enterprise distributed by an Israeli resident company to a U.S. resident: (i) if the U.S. resident is a corporation which holds during that portion of the taxable year which precedes the date of payment of the dividend and during the whole of its prior taxable year (if any), at least 10% of the outstanding shares of the voting share capital of the Israeli resident paying corporation and not more than 25% of the gross income of the Israeli resident paying corporation for such prior taxable year (if any) consists of certain type of interest or dividends - the tax rate is 12.5%. Notwithstanding the foregoing, dividends distributed from income attributed to a Benefited Enterprise or Preferred Enterprise are not entitled to such reduction under such tax treaty but are subject to withholding tax at the rate of 15% or 20% for such a United States corporate shareholder, provided that the conditions related to the holding of 10% of our voting capital and to our gross income for the previous year (as set forth in the previous sentence) are met. The aforementioned rates under the Israel U.S. Double Tax Treaty will not apply if the dividend income was derived through a permanent establishment of the U.S. resident in Israel.

 

A non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer, (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed, and (iii) the taxpayer is not obligated to pay excess tax (as further explained below).

 

Payers of dividends on our Ordinary Shares, including the Israeli stockbroker effectuating the transaction, or the financial institution through which the securities are held, are generally required, subject to any of the foregoing exemptions, reduced tax rates and the demonstration of a shareholder regarding his, her or its foreign residency, to withhold tax upon the distribution of dividend at the rate of 25%, so long as the shares are registered with a nominee company.

 

We paid a dividend in December 2022 but do not expect to further pay any cash dividends in the near future. Following the receipt of a tax ruling from the Israeli Tax Authorities, the payment was not subject to tax withholding in Israel and the Company paid the cash capital amount in full.

 

80

 

 

Excess Tax

 

Subject to the provisions of an applicable tax treaty, individuals who are subject to tax in Israel (whether any such individual is an Israeli resident or non-Israeli resident) are also subject to an additional tax at a rate of 3% on annual income (including, but not limited to, income derived from dividends, interest and capital gains) exceeding NIS 721,560 for 2024, which amount is linked to the annual change in the CPI index (with the exception that based on Israeli new legislation such amount, and certain other statutory amounts will not be linked to the Israeli consumer price index for the years 2025-2027). According to new legislation, in effect as of January 1, 2025, an additional 2% excess tax is imposed on Capital-Sourced Income (defined as income from any source other than employment income, business income or income from “personal effort”), to the extent that the Individual’s Capital Sourced Income exceeds the specified threshold of NIS 721,560 (and regardless of the employment/business income amount of such individual). This new excess tax applies, among other things, to income from capital gains, dividends, interest, rental income, or the sale of real property..

 

Foreign Exchange Regulations

 

Non-residents of Israel who hold our Ordinary Shares are able to receive any dividends, and any amounts payable upon the dissolution, liquidation and winding up of our affairs, repayable in non-Israeli currency at the rate of exchange prevailing at the time of conversion. However, Israeli income tax is generally required to have been paid or withheld on these amounts. In addition, the statutory framework for the potential imposition of currency exchange control has not been eliminated and may be restored at any time by administrative action.

 

Estate and Gift Tax

 

Israeli law presently does not impose estate or gift taxes.

 

Certain Material U.S. Federal Income Tax Consequences

 

The following discussion describes certain material U.S. federal income tax consequences to U.S. Holders (as defined below) under present law of an investment in our Ordinary Shares or ADSs. This discussion applies only to U.S. Holders that hold our Ordinary Shares or ADSs as capital assets within the meaning of Section 1221 of the Internal Revenue Code of 1986, as amended (the “Code”), that have acquired their Ordinary Shares or ADSs and that have the U.S. dollar as their functional currency.

 

This discussion is based on the tax laws of the United States, including the Code, as in effect on the date hereof and on U.S. Treasury regulations as in effect or, in some cases, as proposed, on the date hereof, the United States-Israel Tax Treaty (the “Treaty”), as well as judicial and administrative interpretations thereof available on or before such date. All of the foregoing authorities are subject to change, which change could apply retroactively and could affect the tax consequences described below. We have not sought, and will not seek, a ruling from the IRS or an opinion of counsel as to any U.S. federal income tax consequence described herein. There can be no assurances that the IRS will not take a different position concerning the tax consequences of the acquisition, ownership and disposition of our Ordinary Shares or ADSs or that such a position would not be sustained. This summary does not address any estate or gift tax consequences, the alternative minimum tax, the Foreign Account Tax Compliance Act or any state, local, or non-U.S. tax consequences.

 

81

 

 

The following discussion neither deals with the tax consequences to any particular investor nor describes all of the tax consequences applicable to persons in special tax situations such as:

 

banks;

 

certain financial institutions;

 

insurance companies;

 

regulated investment companies;

 

real estate investment trusts;

 

broker-dealers;

 

traders that elect to mark to market;

 

certain former citizens or residents of the United States;

 

tax-exempt entities;

 

persons holding our Ordinary Shares or ADSs as part of a straddle, hedging, constructive sale, conversion or integrated transaction;

 

persons that actually (directly or indirectly) or constructively own 10% or more of our total voting power or value;

 

persons that are residents or ordinarily resident in or have a permanent establishment in a jurisdiction outside the United States;

 

persons who acquired our Ordinary Shares or ADSs pursuant to the exercise of any employee share option or otherwise as compensation;

 

S-corporation and partnerships, including entities classified as partnerships for U.S. federal income tax purposes;

 

governments or agencies or instrumentalities thereof;

 

grantor trusts;

 

passive foreign investment companies; or

 

controlled foreign corporations.

 

INVESTORS ARE URGED TO CONSULT THEIR TAX ADVISORS ABOUT THE APPLICATION OF THE U.S. FEDERAL TAX RULES TO THEIR PARTICULAR CIRCUMSTANCES AS WELL AS THE STATE, LOCAL, NON-U.S. AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES OR ADSs.

 

The discussion below of the U.S. federal income tax consequences to “U.S. Holders” will apply to you if you are the beneficial owner of our Ordinary Shares or ADSs and you are, for U.S. federal income tax purposes,

 

an individual who is a citizen or resident of the United States;

 

82

 

 

a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in the United States or under the laws of the United States, any state thereof or the District of Columbia;

 

an estate, the income of which is subject to U.S. federal income taxation regardless of its source; or

 

a trust that (1) is subject to the primary supervision of a court within the United States and the control of one or more U.S. persons for all substantial decisions or (2) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.

 

If an entity or other arrangement treated as a partnership for U.S. federal income tax purposes holds our Ordinary Shares or ADSs, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. A person that would be a U.S. Holder if it held our Ordinary Shares or ADSs directly and that is a partner of a partnership holding our Ordinary Shares or ADSs is urged to consult its own tax advisor.

 

Ownership of ADSs

 

For U.S. federal income tax purposes, we expect that a holder of ADSs generally should be treated as the owner of the Ordinary Shares represented by such ADSs. Gain or loss is generally not expected to be recognized on account of exchanges of Ordinary Shares for ADSs, or of ADSs for Ordinary Shares. References to ordinary shares in the discussion below are deemed to include ADSs, unless context otherwise requires.

 

Passive Foreign Investment Company

 

Based on our anticipated income and the composition of our income and assets, we do not believe we were a PFIC for our 2024 taxable year . Because the PFIC determination is highly fact intensive, there can be no assurance that we were not a PFIC in 2024 and will not be a PFIC in 2025 or any other year, as our operating results for any such years may cause us to be a PFIC. A non-U.S. entity treated as a corporation for U.S. federal income tax purposes will generally be a PFIC for U.S. federal income tax purposes for any taxable year after applying certain look-through rules with respect to the income and assets of subsidiaries if either:

 

at least 75% of its gross income for such year is passive income (such as interest income); or

 

at least 50% of the value of its assets (based on an average of the quarterly values of the assets) during such year is attributable to assets that produce passive income or are held for the production of passive income.

 

Passive income for this purpose generally includes dividends, interest, royalties, rents, gains from commodities and securities transactions, the excess of gains over losses from the disposition of assets which produce passive income, and includes amounts derived by reason of the temporary investment of funds raised in offerings of our shares.

 

For this purpose, we will be treated as owning our proportionate share of the assets and earning our proportionate share of the income of any other entity treated as a corporation for U.S. federal income tax purposes in which we own, directly or indirectly, 25% or more (by value) of the stock.

 

A separate determination must be made after the close of each taxable year as to whether we were a PFIC for that year. Because the value of our assets for purposes of the PFIC test will generally be determined by reference to the market price of our Ordinary Shares, our PFIC status may depend in part on the market price of our Ordinary Shares, which may fluctuate significantly. In addition, there may be certain ambiguities in applying the PFIC test to us. No rulings from the U.S. Internal Revenue Service, or IRS, however, have been or will be sought with respect to our status as a PFIC. If we are a PFIC for any taxable year during which you hold our Ordinary Shares, we generally will continue to be treated as a PFIC with respect to your investment in our Ordinary Shares for all succeeding years during which you hold our Ordinary Shares, unless we cease to be a PFIC and you make a “deemed sale” election with respect to our Ordinary Shares. If such election is made, you will be deemed to have sold our Ordinary Shares you hold at their fair market value on the last day of the last taxable year in which we were a PFIC, and any gain from such deemed sale would be subject to taxation under the excess distribution regime described below. After the deemed sale election, your Ordinary Shares with respect to which the deemed sale election was made will not be treated as shares in a PFIC unless we subsequently become a PFIC.

 

83

 

 

For each taxable year that we are treated as a PFIC with respect to you, you will be subject to special tax rules with respect to any “excess distribution” (as defined below) you receive and any gain you realize from a sale or other disposition (including a pledge) of our Ordinary Shares, unless you make a valid “mark-to-market” election as discussed below. Distributions you receive in a taxable year that are greater than 125% of the average annual distributions you received during the shorter of the three preceding taxable years or your holding period for our Ordinary Shares will be treated as an excess distribution. Under these special tax rules:

 

the excess distribution or gain will be allocated ratably over your holding period for our Ordinary Shares;

 

the amount allocated to the current taxable year, and any taxable years in your holding period prior to the first taxable year in which we were a PFIC, will be treated as ordinary income; and

 

the amount allocated to each other taxable year will be subject to the highest tax rate in effect for individuals or corporations, as applicable, for each such year and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.

 

The tax liability for amounts allocated to taxable years prior to the year of disposition or excess distribution cannot be offset by any net operating losses, and gains (but not losses) realized on the sale of our Ordinary Shares cannot be treated as capital gains, even if you hold our Ordinary Shares as capital assets.

 

If we are treated as a PFIC with respect to you for any taxable year, to the extent any of our subsidiaries are also PFICs, you may be deemed to own shares in such lower-tier PFICs that are directly or indirectly owned by us in that proportion which the value of our Ordinary Shares you own bears to the value of all of our Ordinary Shares, and you may be subject to the adverse tax consequences described above with respect to the shares of such lower-tier PFICs you would be deemed to own. As a result, you may incur liability for any excess distribution described above if we receive a distribution from our lower-tier PFICs or if any shares in such lower-tier PFICs are disposed of (or deemed disposed of). You should consult your tax advisor regarding the application of the PFIC rules to any of our subsidiaries.

 

A U.S. Holder of “marketable stock” (as defined below) in a PFIC may make a mark-to-market election for such stock to elect out of the tax treatment discussed above. If you make a valid mark-to-market election for our Ordinary Shares, you will include in income for each year that we are treated as a PFIC with respect to you an amount equal to the excess, if any, of the fair market value of our Ordinary Shares as of the close of your taxable year over your adjusted basis in such Ordinary Shares. You will be allowed a deduction for the excess, if any, of the adjusted basis of our Ordinary Shares over their fair market value as of the close of the taxable year. However, deductions will be allowable only to the extent of any net mark-to-market gains on our Ordinary Shares included in your income for prior taxable years. Amounts included in your income under a mark-to-market election, as well as gain on the actual sale or other disposition of our Ordinary Shares, will be treated as ordinary income. Ordinary loss treatment will also apply to the deductible portion of any mark-to-market loss on our Ordinary Shares, as well as to any loss realized on the actual sale or disposition of our Ordinary Shares, to the extent the amount of such loss does not exceed the net mark-to-market gains for such Ordinary Shares previously included in income. Your basis in our Ordinary Shares will be adjusted to reflect any such income or loss amounts. If you make a mark-to-market election, any distributions we make would generally be subject to the rules discussed below under “- Taxation of dividends and other distributions on our Ordinary Shares,” except the lower rates applicable to qualified dividend income would not apply.

 

84

 

 

The mark-to-market election is available only for “marketable stock,” which is stock that is regularly traded on a qualified exchange or other market, as defined in applicable U.S. Treasury regulations. We expect our Ordinary Shares will continue to be listed on Nasdaq. Because a mark-to-market election cannot be made for equity interests in any lower-tier PFICs we own, you generally will continue to be subject to the PFIC rules with respect to your indirect interest in any investments held by us that are treated as an equity interest in a PFIC for U.S. federal income tax purposes. The Nasdaq is a qualified exchange, but there can be no assurance that the trading in our Ordinary Shares will be sufficiently regular to qualify our Ordinary Shares as marketable stock. You should consult your tax advisor as to the availability and desirability of a mark-to-market election, as well as the impact of such election on interests in any lower-tier PFICs. Alternatively, if a non-U.S. entity treated as a corporation is a PFIC, a holder of shares in that entity may avoid taxation under the PFIC rules described above regarding excess distributions and recognized gains by making a “qualified electing fund” election to include in its income, on a current basis: (1) as ordinary income, its pro rata share of the “ordinary earnings” of the qualified electing fund; and (2) as long-term capital gain, its pro rata share of the “net capital gain” of the qualified electing fund. However, you may make a qualified electing fund election with respect to your Ordinary Shares only if we furnish you annually with certain tax information, and we currently do not intend to prepare or provide such information.

 

A U.S. Holder of a PFIC may be required to file an IRS Form 8621. The failure to file this form when required could result in substantial penalties. If we are a PFIC, you should consult your tax advisor regarding any reporting requirements that may apply to you. You are urged to consult your tax advisor regarding the application of the PFIC rules to the acquisition, ownership and disposition of our Ordinary Shares.

 

YOU ARE STRONGLY URGED TO CONSULT YOUR TAX ADVISOR REGARDING THE IMPACT OF OUR BEING A PFIC ON YOUR INVESTMENT IN OUR ORDINARY SHARES OR ADSs AS WELL AS THE APPLICATION OF THE PFIC RULES AND THE POSSIBILITY OF MAKING A MARK-TO-MARKET ELECTION.

 

Taxation of Dividends and Other Distributions on our Ordinary Shares

 

Subject to the PFIC rules discussed above, the gross amount of any distributions we make to you (including the amount of any tax withheld) with respect to our Ordinary Shares generally will be includible in your gross income as dividend income on the date of your receipt, but only to the extent the distribution is paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). The dividends will not be eligible for the dividends-received deduction allowed to corporations in respect of dividends received from other U.S. corporations. To the extent the amount of the distribution exceeds our current and accumulated earnings and profits (as determined under U.S. federal income tax principles), such excess amount will be treated first as a tax-free return of your tax basis in your Ordinary Shares, and then, to the extent such excess amount exceeds your tax basis in your Ordinary Shares, as capital gain. We currently do not, and we do not intend to, calculate our earnings and profits under U.S. federal income tax principles . Therefore, you should expect that a distribution will generally be reported as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above.

 

With respect to certain non-corporate U.S. Holders, including individual U.S. Holders, dividends may be taxed at the lower capital gain rates applicable to “qualified dividend income,” provided (1) our Ordinary Shares are readily tradable on an established securities market in the United States (such as Nasdaq) or we are eligible for benefits under the Treaty, (2) we are neither a PFIC nor treated as such with respect to you (as discussed above) for either the taxable year in which the dividend was paid or the preceding taxable year, (3) certain holding period requirements are met and (4) you are not under an obligation to make related payments with respect to positions in substantially similar or related property. As discussed above under “Passive Foreign Investment Company,” there is a significant risk that we will be a PFIC for U.S. federal income tax purposes, and, as a result, the qualified dividend rate may be unavailable with respect to dividends we pay.

 

85

 

 

The amount of any distribution paid in a currency other than U.S. dollars will be equal to the U.S. dollar value of such currency on the date such distribution is includible in your income, regardless of whether the payment is in fact converted into U.S. dollars at that time. If the foreign currency is converted into U.S. dollars on the date of receipt, a U.S. Holder generally will not be required to recognize foreign currency gain or loss in respect of the distribution. A U.S. Holder may have foreign currency gain or loss if the foreign currency is converted into U.S. dollars after the date of receipt, depending on the exchange rate at the time of conversion. Any gains or losses resulting from the conversion of foreign currency into U.S. dollars generally will be treated as ordinary income or loss, as the case may be, and generally will be treated as U.S. source. The amount of any distribution of property other than cash will be equal to the fair market value of such property on the date of distribution.

 

Subject to certain significant conditions and limitations, including potential limitations under the Treaty, U.S. Holders may be entitled to a credit against their U.S. federal income tax liability or a deduction against U.S. federal taxable income in an amount equal to the non-refundable Israeli tax withheld on distributions on our Ordinary Shares. The election to deduct, rather than credit, foreign taxes, is made on a year-by-year basis and applies to all foreign taxes paid by a U.S. Holder or withheld from a U.S. Holder that year. Distributions paid on our Ordinary Shares will generally be treated as passive income that is foreign source for U.S. foreign tax credit purposes. A withholding tax may need to satisfy certain additional requirements in order to be considered a creditable tax for a U.S. Holder. We have not determined whether these requirements have been met  and, accordingly, no assurance can be given that any withholding tax on dividends paid by us will be creditable. U.S. Holders should consult their own tax advisors to determine whether and to what extent they would be entitled to such credit.

 

Taxation of Disposition of Ordinary Shares

 

Subject to the PFIC rules discussed above, upon a sale or other disposition of Ordinary Shares, you will generally recognize capital gain or loss for U.S. federal income tax purposes in an amount equal to the difference between the amount realized (including the amount of any tax withheld) and your tax basis in such Ordinary Shares.

 

Your tax basis in our Ordinary Shares generally will equal the cost of such Ordinary Shares. If you are a non-corporate U.S. Holder, capital gain from the sale, exchange or other disposition of shares is generally eligible for a preferential rate of taxation applicable to capital gains, if your holding period determined at the time of such sale, exchange or other disposition for such shares exceeds one year (i.e., such gain is long-term capital gain). The deductibility of capital losses is subject to significant limitations. The gain or loss will generally be income or loss from sources within the United States for U.S. foreign tax credit purposes, subject to certain possible exceptions under the Treaty.

 

U.S. Investors should consult their own tax advisors regarding the U.S. federal income tax consequences of receiving currency other than Dollars upon the disposition of ordinary shares or ADSs.

 

Information with respect to Net Investment Income Tax

 

Certain U.S. Holders who are individuals, estates or trusts may be required to pay an additional 3.8% Net Investment Income Tax, or NIIT, on, among other things, dividends and capital gains from the sale or other disposition of our shares. For individuals, the additional NIIT tax applies to the lesser of (i) “net investment income” or (ii) the excess of “modified adjusted gross income” over $200,000 ($250,000 if married and filing jointly or $125,000 if married and filing separately). “Net investment income” generally equals the taxpayer’s gross investment income reduced by the deductions that are allocable to such income. U.S. Holders will likely not be able to credit foreign taxes against the 3.8% NIIT.

 

Information with respect to Reporting Requirements

 

Certain U.S. Holders may be required to file IRS Form 926, Return by U.S. Transferor of Property to a Foreign Corporation and IRS Form 5471, Information Return of U.S. Persons With Respect to Certain Foreign Corporations, reporting transfers of cash or other property to us and information relating to the U.S. Holder and us. Substantial penalties may be imposed upon a U.S. Holder that fails to comply.

 

86

 

 

Certain U.S. Holders owning “specified foreign financial assets” with an aggregate value in excess of $50,000 on the last day of the taxable year or $75,000 at any time during the taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance) may be required to file IRS Form 8938, or Statement of Specified Foreign Financial Assets, with respect to such assets with their tax returns. “Specified foreign financial assets” generally include any financial accounts maintained by foreign financial institutions, as well as any of the following, but only if they are not held in accounts maintained by financial institutions: (i) stocks and securities issued by non-U.S. persons (ii) financial instruments and contracts held for investment that have non-U.S. issuers or counterparties and (iii) interests in foreign entities. The IRS has issued guidance exempting “specified foreign financial assets” held in a financial account from reporting under this provision (although the financial account itself, if maintained by a foreign financial institution, may remain subject to this reporting requirement). The failure to file this form when required could result in substantial penalties. You are urged to consult your tax advisors regarding the application of these requirements to your ownership of our shares.

 

In addition, certain U.S. Holders may be required to report additional information relating to an interest in our Ordinary Shares, subject to certain exceptions. You are urged to consult your tax advisors regarding your information reporting obligations, if any, with respect to your ownership and disposition of our Ordinary Shares.

 

Backup Withholding Tax

 

Generally, information reporting requirements will apply to distributions on our Ordinary Shares or proceeds on the disposition of our Ordinary Shares paid within the United States (and, in certain cases, outside the United States) to U.S. Holders other than certain exempt recipients, such as corporations. Furthermore, backup withholding may apply to such amounts if the U.S. Holder fails to (i) provide a correct taxpayer identification number, (ii) report interest and dividends required to be shown on its U.S. federal income tax return, or (iii) make other appropriate certifications in the required manner. U.S. Holders who are required to establish their exempt status generally must provide such certification on IRS Form W-9.

 

Backup withholding is not an additional tax. Amounts withheld as backup withholding from a payment may be credited against a U.S. Holder’s U.S. federal income tax liability and such U.S. Holder may obtain a refund of any excess amounts withheld by timely filing the appropriate claim for refund with the IRS and furnishing any required information in a timely manner.

 

THE SUMMARY OF CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES SET OUT ABOVE IS FOR GENERAL INFORMATIONAL PURPOSES ONLY. INVESTORS ARE URGED TO CONSULT THEIR TAX ADVISORS ABOUT THE APPLICATION OF THE U.S. FEDERAL TAX RULES TO THEIR PARTICULAR CIRCUMSTANCES AS WELL AS THE STATE, LOCAL, NON-U.S. AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES OR ADSs.

 

F. Dividends and Paying Agents

 

Not applicable.

 

G. Statements by Experts

 

Not applicable.

 

H. Documents on Display

 

You may read and copy this annual report on Form 20-F, including the related exhibits and schedules, and any document we file with the SEC through the SEC’s website at www.sec.gov.

 

87

 

 

As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. Furthermore, as a foreign private issuer, we are also not subject to the requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act. In addition, we are not required under the Exchange Act to file annual or other reports and consolidated financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. Instead, we must file with the SEC, within 120 days after the end of each fiscal year, or such other applicable time as required by the SEC, an annual report on Form 20-F containing consolidated financial statements audited by an independent registered public accounting firm. We also intend to furnish certain other material information to the SEC under cover of Form 6-K.

 

We maintain a corporate website at www.medigus.com. Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 20-F. We have included our website address in this annual report on Form 20-F solely as an inactive textual reference.

 

I. Subsidiary Information

 

Not applicable.

 

J. Annual Report to Security Holders

 

Not Applicable.

 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Market risk is the risk of loss related to changes in market prices, including interest rates and foreign exchange rates, of financial instruments that may adversely impact our consolidated financial position, results of operations or cash flows.

 

Risk of Interest Rate Fluctuation

 

Currently, our investments consist primarily of cash and cash equivalents and short-term bank deposits. We follow an investment policy that was set by our board of directors, pursuant to which we currently invest in tradable short term Israeli government loans or bank deposits. Our investments are exposed to market risk due to fluctuation in interest rates, which may affect our interest income and the fair market value of our investments. Our interest income is not material and a change in interest rates would not have a significant impact on us. We manage this exposure by performing ongoing evaluations of our investments. Due to the short-term maturities of our investments to date, their carrying value has always approximated their fair value. It is our current policy to hold investments to maturity in order to limit our exposure to interest rate fluctuations.

 

Foreign Currency Exchange Risk

 

Our reporting and functional currency is the U.S. dollar. Our revenues are currently primarily payable in the U.S. dollars and Euros, and we expect our future revenues to be denominated primarily in U.S. dollars and Euros. However, certain amount of our expenses are in NIS and as a result, we are exposed to the currency fluctuation risks relating to the recording of our expenses in the U.S. dollars. We may, in the future, decide to enter into currency hedging transactions. These measures, however, may not adequately protect us from material adverse effects.

 

To date, we have not engaged in hedging transactions, however we hold our investments in both NIS and US dollars. In the future, we may enter into currency hedging transactions to decrease the risk of financial exposure from fluctuations in the exchange rates of our principal operating currencies. These measures, however, may not adequately protect us from the material adverse effects of such fluctuations.

 

Our interest rate risk exposure is in respect to bank deposits, which expose us to risk due to changes in fair value interest rates. As of December 31, 2024, these deposits carried relatively low interest rates and under these low interest rates, reasonable changes in interest rates are expected to have negligible impact on the fair value of these assets.

 

88

 

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

A. Debt Securities.

 

Not applicable.

 

B. Warrants and rights.

 

Not applicable.

 

C. Other Securities.

 

Not applicable.

 

D. American Depositary Shares.

 

General

 

The following is a summary description of the ADSs and does not purport to be complete. Each ADS represents 40 Ordinary Shares (or a right to receive 40 Ordinary Shares) deposited with The Bank of New York Mellon, located in Manchester, as custodian for The Bank of New York Mellon as the Depositary. Each ADS also represents any other securities, cash or other property which may be held by the Depositary. The Depositary’s office at which the ADSs will be administered is located at 240 Greenwich Street, New York, New York 10286.

 

The form of the deposit agreement for the ADSs and the form of American Depositary Receipt (ADR) that represents an ADS are filed as exhibits to the Company’s registration statement on Form F-6 with the SEC on May 7, 2015, as amended on October 26, 2020. Copies of the deposit agreement are available for inspection at the principal office of the Bank of New York Mellon, located at 240 Greenwich Street, New York, New York 10286.

 

Fees and Expenses

 

Persons depositing or withdrawing shares or ADS holders must pay:   For:
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)   Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property
    Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates
$0.05 (or less) per ADS (or a portion thereof)   Any cash distribution to ADS holders
A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs   Distribution of securities distributed to holders of deposited securities which are distributed by the Depositary to ADS holders
$0.05 (or less) per ADS per calendar year (or a portion thereof)   Depositary services
Registration or transfer fees   Transfer and registration of shares on our share register to or from the name of the Depositary or its agent when you deposit or withdraw shares
Expenses of the Depositary   Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement)
    converting foreign currency to U.S. dollars
Taxes and other governmental charges the Depositary or the custodian has to pay on any ADSs or shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes   As necessary
Any charges incurred by the depositary or its agents for servicing the deposited securities   As necessary

 

The Depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The Depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The Depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The Depositary may collect any of its fees by deduction from any cash distribution payable to ADS holders that are obligated to pay those fees. The Depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.

 

From time to time, the Depositary may make payments to us to reimburse and/or share revenue from the fees collected from ADS holders, or waive fees and expenses for services provided, generally relating to costs and expenses arising out of establishment and maintenance of the ADS program. In performing its duties under the deposit agreement, the Depositary may use brokers, dealers or other service providers that are affiliates of the Depositary and that may earn or share fees or commissions.

 

Payment of Taxes

 

You will be responsible for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs. The Depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until such taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the Depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes.

89

 

 

PART II

 

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

 

There are no defaults, dividend arrangements or delinquencies that are required to be disclosed.

 

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

 

Not applicable.

 

ITEM 15. CONTROLS AND PROCEDURES

 

(a) Disclosure controls and procedures

 

Our management, including our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2024. The term “disclosure controls and procedures”, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to the our management, including our Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2024, our disclosure controls and procedures were effective.

 

(b) Management report on internal control over financial reporting

 

Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over our financial reporting. The Company’s internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, means a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes policies and procedures that:

 

  pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and asset dispositions.

 

  provide reasonable assurance that transactions are recorded as necessary to permit the preparation of our financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

  provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.

 

Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management evaluated the effectiveness of our internal control over financial reporting as of December 31, 2024, based on the criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, our management concluded that, as of December 31, 2024, the Company’s internal control over financial reporting was effective.

 

90

 

 

(c) Attestation Report of the Registered Public Accounting Firm

 

Not applicable.

 

(d) Changes in internal control over financial reporting

 

There were no changes in internal control over financial reporting during the year ended December 31, 2024, that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

 

ITEM 16. RESERVED

 

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

 

Our board of directors has determined that Mr. Eliyahu Yoresh is an audit committee financial expert as defined under the rules under the Exchange Act, and is independent in accordance with applicable Exchange Act rules and Nasdaq Stock Market rules.

 

ITEM 16B. CODE OF ETHICS

 

In March 2016, we adopted a written code of ethics and business conduct, which applies to all our directors, officers and employees, including without limitation our, Chief Executive Officer, Chief Financial Officer, and controller, or persons performing similar functions. This code of ethics is posted on our website, www.medigus.com.

 

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Fees and services 

 

Brightman Almagor Zohar and Co., Certified Public Accountant (Isr.), a firm in the Deloitte Global Network, has served as our principal independent registered public accounting firm for the years ended December 31, 2024, and 2023.

 

The following table provides information regarding consolidated fees related to Brightman Almagor Zohar and Co., for all services, including audit services, for the year ended December 31, 2024, and for the year ended December 31, 2023:

 

   Year Ended
December 31,
2024
   Year Ended
December 31,
2023
 
   (USD in thousands) 
Audit fees(1)   437    717 
Audit-Related Fees(2)   80    50 
Tax fees(3)   91    68 
Total   608    835 

 

91

 

 

(1)

Includes professional services rendered in connection with the audit of our annual financial statements and the review of our interim financial statements. This category also includes services that generally the independent accountant provides, such as consents and assistance with and review of documents filed with the SEC. (These fees do not include audit services provided for Charging Robotics, by CPA Elkana Amitai).

 

For the year ended December 31, 2024, audit fees included are for Xylo Technologies, Eventer, Gix Internet,Jeffs’ Brands (until the deconsolidation on January 28,2024) and Charging Robotics (excluding services provided by CPA Elkana Amitai for Charging Robotics).

 

For the year ended December 31, 2023, audit fees included are for Xylo Technologies, Eventer, Gix Internet and Jeffs’ Brands.

 

(2)

Includes mainly offering costs and related services by the principal accountant that are reasonably related to the performance of the audit or review of the registrant’s financial statements (excluding services provided by CPA Elkana Amitai for Charging Robotics).

 

For the year ended December 31, 2024, audit related fee included Xylo Technologies, Eventer, Gix Internet, Jeffs’ Brands (until the deconsolidation on January 28,2024) and Charging Robotics (excluding services provided by CPA Elkana Amitai for Charging Robotics).

 

For the year ended December 31, 2023, audit related fee included Xylo Technologies, Eventer, Gix Internet and Jeffs’ Brands.

 

(3) Represents fees for professional services rendered by our independent registered public accounting firm for tax compliance and tax advice on actual or contemplated transactions (excluding services provided by CPA Elkana Amitai for Charging Robotics).

 

Our audit committee’s specific responsibilities in carrying out its oversight of the quality and integrity of the accounting, auditing and reporting practices of our Company include the approval of audit and non-audit services to be provided by the external auditor. The audit committee approves in advance the particular services or categories of services to be provided to us during the following yearly period and also sets forth a specific budget for such audit and non-audit services. Additional non-audit services may be pre-approved by the audit committee.

 

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

 

None.

 

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

 

Not applicable.

 

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

Not applicable.

 

ITEM 16G. CORPORATE GOVERNANCE

 

Nasdaq Stock Market Listing Rules and Home Country Practices

 

As a foreign private issuer, we are permitted to follow Israeli corporate governance practices instead of Nasdaq Marketplace rules, provided that we disclose which requirements we are not following and the equivalent Israeli requirement. We rely on this “foreign private issuer exemption” with respect to the following items:

 

  Quorum. While the Marketplace Rules of the Nasdaq Stock Market require that the quorum for purposes of any meeting of the holders of a listed company’s common voting stock, as specified in the company’s bylaws, be no less than 33 1/3% of the company’s outstanding common voting stock, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our amended and restated articles of association provide that a quorum of two or more shareholders holding at least 10% of the voting rights in person or by proxy is required for commencement of business at a general meeting so long as (i) such general meeting was initiated by and convened pursuant to a resolution adopted by the Board of Directors and (ii) at the time of such general meeting the Company is qualified to use the forms of a “foreign private issuer” under US securities laws. However, the quorum set forth in our amended and restated articles of association with respect to an adjourned meeting consists of any number of shareholders present in person or by proxy.

 

92

 

 

  Approval of Related Party Transactions. All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions, set forth in sections 268 to 275 of the Companies Law, and the regulations promulgated thereunder, which require the approval of the audit committee, the compensation committee, the board of directors and shareholders, as may be applicable, for specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required under the Listing Rules of the Nasdaq Stock Market.

 

  Equity Compensation Plans. We do not necessarily seek shareholder approval for the establishment of, and amendments to, stock option or equity compensation plans (as set forth in Nasdaq Listing Rule 5635(c)), as such matters are not subject to shareholder approval under Israeli law. We will attempt to seek shareholder approval for our stock option or equity compensation plans (and the relevant annexes thereto) to the extent required in order to ensure they are tax qualified for our employees in the United States. However, even if such approval is not received, then the stock option or equity compensation plans will continue to be in effect, but we will not be able to grant options to our U.S. employees that qualify as Incentive Stock Options for U.S. federal tax purpose. Our stock option or other equity compensation plans are also available to our non-U.S. employees, and provide features necessary to comply with applicable non-U.S. tax laws.

 

  Shareholder approval. Rather than follow the Nasdaq rules requiring shareholder approval for the issuance of securities in certain circumstances, we follow Israeli law, under which a private placement of securities requires approval by our board of directors and shareholders if it will cause a person to become a controlling shareholder (generally presumed at 25% ownership) or if: (a) the securities issued amount to 20% or more of our outstanding voting rights before the issuance; (b) some or all of the consideration is other than cash or listed securities or the transaction is not on market terms; and (c) transaction will increase the relative holdings of a shareholder that holds 5% or more of our outstanding share capital or voting rights or will cause any person to become, as a result of the issuance, a holder of more than 5% of our outstanding share capital or voting rights.

 

Otherwise, we comply with the rules generally applicable to U.S. domestic companies listed on the Nasdaq Stock Market. We may in the future decide to use the foreign private issuer exemption with respect to some or all of the other Nasdaq Marketplace Rules related to corporate governance. We also comply with Israeli corporate governance requirements under the Israeli Companies Law applicable to public companies.

 

ITEM 16H. MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

ITEM 16J. INSIDER TRADING POLICIES

 

We have adopted an insider trading policy that governs the purchase, sale and other dispositions of the Company’s securities by senior management, directors and employees that are reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and any listing standards applicable to the Company. A copy of our insider trading policy is filed as Exhibit 11.1 to this Annual Report.

 

ITEM 16K. CYBERSECURITY RISK MANAGEMENT POLICIES AND PROCEDURES

 

The Company engages a third-party provider to maintain our systems and management participates in the assessment to identify any risks from cybersecurity threats. Our third-party provider monitors our firewall, network, system security and internal and external backups and reports any issues to the Company.

 

The Company’s board of director, together with management, is engaged in our cybersecurity monitoring managed by our third-party provider and it is constantly changing. Any issues are appropriately addressed timely.

 

To date, we have not experienced any cybersecurity incidents that materially affected our business strategy, results of operations or financial condition.

 

93

 

 

PART III

 

ITEM 17. FINANCIAL STATEMENTS

 

Not applicable.

 

ITEM 18. FINANCIAL STATEMENTS

 

The consolidated financial statements and the related notes required by this Item are included in this annual report on Form 20-F beginning on page F-1.

 

ITEM 19. EXHIBITS  

 

        Incorporation by Reference
Exhibit No.   Description   Form   File No.   Exhibit No.   Filing Date   Filed / Furnished
1.1   Articles of Association, as amended   20-F   001-37381   1.1   April 22, 2024  
2.1   Form of Deposit Agreement between Medigus Ltd., The Bank of New York Mellon as Depositary, and owners and holders from time to time of ADSs issued thereunder, including the Form of American Depositary Shares   20-F   001-37381   2.1   May 7, 2015    
2.2   Description of Securities   20-F   001-37381   2.2   April 22, 2024  
4.1††   2013 Share Option and Incentive Plan   20-F   001-37381   4.6   May 7, 2015    
4.2††   2023 Share Incentive Plan   20-F   001-37381   4.2  

April 22, 2024

 
4.3††   Compensation Policy as adopted on October 30, 2025                   *
4.4††   Form of Indemnification and Exculpation Undertaking   20-F   001-37381   4.15   May 7, 2015    
4.5   Loan Agreement by and between the Company and Gix Internet Ltd. dated October 12, 2021   20-F   001-37381   4.6   May 3, 2023    
4.6   Amendment to the Loan Agreement by and between the Company and Gix Internet Ltd. dated August 25, 2022, and effective as of July 1, 2022   20-F   001-37381   4.7   May 3, 2023    
4.7   Amendment to the Loan Agreement by and between the Company and Gix Internet Ltd. dated August 29, 2023, and effective as of July 1, 2023   20-F   001-37381   4.9   April 22, 2024  
4.8   Amendment to the Loan Agreement by and between the Company and Gix Internet Ltd. dated November 8, 2023   20-F  

001-37381

  4.10   April 22, 2024  
4.9   Amendment to the Loan Agreement by and Between the Company and Gix Internet Ltd. dated January 1, 2024   20-F   001-37381   4.11   April 22, 2024  
4.10   Share Purchase Agreement, by and among the Company, Parazero, Delta Drone International Ltd., L.I.A Pure Capital Ltd. and other entities listed therein., dated January 28, 2022   20-F   001-37381   4.8   May 3, 2023    
4.11   Securities Exchange Agreement by and between Medigus Ltd., the additional shareholders of Charging Robotics Ltd. and Fuel Doctor Holdings, Inc. dated March 28, 2023   20-F   001-37381   4.9   May 3, 2023    
4.12   Summary of Agreement by and among the Company, Metagramm Software Ltd. and others listed therein, dated April 13, 2023   20-F   001-37381   4.14   April 22, 2024    
4.13   Share Purchase Agreement, by and between the Company, Polyrizon Ltd. and other investors, dated June 20, 2023   20-F   001-37381   4.15   April 22, 2024    
4.14   Operating Agreement by and between the Company and Zig Investment Group LLC, dated September 13, 2023   20-F   001-37381   4.16   April 22, 2024    
4.15   Loan Agreement by and between Viewbix Ltd. and the Lenders listed therein, dated November 15, 2023,   20-F   001-37381   4.17   April 22, 2024    
4.16   Private Placement Agreement by and between the Company and Gix Internet, dated December 11, 2023   20-F   001-37381   4.18   April 22, 2024    
4.17   Amendment to the Loan Agreement by and between the Company and Gix Internet Ltd. dated August 22, 2024                   *
4.18   Amendment to the Loan Agreement by and between the Company and Gix Internet Ltd. dated October 6, 2024                   *
4.19   Amendment to the Loan Agreement by and between the Company and Gix Internet Ltd. dated January 26, 2025                   *
4.20   Warrants Purchase Agreement by and between the Company and an institutional investor, dated November 15, 2024   6-K   001-37381   10.1   November 15, 2024    

 

94

 

 

8.1   List of Subsidiaries                    *
11.1   Xylo Technologies Ltd. Insider Trading Policy                   *
12.1   Certification of Chief Executive Officer as required by rule 13a-14(a)(1)                   **
12.2   Certification of Chief Financial Officer as required by rule 13a-14(a)                   **
13.1   Certification of Chief Executive Officer as required by rule 13a-14(a) and Section 1350 of Chapter 63 of Title 18 of the United States Code                   **
13.2   Certification of Chief Financial Officer as required by rule 13a-14(a) and Section 1350 of Chapter 63 of Title 18 of the United States Code                   **
15.1   Consent of Brightman Almagor Zohar & Co., Certified Public Accountant (Isr.), a firm in the Deloitte Global Network, independent registered public accounting firm for Xylo Technologies Ltd.                   *
97   Clawback Policy   20-F   001-37381   97   April 22, 2024    
101.INS   Inline XBRL Instance Document                    
101.SCH   Inline XBRL Taxonomy Extension Schema Document.                    
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.                    
101.DEF   Inline XBRL Taxonomy Definition Linkbase Document.                    
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.                    
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document                    
104   Inline XBRL for the cover page of this Annual Report on Form 20-F (embedded within the Inline XBRL document)                   **

 

*Filed herewith.

 

**Furnished herewith.

 

Certain confidential information contained in this exhibit, marked by brackets, was omitted because it is both (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. “[†]” indicates where the information has been omitted from this exhibit.

 

Indicates management contract or compensatory plan or arrangement.

 

Certain agreements filed as exhibits to this Annual Report contain representations and warranties that the parties thereto made to each other. These representations and warranties have been made solely for the benefit of the other parties to such agreements and may have been qualified by certain information that has been disclosed to the other parties to such agreements and that may not be reflected in such agreements. In addition, these representations and warranties may be intended as a way of allocating risks among parties if the statements contained therein prove to be incorrect, rather than as actual statements of fact. Accordingly, there can be no reliance on any such representations and warranties as characterizations of the actual state of facts. Moreover, information concerning the subject matter of any such representations and warranties may have changed since the date of such agreements.

 

95

 

 

SIGNATURE

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this registration statement on its behalf.

 

  Xylo Technologies Ltd.
     
Date: April 30, 2025 By: /s/ Liron Carmel
    Liron Carmel
    Chief Executive Officer
     
  By: /s/ Tali Dinar
    Tali Dinar
    Chief Financial Officer

 

96

 

 

XYLO TECHNOLOGIES LTD.

Index to Consolidated Financial Statements

 

Report of Independent Registered Public Accounting Firm
(Firm Name: Brightman Almagor Zohar & Co / PCAOB ID No. 1197)
  F-2 to F-3
Consolidated Statements of Financial Position   F-4 to F-5
Consolidated Statements of Income/Loss and Other Comprehensive Income/Loss   F-6
Consolidated Statements of Changes in Equity   F-7 to F-9
Consolidated Statements of Cash Flows   F-10 to F-13
Notes to Consolidated Financial Statements   F-14 to F-97

 

F-1

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and the Board of Directors of Xylo Technologies Ltd.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated statements of financial position of Xylo Technologies Ltd. and its subsidiaries (the “Company”) as of December 31, 2024, and 2023, and the related consolidated statements of income (loss) and other comprehensive income (loss), changes in equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and the results of its operations and its cash flows for the each of the three years in the period ended December 31, 2024, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board (IASB).

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

 

F-2

 

 

 

Goodwill Impairment – Online Advertising & Internet Traffic Routing Reporting Unit – Refer to Note 2D and 9C to the Consolidated Financial Statements

 

Critical Audit Matter Description

 

The Company’s quantitative goodwill impairment test involves the comparison of the fair value of each reporting unit to its carrying value. In estimating the fair value of the online advertising & internet traffic routing reporting unit, the Company used the income approach method, which requires management to make significant estimates and assumptions related to future cash flows and discount rates. Any excess carrying value over the applicable fair value is recognized as impairment.

 

During 2024, the Company recognized an impairment loss of USD 2,919 thousand for the online advertising & internet traffic routing reporting unit’s goodwill. After considering the impact of the impairment charges, the carrying amount of the online advertising & internet traffic routing reporting unit’s goodwill as of December 31, 2024, was USD 4.8 million.

 

We identified impairment of the online advertising & internet traffic routing reporting unit as a critical audit matter because of the significant judgments made by management to estimate the fair value. This required a high degree of auditor judgment and an increased extent of effort, in relation to our audit as a whole, including the need to involve our fair value specialists when performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions related to future cash flows and discount rate. 

 

How the Critical Audit Matter Was Addressed in the Audit

 

Our audit procedures related to forecasts used by management to estimate the fair value of the online advertising & internet traffic routing reporting unit included the following, among others:

 

  We evaluated the reasonableness of management’s forecasts of future cash flows, including underlying revenues growth rates, by comparing the forecasts to historical results and by evaluating revenue trends and material events that occurred during and after the reporting period and their potential influence on management’s forecasts, as well as by testing the other underlying source information for accuracy and completeness. 

 

  With the assistance of our fair value specialists, we evaluated the valuation methodologies and the reasonableness of the discount rate, including testing the mathematical accuracy of the calculations, and developing a range of independent estimates and comparing those to the discount rate selected by management.

  

/s/ Brightman Almagor Zohar & Co.

Certified Public Accountants

A Firm in the Deloitte Global Network

 

Tel Aviv, Israel

April 30, 2025

 

We have served as the Company’s auditor since 2020.

 

 

F-3

 

 

(Concluded) – 1

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

       December 31, 
   Note   2024   2023 
       USD in thousands 
             
ASSETS              
               
CURRENT ASSETS:              
Cash and cash equivalents  6    8,753    9,357 
Short term deposits  6    12    12 
Restricted cash  6    58    166 
Trade accounts receivable       1,942    12,320 
Other receivables  7a    2,154    2,144 
Inventory  8    
-
    2,386 
Loans to associates  16b2    1,820    1,684 
Loans to others  7b, 16b3    276    376 
Related parties  16b1    63    59 
Financial assets at fair value through profit or loss  5    5,906    3,167 
        20,984    31,671 
               
NON-CURRENT ASSETS:              
Property and equipment, net       66    353 
Right-of-use assets, net  10    
-
    496 
Investments accounted for using the equity method  4B1    341    2,995 
Intangible assets, net  9    14,770    27,336 
Deferred tax asset  11    170    273 
Financial assets at fair value through profit or loss  5    1,218    772 
        16,565    32,225 
               
TOTAL ASSETS       37,549    63,896 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

(Concluded) – 2

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

      December 31, 
   Note  2024   2023 
      USD in thousands 
            
LIABILITIES AND EQUITY           
            
CURRENT LIABILITIES:           
Trade accounts payable  12a   5,980    13,248 
Short-term loans  4F   2,530    8,982 
Current maturities of long-term loans  4F   3,064    
-
 
Short-term convertible loans  4F   773    
-
 
Lease liabilities  10   
-
    102 
Embedded derivatives  4F   27    
-
 
Liability to event producers      1,256    967 
Warrants at fair value issued by subsidiaries  4E, 4F   2,340    1,897 
Related parties  16b5   907    909 
Accrued expenses and other current liabilities  12b   1,546    3,163 
       18,423    29,268 
              
NON-CURRENT LIABILITIES:             
Lease liabilities  10   
-
    468 
Long-term loans  4F, 16b6   496    234 
Deferred tax liability  11   1,024    1,465 
Accrued severance pay, net      17    26 
       1,537    2,193 
              
TOTAL LIABILITIES      19,960    31,461 
              
EQUITY:  13          
Share capital – ordinary shares with no par value:  authorized – December 31,2024 – 200,000,000 and December 31, 2023 – 200,000,000 shares; issued and outstanding – December 31, 2024 – 32,258,663 shares December 31, 2023 – 27,989,465 shares      
-
    
-
 
Share premium      114,120    112,883 
Other capital reserves      11,304    12,106 
Warrants      197    197 
Accumulated deficit      (107,637)   (101,610)
Equity attributable to owners of Xylo Technologies Ltd.      17,984    23,576 
Non-controlling interests  4A2   (395)   8,859 
       17,589    32,435 
              
TOTAL LIABILITIES AND EQUITY      37,549    63,896 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF INCOME/LOSS AND OTHER COMPREHENSIVE INCOME/LOSS

 

      Year Ended December 31 
   Note  2024   2023   2022 
      USD in thousands 
Revenues  17               
Products      1,002    10,008    5,861 
Services      28,856    81,716    85,997 
       29,858    91,724    91,858 
                   
Cost of revenues  14               
Products      927    9,019    5,059 
Services      22,248    70,864    72,347 
       23,175    79,883    77,406 
                   
Gross profit      6,683    11,841    14,452 
Research and development expenses  14   4,917    5,888    5,221 
Sales and marketing expenses  14   3,038    4,660    4,372 
General and administrative expenses  14   7,222    12,108    13,440 
Loss (Gain) from changes in fair value of financial assets at fair value through profit or loss  5   (3,623)   3,830    2,713 
Equity losses  4B2   367    4,107    2,659 
Net loss (gain) from derecognition of investments accounted for using the equity method  4C, 4L   (140)   2,227    (169)
Impairment of goodwill and other intangible assets  9   2,919    1,812    
-
 
Amortization of excess purchase price of associates  4P   
-
    530    
-
 
Operating loss      (8,017)   (23,321)   (13,784)
                   
Loss from deconsolidation of Jeffs’ Brands  4E   1,318    
-
    
-
 
Gain from initial recognition of assets and liabilities upon consolidation of Gix Internet  4F   
-
    
-
    (2,300)
Loss (gain) from sale of investments in financial assets at fair value through profit or loss and investments accounted for using the equity method      (10)   
-
    127 
Other income, net      -    (329)   (45)
Changes in fair value of warrants issued to investors      
-
    (396)   (159)
Changes in fair value of warrants issued to third party investors by subsidiaries  5   53    (2,322)   (3,619)
Loss in connection with issuance of warrants by Viewbix Inc,  4F   1,833    
-
    
-
 
Financial loss, net      1,051    1,532    2,309 
Loss before taxes on income      (12,262)   (21,806)   (10,097)
Tax expense (benefit)  11   (257)   (74)   111 
Net loss for the year      (12,005)   (21,732)   (10,208)
                   
Other comprehensive income (loss)                  
Items that may be reclassified to profit or loss                  
Share of other comprehensive income (loss) of consolidated subsidiaries and associates accounted for using the equity method      (118)   (121)   460 
Total comprehensive loss for the year      (12,123)   (21,853)   (9,748)
                   
Net loss for the year is attributable to:                  
Owners of Xylo Technologies Ltd.      (6,027)   (16,025)   (9,815)
Non-controlling interests      (5,978)   (5,707)   (393)
       (12,005)   (21,732)   (10,208)
Total comprehensive loss for the year is attributable to:                  
Owners of Xylo Technologies Ltd.      (6,015)   (16,210)   (9,503)
Non-controlling interests      (6,108)   (5,643)   (245)
       (12,123)   (21,853)   (9,748)
Loss per ordinary share attributed to Xylo Technologies Ltd.                  
Basic  15   (0.20)   (0.63)   (0.4)
Diluted  15   (0.20)   (0.63)   (0.4)
                   
Weighted average ordinary shares outstanding (in thousands)                  
Basic      29,756    25,292    24,385 
Diluted      29,756    25,292    24,385 

 

The accompanying notes are an integral part of these consolidated financial statements.

F-6

 

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

      Equity attributable to owners of Xylo Technologies Ltd.         
   Note  Ordinary
shares
   Share
premium
   Capital
reserves
from
options
granted
   Other
reserves
   Capital
reserves
from
transactions
with
non-
controlling
interests
   Currency
translation
differences
   Warrants   Accumulated
deficit
   Total   Non-
controlling
interests
   Total
equity
 
      USD in thousands 
BALANCE AS OF JANUARY 1, 2024      
        -
    112,883    2,787    1,239    8,955    (875)   197    (101,610)   23,576    8,859    32,435 
                                                           
Net loss for the year                                         (6,027)   (6,027)   (5,978)   (12,005)
Other comprehensive income (loss) for the year                               12              12    (130)   (118)
TOTAL COMPREHENSIVE LOSS FOR THE YEAR                               12         (6,027)   (6,015)   (6,108)   (12,123)
                                                           
TRANSACTIONS WITH SHAREHOLDERS:                                                          
Issuance of shares by Viewbix Inc.  4F   
-
    
-
    
-
    
-
    (969)   
-
    
-
    
-
    (969)   1,710    741 
Issuance of shares by Charging Robotics Inc.  4K   
-
    
-
    
-
    
-
    290    
-
    
-
    
-
    290    120    410 
Issuance of shares in consideration for Eventer shares  4D   
-
    250    
-
    
-
    (464)   
-
    
-
    
-
    (214)   214    
-
 
Issuance of prefunded warrants  13a   
-
    932    
-
    
-
    
-
    
-
    
-
    
-
    932    
-
    932 
Deconsolidation of Jeffs’ Brands  4E   
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    (5,245)   (5,245)
Subsidiaries’ share-based compensation to employees and service providers      
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    55    55 
Share based compensation to employees and service providers  13b   
-
    36    348    
-
    
-
    
-
    
-
    
-
    384    
-
    384 
Expiration of options  13b, 13c   
-
    19    (19)   
-
    
-
         
-
    
-
    
-
    
-
    
-
 
                                -                          
TOTAL TRANSACTIONS WITH SHAREHOLDERS      
-
    1,237    329    
-
    (1,143)   12    
-
    (6,027)   (5,592)   (9,254)   (14,846)
                                                           
BALANCE AS OF DECEMBER 31, 2024      
-
    114,120    3,116    1,239    7,813    (863)   197    (107,637)   17,984    (395)   17,589 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7

 

 

XYLO TECHNOLOGIES LTD.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

      Equity attributable to owners of Xylo Technologies Ltd.     
   Note  Ordinary
shares
   Share
premium
   Capital
reserves
from
options
granted
   Other
reserves
   Capital
reserves
from
transactions
with
non-
controlling
interests
   Currency
translation
differences
   Warrants   Accumulated
deficit
   Total   Non-
controlling
interests
   Total
equity
 
      USD in thousands 
BALANCE AS OF JANUARY 1, 2023        
      -
    111,322    3,260    949    9,689    (690)   197    (85,586)   39,141    15,548    54,689 
                                                           
Net loss for the year      
-
    
-
    
-
    
-
    
-
    
-
    
-
    (16,025)   (16,025)   (5,707)   (21,732)
Other comprehensive income (loss) for the year      
-
    
-
    
-
    
-
    
-
    (185)   
-
    
-
    (185)   64    (121)
TOTAL COMPREHENSIVE LOSS FOR THE YEAR      
-
    
-
    
-
    
-
    
-
    (185)   
-
    (16,025)   (16,210)   (5,643)   (21,853)
                                                           
TRANSACTIONS WITH SHAREHOLDERS:                                                          
Issuance of shares in consideration for investments      
-
    314    
-
    
-
    
-
    
-
    
-
    
-
    314    
-
    314 
Subsidiaries’ share-based compensation to employees and service providers      
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    244    244 
Share based compensation to employees and service providers      
-
    185    590    
-
    
-
    
-
    
-
    
-
    775    
-
    775 
Dividends declared by subsidiaries      
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    (153)   (153)
Deemed issuance of shares by a subsidiary      
-
    
-
    
-
    
-
    143    
-
    
-
    
-
    143    322    465 
Deemed stock exchange listing expenses      
-
    
-
    
-
    290    
-
    
-
    
-
    
-
    290    
-
    290 
Issuance of warrants and shares by Gix Internet      
-
    
-
    
-
    
-
    (226)   
-
    
-
    
-
    (226)   226    
-
 
Issuance of shares by Jeffs’ Brands      
-
    
-
    
-
    
-
    (129)   
-
    
-
    
-
    (129)   418    289 
Transaction with non-controlling interest by Gix Internet      
-
    
-
    
-
    
-
    (522)   
-
    
-
    
-
    (522)   (2,103)   (2,625)
Expiration of options      
-
    1,062    (1,063)   
-
    
-
    
-
    
-
    1    
-
    
-
    
-
 
TOTAL TRANSACTIONS WITH SHAREHOLDERS      
-
    1,561    (473)   290    (734)   
-
    
-
    1    645    (1,046)   (401)
                                                           
BALANCE AS OF DECEMBER 31, 2023      
-
    112,883    2,787    1,239    8,955    (875)   197    (101,610)   23,576    8,859    32,435 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-8

 

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

      Equity attributable to owners of Xylo Technologies Ltd.     
   Note  Ordinary
shares
   Share
premium
   Capital
reserves
from
options
granted
   Other
reserves
   Capital
reserves
from
transactions
with
non-
controlling
interests
   Currency
translation
differences
   Warrants   Accumulated
deficit
   Total   Non-
controlling
interests
   Total
equity
 
      USD in thousands 
BALANCE AS OF JANUARY 1, 2022       
         -
    110,562    2,579    634    10,408    (1,002)   197    (74,188)   49,190    2,243    51,433 
                                                           
Net loss for the year      
-
    
-
    
-
    
-
    
-
    
-
    
-
    (9,815)   (9,815)   (393)   (10,208)
Other comprehensive income      
-
    
-
    
-
    
-
    
-
    312    
-
    
-
    312    148    460 
TOTAL COMPREHENSIVE INCOME (LOSS) FOR THE YEAR      
-
    
-
    
-
    
-
    
-
    312    
-
    (9,815)   (9,503)   (245)   (9,748)
                                                           
TRANSACTIONS WITH SHAREHOLDERS:                                                          
Issuance of warrants and shares by Gix Internet      
-
    
-
    
-
    
-
    (567)   
-
    
-
    
-
    (567)   682    115 
Deemed contributions to Jeffs’ Brands      
-
    
-
    
-
    148    (598)   
-
    
-
    
-
    (450)   743    293 
Issuance of shares in consideration for investments      
-
    900    
-
    
-
    
-
    
-
    
-
    
-
    900    
-
    900 
Issuance of shares by Eventer      
-
    
-
    
-
    
-
    (12)   
-
    
-
    
-
    (12)   11    (1)
Consolidation of Gix Internet      
-
    (144)   
-
    
-
    
-
    
-
    
-
    
-
    (144)   7,849    7,705 
Subsidiaries’ share-based compensation to employees and service providers      
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    102    102 
Share based compensation to employees and service providers      
-
    
-
    685    
-
    
-
    
-
    
-
    
-
    685    
-
    685 
Amendment of long-term related party payable by Eventer      
-
    
-
    
-
    167    
-
    
-
    
-
    
-
    167    253    420 
Issuance of shares and warrants by Jeffs’ Brands upon completion of IPO      
-
    
-
    -    
-
    504    
-
    
-
    
-
    504    5,885    6,389 
Dividend      
-
    
-
    
-
    
-
    
-
    
-
    
-
    (1,583)   (1,583)   
-
    (1,583)
Dividends declared by subsidiaries      
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
    (2,021)   (2,021)
Reorganization transaction by Gix Internet      
-
    
-
    
-
    
-
    (46)   
-
    
-
    
-
    (46)   46    
-
 
Expiration of options      
-
    4    (4)   
-
    
-
    
-
    
-
    
-
    
-
    
-
    
-
 
TOTAL TRANSACTIONS WITH SHAREHOLDERS      
-
    760    681    315    (719)   
-
    
-
    (1,583)   (546)   13,550    13,004 
                                                           
BALANCE AS OF DECEMBER 31, 2022      
-
    111,322    3,260    949    9,689    (690)   197    (85,586)   39,141    15,548    54,689 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-9

 

 

(Continued) – 1

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the year ended December 31, 
   2024   2023   2022 
   USD in thousands 
CASH FLOWS USED IN OPERATING ACTIVITIES:            
Cash flows used in operations (see Appendix A)   (1,013)   (4,670)   (4,428)
Dividend received   
-
    
-
    171 
Interest paid   (690)   (953)   (1,019)
Income tax paid   (121)   (624)   (380)
Net cash flow used in operating activities   (1,824)   (6,247)   (5,656)
                
CASH FLOWS FROM (USED IN) INVESTING ACTIVITIES:               
Purchase of property and equipment   (12)   (51)   (74)
Investments and acquisitions of associates (note 4)   (564)   (5,241)   (1,895)
Acquisitions of investments at fair value through profit or loss (note 5)   (330)   (83)   (3,204)
Deconsolidation of Jeffs’ Brands (Appendix B and note 4E)   (142)   
-
    
-
 
Consolidation of subsidiaries upon gain of control (Appendix C and note 4F)   
-
    
-
    2,737 
Purchase of intangible assets (note 10 and supplemental disclosure of cash flow information)   
-
    (1,696)   
-
 
Loans to associates (note 17b2)   
-
    (1,870)   (660)
Loans to others (note 7b)   
-
    (250)   (1,018)
Proceeds from sale of financial assets at fair value through profit or loss and securities of an associate (note 4C and note 5)   3,324    6,102    453 
Repayment of loans to associates (note 4L)   
-
    785    
-
 
Changes in short term deposits and restricted cash   108    866    (815)
Net cash flow used in investing activities   2,384    (1,438)   (4,476)
                
CASH FLOWS FROM (USED IN) FINANCING ACTIVITIES:               
Proceeds from issuance of shares and warrants by subsidiaries, net of issuance costs (note 4E, note 4F)   
-
    
-
    12,567 
Cash paid to non-controlling interests by Viewbix Inc. (note 4F)   
-
    (2,625)   
-
 
Proceeds from deemed issuance of shares by Charging Robotics Ltd. (note 4K)   
-
    466    
-
 
Receipt of short-term loans (note 4E, note 4F)   1,302    1,230    1,752 
Receipt of short-term convertible loans (note 4F)   630    
-
    
-
 
Repayment of short-term loans (note 4E, note 4F)   (3,967)   (1,311)   (2,520)
Receipt of long-term loans (note 4E)   
-
    1,780    
-
 
Repayment of long-term loans (note 4F)   (510)   (1,811)   (1,974)
Repayment of related party debt (note 4D)   
-
    
-
    (163)
Proceeds from issuance of common stock in a private placement offering by Charging Robotics Inc. (note 4K)   410    
-
    
-
 
Issuance of shares and warrants in connection with a private placement issued by Viewbix Inc. (note 4F)   246    
-
    
-
 
Dividend paid to shareholders   
-
    
-
    (1,583)
Dividend paid to non-controlling interests (note 4F)   
-
    (728)   (2,603)
Principal elements of lease liability   (41)   (150)   (66)
Proceeds from issuance of prefunded shares, net of issuances costs (note 13)   932    
-
    
-
 
Net cash flow from (used in) financing activities   (998)   (3,149)   5,410 
                
DECREASE IN CASH AND CASH EQUIVALENTS   (438)   (10,834)   (4,722)
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR   9,357    20,065    24,025 
GAINS (LOSSES) FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS   (166)   126    762 
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF YEAR   8,753    9,357    20,065 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-10

 

 

(Continued) – 2

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

APPENDIX A TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS:

 

   For the year ended December 31, 
   2024   2023   2022 
   USD in thousands 
NET CASH USED IN OPERATIONS:            
             
Loss for the year before taxes on income   (12,262)   (21,806)   (10,097)
Adjustment in respect of:               
Depreciation and amortization   3,705    3,979    3,237 
Loss (Gain) from changes in fair value of financial assets at fair value through profit or loss   (3,623)   3,830    2,713 
Viewbix June 2024 Facility Agreement (note 4F and note 5)   2,286    
-
    
-
 
Changes in fair value of warrants (note 5)   31    (2,718)   (3,778)
Equity losses   367    4,107    2,659 
Net loss (Gain) from derecognition of investments accounted for using the equity method   (140)   2,227    (169)
Finance expenses, net   880    105    2,254 
Amortization of excess purchase price of associates   
-
    530    
-
 
Dividend received   
-
    
-
    (171)
Interest received   
-
    
-
    
-
 
Interest paid   690    953    1,019 
Income tax paid   121    624    380 
Share based compensation to employees and service providers   384    1,019    787 
Gain from initial recognition of assets and liabilities upon consolidation of Gix Internet (note 4F)   
-
    
-
    (2,300)
Loss from deconsolidation of Jeffs’ Brands (note 4E)   1,318    
-
    
-
 
Loss (Gain) from sales of investments (note 5)   (10)   
-
    155 
Impairment of goodwill and other intangible assets   2,919    1,812    
-
 
                
CHANGES IN OPERATING ASSET AND LIABILITY ITEMS:               
Decrease (Increase) in trade accounts receivable   10,206    9,126    (7,838)
Decrease (Increase) in inventory   161    (595)   (564)
Decrease (Increase) in other current assets   226    (209)   (122)
Decrease in deferred offering costs   
-
    
-
    1,763 
Increase (Decrease) in trade accounts payable   (6,833)   (8,124)   5,837 
Decrease in accrued compensation expenses   (8)   (99)   (22)
Increase (Decrease) in accrued expenses and other current liabilities   (1,431)   569    (171)
CASH FLOWS USED IN OPERATIONS   (1,013)   (4,670)   (4,428)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-11

 

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

 

   For the year ended December 31, 
   2024   2023   2022 
   USD in thousands 
Right of use assets obtained in exchange for lease liabilities   
-
    46    152 
Non-cash investments in securities   100    598    900 
Non-cash sale and purchase of securities (note 4J)        1,129    
-
 
Consideration payable by Jeffs’ Brands to sellers of intangible assets (note 4E)   
-
    430    
-
 
Conversions of loans into shares (note 4H, note 4L and note 4P)   
-
    1,686    
-
 
Purchase of a software license on credit (note 4D)   
-
    
-
    35 
Dividend included in other payables   
-
    
-
    580 
Decrease in long-term related party payable in exchange for advertising services (note 4D)   
-
    
-
    656 
Substantial modification of shareholders loans recorded in equity   
-
    
-
    222 
Issuance of ordinary shares upon conversion of shareholders loans   
-
    
-
    587 
Deemed extinguishment and re-issuance of debt by Viewbix Inc. (note 4F)   290           
Derecognition of right of use asset and lease liability upon lease termination (note 4F)   389           
Deferred debt issuance costs paid in shares (note 4F)   484    
-
    
-
 
Deferred debt issuance costs paid in warrants (note 4F)   298    
-
    
-
 

 

APPENDIX B TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS:

 

   As of
January 28,
2024
 
   USD
in thousands
 
Deconsolidation of Jeffs’ Brands (note 4E):    
     
Net working capital other than cash   (1,075)
Property and equipment, net   (58)
Investments accounted for using the equity method   (1,927)
Intangible assets, net   (6,551)
Financial assets at fair value through profit or loss   (50)
Deferred tax asset   (231)
Lease liabilities   45 
Warrants at fair value issued by Jeffs’ Brands   1,874 
Derecognition of non-controlling interests   5,245 
Recognition of Jeffs’ Brands shares as financial assets at fair value   1,393 
Recognition of Jeffs’ Brands warrants as financial assets at fair value   159 
Loss arising from deconsolidation   1,318 
Net cash deconsolidated upon loss of control   142 

 

F-12

 

 

XYLO TECHNOLOGIES LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

APPENDIX C TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS:

 

   February 28, 
   2022 
Consolidation of Gix Internet upon gain of control:    
Net working capital other than cash   646 
Intangible assets   17,705 
Accrued severance pay, net   (126)
Derecognition of investments accounted for using the equity method   (4,606)
Deferred tax liability   (1,999)
Rights of use assets, property and equipment, net   888 
Lease liabilities   (570)
Non-controlling interests   (7,849)
Short- term borrowings   (6,296)
Long- term borrowings   (6,394)
Goodwill   8,164 
Gain arising from consolidation upon gain of control   (2,300)
Net cash acquired   (2,737)

 

F-13

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL

 

A. Xylo Technologies Ltd. (the “Company” or “Xylo Technologies”) was incorporated under the laws of the State of Israel on December 9, 1999. The Company’s registered office and principal place of business is located in Israel. The address of its registered office is Hanehoshet 10, Tel-Aviv POB 6971072, Israel.

 

On April 1, 2024, the Company changed its name from Medigus Ltd. to Xylo Technologies Ltd.

 

The Company, together with its subsidiaries and associates, operate in the technology sector, focusing primarily on internet related activities, including ad tech and online events management, as well as on electric vehicle wireless charging solutions.

 

Additionally, the Company is engaged in the licensing of intellectual property relating to its legacy product, the Medigus Ultrasonic Surgical Endostapler (“MUSE”), to Golden Grand Medical Instruments Ltd., a China based medical services provider, and in the investment of its excess cash resources, primarily in equity securities.

 

“Group” – the Company together with Charging Robotics Inc., GERD IP Inc., Eventer Technologies Ltd. and Gix Internet Ltd.

 

“Subsidiaries” – entities under the control of the Company.

 

GERD IP Inc.

 

As of December 31, 2024, and 2023, the Company held 90% of the issued and outstanding share capital of GERD IP Inc. (“GERD IP”).

 

For additional information, see note 4N.

 

Eventer Technologies Ltd.

 

As of December 31, 2024, and 2023, the Company held approximately 58.4% and 46.21% of the issued and outstanding share capital of Eventer Technologies Ltd. (“Eventer”), respectively.

 

For additional information, see note 4D.  

 

 

F-14

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL: (continued)

 

A. (continued)

 

Gix Internet Ltd.  

 

As of December 31, 2024, and 2023, the Company held 45.74% of the issued and outstanding share capital of Gix Internet Ltd. (“Gix Internet”).

 

For additional information, see note 4F.

 

Charging Robotics Inc.

  

As of December 31, 2024, and 2023, the Company held 64.36% and 67% of the issued and outstanding common stock of Charging Robotics Inc., respectively.

   

For additional information, see notes 4I and 4K. 

 

Jeffs’ Brands Ltd.

 

As of December 31, 2023, the Company held 34.11% of the issued and outstanding share capital of Jeffs’ Brands Ltd. (“Jeffs’ Brands”).

 

On January 25, 2024, Jeffs’ Brands entered into a private placement transaction with certain institutional investors for aggregate gross proceeds of approximately USD 7,275 thousand.

 

The Company did not participate in the private placement and as a result its holdings in Jeffs’ Brands decreased to 13.37% of Jeffs’ Brands issued and outstanding share capital, which resulted in loss of control in Jeffs’ Brands as of January 28, 2024. Accordingly, Jeffs’ Brands was deconsolidated as of such date.

 

As of December 31, 2024, the Company held 1.86% of the issued and outstanding share capital of Jeffs’ Brands

 

For additional information, see note 4E.

 

F-15

 

 

XYLO TECHNOLOGIES LTD.

 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL: (continued)

 

A. (continued)

 

Interests in other entities

 

As of December 31, 2024, the Company also held 5.7% in Parazero Technologies Ltd. (“Parazero”) (see note 4L), 19.7% in Laminera Flow Optimization Ltd. (“Laminera”) (see note 4M), 13.14% in Solterra Eneregy Ltd. (formerly known as A.I. Conversation Systems Ltd.) (“Solterra Energy”) (see note 4P), 19.99% in Metagramm Software Ltd. (“Metagramm”) (see note 4O) and 60% in Zig Miami 54 LLC (“Zig Miami 54”) (see note 4G).

 

B.

As of the approval date of these consolidated financial statements, the Company has cash and cash equivalents in the amount of USD 6 million. The Company anticipates such cash and cash equivalents will provide sufficient liquidity for more than a twelve-month period from the date of these consolidated financial statements.

 

However, since inception, the Company’s activities have been funded mainly by its shareholders. Furthermore, in the recent years the Company has suffered recurring losses from operations, negative cash flows from operating activities, and has an accumulated deficit as of December 31, 2024.

 

As such, the Company’s ability to continue operating may be dependent on several factors, mainly its ability to raise sufficient additional funding, which may not necessarily be available to the Company or provide the Company with sufficient funds to meet its objectives.

 

During the year ended December 31, 2024, Viewbix Inc., Gix Internet’s subsidiary, experienced a decrease in its revenues from the digital content and search segments, as a result of a decrease in user traffic acquired from third party advertising platforms, an industry-wide decrease in advertising budget, changes and updates to internet browsers’ technology, which adversely impacted Viewbix’s Inc. ability to acquire traffic in the search segment and a decrease in revenues from routing of traffic acquired from third-party strategic partners in the search segment, as a result of lack of availability of suppliers credit from such third party strategic partners.

 

The decline in revenues and other circumstances described above raise substantial doubts about Viewbix Inc.’s ability to continue as a going concern during the 12-month period following the issuance date of these financial statements. The Company has no contractual obligations to support Viewbix Inc.

 

C. Iron Swords War
   
 

 On October 7, 2023, following the brutal attacks on Israel by Hamas, a terrorist organization located in the Gaza Strip that infiltrated Israel’s southern border and conducted a series of attacks on civilian and military targets, Israel’s security cabinet declared war (the “War”). Following the commencement of the War, hostilities also intensified between Israel and Hezbollah, a terrorist organization located in Lebanon. Hostilities between Israel and Hezbollah eventually led to an Israeli invasion of southern Lebanon and eventual ceasefire with Lebanon. The War led to a reduction of business activities in Israel, evacuation of residences located in the northern and southern borders of Israel, a significant call up of military reserves and lower availability of work force.

 

The activities of the subsidiary Eventer, which operates in the Israeli market, were directly affected by the War due to the decrease in physical events in Israel which directly affected Eventer’s revenues in this field.

 

The activities of the subsidiaries Gix Internet and Jeffs’ Brands were not directly affected by the War, as their customers are predominantly from the U.S., Europe and U.K. markets that were not influenced by the War. However, there is no assurance that future developments of the War will not have any impact for reasons beyond the Group’s control such as expansion of the War to additional regions and the recruitment of senior employees.

 

The Group has business continuity procedures in place, and will continue to follow developments, assessing potential impact, if any, on the Group’s business, financials and operations.

 

F-16

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION:

 

A. Basis of accounting

 

The financial statements of the Group have been prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (“IASB”).

 

The financial statements have been prepared on the historical cost basis, except for the revaluation of certain financial instruments that are measured at revalued amounts or fair values at the end of each reporting period, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, regardless of whether that price is directly observable or estimated using another valuation technique. In estimating the fair value of an asset or a liability, the Group takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date. Fair value for measurement and/or disclosure purposes in these consolidated financial statements is determined on such a basis, except for share-based payment transactions that are within the scope of IFRS 2 Share-based Payment, leasing transactions that are within the scope of IFRS 16 Leases, and measurements that have some similarities to fair value but are not fair value, such as net realizable value in IAS 2 Inventories or value in use in IAS 36 Impairment of Assets.

 

The consolidated financial statements were authorized for issue by the Board of Directors on April 29, 2025.

 

The significant accounting policies set out below have been consistently applied to in the preparation of these consolidated financial statements for all years presented, unless otherwise stated.

 

B. Basis of consolidation

 

The consolidated financial statements incorporate the financial statements of the Company and entities controlled by the Company (its subsidiaries) made up to 31 December each year.

 

When the Company has less than a majority of the voting rights of an investee, it considers that it has power over the investee when the voting rights are sufficient to give it the practical ability to direct the relevant activities of the investee unilaterally. The Company considers all relevant facts and circumstances in assessing whether or not the Company’s voting rights in an investee are sufficient to give it power, including:

 

  The size of the Company’s holding of voting rights relative to the size and dispersion of holdings of the other vote holders.

 

  Potential voting rights held by the Company, other vote holders or other parties.

 

  Rights arising from other contractual arrangements.

 

  Any additional facts and circumstances that indicate that the Company has, or does not have, the current ability to direct the relevant activities at the time that decisions need to be made, including voting patterns at previous shareholders’ meetings.

 

Non-controlling interests in subsidiaries are identified separately from the Group’s equity therein. Those interests of non-controlling shareholders that are present ownership interests entitling their holders to a proportionate share of net assets upon liquidation may initially be measured at fair value or at the non-controlling interests’ proportionate share of the fair value of the acquiree’s identifiable net assets. The choice of measurement is made on an acquisition-by-acquisition basis. Other non-controlling interests are initially measured at fair value. Subsequent to acquisition, the carrying amount of non-controlling interests is the amount of those interests at initial recognition plus the non-controlling interests’ share of subsequent changes in equity.

 

F-17

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

C. Business combinations

   

Acquisitions of businesses are accounted for using the acquisition method. The consideration transferred in a business combination is measured at fair value, which is calculated as the sum of the acquisition-date fair values of assets transferred by the Group, liabilities incurred by the Group to the former owners of the acquiree and the equity interest issued by the Group in exchange for control of the acquiree. Acquisition-related costs are recognized in profit or loss as incurred.

 

When the consideration transferred by the Group in a business combination includes a contingent consideration arrangement, the contingent consideration is measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. Changes in fair value of the contingent consideration that qualify as measurement period adjustments are adjusted retrospectively, with corresponding adjustments against goodwill. Measurement period adjustments are adjustments that arise from additional information obtained during the ‘measurement period’ (which cannot exceed one year from the acquisition date) about facts and circumstances that existed at the acquisition date.

 

The subsequent accounting for changes in the fair value of the contingent consideration that do not qualify as measurement period adjustments depends on how the contingent consideration is classified. Contingent consideration that is classified as equity is not remeasured at subsequent reporting dates and its subsequent settlement is accounted for within equity. Other contingent consideration is remeasured to fair value at subsequent reporting dates with changes in fair value recognized in profit or loss.

 

When a business combination is achieved in stages, the Group’s previously held interests in the acquired entity are remeasured to its acquisition-date fair value and the resulting gain or loss, if any, is recognized in profit or loss. Amounts arising from interests in the acquiree prior to the acquisition date that have previously been recognized in other comprehensive income are reclassified to profit or loss, where such treatment would be appropriate if that interest were disposed of.

 

If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, the Group reports provisional amounts for the items for which the accounting is incomplete. Those provisional amounts are adjusted during the measurement period (see above), or additional assets or liabilities are recognized, to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the amounts recognized as of that date.

 

D. Goodwill

 

Goodwill is initially recognized and measured as set out above.

 

Goodwill is not amortized but is reviewed for impairment at least annually. For the purpose of impairment testing, goodwill is allocated to each of the Group’s cash-generating units (or groups of cash-generating units) expected to benefit from the synergies of the combination. Cash-generating units to which goodwill has been allocated are tested for impairment annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit. For more information, see note 9.

 

An impairment loss recognized for goodwill is not reversed in a subsequent period.

 

E. Investments in associates

 

An associate is an entity over which the Group has significant influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee. The Group is presumed to have significant influence when it holds 20 percent or more of the voting rights of an investee, unless it can be clearly demonstrated that this is not the case. The Group does not control its associates.

 

Under the equity method, an investment in an associate is recognized initially in the consolidated statements of financial position at cost and adjusted thereafter to recognize the Group’s share of the profit or loss and other comprehensive income of the associate. Dividends received or receivable from associates are recognized as a reduction in the carrying amount of the investment. When the Group’s share of losses of an associate or exceeds the Group’s interest in that associate (which includes any long-term interests that, in substance, form part of the Group’s net investment in the associate), the Group discontinues recognizing its share of further losses. Additional losses are recognized only to the extent that the Group has incurred legal or constructive obligations or made payments on behalf of the associate.

 

F-18

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

E. Investments in associates (continued)

 

If there is objective evidence that the Group’s net investment in an associate is impaired, the requirements of IAS 36 are applied to determine whether it is necessary to recognize any impairment loss with respect to the Group’s investment. When necessary, the entire carrying amount of the investment (including goodwill) is tested for impairment in accordance with IAS 36 as a single asset by comparing its recoverable amount (higher of value in use and fair value less costs of disposal) with its carrying amount. Any impairment loss recognized is not allocated to any asset, including goodwill that forms part of the carrying amount of the investment. Any reversal of that impairment loss is recognized in accordance with IAS 36 to the extent that the recoverable amount of the investment subsequently increases.

 

F. Foreign currencies

 

The functional currency and the presentation currency

 

The reporting and functional currency of the Company and each of its subsidiaries, GERD IP and Charging Robotics Inc. is USD while Eventer and Gix Internet is NIS.

 

The consolidated financial statements are presented in USD and rounded to the nearest thousand.

 

The consolidation of Gix’s Internet and Eventer’s financial statements is accounted for as a foreign operation using IAS 21, the Effects of Changes in Foreign Exchange Rates.

  

Transactions and balances

 

In preparing the financial statements of the Group entities, transactions in currencies other than the entity’s functional currency (“Foreign Currencies”) are recognized at the rates of exchange prevailing on the dates of the transactions. At each reporting date, monetary assets and liabilities that are denominated in Foreign Currencies are retranslated at the rates prevailing at that date. Non-monetary items carried at fair value that are denominated in Foreign Currencies are translated at the rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

Exchange differences are recognized in profit or loss in the period in which they arise.

 

F-19

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

G. Property and equipment

 

Depreciation is calculated using the straight-line method over the estimated useful life of the asset as follows:

 

Machinery and equipment  6 – 10 years (primarily 10)
Leasehold improvements and furniture  714 years
Computers and programs  3 years

 

Leasehold improvements are depreciated using the straight-line method over the shorter of the term of the lease or the estimated useful lives of the assets.

 

H. Financial instruments

 

Financial assets and financial liabilities are recognized in the Group’s consolidated statements of financial position when the Group becomes a party to the contractual provisions of the instrument.

 

Financial assets and financial liabilities are initially measured at fair value, except for trade receivables that do not have a significant financing component which are measured at transaction price. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss are recognized immediately in profit or loss. 

 

Financial assets

 

All recognized financial assets are measured subsequently in their entirety at either amortized cost or fair value, depending on the classification of the financial assets.

 

Classification

 

The Group classifies its financial assets in the following measurement categories:

 

  those to be measured subsequently at fair value through profit or loss, and

 

  those to be measured at amortized cost.

 

The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows.

 

For assets measured at fair value, gains and losses will be recorded in profit or loss.

 

F-20

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

  

H. Financial instruments (continued)

 

Recognition

 

Regular way purchases and sales of financial assets are recognized on trade date, being the date on which the Group commits to purchase or sell the asset. Financial assets are derecognized when the rights to receive cash flows from the financial assets have expired or have been transferred and the Group has transferred substantially all the risks and rewards of ownership.

  

Measurement

 

At initial recognition, the Group measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss (“FVTPL”), transaction costs that are directly attributable to the acquisition of the financial asset. Transaction costs of financial assets carried at FVTPL are expensed in profit or loss.

 

Financial assets with embedded derivatives are considered in their entirety when determining whether their cash flows are solely payment of principal and interest.

 

Debt instruments

 

Subsequent measurement of investments in debt instruments depends on the Group’s business model for managing the asset and the cash flow characteristics of the asset. There are two measurement categories into which the Group classifies its investments in debt instruments:

 

  Amortized cost: Financial assets are measured at amortized cost if both of the following conditions are met:

 

  - the financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows; and

 

  - the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

 

Interest income from these financial assets is included in finance income using the effective interest rate method. Any gain or loss arising on derecognition is recognized directly in profit or loss and presented in other gains/(losses) together with foreign exchange gains and losses.

 

  Fair value through profit or loss: A gain or loss on a debt investment that is subsequently measured at FVTPL is recognized in profit or loss and presented net within other gains/(losses) in the period in which it arises.

 

Equity instruments

 

The Group subsequently measures investments in equity instruments at fair value through profit or loss except when the Group has control or significant influence. Dividends from such investments continue to be recognized in profit or loss as other income when the Group’s right to receive payments is established.

 

Changes in the fair value of financial assets at FVTPL are recognized in “net change in fair value of financial assets at fair value through profit or loss” in the Consolidated statements of loss and other comprehensive loss, as applicable.

 

F-21

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

H. Financial instruments (continued)

 

Impairment of financial assets

 

The Group recognizes a loss allowance for expected credit losses on financial assets at amortized cost.

 

At each reporting date, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition. If the financial instrument is determined to have a low credit risk at the reporting date, the Company assumes that the credit risk on a financial instrument has not increased significantly since initial recognition.

 

The Group measures the loss allowance for expected credit losses on trade receivables and on financial instruments for which the credit risk has increased significantly since initial recognition based on lifetime expected credit losses based on information available on their credit condition, current aging, historical experience, future economic and market conditions. The Group has determined that the estimates of current and expected credit losses are immaterial.

 

Financial liabilities and equity

 

Classification as debt or equity

 

Debt and equity instruments are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.

 

Equity instruments

 

An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. Equity instruments issued by the Group are recognized at the proceeds received, net of direct issue costs.

 

Repurchase of the Company’s own equity instruments is recognized and deducted directly in equity. No gain or loss is recognized in profit or loss on the purchase, sale, issue or cancellation of the Company’s own equity instruments.

 

Compound instruments

 

The component parts of convertible loan notes issued by the Group are classified separately as financial liabilities and equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument. A conversion option that will be settled by the exchange of a fixed amount of cash or another financial asset for a fixed number of the Company’s own equity instruments is an equity instrument.

 

At the date of issue, the fair value of the liability component is estimated using the prevailing market interest rate for a similar non-convertible instrument. This amount is recorded as a liability on an amortized cost basis using the effective interest method until extinguished upon conversion or at the instrument’s maturity date.

 

The conversion option classified as equity is determined by deducting the amount of the liability component from the fair value of the compound instrument as a whole. This is recognized and included in equity, net of income tax effects, and is not subsequently remeasured. In addition, the conversion option classified as equity will remain in equity until the conversion option is exercised, in which case the balance recognized in equity will be transferred to share premium. Where the conversion option remains unexercised at the maturity date of the convertible loan note, the balance recognized in equity will be transferred to retained earnings. No gain or loss is recognized in profit or loss upon conversion or expiration of the conversion option.

 

F-22

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

H. Financial instruments (continued)

 

Compound instruments (continued)

 

Transaction costs that relate to the issue of the convertible loan notes are allocated to the liability and equity components in proportion to the allocation of the gross proceeds. Transaction costs relating to the equity component are recognized directly in equity. Transaction costs relating to the liability component are included in the carrying amount of the liability component and are amortized over the lives of the convertible loan notes using the effective interest method.

 

Financial liabilities

 

Financial liabilities are initially recognized at their fair value minus, in the case of a financial liability not at fair value through profit or loss, transaction costs that are directly attributable to the issue of the financial liability.

 

Financial liabilities are subsequently measured at amortized cost using the effective interest method, except for derivative financial instruments, which are subsequently measured at fair value through profit or loss (FVTPL).

   

The Group has early adopted the narrow-scope amendment to IAS 1. Accordingly, financial liabilities are classified as non-current if the Group has a substantive right to defer settlement for at least 12 months at the end of the reporting period, otherwise, they are classified as current liabilities.

 

The Group’s financial liabilities at amortized cost are included in accounts payable, accrued expenses, other current liabilities, payable in respect of the intangible asset and lease liabilities.

 

The derivative financial instruments represent warrants that confer the right to net share settlement.

 

The Group derecognizes a financial liability (or a part of a financial liability) when, and only when, it is extinguished (when the obligation specified in the contract is discharged, cancelled or expired).

 

Derecognition of financial liabilities

 

The Group derecognizes financial liabilities when, and only when, the Group’s obligations are discharged, cancelled or have expired. The difference between the carrying amount of the financial liability derecognized and the consideration paid and payable is recognized in profit or loss.

 

When the Group exchanges with the existing lender one debt instrument into another one with substantially different terms, such exchange is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. Similarly, the Group accounts for substantial modification of terms of an existing liability or part of it as an extinguishment of the original financial liability and the recognition of a new liability. It is assumed that the terms are substantially different if the discounted present value of the cash flows under the new terms, including any fees paid net of any fees received and discounted using the original effective interest rate is at least 10 per cent different from the discounted present value of the remaining cash flows of the original financial liability. If the modification is not substantial, the difference between: (1) the carrying amount of the liability before the modification; and (2) the present value of the cash flows after modification is recognized in profit or loss as the modification gain or loss within other gains and losses.

 

I. Inventories

 

Inventories are stated at the lower of cost and net realizable value. Cost comprises direct materials and, where applicable, direct labor costs and those overheads that have been incurred in bringing the inventories to their present location and condition. Cost is calculated using the weighted average cost method. Net realizable value represents the estimated selling price less all estimated costs of completion and costs to be incurred in marketing, selling and distribution.

 

The Group periodically evaluates the condition and age of inventories and makes provisions for slow moving inventories accordingly.

 

F-23

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

J. Cash and cash equivalents

 

In the statement of financial position, cash and bank balances comprise cash (i.e., cash on hand and demand deposits) and cash equivalents. Cash equivalents are short-term (generally with original maturity of three months or less), highly liquid investments that are readily convertible to a known amount of cash and which are subject to an insignificant risk of changes in value. Cash equivalents are held for the purpose of meeting short-term cash commitments rather for investment or other purposes.

 

Bank balances for which use by the Group is subject to third party contractual restrictions are included as part of cash unless the restrictions result in a bank balance no longer meeting the definition of cash. If the contractual restrictions to use the cash extend beyond 12 months after the end of the reporting period, the related amounts are classified as non-current in the statement of financial position.

 

For the purposes of the statement of cash flows, cash and cash equivalents consist of cash and cash equivalents as defined above, net of outstanding bank overdrafts which are repayable on demand and form an integral part of the Group’s cash management. Such overdrafts are presented as short-term borrowings in the statement of financial position.  

 

K. Taxation

 

The income tax expense represents the sum of the tax currently payable and deferred tax.

 

Current Tax

 

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in profit or loss because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

 

A provision is recognized for those matters for which the tax determination is uncertain, but it is considered probable that there will be a future outflow of funds to a tax authority. The provisions are measured at the best estimate of the amount expected to become payable. The assessment is based on the judgement of tax professionals within the Company supported by previous experience in respect of such activities and in certain cases based on specialist independent tax advice.

 

Deferred Tax

 

Deferred tax is the tax expected to be payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit and is accounted for using the liability method. Deferred tax liabilities are generally recognized for all taxable temporary differences and are recognized to the extent that it is probable that taxable profits will be available against which deductible temporary differences can be utilized. Such assets and liabilities are not recognized if the temporary difference arises from the initial recognition (other than in a business combination) of other assets and liabilities in a transaction that affects neither the taxable profit nor the accounting profit. In addition, a deferred tax liability is not recognized if the temporary difference arises from the initial recognition of goodwill.

 

Deferred tax liabilities are recognized for taxable temporary differences arising on investments in subsidiaries and associates, except where the Group is able to control the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax assets arising from deductible temporary differences associated with such investments are only recognized to the extent that it is probable that there will be sufficient taxable profits against which to utilize the benefits of the temporary differences and they are expected to reverse in the foreseeable future.

 

F-24

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

  

L. Short-term and other long-term employee benefits  

 

Pension and severance pay obligations

 

Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (“Section 14”), all of the Company’s employees in Israel are entitled a monthly contribution, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Contributions under Section 14 relieve the Company from any future severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Company’s consolidated statements of financial position, and there is no liability recorded as the Company does not have a future obligation to make any additional payments.

 

The asset and the liability for severance pay presented in the consolidated statements of financial position reflects employees that began employment prior to automatic application of Section 14.

 

The severance pay liability of the Company to its employees that began employment prior to automatic application of Section 14 based upon the number of years of service and the latest monthly salary and is partly covered by regular deposits with recognized pension funds and deposits with severance pay funds. Under labor laws, these deposits are in the employees’ names and, subject to certain limitations, are the property of the employees. The Company records the obligation as if it were payable at each statement of financial position date on an undiscounted basis.

 

Vacation and recreation pay

 

Under the Israeli law, each employee is legally entitled to vacation and recreation benefits. The entitlement is based on term of employment. The Group records such obligations as incurred.

 

Bonus plans

 

The Group record bonus obligation when a contractual or constructive obligation exists. Such bonus obligation is record in the amount expected to be paid, to the extent that the Group can reliably estimate the amount expected to be paid.

 

M. Provisions

 

Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that the Group will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

 

The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

 

F-25

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

N. Share-based payments

 

Equity-settled share-based payments to employees and others providing similar services are measured at the fair value of the equity instruments at the grant date. The fair value excludes the effect of non-market-based vesting conditions. Details regarding the determination of the fair value of equity-settled share-based transactions are set out in note 14.

 

The fair value determined at the grant date of the equity-settled share-based payments is expensed on a straight-line basis over the vesting period, based on the Group’s estimate of the number of equity instruments that will eventually vest. At each reporting date, the Group revises its estimate of the number of equity instruments expected to vest as a result of the effect of non-market-based vesting conditions. The impact of the revision of the original estimates, if any, is recognized in profit or loss such that the cumulative expense reflects the revised estimate, with a corresponding adjustment to reserves.

 

Equity-settled share-based payment transactions with parties other than employees are measured at the fair value of the goods or services received, except where that fair value cannot be estimated reliably, in which case they are measured at the fair value of the equity instruments granted, measured at the date the entity obtains the goods or the counterparty renders the service.

 

O. Revenue recognition

 

The Group recognizes revenue from the following major sources:

 

  Product revenue

 

  Service revenue

 

Revenue is measured based on the consideration to which the Group expects to be entitled in a contract with a customer and excludes amounts collected on behalf of third parties. The Group recognizes revenue when it transfers control of a product or service to a customer.

 

Product Revenue through Jeffs’ Brands

 

Revenues from product sales of Jeffs’ Brands, directly to Jeffs’ Brands customers through Jeffs’ Brands own online Amazon stores.

 

F-26

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

O. Revenue recognition (continued)

 

Product Revenue through Jeffs’ Brands (continued)

 

For sales of goods to retail customers, revenue is recognized when control of the goods has transferred to the customer, being at the point the goods are delivered to the customer. Payment of the transaction price is due immediately at the point the customer purchases the goods.

 

Under Jeffs’ Brands standard contract terms, customers have a right of return within 45 days. Jeffs’ Brands uses its accumulated historical experience to estimate the number of returns on a portfolio level using the expected value method. It is considered highly probable that a significant reversal in the cumulative revenue recognized will not occur given the consistent level of returns over previous years.

 

Service Revenue through Gix Internet

 

Gix Internet generates revenues from obtaining internet user traffic and routing such traffic to its customers. Gix Internet is entitled to receive consideration for its service upon each individual internet user traffic routed to and monetized by its customers.

 

Gix Internet’s revenues are measured according to the amount of consideration that Gix Internet expects to be entitled to in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties, such as VAT taxes. Revenues are presented net of VAT.

 

As Gix Internet operates as the primary obligor in its arrangements and has sole discretion in determining to which of its customers internet user traffic is to be routed, revenues are presented on a gross basis.

  

Service Revenues through Eventer

 

Eventer generates revenues through collecting commissions from customers for ticket sales on Eventer’s event production platform. These services constitute a performance obligation that is fulfilled at one point in time and therefore the Group recognizes revenues at the time of the event.

 

Revenues are presented on a net basis, since Eventer’s activity is to arrange for the consideration of tickets to be provided to a third party.

 

F-27

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

P. Leases

 

The Group assesses whether a contract is or contains a lease, at inception of the contract. The Group recognizes a right-of-use asset and a corresponding lease liability with respect to all lease arrangements in which it is the lessee, except for short-term leases (defined as leases with a lease term of 12 months or less) and leases of low value assets (such as tablets and personal computers, small items of office furniture and telephones). For these leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease unless another systematic basis is more representative of the time pattern in which economic benefits from the leased assets are consumed.

 

The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. If this rate cannot be readily determined, the Group uses its incremental borrowing rate. 

 

The incremental borrowing rate depends on the term, currency and start date of the lease and is determined based on a series of inputs including: the risk-free rate based on government bond rates; a country-specific risk adjustment; a credit risk adjustment based on bond yields; and an entity-specific adjustment when the risk profile of the entity that enters into the lease is different to that of the Group and the lease does not benefit from a guarantee from the Group.

 

Lease payments included in the measurement of the lease liability comprise:

 

  Fixed lease payments (including in-substance fixed payments), less any lease incentives receivable

 

  Variable lease payments that depend on an index or rate, initially measured using the index or rate at the commencement date

 

  The amount expected to be payable by the lessee under residual value guarantees

 

  The exercise price of purchase options, if the lessee is reasonably certain to exercise the options

 

  Payments of penalties for terminating the lease, if the lease term reflects the exercise of an option to terminate the lease

  

The lease liability is subsequently measured by increasing the carrying amount to reflect interest on the lease liability (using the effective interest method) and by reducing the carrying amount to reflect the lease payments made.

 

The right-of-use assets comprise the initial measurement of the corresponding lease liability, lease payments made at or before the commencement day, less any lease incentives received and any initial direct costs. They are subsequently measured at cost less accumulated depreciation and impairment losses.

 

Right-of-use assets are depreciated over the shorter period of lease term and useful life of the right-of-use asset. The depreciation starts at the commencement date of the lease.

 

F-28

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

Q. Intangible assets

 

Intangible assets acquired separately

 

Intangible assets with finite useful lives that are acquired separately are carried at cost less accumulated amortization and accumulated impairment losses. Amortization is recognized on a straight-line basis over their estimated useful lives. The estimated useful life and amortization method are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis. Intangible assets with indefinite useful lives that are acquired separately are carried at cost less accumulated impairment losses.

 

Internally generated intangible assets – research and development expenditure

 

Expenditure on research activities is recognized as an expense in the period in which it is incurred.

 

An internally generated intangible asset arising from development (or from the development phase of an internal project) is recognized if, and only if, all of the following conditions have been demonstrated:

 

  The technical feasibility of completing the intangible asset so that it will be available for use or sale

 

  The intention to complete the intangible asset and use or sell it

 

  The ability to use or sell the intangible asset

 

  How the intangible asset will generate probable future economic benefits

 

  The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset

 

  The ability to measure reliably the expenditure attributable to the intangible asset during its development

 

The amount initially recognized for internally generated intangible assets is the sum of the expenditure incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally generated intangible asset can be recognized, development expenditure is recognized in profit or loss in the period in which it is incurred.

 

F-29

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

Q. Intangible assets (continued)

 

Internally generated intangible assets – research and development expenditure (continued)

 

Subsequent to initial recognition, internally generated intangible assets are reported at cost less accumulated amortization and accumulated impairment losses, on the same basis as intangible assets that are acquired separately.

 

Intangible assets acquired in a business combination

 

Intangible assets acquired in a business combination and recognized separately from goodwill are recognized initially at their fair value at the acquisition date (which is regarded as their cost).

 

Subsequent to initial recognition, intangible assets acquired in a business combination are reported at cost less accumulated amortization and accumulated impairment losses, on the same basis as intangible assets that are acquired separately.

 

Derecognition of intangible assets

 

An intangible asset is derecognized on disposal, or when no future economic benefits are expected from use or disposal. Gains or losses arising from derecognition of an intangible asset, measured as the difference between the net disposal proceeds and the carrying amount of the asset, and are recognized in the consolidated statements of income/loss and other comprehensive income/loss as profit/loss when the asset is derecognized.

 

F-30

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

R. Impairment of property and equipment and intangible assets excluding goodwill

 

At each reporting date, the Group reviews the carrying amounts of its property and equipment and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated to determine the extent of the impairment loss (if any). Where the asset does not generate cash flows that are independent from other assets, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs. When a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.

 

Intangible assets with an indefinite useful life are tested for impairment at least annually and whenever there is an indication at the end of a reporting period that the asset may be impaired.

 

Recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognized immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease and to the extent that the impairment loss is greater than the related revaluation surplus, the excess impairment loss is recognized in profit or loss.

 

Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognized immediately in profit or loss to the extent that it eliminates the impairment loss which has been recognized for the asset in prior years. Any increase in excess of this amount is treated as a revaluation increase. 

 

F-31

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

  

S. New and amended IFRS Accounting Standards that are effective for the current year

 

In the current year, the Group has applied a number of amendments to IFRS Accounting Standards issued by the International Accounting Standards Board (IASB) that are mandatorily effective for an accounting period that begins on or after 1 January 2024. Their adoption has not had any material impact on the disclosures or on the amounts reported in these consolidated financial statements.

 

Amendments to IAS 1 Presentation of Financial Statements – Classification of Liabilities as Current or Non-current

 

The Group has adopted the amendments to IAS 1, published in January 2020, for the first time in the current year.

 

The amendments affect only the presentation of liabilities as current or non-current in the statement of financial position and not the amount or timing of recognition of any asset, liability, income or expenses, or the information disclosed about those items.

 

The amendments clarify that the classification of liabilities as current or non-current is based on rights that are in existence at the end of the reporting period, specify that classification is unaffected by expectations about whether an entity will exercise its right to defer settlement of a liability, explain that rights are in existence if covenants are complied with at the end of the reporting period, and introduce a definition of ’settlement’ to make clear that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services.

 

Amendments to IAS 1 – Non-current Liabilities with Covenants

 

The Group has adopted the amendments to IAS 1, published in November 2022, for the first time in the current year.

 

The amendments specify that only covenants that an entity is required to comply with on or before the end of the reporting period affect the entity’s right to defer settlement of a liability for at least twelve months after the reporting date (and therefore must be considered in assessing the classification of the liability as current or non-current). Such covenants affect whether the right exists at the end of the reporting period, even if compliance with the covenant is assessed only after the reporting date (e.g. a covenant based on the entity’s financial position at the reporting date that is assessed for compliance only after the reporting date).

 

The IASB also specifies that the right to defer settlement of a liability for at least twelve months after the reporting date is not affected if an entity only has to comply with a covenant after the reporting period. However, if the entity’s right to defer settlement of a liability is subject to the entity complying with covenants within twelve months after the reporting period, an entity discloses information that enables users of financial statements to understand the risk of the liabilities becoming repayable within twelve months after the reporting period. This would include information about the covenants (including the nature of the covenants and when the entity is required to comply with them), the carrying amount of related liabilities and facts and circumstances, if any, that indicate that the entity may have difficulties complying with the covenants.

 

F-32

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

T. New and revised IFRS Accounting Standards in issue but not yet effective

 

At the date of authorization of these consolidated financial statements, the Group has not applied the following new and revised IFRS Accounting Standards that have been issued but are not yet effective.

  

Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates titled Lack of Exchangeability

 

The amendments specify how to assess whether a currency is exchangeable, and how to determine the exchange rate when it is not.

 

The amendments state that a currency is exchangeable into another currency when an entity is able to obtain the other currency within a time frame that allows for a normal administrative delay and through a market or exchange mechanism in which an exchange transaction would create enforceable rights and obligations.

 

An entity assesses whether a currency is exchangeable into another currency at a measurement date and for a specified purpose. If an entity is able to obtain no more than an insignificant amount of the other currency at the measurement date for the specified purpose, the currency is not exchangeable into the other currency.

 

The assessment of whether a currency is exchangeable into another currency depends on an entity’s ability to obtain the other currency and not on its intention or decision to do so.

 

When a currency is not exchangeable into another currency at a measurement date, an entity is required to estimate the spot exchange rate at that date. An entity’s objective in estimating the spot exchange rate is to reflect the rate at which an orderly exchange transaction would take place at the measurement date between market participants under prevailing economic conditions.

 

The Group anticipates that the application of these amendments will not have an impact on the Group’s consolidated financial statements in future periods.

 

IFRS 18 Presentation and Disclosures in Financial Statements

 

IFRS 18 replaces IAS 1, carrying forward many of the requirements in IAS 1 unchanged and complementing them with new requirements. In addition, some IAS 1 paragraphs have been moved to IAS 8 and IFRS 7. Furthermore, the IASB has made minor amendments to IAS 7 and IAS 33 Earnings per Share.

 

IFRS 18 introduces new requirements to:

 

present specified categories and defined subtotals in the statement of profit or loss

 

provide disclosures on management-defined performance measures (MPMs) in the notes to the financial statements

 

improve aggregation and disaggregation.

 

An entity is required to apply IFRS 18 for annual reporting periods beginning on or after 1 January 2027, with earlier application permitted. The amendments to IAS 7 and IAS 33, as well as the revised IAS 8 and IFRS 7, become effective when an entity applies IFRS 18. IFRS 18 requires retrospective application with specific transition provisions.

 

The Group anticipates that the application of these amendments may have an impact on the Group’s consolidated financial statements in future periods.

 

F-33

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – MATERIAL ACCOUNTING POLICY INFORMATION: (continued)

 

T. New and revised IFRS Accounting Standards in issue but not yet effective (continued)

 

IFRS 19 Subsidiaries without Public Accountability: Disclosures

 

IFRS 19 permits an eligible subsidiary to provide reduced disclosures when applying IFRS Accounting Standards in its financial statements.

 

A subsidiary is eligible for the reduced disclosures if it does not have public accountability and its ultimate or any intermediate parent produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.

 

An entity is only permitted to apply IFRS 19 if, at the end of the reporting period:

 

it is a subsidiary (this includes an intermediate parent)

 

it does not have public accountability, and

 

its ultimate or any intermediate parent produces consolidated financial statements available for public use that comply with IFRS Accounting Standards.

 

A subsidiary has public accountability if:

 

its debt or equity instruments are traded in a public market or it is in the process of issuing such instruments for trading in a public market (a domestic or foreign stock exchange or an over-the-counter market, including local and regional markets), or

 

it holds assets in a fiduciary capacity for a broad group of outsiders as one of its primary businesses (for example, banks, credit unions, insurance entities, securities brokers/dealers, mutual funds and investment banks often meet this second criterion).

 

Eligible entities can apply IFRS 19 in their consolidated, separate or individual financial statements. An eligible intermediate parent that does not apply IFRS 19 in its consolidated financial statement may do so in its separate financial statements.

 

The Group does not anticipate that IFRS 19 will be applied for purposes of the consolidated financial statements of the Group.

    

NOTE 3 – KEY SOURCES OF ESTIMATION UNCERTAINTY:

 

In applying the Group’s accounting policies, which are described in note 2, the management is required to make estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimate are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

 

The key assumptions concerning the future, and other key sources of estimation uncertainty at the reporting period that may have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year, are discussed below.

 

F-34

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 – KEY SOURCES OF ESTIMATION UNCERTAINTY: (continued)

  

Fair value measurements and valuation process of financial assets and liabilities measured at fair value through profit or loss (FVTPL)

 

Some of the Group’s financial assets and financial liabilities are measured at fair value for financial reporting purposes.

 

In estimating the fair value of such assets or liabilities, the Group uses market-observable data. Where Level 1 or 2 inputs are not available, the Group determines the fair value of the financial instrument using acceptable valuation techniques and, as applicable, engages third party qualified valuation specialists to perform the valuation.

 

Further information on the relevant unobservable inputs is provided in note 5.

 

Impairment of Intangible Assets

 

During 2024, the Group recognized an impairment loss of USD 2,919 thousand for the online advertising & internet traffic routing reporting unit’s goodwill, reducing the book value of goodwill to USD 4.8 million as of December 31, 2024. The Group’s quantitative goodwill impairment test involves the comparison of the fair value of each reporting unit to its carrying value. In estimating the fair value of the online advertising & internet traffic routing reporting unit (Gix Internet) the Group used the income approach method, which requires management to make significant estimates and assumptions related to future cash flows and discount rates.

 

F-35

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES:

 

A. Investments in subsidiaries:

 

1. Additional information about Subsidiaries held by the Company:

 

General information

 

   Main place of
the business
  Ownership rights
held by the Company
   Ownership rights
held by
non- controlling
interests
 
December 31, 2024           
Eventer  Israel   58.44%   41.56%
Charging Robotics Inc.  USA   63.75%   36.25%
GERD IP  USA   90%   10%
Gix Internet  Israel   45.74%   54.26%

 

   Main place of
the business
  Ownership rights
held by the Company
   Ownership rights
held by
non- controlling
interests
 
December 31, 2023           
Jeffs’ Brands  Israel   34.11%   65.89%
Eventer  Israel   46.21%   53.79%
Charging Robotics Inc.  USA   67%   33%
GERD IP  USA   90%   10%
Gix Internet  Israel   45.75%   54.25%

 

F-36

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

A. Investments in subsidiaries: (continued)

 

2. Information related to non-controlling interests:

 

Balance of non-controlling interests:

 

   December 31,
2024
   December 31,
2023
 
   USD in thousands 
Eventer   446    371 
Jeffs’ Brands   
-
    5,628 
Gix Internet   (878)   2,642 
GERD IP   57    57 
Charging Robotics Inc.   (20)   161 
    (395)   8,859 

 

Net income (loss) attributed to non-controlling interests:

 

  

Year ended
December 31,

2024

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
   USD in thousands 
             
Eventer   (151)   (383)   (691)
Jeffs’ Brands (**)   (383)   (1,989)   (396)
Gix Internet   (5,123)   (3,085)   (*) 687 
GERD IP   
-
    
-
    7 
Charging Robotics Inc.   (321)   (250)   
-
 
    (5,978)   (5,707)   (393)

 

(*) For the period from February 28, 2022, until December 31, 2022. For additional information see note 4F.

 

(**) For the period from January 1, 2024, until January 28, 2024. For additional information see note 4E.

 

F-37

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

A. Investments in subsidiaries: (continued)

 

3. Summarized financial information of material subsidiaries:

 

The summarized financial information below is prior to eliminating intragroup balances and transactions.

 

Gix Internet:

 

   December 31,
2024
   December 31,
2023
 
   USD in thousands (*) 
Current assets   3,826    14,400 
Non-current assets   14,516    20,778 
Current liabilities   16,798    23,555 
Non-current liabilities   1,471    2,168 

 

  (*) Translated according to the exchange rates at the date of each statement of financial position.

 

  

Year ended
December 31,

2024

   Year ended
December 31,
2023
  

February 28,

2022 –

December 31,

2022 (**)

 
   USD in thousands (***) 
Revenues   26,941    79,613    83,532 
Net income (loss) for the period   (10,019)   (4,971)   414 
Total comprehensive income (loss) for the period   (116)   (4,791)   913 
Cash flows from operating activities   1,302    678    4,232 
Cash flows from investing activities   119    19    13 
Cash flows used in financing activities   (2,662)   (3,113)   (3,309)
Net increase (decrease) in cash and cash equivalents   (1,241)   (2,416)   809 

 

(**) Gix Internet was consolidated as of February 28, 2022. For additional information see note 4F.

 

(***) Translated according to the average exchange rates for each period.

 

F-38

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

B. Investments accounted for using the equity method:

 

1. The following table summarizes the total investments accounted for using the equity method:

 

   December 31,
2024
   December 31,
2023
 
   USD in thousands 
Polyrizon (7)   
-
    499 
SciSparc Nutraceuticals (2)   
-
    1,940 
Solterra Energy (note 4P)   
-
    76 
Revoltz (note 4I)   73    110 
Zig Miami 54 (note 4G)   268    370 
    341    2,995 

 

2. The following table summarizes the total share of loss (profit) of investments accounted for using the equity method:

 

  

Year ended
December 31,

2024

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
   USD in thousands 
Odysight.ai (1)   
-
    660    1,360 
Gix Internet (3)   
-
    
-
    215 
Parazero (4)   
-
    544    615 
Laminera (note 4M)   
-
    1,176    157 
SciSparc Nutraceuticals (2)   13    1,249    
-
 
Polyrizon (7)   140    209    234 
Elbit Imaging Ltd. (5)   
-
    
-
    36 
Solterra Energy (6)   76    158    
-
 
Revoltz (note 4I)   36    26    42 
Zig Miami 54 (note 4G)   102    85    
-
 
    367    4,107    2,659 

  

(1) Odysight.ai investment was accounted for as assets at fair value through profit or loss from March 21, 2023 (note 4C).

 

(2) Jeffs’ Brands was deconsolidated on January 28, 2024, and was accounted for as assets at fair value through profit or loss from this date.

 

(3) Gix Internet was consolidated from February 28, 2022 (note 4F).

 

(4) Parazero investment was accounted for as assets at fair value through profit or loss from October 30, 2023 (note 4M).

 

(5) Elbit Imaging Ltd. investment was accounted for as assets at fair value through profit or loss from October 18, 2022.

 

(6) Solterra Energy investment was accounted for as assets at fair value through profit or loss from September 5, 2024 (note 4P).

 

(7) Polyrizon investment was accounted for as assets at fair value through profit or loss from October 30, 2024 (note 4H).

 

F-39

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

B. Investments accounted for using the equity method: (continued)

 

3. This table summarize the Company’s rights in share capital and voting rights:

 

   Main place
of the
  Company rights in share
capital and voting rights
 
   business  % 
December 31, 2024       
Laminera  Israel  19.70%
Revoltz  Israel   19.90%
Zig Miami 54  USA   60%
         
December 31, 2023        
Laminera  Israel   19.70%
Polyrizon  Israel   38.76%
SciSparc Nutraceuticals  USA   49%
Solterra Energy  Israel   36.08%
Revoltz  Israel   19.90%
Zig Miami 54  USA   60%

 

F-40

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

C. Odysight.ai

 

As of December 31, 2022, the Company held 27.02% of the outstanding common stock of Odysight.ai.

 

On March 21, 2023, Odysight.ai completed a private placement to existing stockholders, of 3,294,117 units, at a purchase price of USD 4.25 per unit, with each unit consisting of one share of Odysight.ai’s common stock and one warrant to purchase one share of Odysight.ai’s common stock at an exercise price of USD 5.50 per share. The Company did not participate in the private placement. Following the private placement, the Company’s holdings in Odysight.ai were diluted to 18.45% and the remaining holding was accounted for as investment at fair value through profit or loss (FVTPL). As a result of the transition, the Company recognized a loss of USD 2,946 thousand.

 

On May 17, 2023, the Company signed a stock transfer agreement to sell its entire holdings in Odysight.ai for total proceeds of approximately USD 5.7 million.

 

D. Eventer

 

General

 

As of December 31, 2023, the Company held 46.21% of Eventer’s issued and outstanding common stock.

 

On August 27, 2024, Julian Azoulay, Eventer’s CEO exercised options to acquire ordinary shares, and as a result the Company’s holdings in Eventer decreased to 44.52%.

 

On December 6, 2023, the Company signed a share purchase agreement with Keshet Holdings LP (“Keshet”) to purchase its entire stake in Eventer in consideration of USD 250 thousand which will be paid in the Company’s shares. The closing of the transaction occurred on August 28, 2024. Following this transaction, the Company’s holdings in Eventer increased to 58.44% of Eventer’s issued and outstanding common stock. The transaction was recorded as transaction with non-controlling interests in the Group’s consolidated statements of changes in shareholders equity for the year ended December 31, 2024.

 

Exchange agreement

 

On October 14, 2020, the Company entered into an exchange agreement with Eventer’s shareholders, pursuant to which, during the period commencing on the second anniversary of the exchange agreement and ending fifty-four (54) months following the date of the exchange agreement, Eventer’s shareholders may elect to exchange all of their Eventer shares for ordinary shares of the Company. The Company treated the exchange agreement at the date of the business combination from accounting perspective as recognition of noncontrolling interests, in addition to the recognition of a liability in respect of a derivative (exchange options) which will be measured at fair value at each cut-off date. The changes in the fair value at each cut-off date will be recorded as a financial income/expense.

 

As of December 31, 2024, and December 31, 2023, the Company concluded that the fair value of this derivative is immaterial.

 

For more information, see contingent liabilities section below.

 

F-41

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

D. Eventer (continued)

 

Loan agreements between Eventer and the Company

 

On October 14, 2020, the Company signed a revolving loan agreement with Eventer, according to which, the Company granted a loan to Eventer in the amount of USD 250 thousand. Additionally, in November 2021, the Company loaned an additional amount of USD 250 thousand. The loans will bear interest at a rate equal to the higher of (i) 4% per year, or (ii) the interest rate determined by the Israeli Income Tax Ordinance [New Version] 5721-1961 and the rules and regulation promulgated thereunder.

 

On October 30, 2022, the Company and Eventer signed an amendment pursuant to which the maturity date of the loans between Eventer and the Company was extended to May 30, 2024. In the event Eventer issues securities in consideration of at least USD 2 million or in the event of an IPO or rights offering (the “Investment”), the outstanding loans will automatically be converted into shares. The number of shares will be calculated by dividing the outstanding balance as of the closing date of the Investment by a price per share which shall reflect a 20% discount off the lowest price per share paid in the Investment.

 

As of the issuance date of these financial statements, the Company and Eventer are renegotiating the terms of the loan agreement.

 

Contingent liabilities

 

  a. On December 14, 2022, a motion to certify a class action suit was filed against Eventer and two of its directors, alleging the violation of the provisions of the Prohibition of Discrimination in Products, Services, and Entry into Places of Entertainment and Public Places Law. The plaintiff claims that Eventer enables the allocation of different kinds of tickets to different groups (such as women, children etc.), thereby allowing structured discrimination. According to the opinion of Eventer’s legal counsel. the likelihood of the class action being dismissed - both in regard to Eventer and its directors - is greater than not. A preliminary hearing was held on March 18, 2025. Following the hearing, the court granted the parties a 25-day period to engage in settlement discussions in an effort to reach a mutually agreeable resolution. Negotiations took place on March 24, 2025; however, no agreement was reached. Eventer’s legal representatives subsequently informed the court that the talks had failed. Eventer is currently awaiting the scheduling of a trial date.

 

  b. On April 1, 2024, a lawsuit seeking declaratory judgement was filed in the District Court of Tel Aviv-Jaffa in Israel by minority shareholders of Eventer against Eventer and the Company (together, the “Defendants”). The minority shareholders of Eventer (the “Plaintiffs”), hold in aggregate 31.86% of the outstanding ordinary shares of Eventer.

 

The Plaintiffs allege, among others, that the Defendants violated the agreement whereby the Company acquired control of Eventer (the “Purchase Agreement”), which established a “separation” mechanism, pursuant to which certain Plaintiffs were granted an option to convert their shares in Eventer into shares of the Company. The claim alleges that the Company has violated the terms of the Purchase Agreement by refusing to negotiate Eventer’s valuation to enable certain of the Plaintiffs to exercise their option to convert their shares of Eventer into shares of the Company. The Plaintiffs seek an aggregate of NIS 8,602 thousand from the Company as consideration for the Plaintiffs’ shares in Eventer or as an alternative remedy, to convert Eventer’s shares into the Company shares for an aggregate value of NIS 8,602 thousand (approximately USD 2,348 thousand) following which all the Plaintiffs shares in Eventer would be transferred to the Company.

 

2.In addition, certain of the Plaintiffs seek an aggregate of NIS 2,259 thousand from Eventer due to claims of breach of agreements (approximately USD 600 thousand).  

 

The Company submitted its response to the District Court of Tel Aviv – Jaffa and it intends to defend its position vigorously. As of the date of issuance of these financial statements, The Company estimates the chances of a court ruling or a settlement in which the Plaintiffs will be awarded a consideration for their Eventer shares that is materially in excess of their fair value is remote. Accordingly, no loss contingency has been recorded as of December 31, 2024. See also note 20.

 

F-42

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

D. Eventer (continued)

 

Agreement with Screenz Cross Media Ltd.

 

On February 4, 2021, Eventer signed an addendum to the agreement with Screenz Cross Media Ltd. (a company indirectly controlled and managed by Eli Uzan who served as Eventer’s Director) (hereafter “Screenz”). The agreement was signed during November 2020 for the purpose of collaborating in the field of virtual conferences.

 

In December 2021, March 2022 and December 2022, several amendments were signed between Eventer and Screenz in order to modify the terms of the agreement.

 

Following the last amendment in December 2022, it was determined that Screenz will have the first right to receive any money received by Eventer and resulting from a digital ticketing platform for interactive virtual events up to a total amount of USD 480 thousand. As of December 31, 2024, no revenues were generated by Eventer from interactive virtual events.

 

E. Jeffs’ Brands

 

General

 

As of December 31, 2023, the Company held 34.11% of the issued and outstanding share capital of Jeffs’ Brands Ltd. (“Jeffs’ Brands”).

 

On January 25, 2024, Jeffs’ Brands entered into a private placement transaction with certain institutional investors for aggregate gross proceeds of approximately USD 7,275 thousand.

 

The Company did not participate in the private placement and as a result its holdings in Jeffs’ Brands decreased to 13.37% of Jeffs’ Brands issued and outstanding share capital, which resulted in loss of control in Jeffs’ Brands as of January 28, 2024. Accordingly, Jeffs’ Brands was deconsolidated as of such date and the remaining holdings were accounted for as financial assets at fair value through profit or loss (FVTPL). As a result, the Company recorded a loss of USD 1,318 thousand in the interim condensed consolidated statements of loss and other comprehensive income.

 

Throughout the period between March 2024 and December 2024, warrants were exercised by certain institutional investors. As a result, as of December 31, 2024, the Company held 1.86% of the issued and outstanding share capital of Jeffs’ Brands.

 

Wellution Agreement

 

On February 23, 2023, Jeffs’ Brands and Jeffs’ Brands Holdings, entered into a stock purchase agreement (the “Wellution Agreement”), with SciSparc Ltd. (“SciSparc”), a related party of Jeffs’ Brands, pursuant to which, on March 22, 2023, Jeffs’ Brands Holdings acquired from SciSparc 49% of the issued and outstanding common of SciSparc Nutraceuticals Inc. (“SciSparc Nutraceuticals”), a wholly-owned subsidiary of SciSparc that owns and operates Wellution, an Amazon food supplements and cosmetics brand, for approximately USD 2,989 thousand in cash (“Purchase Price”).

 

F-43

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

E. Jeffs’ Brands (continued)

 

Wellution Agreement (continued) 

  

Jeffs’ Brands did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by IFRS 3, Business Combinations.

 

The Purchase Price and the transaction costs were allocated between the individual assets and liabilities of SciSparc Nutraceuticals based on their relative fair values at the date of the acquisition.

 

Jeffs’ Brands Holdings owns 49% of the voting rights in SciSparc Nutraceuticals and has the right to appoint two out of five directors. Management of Jeffs’ Brands has determined that it has significant influence over SciSparc Nutraceuticals and accordingly accounted for its investment under the equity method.

 

As of December 31, 2023, management of Jeffs’ Brands assessed whether there was objective evidence that its net investment in SciSparc Nutraceuticals was impaired. Management of Jeffs’ Brands determined that the decrease in revenues and operating losses of SciSparc Nutraceuticals were indicative of such objective evidence. Accordingly, Jeffs’ Brands management’s fair value expert performed an impairment test in accordance with IAS 36 and determined that the carrying value of the investment exceeded its recoverable amount. As a result, an impairment loss of USD 955 thousand was recorded within equity losses in the consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2023.

 

Fort share purchase agreement

 

On March 2, 2023, Jeffs’ Brands entered into a share purchase agreement (the “Fort SPA”), with the holders (the “Sellers”), of all of the issued and outstanding share capital of Fort Products Ltd. (“Fort”), a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through Amazon.uk, pursuant to which, on March 9, 2023, Jeffs’ Brands acquired all of the issued and outstanding share capital of Fort, for approximately £2,000 thousand (approximately USD 2,400 thousand) in cash (the “Fort Acquisition”). As of December 31, 2023, Jeffs’ Brands had an outstanding liability to the sellers of USD 332 thousand included in accrued expenses and other current liabilities in the consolidated statements of financial position.

 

On February 29, 2024, Jeffs’ Brands extended a side letter to the Fort SPA with the Sellers, pursuant to which, Jeffs’ Brands agreed to increase certain adjustment amount payments to the Sellers by approximately £100 thousand (approximately USD 128 thousand). These adjustments were included in the outstanding liability as of December 31 ,2023.

 

Jeffs’ Brands did not obtain any substantive processes, assembled workforce, or employees capable of producing outputs in connection with the acquisition. Therefore, the transaction was accounted for as an asset acquisition, as the acquired assets did not meet the definition of a business as defined by IFRS 3, Business Combinations.

 

The purchase price and the transaction costs were allocated between the individual assets and liabilities of Fort based on their relative fair values at the date of the acquisition.

 

F-44

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

E.Jeffs’ Brands (continued)

 

Initial Public Offering

 

On August 30, 2022, Jeffs’ Brands completed its initial public offering (“IPO”) on the NASDAQ. In connection with the IPO, Jeffs’ Brands issued ordinary shares and warrants (“IPO Warrants”) to purchase ordinary shares.

 

Jeffs’ Brands received total net proceeds of USD 13.4 million after deducting issuance costs of USD 2.1 million.

 

Following the IPO completion, the Company’s holdings in Jeffs’ Brands decreased to 35.94% of the issued and outstanding share capital of Jeffs’ Brands.

 

The IPO Warrants have a cashless exercise mechanism.

  

Additionally, additional warrants were issued to each qualified buyer who continued to hold at least 120,192 IPO Warrants as of November 28, 2022 (the “Additional Warrants”). Each Additional Warrant has substantially the same terms as the IPO Warrants.

 

Furthermore, so long as the Additional Warrants are outstanding, each Additional Warrant holder receives semi-annual payments equal to approximately 2.3% of Jeffs’ Brands gross revenues, calculated for the first and second six-month fiscal periods (“Other revenues Payment”).

 

The IPO Warrants and the Additional Warrants were accounted for as derivative liabilities measured at fair value through profit or loss (FVTPL) (see note 5).

 

F-45

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet

 

General

 

As of December 31, 2024, and December 31, 2023, the Company held 45.74% and 45.75% of the issued and outstanding share capital of Gix Internet, respectively.

 

Gix Internet is the parent of Viewbix Inc. a publicly traded company which is the majority shareholder of Gix Media Ltd. (“Gix Media”). Gix Media is the majority holder of Cortex Media Group Ltd. (“Cortex”), a digital advertising platform that develops and markets a variety of technological platforms that automate, optimize and monetize digital online campaigns. 

 

On January 5, 2025, Gix Internet entered into an agreement with a robotics company specializing in artificial intelligence autonomous robotics solutions, mainly for logistics distributions in certain medical centers, Delivers.AI Ltd. (“Delivers.AI”), and with all of Delivers.AI’s shareholders (the “Sellers”) (the “Delivers.AI Transaction”), pursuant to which Gix Interent will acquire all (100%) of the share capital of Delivers.AI from the Sellers, in exchange for the allocation of 25% of Gix Internet’s share capital to the Sellers and the allocation of 5% of Gix Internet’s share capital to the entrepreneur upon completion. Also, within the framework of the agreement, a number of milestones were determined. See note 21.

 

Financing Agreement with Gix Media

 

On October 13, 2021, Gix Media entered into a financing agreement with Bank Leumi Le Israel Ltd (“Bank Leumi”), an Israeli bank, for the provision of a line of credit in the total amount of up to USD 3,500 thousand and a long-term loan totaling USD 6,000 thousand (the “Financing Agreement”).

 

On July 25, 2022, Gix Media and Bank Leumi entered into an addendum to the Financing Agreement, according to which, Bank Leumi will provide Gix Media with a loan of USD 1,500 thousand, to be withdrawn at the discretion of Gix Media no later than January 31, 2023 (the “Additional Loan”).

 

On January 23, 2023, Gix Media acquired an additional 10% of Cortex’s capital shares increasing its holdings from 70% to 80% of Cortex's capital shares which was financed by Gix Media’s existing cash balances and by the Additional Loan received on January 17, 2023, in the amount of USD 1,500 thousand to be repaid in 42 monthly payments at an annual interest rate of SOFR + 5.37%.

 

On October 10, 2023, Gix Media and Bank Leumi entered into a second addendum to the Financing Agreement, according to which, Bank Leumi extended an existing monthly renewable credit line of USD 3,500 thousand (the “Gix Media Credit Line”) by one year which will expire on October 13, 2024. The amounts that are drawn from the Gix Media Credit Line bear an annual interest of SOFR + 4.05%.

 

F-46

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

On June 13, 2024, Gix Media and Bank Leumi entered into a third addendum to the Financing Agreement between the parties which was effective as of May 15, 2024, pursuant to which: (i) the addendum will be effective until August 31, 2024; (ii) Viewbix Inc. is obligated to transfer to Gix Media USD 600 thousand; (iii) a new covenant, measured by reference to positive EBTIDA was implemented; (iv) all payments due to Bank Leumi long-term bank loan were deferred to August 31, 2024 and from September 1, 2024, payments will be repaid as schedule until the end of the long-term bank loan; (v) a new USD 350 thousand loan was granted to Gix Media on June 13, 2024, to be repaid until August 30, 2024, alongside the existing credit facility to Gix Media, which remains equal to 80% of Gix Media’s customer balance; and (vi) Gix Media is obligated to perform a reduction in expenses, including reduction in force.

 

As of December 31, 2024, Gix Media has drawn USD 788 thousand of the Gix Media Credit Line.

 

On September 11, 2024, Gix Media and Bank Leumi entered into a fourth addendum to the Financing Agreement which was effective from August 30, 2024, pursuant to which, inter alia: (i) the addendum will be effective until February 27, 2025; (ii) Viewbix Inc. is obligated to transfer to Gix Media USD 2 million until December 31, 2024; (iii) all payments due to Bank Leumi long-term bank loan were deferred to December 31, 2024 and from January 1, 2025, all due payments will be repaid as schedule until the end of the long-term bank loan.

 

On September 16, 2024, Gix Media repaid an aggregate amount of USD 350 thousand, consisting of the short-term bank loan in the amount of USD 160 thousand and principal amounts of the long-term bank loans totaling USD 190 thousand. On the same date, Gix Media received a new short-term bank loan of USD 350 thousand which replaced the repaid amounts. The new loan bears an annual interest rate of SOFR + 4.60% and is to be repaid in one single payment on January 2, 2025.

 

On September 19, 2024, Gix Media received a short-term loan of USD 75 thousand. The loan bears an annual interest rate of SOFR + 4.60% and was repaid in monthly installments of USD 25 thousand over a 3-month period from October to December 2024.

 

On February 4, 2025, Gix Media and Bank Leumi entered into a fifth addendum to the Financing Agreement, which was effective from January 29, 2025, according to which, the Gix Media Credit Line will be extended until March 31, 2025 (see note 21.2).

 

On March 27, 2025, a primary traffic provider of Gix Media filed a petition against it in the District Court of Tel Aviv for an order to commence insolvency proceedings under the Insolvency and Economic Rehabilitation Law, 5778 – 2018. Due to the filing of the petition and in accordance with the loan terms, the banking corporation may demand immediate repayment of these loans. See also note 21.9.

 

On March 30, 2025, Gix Media and Bank Leumi entered into an additional addendum to the loan agreement, according to which the agreement will be extended from February 4, 2025, to April 30, 2025, with all other conditions remaining unchanged. See also note 21.10.

 

F-47

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

Cortex Credit Line

 

On September 21, 2022, Cortex and Bank Leumi entered into an addendum to an existing loan agreement (“Cortex Loan Agreement”) between the parties, dated August 15, 2021. As part of the addendum to the loan agreement, Bank Leumi provided Cortex with a monthly renewable credit line of USD 1,500 thousand (the “Cortex Credit Line”). The Cortex Credit Line is determined every month at the level of 70% of Cortex’s customers’ balance. The amounts that are drawn from the Cortex Credit Line bear an annual interest of SOFR + 3.52% (Overnight Financing Rate Secured, guaranteed daily interest as determined in accordance with the Federal Bank in New York).

 

On April 27, 2023, Bank Leumi increased the Cortex Credit Line by USD 1,000.

 

In September 2023, Cortex and Bank Leumi entered into an additional addendum to the Cortex Loan Agreement, in which Bank Leumi extended the Cortex Credit Line of USD 2,500 by one year which will expire on September 20, 2024. The amounts that are drawn from the Cortex Credit Line bear an annual interest of SOFR + 4.08%.

 

On May 27, 2024, Cortex and Bank Leumi entered into an amendment to Cortex Loan Agreement, pursuant to which, the credit facility to Cortex will be 80% of Cortex’s customer balance and up to USD 2,000 thousand.

 

On August 15, 2024, Cortex and Bank Leumi entered into an additional amendment to Cortex Loan Agreement, pursuant to which, the credit line in the amount of USD 2,000 thousand to Cortex will be extended until February 27, 2025 and bears an annual interest of SOFR + 4.35%. 

 

As of December 31, 2024, Cortex has drawn USD 830 thousand of the Cortex Credit Line.

 

On February 28, 2025, Cortex and Bank Leumi entered into an additional amendment to Cortex Loan Agreement (see note 21.3).

 

Loan agreement between the Company and Gix Internet

 

On October 13, 2021, the Company entered into a loan agreement with Gix Internet, pursuant to which, Gix Internet received an aggregate amount of USD 1,240 thousand (NIS 4,000 thousand) from the Company. The loan bears interest at a rate equivalent to the minimal interest rate recognized and attributed by the Israel Tax Authority (5.18% in 2024). According to the agreement, the loan will be repaid in full, together with the accrued interest, in one (1) instalment upon the earliest of: (i) the closing of a rights offering by Gix Internet for an aggregate amount of at least NIS 12,000 thousand (approximately USD 3,858 thousand); or (ii) June 30, 2022.

 

On August 25, 2022, the Company and Gix Internet signed an addendum to the loan agreement, effective as of July 1, 2022. The addendum changes the repayment terms of the loan in the amount of NIS 3 million (USD 810 thousand) to June 30, 2023. In addition, the Company will be entitled to request the conversion of all or part of the balance of the extended loan in exchange for Gix Internet’s shares.

 

On February 8, 2024, the Company and Gix Internet signed an addendum to the loan agreement, effective as of January 1, 2024. Pursuant to the addendum, the loan repayment will be postponed until July 1, 2024. In addition, the Company will be entitled to request conversion of all or part of the balance loan in the following events (1) a change in the Gix Internet’s main business or entry into a new field of activity; or (2) completion of a transaction merger or consolidation with or into another corporation.

 

On August 22, 2024, the Company and Gix Internet signed an addendum to the loan agreement, effective as of July 1, 2024. Pursuant to the addendum, the loan repayment will be postponed until December 31, 2024.

 

F-48

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

On October 6, 2024, the Company and Gix Internet signed an additional addendum to the loan agreement pursuant to which, the loan amount will increase by additional NIS 150 thousand.

 

The Company concluded that the modified loan terms during 2024 do not represent a substantial modification in accordance with IFRS 9.

 

On January 26, 2025, the Company and Gix Internet signed an addendum to the loan agreement, effective as of December 31, 2024. Pursuant to the addendum, the loan repayment will be postponed until April 30, 2025, and the loan amount will increase in an additional NIS 150 thousand.

 

Loan agreement between the Company and Viewbix Ltd.

 

On November 15, 2023, the Company (along with several lenders) signed a loan agreement with Viewbix Ltd., a wholly owned subsidiary of Viewbix Inc., in an aggregate amount of USD 480 thousand. The Company’s portion in this loan was USD 200 thousand (the “2023 Loan”).

 

In connection with the 2023 Loan, Viewbix Inc. issued to each lender a warrant to purchase shares of common stock (the “2023 Warrants”). The 2023 Warrants are exercisable to 120,000 shares of common stock, at an exercise price of USD 2 per share and will expire and cease to be exercisable on December 31, 2025.

 

The terms of the 2023 Loan were substantially amended on June 18, 2024, by the June 2024 Facility Agreement (see below). These amendments represent a substantial modification in accordance with IFRS 9. Accordingly, the terms modification was accounted for as an extinguishment of the original financial liability and the initial recognition of new financial instruments issued at their fair value as of the effective date of the June 2024 Facility Agreement.

 

As a result of the substantial modification of terms, the Group recognized a finance expense of USD 81 thousand and USD 1,833 thousand was recognized as a loss in connection with issuance of warrants in its consolidated statement of loss and other comprehensive income for the year ended December 31, 2024.

 

F-49

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

June 2024 Facility Agreement

 

On June 18, 2024, Viewbix Inc. entered into a credit facility agreement with a group of lenders including a lead lender (the “June 2024 Lead Lender”, and collectively, the “June 2024 Lenders”) for an amount of up to USD 1 million which was amended and restated on July 22, 2024 (the “June 2024 Facility Agreement”). The June 2024 Facility Agreement also includes USD 531 of outstanding debt owed by Viewbix Inc. to the June 2024 Lenders of the 2023 Loan (see above), such that the total amount of the credit line reached USD 1.53 million (the “Total Credit Facility Amount”). The Total Credit Facility Amount will be due for repayment following 12 months from the date of the June 2024 Facility Agreement (the “Initial Maturity Date”) or alternatively, in the event the completion of an uplisting of Viewbix Inc. shares of common stock to a national securities exchange (the “Uplist”) prior to the Initial Maturity Date, then the Total Credit Facility Amount will be due for repayment following 12 months from the Uplist date. The Total Credit Facility Amount will be available for use as follows: (a) USD 350 thousand upon the date of the June 2024 Facility Agreement, (b) USD 150 thousand upon submitting a prospectus for the registration of shares to be issued to the June 2024 Lenders, and (c) USD 500 thousand upon the completion of the Uplist.

 

The Total Credit Facility Amount will accrue interest at a rate of 12% per annum, to be paid in advance.

 

The interest for the first year of the June 2024 Facility Agreement, which was equal to USD 184 thousand, was paid by Viewbix Inc. in advance in: (a) 183,679 shares of Viewbix Inc. common stock, reflecting a value of USD 1.00 per share for each dollar of interest accrued on the Total Credit Facility Amount, and (b) 183,679 warrants to purchase 183,679 shares of Viewbix Inc, common stock at an exercise price of USD 1.00 per share. The warrants will be exercisable for a three-year period from the date of the June 2024 Facility Agreement.

 

Immediately following the effectiveness of the Uplist, USD 663 thousand of the Total Credit Facility Amount will be automatically converted into units, which will include shares of common stock at a conversion rate of USD 1.00 per share, equal to an aggregate of 662,957 shares of common stock and the same amount of warrants to purchase common stock of Viewbix Inc. with an exercise price of USD 1.00 per share. The warrants will be exercisable for a three-year period from the Uplist date.

 

During the term of the June 2024 Facility Agreement, some of the June 2024 Lenders whose portion of the Total Credit Facility Amount is not automatically converted as part of the Uplist will have the right to convert their portion of the Total Credit Facility Amount within 12 months from the Uplist date into units, which will include shares of common stock of Viewbix Inc. at a conversion rate of USD 1.00 per share, equal to an aggregate of up to 362,004 shares of common stock and the same amount of warrants to purchase common stock of Viewbix Inc. with an exercise price of USD 1.00 per share. The warrants will be exercisable for a three-year period from the issuance date.

 

In addition, Viewbix Inc. paid to the June 2024 Lead Lender a commission consisting of: (a) 50,000 common stock of Viewbix Inc., (b) 50,000 warrants to purchase 50,000 common stock of Viewbix Inc. at an exercise price of USD 1.00 per share (c) 625,000 warrants for the purchase of 625,000 common stock with an exercise price of USD 4.00 per share (“June 2024 Lead Lender Fee Warrants”). The June 2024 Lead Lender Fee Warrants will be exercisable for a three-year period from the date of the June 2024 Facility Agreement.

 

F-50

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

In July 2024, following the closing of the Private Placement (as defined below), the exercise price of the June 2024 Lead Lender Fee Warrants was adjusted to USD 0.472, which is equal to the effective price per share of common stock in the Private Placement, and the number of shares of common stock issuable upon the exercise of the June 2024 Lead Lender Fee Warrants was also adjusted to a total of 5,296,610 shares, such that the adjusted exercise price and number of warrants issued is equal to an aggregate amount of USD 2.5 million.

 

The conversion related features of the June 2024 Facility Agreement were bifurcated from their host debt contract and recognized as liabilities measured at fair value at each cut-off date. The facility loan was initially recorded at its fair value and subsequently measured at cost. The shares and Warrants A issued as prepayment of interest and as commission to the June 2024 Lead Lender were initially recognized at fair value and classified as a liability measured at fair value at each cut-off date (see note 5).

 

The June 2024 Lead Lender Fee Warrants were initially recognized in fair value at the amount of USD 1,833 and classified as a liability measured at fair value at each cut-off date. As of December 31, 2024, the fair value was USD 2,340.

 

Following the June 2024 Facility Agreement, Gix Internet’s holdings in Viewbix Inc. decreased from 76% to 71.11%. The transaction was recorded as a transaction with non-controlling interests in the Group’s consolidated statements of changes in shareholders equity for the year ended December 31, 2024.

 

Private Placement

 

On July 3, 2024, Viewbix Inc. entered into a definitive securities purchase agreement with a certain investor (the “Lead Investor”) for the purchase and sale in a private placement (the “Private Placement”) of units consisting of (i) 256,875 shares of Viewbix Inc. common stock at a purchase price of USD 1.00 per share and (ii) 385,332 warrants to purchase 385,332 shares of Viewbix Inc. common stock (the “PIPE Warrants”) to the Lead Investor and other investors acceptable to the Lead Investor and the Company. The PIPE Warrants are exercisable upon issuance at an exercise price of USD 1.00 per share and have a three-year term from the issuance date. In addition, the PIPE Warrants are subject to an automatic exercise provision in the event that Viewbix Inc. shares of common stock are approved for listing on the Nasdaq Capital Market.

 

The aggregate gross proceeds received by Viewbix Inc. from the Private Placement were USD 257 thousand, of which USD 237 thousand received in June 2024 and the USD 20 thousand remaining received in July 2024.

 

Upon the closing of the Private Placement, Viewbix Inc. agreed to pay the Lead Investor: (1) USD 10 thousand for actual and documented fees and expenses incurred and, (2) a commission consisting of (i) a cash fee of USD 13 thousand and (ii) 12,844 shares of Viewbix Inc. common stock.

 

In July 2024, Viewbix Inc. issued 269,719 shares of common stock and 385,332 warrants in connection with the Private Placement. Viewbix Inc. incurred share issuance costs of USD 65 thousand ( USD 59 thousand in cash and USD 6 thousand in shares of common stock).

 

Following the Private Placement, Gix Internet’s holdings in Viewbix Inc. decreased from 71.11% to 66.58%. The transaction was recorded as a transaction with non-controlling interests in the Group’s consolidated statements of changes in shareholders equity for the year ended December 31, 2024.

 

F-51

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

First July 2024 Facility Agreement 

 

On July 4, 2024, Viewbix Inc. entered into a credit line agreement with a certain lender (the “First July 2024 Facility Agreement”). Under the First July 2024 Facility Agreement and amendments from July 22, 2024, and July 25, 2024, the lender will provide a total credit line of USD 2.5 million (the “First July 2024 Facility Loan Amount”), which will be available for use as follows: (a) USD 50 thousand upon the date of the First July 2024 Facility Agreement, (b) USD 50 thousand upon the Uplist, and (c) after the Uplist, USD 200 thousand will be available for use on a quarterly basis until the total amount reaches USD 2.5 million.

 

The First July 2024 Facility Agreement will remain available until the earliest of: (a)(1) full utilization of the First July 2024 Facility Loan Amount, (a)(2) after 36 months from the date of the First July 2024 Facility Agreement, and (b) upon such date that Viewbix Inc. completes a USD 2.0 million financing transaction (the “First July 2024 Facility Term”). In the event the First July 2024 Facility Term lapses, the First July 2024 Facility Loan Amount will be repaid to the lender immediately.

 

The First July 2024 Facility Agreement Amount will accrue interest at a rate of 12% per annum. The interest for the first year was paid in advance in: (a) 300,000 shares of Viewbix Inc. common stock at a conversion rate of USD 1.00 for each dollar of interest accrued on the total amount, and (b) 300,000 warrants to purchase 300,000 shares of Viewbix Inc. common stock an exercise price of USD 1.00 per share. The warrants are exercisable upon issuance at an exercise price of USD 1.00 per share of common stock and will be exercisable for a three-year period from the date of the First July 2024 Facility Agreement.

 

Immediately after the Uplist, USD 100 thousand from the First July 2024 Facility Loan Amount will be automatically converted into common stock of Viewbix Inc. at an exercise price of USD 1.00 per share. Additionally, Viewbix Inc. will issue an identical number of warrants to purchase common stock of Viewbix Inc. at an exercise price of USD 1.00 per share.

 

Furthermore, Viewbix Inc. paid the lender of the First July 2024 Facility Agreement a one-time fee consisting of: (a) 125,000 common stock of Viewbix Inc., which representing a fee of five percent (5%) of the First July 2024 Facility Loan Amount, at a share price of $1.00 per share, and (b) 250,000 warrants to purchase 250,000 common stock of Viewbix Inc. at an exercise price of USD 1.00 per share. The warrants will be exercisable for three years from the date of the First July 2024 Facility Agreement.

 

In connection with the First July 2024 Facility Agreement, Viewbix Inc. received a loan of USD 50 thousand which was recorded as a short-term convertible loan. The fair value of this loan was substantially the same as the amount received.

 

As of December 31, 2024, Viewbix Inc. incurred deferred debt issuance costs of USD 315 thousand which were recorded in other current assets in the Group’s consolidated statements of financial position for the year ended December 31, 2024. These costs consisted of a one-time fee to the lender of the First July 2024 Facility Agreement, an annual advance interest payment and other additional direct costs.

 

Following the First July 2024 Facility Agreement, Gix Internet’s holdings in Viewbix Inc. decreased from 66.58% to 60.50%. The transaction was recorded as a transaction with non-controlling interests in the Group’s consolidated statements of changes in shareholders equity for the year ended December 31, 2024.

 

F-52

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

Second July 2024 Facility Agreement

 

On July 28, 2024, Viewbix Inc. entered into a credit line agreement with certain lenders (the “Second July 2024 Facility Agreement”) for a total amount of USD 3 million (the “Second July 2024 Facility Loan Amount”).

 

The Second July 2024 Facility Agreement will remain available until the earliest of: (a) (1) full utilization of the Second July 2024 Facility Loan Amount, (a)(2) after 40 months from the date of Second July 2024 Facility Agreement, and (b) upon such date that Viewbix Inc. completes a USD 2.5 million financing transaction.

 

The Second July 2024 Facility Loan Amount will accrue interest at a rate of 12% per annum. The interest for the first year was paid in advance in: (a) 360,000 shares of Viewbix Inc. common stock, reflecting a share price of USD 1.00 per share for each dollar of interest accrued on the total amount, and (b) 360,000 warrants to purchase 360,000 common stock of Viewbix Inc. at an exercise price of USD 1.00 per share. The warrants are exercisable for three years from the date of Second July 2024 Facility Agreement. Starting from the second year of the Second July 2024 Facility Agreement, the interest will be paid in cash to the lenders.

 

Immediately after the Uplist, USD 160 thousand out of the Second July 2024 Facility Loan Amount will be automatically converted into common stock of Viewbix Inc. at an exercise price of USD 1.00 per share. Additionally, Viewbix Inc. will issue an identical number of warrants to purchase common stock of Viewbix Inc. at an exercise price of USD 1.00 per share.

 

Furthermore, Viewbix Inc. paid the lenders of the Second July 2024 Facility Agreement a one-time fee consisting of 150,000 common stock of Viewbix Inc., which representing a fee of five percent (5%) of the Second July 2024 Facility Loan Amount at a share price of USD 1.00 per share.

 

In connection with the Second July 2024 Facility Agreement, Viewbix Inc. received a loan of USD 80 thousand which was recorded as a short-term convertible loan. The fair value of this loan was substantially the same as the amount received.

 

As of December 31, 2024, Viewbix Inc. incurred deferred debt issuance costs of USD 302 thousand which were recorded in other current assets in the Group’s consolidated statements of financial position for the year ended December 31, 2024. These costs consisted of a one-time fee to the lenders of the Second July 2024 Facility Agreement, an annual advance interest payment and other additional direct costs.

 

Following the Second July 2024 Facility Agreement, Gix Internet’s holdings in Viewbix Inc. decreased from 60.50% to 54.53%. The transaction was recorded as a transaction with non-controlling interests in the Group’s consolidated statements of changes in shareholders equity for the year ended December 31, 2024.

 

Reverse Stock Split

 

On July 15, 2024, Viewbix Inc. filed an amendment to its Certificate of Incorporation to affect a 1-for-4 reverse stock split of Viewbix Inc. Common Stock (the “Reverse Stock Split”). The Reverse Stock Split became effective on March 14, 2025, following the process and announcement by Financial Industry Regulatory Authority, Inc. (“FINRA”).

 

F-53

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

F.Gix Internet (continued)

 

Securities Exchange Agreement with Metagramm

 

On  March 24, 2025, Viewbix Inc. entered into a securities exchange agreement (the “Agreement”) with Metagramm Software Ltd., an Israeli company (“Metagramm”), and all of the shareholders of Metagramm (the “Metagramm Shareholders”), pursuant to which Viewbix issued the Metagramm Shareholders an aggregate of 19.99% of its issued and outstanding capital stock on a pro rata and post-closing basis, equal to 1,323,000 shares of Viewbix’s common stock, in exchange for 100% of Metagramm’s issued and outstanding share capital on a fully diluted and post-closing basis, equal to 718,520 Metagramm ordinary shares (the “Acquisition”). The Acquisition was completed on March 24, 2025, and resulted in Metagramm becoming a wholly owned subsidiary of Viewbix.

 

Viewbix also agreed to pay the Metagramm Shareholders cash earn-out payments of up to an aggregate sum of USD 2 million on a pro rata basis upon the achievement of certain financing and revenue milestones during the three-year period following the closing date of the transactions contemplated by the Agreement.

 

Consultants Agreements

 

On July 14, 2024, and July 25, 2024, Viewbix Inc. entered into consulting agreements with certain consultants (the “Consultants”) pursuant to which the Consultants agreed to provide certain services to Viewbix Inc. in connection with the Uplist. In consideration with the Consultants’ services, Viewbix Inc. issued to the Consultants 120,000 shares of common stock in July 2024. Viewbix Inc. recorded a share-based compensation expense of USD 57 thousand in connection with the issuance of shares to the Consultants.

 

Following the shares issuance to the Consultants, Gix Internet’s holdings in Viewbix Inc. decreased to 53.30%.

 

Share Option Plan

 

On March 2, 2023, the Board of Directors of Viewbix Inc. approved the adoption of the 2023 stock incentive plan (the “2023 Plan”). The 2023 Plan permits the issuance of up to (i) 625,000 shares of Common Stock, plus (ii) an annual increase equal to the lesser of (A) 5% of Viewbix Inc.’s outstanding capital stock on the last day of the immediately preceding calendar year; and (B) such smaller amount as determined by the Board of Directors, provided that no more than 625,000 shares of common stock may be issued upon the exercise of incentive stock options. If any outstanding awards expire, are canceled or are forfeited, the underlying shares would be available for future grants under the 2023 Plan. As of the date of approval of the financial statements, Viewbix Inc. had reserved 625,000 shares of common stock for issuance under the 2023 Plan.

 

On July 20, 2023, Viewbix Inc. granted 12,756 restricted share units (the “RSUs”) under the 2023 Plan to Gix Media’s CEO, as part of his employment terms, (the “Grantee”) under the following terms and conditions: (1) 12,756 of Common Stock underlying the grant of RSUs (2) Vesting Commencement Date: July 1, 2023 (3) vesting schedule: 50% of the RSUs will vest immediately upon the Vesting Commencement Date (the “First Tranche”) and the remaining 50% of the RSUs will vest 12 months after the Vesting Commencement Date (the “Second Tranche”), provided, in each case, that the Grantee remains continuously as a Service Provider (as defined under the 2023 Plan) of Gix Media or its affiliates throughout each such vesting date (the “Grant”).

 

On July 1, 2023, upon the vesting of the First Tranche, Viewbix Inc. issued 6,378 shares of Common Stock to the Grantee. On July 1, 2024, upon the vesting of the Second Tranche, Viewbix Inc issued 6,378 shares of Common Stock to the Grantee.

 

As of December 31, 2024, and December 31, 2023, the Group recorded a share-based compensation expense in general and administrative expenses of USD 38 thousand and USD 12 thousand, respectively, in connection with the Grant.

 

F-54

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

G.Zig Miami 54

 

On September 13, 2023, the Company signed an operating agreement with Zig Investment Group LLC (“Zig Investment Group”), a Florida limited liability company, pursuant to which they formed a company, under the name Zig Miami 54 LLC (“Zig Miami 54”), a Florida limited liability company. The purpose of Zig Miami 54 is to acquire, improve, renovate, develop, manage, sell and otherwise deal with a commercial property located in Miami, Florida. The rights of Zig Miami 54 are exercised by Zig Investment Group, and the business and affairs of Zig Miami 54 are managed under the direction of Zig Investment Group (the “Manager”).

 

Under the terms of the agreement, the Company invested an amount of USD 2,000 thousand (the “Initial Capital Contribution”) in consideration of 60% of the issued and outstanding share capital of Zig Miami 54. The remaining 40% were allocated, without consideration, to Zig Investment Group.

 

In addition, Zig Miami 54 is entitled to receive a loan from the seller of the property (“Seller Loan”) in the amount of up to USD 1,500 thousand which is secured by a first lien on the property.

 

Additionally, under the terms of the agreement, commencing upon completion of phase I of the renovation work, the Manager shall distribute net cash from operations, with respect to each calendar quarter, during the next succeeding calendar quarter, or more frequently as determined by the Manager. All distributions of net cash from operations and net cash from capital transactions, including refinancing the existing Seller Loan, shall be made in the following order: (i) one hundred percent (100%) to repay all debts, regular operating expenses and obligations of Zig Miami 54, including the current periodic installments of principal and interest due on the Seller Loan; (ii) one hundred percent (100%) to the Company until the Company has received a return of one hundred percent (100%) of its Initial Capital Contribution; (iii) one hundred percent (100%) to Zig Investment Group to repay all cost overruns incurred by Zig Investment Group, if any, up to the maximum amount of USD 180 thousand; and (iv) pro rata to the Company and Zig Investment Group in accordance with their percentage interests.

 

Moreover, upon such time that the Company has received a distribution of one hundred percent (100%) of its Initial Capital Contribution, the Manager shall cause Zig Miami 54 to redeem from the Company, without any further consent or action of the Company, fifty percent (50%) of the Company’s interests in Zig Miami 54, equaling a thirty percent (30%) percentage interest in Zig Miami 54 and to, thereafter, issue to Zig Investment Group, additional interests in Zig Miami 54 equaling a thirty percent (30%) interest in Zig Miami 54. Following such redemption and issuance, Zig Investment Group will hold a seventy percent (70%) interest in Zig Miami 54 and the Company will hold a thirty percent (30%) interest in Zig Miami 54.

 

The closing of the agreement was on December 15, 2023 (the “Closing”). Following the Closing, Zig Miami 54 acquired the commercial property for an aggregate amount of USD 2,250 thousand and received a Seller Loan in the amount of USD 1,350 thousand.

 

The Initial Capital Contribution includes a loan and an investment. The Initial Capital Contribution was first allocated to the loan based on its fair value at the date of the Closing in an amount of USD 1,545 thousand (the “Loan”) with the residual of the Initial Capital Contribution in an amount of USD 455 thousand allocated to the investment (“Investment Purchase Price”).

 

The Loan is subsequently measured at fair value through profit or loss (FVTPL). As of December 31, 2024, and December 31, 2023, the fair value of the Loan was USD 1,756 thousand and USD 1,533 thousand, respectively.

 

F-55

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

G.Zig Miami 54 (continued)

 

The activity in the investment in Zig Miami 54 account was as follows:

 

   Year ended
December 31,
2024
 
   USD
in thousands
 
Balance as of January 1, 2024   370 
Loss for the year   (102)
Balance as of December 31, 2024   268 

 

   December 15,
2023 –
December 31,
2023
 
   USD
in thousands
 
Balance as of January 1, 2023   
-
 
Investment Purchase Price   455 
Loss for the period   (85)
Balance as of December 31, 2023   370 

 

F-56

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

H.Polyrizon

 

Investment in shares

 

As of December 31, 2023, the Company held 38.76% of the issued and outstanding share capital of Polyrizon and the investment was accounted for using the equity method.

 

On May 12, 2024, the Company and other investors converted loans into shares of Polyrizon. As a result, the Company’s holdings in Polyrizon decreased to 38.31% of the issued and outstanding share capital of Polyrizon.

 

On July 2, 2024, the Company signed a sales agreement to sell a portion of its stake of 762,046 shares in Polyrizon for total proceeds of approximately USD 340 thousand. As a result, the Company’s holdings in Polyrizon were diluted from 38.31% to 9.75% of the issued and outstanding share capital of Polyrizon and the remaining holding was accounted for as investment at fair value through profit or loss (FVTPL). As a result of the transition, the Company recognized a loss of USD 12 thousand.

 

On October 30, 2024, Polyrizon completed its Initial Public Offering (“IPO”) on the NASDAQ under the symbol PLRZ. The IPO raised a total of USD 4.2 million. The Company did not participate in the IPO and as a result the Company’s holdings in Polyrizon decreased to 7.5% of the issued and outstanding share capital of Polyrizon.

 

Between October and December 2024, the Company sold 222,305 shares of Polyrizon for total proceeds of approximately USD 388 thousand and as a result the Company’s holdings in Polyrizon decreased to 3.48% of the issued and outstanding share capital of Polyrizon.

 

As of December 31, 2024, the Company held 3.48% of the issued and outstanding share capital of Polyrizon.

 

Investment in options

 

In July 2020, the Company was granted an option (the “Original Option”) to invest an additional amount of up to USD 1 million in consideration for 3,107,223 shares of Polyrizon. The Original Option was exercisable until the earlier of (i) April 23, 2023, or (ii) the consummation by Polyrizon of equity financing of at least USD 500 thousand based on a pre-money valuation of at least USD 10 million. The Original Option was terminated on April 23, 2023.

 

On December 15, 2021, the Company was granted a new option (the “Alternative Option”) to invest an amount of USD 2 million in Polyrizon at a price per share equal to 125% the price per share at Polyrizon’s IPO (as defined below). The Alternative option is exercisable for a period of 3 years following the closing of Polyrizon’s initial public offering (“Polyrizon’s IPO”). On November 21, 2023, the Company signed an amendment to the share purchase agreement according to which, the Alternative Option will be exercisable upon a completion of listing Polyrizon’s ordinary shares for trading on the NASDAQ, whether via an initial public offering, merger, or by any other listing, provided however, that such listing takes place on or prior to December 31, 2024.

 

On May 7, 2024, the Company signed an amendment to the share purchase agreement according to which, the Alternative Option will be exercisable, upon successful completion of an initial public offering, into 459,770 ordinary shares of Polyrizon at an exercise price of USD 4.35 per share. The amendment further included a customary down round protection feature for the exercise price. The other material terms of the agreement, including the three-year term of the Alternative Option, as amended, from the date of completion of an initial public offering, did not change.

 

As of December 31, 2024, the fair value of the Alternative Option was USD 451 thousand and as of December 31, 2023, the fair value of the Alternative Option was USD 105 thousand, See note 5.

 

F-57

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

I.Charging Robotics Ltd.

 

Charging Robotics Ltd. is a company operating in the electric vehicle and wireless charging sector. Charging Robotics Ltd. was formed as a wholly owned subsidiary of the Company on February 1, 2021.

 

On February 19, 2021, the Company entered into the venture agreement, with Mr. Amir Zaid and Mr. Weijian Zhou (the founders of Emuze Ltd., a privately held company that designs and develops electric mobility micro vehicles), and Charging Robotics Ltd. (the “Venture Agreement”), under which the Company formed a venture, under the name Revoltz Ltd. (“Revoltz”), to develop and commercialize three modular electric vehicle (“EV”) micro mobility vehicles for urban individual use and “last mile” cargo delivery.

 

Under the terms of the Venture Agreement, the Company invested an amount of USD 250 thousand in consideration of 19,990 ordinary shares of Revoltz, representing 19.99% of Revoltz’s issued and outstanding share capital on a fully diluted basis. The Venture Agreement requires the Company to invest an additional USD 400 thousand in a second tranche, subject to Revoltz achieving certain post-closing milestones, for 37.5% of Revoltz’s issued and outstanding share capital. As of December 31, 2024, the milestones were not achieved, therefore no additional investments occurred. The investment in Revoltz was accounted for using the equity method. The additional investment requirement was accounted for as a derivative liability measured at fair value through profit or loss. As of December 31, 2024, the fair value of the derivative liability was concluded to be immaterial.

 

On July 28, 2022, Charging Robotics Ltd. entered into a convertible loan agreement with Revoltz pursuant to which Charging Robotics invested an amount of USD 60 thousand in Revoltz (the “Loan Principal Amount”). In addition, Charging Robotics Ltd. is entitled to provide Revoltz an additional loan of up to USD 340 thousand, at its sole discretion upon Revoltz’ request (the “Additional Amount”, and together with the Loan Principal Amount, the “Total Loan Amount”). The Total Loan Amount shall carry interest at the minimum rate prescribed by Israeli law. The Loan Principal Amount was accounted for as a financial asset at fair value through profit or loss (FVTPL). The fair value of the loan as of December 31, 2024, was USD 64 thousand.

 

On March 28, 2023, the Company signed a securities exchange agreement with Charging Robotics Inc. to sell all its shares in Charging Robotics Ltd. to Charging Robotics Inc. See note 4K.

 

F-58

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

J.SciSparc Ltd. and Buffalo

 

SciSparc Ltd, is a company formed under the laws of the State of Israel. SciSparc Ltd. listed its American Depository Shares on the OTCQB until December 7, 2021, after which SciSparc Ltd. uplisted to the NASDAQ.

 

Buffalo Investments Ltd. (“Buffalo”), an Israeli private company, owned 150,000 options to purchase 150,000 shares of SciSparc at an exercise price of USD 5.02 per share. On December 7, 2021, the Company entered into an option purchase agreement with Buffalo (the “Buffalo Agreement”) for the purchase of the 150,000 options in consideration for USD 0.72 per option. The Company paid USD 72 thousand in this transaction. Additionally, the Company was obligated to immediately exercise all such options into shares and the Company paid SciSparc an additional USD 753 thousand in this transaction. According to the Buffalo Agreement, Buffalo undertook to purchase 85% of the shares back from the Company within 3 months following the Buffalo Agreement (the “Purchase Period”) in consideration for USD 6.05 per share and for a total consideration of USD 771 thousand.

 

In April 2022, the Buffalo Agreement was amended such that the Company extended the Purchase Period until June 7, 2022.

 

On June 30, 2022, the Buffalo Agreement was amended such that the Company extended the Purchase Period until December 31, 2022, and Buffalo undertook to purchase 90% of the shares back from the Company in consideration for USD 6.05 per share and for a total consideration of USD 817 thousand.

 

On March 16, 2023, the Company signed an amendment to the Buffalo Agreement (the “Amendment”).

 

According to the Amendment, instead of purchasing 90% of the shares back from the Company for a total consideration of USD 817 thousand, which was originally agreed under the Buffalo Agreement, Buffalo will transfer to the Company, without any consideration, 309,000 shares of Hydreight Technologies Inc., 77,980 shares of Viewbix Inc., 84,000 shares of SciSparc, 36,000 shares of Clearmind Medicine Inc. and 31,250 shares of Colugo Systems Ltd. with an aggregate value of USD 937 thousand, reflecting a compensation of USD 120 thousand.

 

As a result, on March 16, 2023, the Company recorded an amount of USD 937 thousand within other receivables and derecognized the forward contract asset in the amount of USD 577 thousand. The difference between the value of the shares to be transferred under the Amendment (USD 937 thousand) and the value of the forward contract asset (USD 577 thousand) was recorded in profit and loss in the consolidated statement of income/loss and other comprehensive income/loss.

 

As of December 31, 2024, the Company received 84,000 shares of SciSparc, 307,000 shares of Hydreight Technologies Inc., 36,000 shares of Clearmind Medicine Inc. and 77,980 shares of Viewbix Inc. The investments were accounted for as investments at fair value through profit or loss (FVTPL).

 

As of December 31, 2024, Colugo Systems’ Ltd. shares were not received. As such, they were recorded within other receivables in the consolidated statements of financial position as of December 31, 2024, in an amount of USD 500 thousand representing their fair value, See note 5. The delay in receiving the Colugo Shares was due to the structure of Colugo Systems Ltd.’s articles of association. The expectation for receiving the Colugo shares is after obtaining approval from all shareholders of Colugo Systems Ltd. to update relevant sections in Colugo Systems Ltd.’s articles of association.

 

F-59

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

K.Charging Robotics Inc.

 

On December 21, 2021, the Company purchased 90,000,000 shares of Charging Robotics Inc., which represented 35.06% of the issued and outstanding shares of Charging Robotics Inc. for a total consideration of USD 263 thousand.

 

On March 28, 2023, the Company signed a securities exchange agreement with Charging Robotics Inc. to sell all its shares in Charging Robotics Ltd. to Charging Robotics Inc. in exchange for 827,543,253 newly issued shares of Charging Robotics’ Inc. common stock equal to 76.25% of the total number of shares of Charging Robitcs’ Inc. common stock issued and outstanding as of April 7, 2023 (the “Closing”) on a fully diluted basis. In the financial statements of Charging Robotics Inc., the share exchange was accounted for as a reverse acquisition where Charging Robotics Ltd. was identified as the accounting acquirer. The financial statements of Charging Robotics Inc. are consolidated in these financial statements from the Closing date.

 

As of December 31, 2023, the Company held 67% of Charging Robotics’ Inc. issued and outstanding share capital. 

 

In December 2024, Charging Robotics Inc. issued 412,123 shares for a total of USD 410 thousand. The transaction was recorded as a transaction with non-controlling interests in the Group’s consolidated statements of changes in shareholders equity for the year ended December 31, 2024. The company did not participated in this investment.

 

As of December 31, 2024, the Company held 63.75% of Charging Robotics’ Inc. issued and outstanding share capital. 

 

L.Parazero

  

Investment in shares and SAFE

  

Parazero is a company that specializes in the design, development, manufacturing, distribution and sales of safety systems for commercial drones. Parazero’s technology enables real-time identification of critical failures of drones, and upon detection of an emergency, a parachute is autonomously deployed in fractions of a second, thus ensuring safe landings at all times. Parazero sells its products internationally with a focus on the U.S. market.

 

As of December 31, 2022, the Company held 40.35% of the issued and outstanding shares of Parazero. The investment was accounted for as an equity investment.

 

In addition, in February, March and May 2022, Parazero entered into several SAFEs under which Parazero received USD 1,500 thousand. The Company invested USD 521 thousand through these SAFEs.

 

The Company’s investments in Parazero SAFEs were accounted for as financial assets at fair value through profit or loss (FVTPL). The Company concluded that there were no material differences between the cost and the fair value of the SAFEs.

 

F-60

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

L.Parazero (continued)

 

Investment in shares and SAFE (continued)

 

On July 31, 2023, Parazero completed its initial public offering (“IPO”) on the NASDAQ for aggregated gross proceeds of approximately USD 7.8 million before deducting underwriting discounts and other estimated offering expenses. The Company participated in the IPO in an amount of USD 1.5 million and converted all of the SAFEs into ordinary shares. Following the IPO and the conversion of the SAFEs, the Company’s holdings in Parazero decreased to 33.36%. As a result, the Company recognized a gain of USD 466 thousand withing equity losses in the consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2023.

  

On October 30, 2023, Parazero completed a private placement of USD 5.1 million. The Company did not participate in this private placement and the Company’s holdings in Parazero decreased to 20.04% and starting from that date the investment was accounted for as investment at fair value through profit or loss (FVTPL). As a result of the transition, the Company recognized a gain of USD 714 thousand in the consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2023.

 

During November and December 2024, the Company sold 1,288,968 shares of Parazero for total proceeds of approximately USD 2,292 thousand and as a result the Company’s holdings in Parazero decreased to 5.7% of the issued and outstanding share capital of Parazero.

 

As of December 31, 2024, the Company held 5.7% of the issued and outstanding share capital of Parazero.

  

Credit facility agreement

 

On October 30, 2022, the Company signed a credit facility agreement with Parazero in the aggregated amount of up to USD 625 thousand. The credit facility agreement does not bear interest and will be repaid on the earlier of: (i) first anniversary date (ii) the closing of an IPO (iii) default event. The credit facility was accounted for as financial assets measured at amortized cost.

 

In June 2023, the Company signed an amendment to the credit facility agreement for an additional USD 125 thousand.

  

Following the completion of the IPO on July 31, 2023, the credit facility was fully repaid.

 

Management agreement with the Company

 

On October 30, 2022, the Company signed a service agreement with Parazero, effective upon completion of the IPO on July 31, 2023.

 

According to the service agreement, Parazero will pay the Company a monthly fee of USD 10 thousand for business development and ongoing consulting services. During the year ended December 31, 2024 and 2023, the Company recognized an income of USD 120 thousand and USD 50 thousand, respectively within other income in the consolidated statements of income/loss and other comprehensive income/loss.

 

F-61

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

M.Laminera

 

As of December 31, 2024 and 2023, the Company held 19.7% of the issued and outstanding shares of Laminera.

 

Management of the Company assessed whether there is objective evidence that its net investment in Laminera was impaired. As Laminera continues to have zero revenues and generate operating losses, and as the Company does not plan additional investments in Laminera, the Company considered the value of the investment as of December 31, 2024 and 2023. As the Company does not believe this investment will generate any cash flows in the foreseeable future, the Company decided to write off the entire amount of the investment in Laminera and recorded an impairment loss of USD 1,176 thousand within equity losses in the consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2023.

 

N.GERD IP

 

GERD IP was incorporated under the laws of the State of Delaware on January 13, 2020. GERD IP is in the business of holding and licensing patents that serves as the foundation of a device used to perform a minimally invasive, trans-oral fundoplication surgical procedure for the treatment of patients suffering from gastroesophageal reflux disease.

 

On May 11, 2021, GERD IP signed a confidential settlement agreement to resolve a lawsuit, concerning alleged infringement of its intellectual property, filed by GERD IP in July 2020 with the United States District Court for the District of Delaware against a US medical device company.

 

The claim for alleged intellectual property infringement referred to two patents issued by the United States Patent and Trademark Office, owned by GERD IP.

 

During 2021 and 2022, GERD IP received USD 1.3 million compensation related to this settlement agreement, and after reduction of legal cost the net amount received summed up to USD 631 thousand.

 

F-62

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

O.Metagramm

 

On April 13, 2023, the Company entered into a share purchase agreement to acquire 19.9% of Metagramm, an AI, machine learning (ML) communication and grammar assistant software. In return, the Company paid Metagramm USD 250 thousand in Company’s shares. The investment was accounted for as investments at fair value through profit or loss (FVTPL).

 

As of December 31, 2024, and December 31, 2023, the Company held 19.9% of the issued and outstanding shares of Metagramm.

 

As of December 31, 2024, and 2023, the fair value of the investment in Metagramm was USD 1,031 thousand and USD 250 thousand, respectively.

 

In addition, pursuant to the share purchase agreement, the Company loaned Metagramm USD 250 thousand in order to fund a pilot. The loan bears an interest rate of 6% per annum. The loan will be repaid upon the completion of the pilot, in eight quarterly installments starting from the first day of the third year after the grant date. The loan was accounted for as financial assets measured at amortized cost.

 

In the event that the pilot approval is not successfully completed within 15 months after the Closing, Metagramm will repay the loan and any interest on a monthly basis. In such case, the Company will have the option to receive additional shares of Metagramm, at no cost, in such number that immediately after, the Company’s holdings in Metagramm will increase to 31.25%. The option is measured at fair value through profit or loss. As of December 31, 2024, the fair value of the option was estimated to be inconsequential.

 

In addition, in the event of any fundraising transaction, the Company will have the option to be reimbursed the full loan amount with accrued interest immediately following the fundraising transaction or to convert the loan into Metagramm’s shares at a 20% discount.

 

On July 21, 2024, the Company and Metagramm signed an amendment to the agreement according to which after 3 months from the amendment date, Metagramm will pay the Company USD 15 thousand per month. In the event the pilot will not be approved commencing 6 months of the amendment date, Metagramm will repay the loan including all recruiting interest, in monthly repayments, at the monthly amount of the highest of: (i) USD 10 thousand or (ii) 60%of Metagramm’s monthly profit. Metagramm will commence the monthly payments at the earlier of 6 months commencing the amendment date or commencing the dated of the pilot approval.

 

On March 19, 2025, the Company converted the loan into 37,869 ordinary shares. Following the securities exchange agreement between Metagramm and Viewbix Inc., the Company received 171,112 ordinary shares of Viewbix Inc. in exchange for its shares in Metaagramm (see note 4F and note 21).

 

F-63

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – INTEREST IN OTHER ENTITIES: (continued)

 

P.Solterra Energy (formerly known as A.I. Conversation Systems)

 

As of December 31, 2023, the Company held 36.08% of the issued and outstanding shares of Solterra Energy. The investment was accounted for using the equity method.

 

On November 18, 2024, Solterra Energy shareholders’ meeting approved a private placement transaction according to which it offered 3,000,000 ordinary shares. As part of the tender, a total of Soltra received a total consideration of approximately EUR 2,149 thousand.

 

The Company participated in this private placement and invested an amount of USD 564 thousand (EUR 534 thousand).

 

On November 28, 2024, Solterra Energy shareholders’ meeting approved a merger agreement with Soltra Renewable Energy by means of an exchange of shares. The closing of the merger occurred on December 1, 2024. According to the merger agreement Soltra Energy issued 2,028,485 ordinary shares and 248,268 warrants to Soltra Renewable Energy shareholders.

 

On November 28, 2024, the Company sold 100,000 shares of Solterra Energy for total proceeds of approximately USD 82 thousand (EUR 78 thousand). As a result of this and as a result of the merger agreement, the Company’s holdings in Solterra Energy decreased to 13.14% and starting from that date the investment was accounted for as investments at fair value through profit or loss (FVTPL). As a result of the transition, the Company recognized a gain of USD 140 thousand in the consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2024.

 

As of December 31, 2024, the Company held 13.14% of the issued and outstanding shares of Solterra Energy.

 

F-64

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT:

 

1)Financial risk factors

 

The Group is exposed to a variety of financial risks such as: market risks, credit risks and liquidity risks. The Group’s overall risk management plan focuses on the unpredictability of financial markets and seeks to minimize the potential adverse effects on the Group’s financial performance.

 

Risk management is performed by the finance department according to the policy authorized by the board of directors.

 

a)Market risk - Currency risk

 

Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates.

 

The Group operates internationally and is exposed to foreign exchange risks due to exposure to Foreign Currencies, primarily the NIS. Foreign exchange risk arises from future commercial transactions, assets or liabilities denominated in foreign currency.

 

The Group’s policy to reduce the exposure to changes in exchange rates is based on maintaining, where possible, the balances of current monetary assets, according to the currency of the current liabilities.

 

As of December 31, 2024, and 2023, if the Group’s functional currency (USD) had weakened/strengthened by 10% against the NIS, with all other variables held constant, the loss for the year would decrease/increase by USD 879 thousand and USD 120 thousand, accordingly.

 

b)Credit risk

 

Credit risk arises when a failure by counterparties to discharge their obligations could reduce the amount of future cash inflows from financial assets on hand at the end of the reporting year.

 

F-65

 

 

XYLO TECHNOLOGIES LTD

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT: (continued)

 

1)Financial risk factors (continued)

 

b)Credit risk (continued)

 

Credit risks are treated at the Group level. Credit risks arise typically from cash and cash equivalents, bank deposits and from credit exposures in connection with outstanding receivables and committed transactions.

 

No credit limits were exceeded during the reported periods and Group’s management does not expect any losses from non-performance of these parties.

 

c)Liquidity risk

 

Liquidity risk exists where the Group might encounter difficulties in meeting its financial obligations as they become due. The Group monitors its liquidity in order to ensure that sufficient liquid resources are available to allow it to meet its obligations.

 

Cash flow forecasting is performed by the Group’s finance department of each of the companies in the Group. The finance department monitors rolling forecasts of the Group’s liquidity requirements to ensure that it has sufficient cash to meet operational needs, while maintaining sufficient headroom on its undrawn committed borrowing facilities, so that the Group does not breach any of its credit facilities.

  

The following tables detail the Group’s remaining contractual maturity for its non-derivative financial liabilities with agreed repayment periods:

 

   Less than
1 year
   1 – 2 years   2-3 years   3-5 years   Total 
   USD in thousands 
December 31, 2024                    
Trade accounts payable   5,980    
-
    
-
    
-
    5,980 
Short-term loans   3,303    
-
    
-
    
-
    3,303 
Current maturities of long-term loans   3,064    
-
    
-
    
-
    3,064 
Long-term loans   
-
    496    
-
    
-
    496 
Liability to event producers   1,256    
-
    
-
    
-
    1,256 
Accrued expenses and other current liabilities   1,564    
-
    
-
    
-
    1,564 
Related Parties liabilities   907    
-
    
-
    
-
    907 
Lease liabilities   
-
    
-
    
-
    
-
    
-
 
    16,074    496    
-
    
-
    16,074 
December 31, 2023                         
Trade accounts payable   13,248    
-
    
-
    
-
    13,248 
Short-term loans   8,982    
-
    
-
    
-
    8,982 
Long-term loans   
-
    234    
-
    
-
    234 
Liability to event producers   967    
-
    
-
    
-
    967 
Accrued expenses and other current liabilities   3,189    
-
    
-
    
-
    3,200 
Related Parties liabilities   909    
-
    
-
    
-
    909 
Lease liabilities   102    162    143    163    570 
    27,631    396    143    163    28,099 

 

  2) Estimates of fair value

  

Below is an analysis of the financial instruments carried at fair value, by valuation method. The different levels have been defined as follows:

 

  Quoted prices (unadjusted) in active markets for identical assets or liabilities (level 1).

 

  Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (level 3).

 

F-66

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT: (continued)

 

  2) Estimates of fair value (continued)

 

Financial assets

 

  A. The following table presents the level 1 and level 3 fair value financial assets – investments in shares, warrants and mutual funds as of December 31, 2024, and December 31, 2023

 

   December 31, 2024   December 31, 2023 
   Level 1   Level 3   Total   Level 1   Level 3   Total 
   USD in thousands 
Investments in shares   4,867    1,431    6,298    2,763    1,050    3,813 
Investments in warrants   37    790    827    6    120    126 
Total   4,904    2,221    7,125    2,769    1,170    3,939 

 

  B. The following table presents the level 1 and level 3 fair value financial assets – loans to associates and others as of December 31, 2024, and December 31, 2023

 

   December 31, 2024   December 31, 2023 
   Level 1   Level 3   Total   Level 1   Level 3   Total 
   USD in thousands 
Loan to Revoltz   
-
    64    64    
-
    62    62 
Loan to Polyrizon   
-
    
-
    
-
    
-
    78    78 
Loan to Zig Miami 54 (note 4G)   
-
    1,756    1,756    
-
    1,545    1,545 
Total   
-
    1,820    1,820    
-
    1,685    1,685 

 

  C. The following table presents the level 1 and level 3 fair value financial assets included in other receivables as of December 31, 2024, and December 31, 2023

 

   December 31, 2024   December 31, 2023 
   Level 1   Level 3   Total   Level 1   Level 3   Total 
   USD in thousands 
Shares receivable from the Amendment of the Buffalo Agreement (note 4J)   
-
    500    500    10    500    510 
Total   
-
    500    500    10    500    510 

 

F-67

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT: (continued)

 

  2) Estimates of fair value (continued)

 

Financial assets (continued)

 

  D. The following table presents the Level 1 financial assets – investments in shares and warrants roll-forward during the years ended December 31, 2024 and 2023:

 

   Investments
in shares
   Investments
in warrants
   Total 
   USD in thousands 
Balance as of January 1, 2023   3,322    9    3,331 
Purchase of securities   583    
-
    583 
Transfer from equity method to FVTPL   9,103    
-
    9,103 
Sale of securities   (7,039)   
-
    (7,039)
Net changes in fair value   (3,206)   (3)   (3,209)
Balance as of December 31, 2023   2,763    6    2,769 
Purchase of securities   259    
-
    259 
Transfer from equity method to FVTPL Level 1   622    
-
    622 
Deconsolidation of Jeffs’ Brands    1,343    42    1,385 
Transfer from Level 3 to Level 1   488    7    495 
Sale of securities   (2,900)   (1)   (2,901)
Net changes in fair value   2,292    (17)   2,275 
Balance as of December 31, 2024   4,867    37    4,904 

 

E.The following table presents the Level 3 financial assets – investments in shares, warrants and SAFEs roll-forward during the years ended December 31, 2024 and 2023:

 

   Investments in shares   Investments in warrants   Investments in SAFEs   Total 
   USD in thousands 
Balance as of January 1, 2023   800    416    822    2,038 
Purchase of securities   250    
-
    
-
    250 
Conversion of SAFEs   
-
    
-
    (964)   (964)
Net changes in fair value   
-
    (296)   142    (154)
Balance as of December 31, 2023   1,050    120    
-
    1,170 
Purchase of securities   
-
    71    
-
    71 
Transfer from equity method to FVTPL Level 3   141    
-
    
-
    141 
Deconsolidation of Jeffs’ Brands    
-
    117    
-
    117 
Transfer from Level 3 to Level 1   
(488
)   
(7
)        (495)
Net changes in fair value   728    489    
-
    1,217 
Balance as of December 31, 2024   1,431    790    
-
    2,221 

 

F-68

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT: (continued)

 

2)Estimates of fair value (continued)

 

Financial assets (continued)

 

  F. The following table presents the Level 3 financial assets – loans to associates and others roll-forward during the years ended December 31, 2024 and 2023:

 

   Loan to
Revoltz
   Loan to
Solterra Energy
   Loan to
Polyrizon
   Loan to
Zig Miami 54
   Total 
   USD in thousands 
Balance as of January 1, 2023   62    940    
-
    
-
    1,002 
Loans granted to associates and others   
-
    
-
    80    1,545    1,625 
Net changes in fair value   
-
    (219)   (2)   
-
    (221)
Loan conversion   
-
    (721)   
-
    
-
    (721)
Balance as of December 31, 2023   62    
-
    78    1,545    1,685 
Net changes in fair value   2    
-
    22    211    235 
Loan conversion   
-
    
-
    (100)   
 
    (100)
Balance as of December 31, 2024   64    
-
    
-
    1,756    1,820 

 

  G. The following table presents the level 1 and level 3 fair value financial assets included in other receivables roll-forward during the year ended December 31, 2024 and 2023:

 

   Shares receivable   Total 
   USD in thousands 
Balance as of January 1, 2023   
-
    
-
 
Shares receivable from the Amendment of the Buffalo Agreement   937    937 
Transfer to investments in shares   (181)   (181)
Net changes in fair value   (246)   (246)
Balance as of December 31, 2023   510    510 
Net changes in fair value   (10)   (10)
Balance as of December 31, 2024   500    500 

 

F-69

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT: (continued)

 

  2) Estimates of fair value (continued)

 

Financial liabilities

  

Level 3 financial liabilities:

 

As of December 31, 2023, the Group had financial liabilities measured at level 3 – mainly from derivative liabilities of Jeffs’ Brands.

 

As of December 31, 2024, the Group had financial liabilities measured at level 3 – mainly from the June 2024 Facility Agreement entered into by Viewbix Inc. (see note 4E).

 

The fair value of the financial instruments under the June 2024 Facility Agreement, as of June 18, 2024, was calculated using the following inputs: share price: USD 0.118, expected volatility: 125%, exercise price: USD 0.25, risk-free interest rate: 4.41%, expected life: 3.0 years.

 

The fair value of the financial instruments under the June 2024 Facility Agreement, as of December 31, 2024, was calculated using the following unobservable inputs: share price: $0.472, expected volatility: 148%, exercise price: $1.00, risk-free interest rate: 4.24%-4.32%, expected life: 0.46-0.50 years.

  

  H. The following table presents the financial liabilities that were measured at fair value through profit or loss at level 3:

 

   December 31,
2024
   December 31,
2023
 
   USD in thousands 
Warrants at fair value issued by subsidiaries   2,340    1,897 
Embedded derivatives   27    
-
 
    2,367    1,897 

 

I.The following table presents the Level 3 financial liabilities roll-forward during 2024 and 2023:

 

   USD
in thousands
 
Balance as of January 1, 2024   1,897 
Deconsolidation of Jeffs’ Brands    (1,874)
Viewbix June 2024 Facility Agreement (note 4F)   2,286 
Net changes in fair value   31 
Balance as of December 31, 2024   2,340 

 

   USD
in thousands
 
Balance as of January 1, 2023   4,159 
Net changes in fair value   (2,262)
Balance as of December 31, 2023   1,897 

 

F-70

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 – CASH AND CASH EQUIVALENTS, SHORT TERM DEPOSITS AND RESTRICTED CASH:

 

   December 31 
   2024   2023 
   USD in thousands 
Cash and cash equivalents   8,753    9,357 
Short term deposits   12    12 
Restricted cash   58    166 
    8,823    9,535 

  

The currencies in which the cash and cash equivalents, short term deposits and restricted cash are denominated or to which they are linked are as follows:

 

   December 31 
   2024   2023 
   USD in thousands 
USD   7,572    7,814 
NIS   1,220    1,510 
GBP   
-
    167 
Other currencies   31    44 
    8,823    9,535 

 

As of December 31, 2024, and 2023, the carrying amount of cash and cash equivalents, short term deposits and restricted cash approximated their fair value.

 

NOTE 7 – OTHER RECEIVABLES AND LOANS TO OTHERS:

 

  a. Other receivables – composition:

 

   December 31 
   2024   2023 
   USD in thousands 
Government institutions   614    685 
Prepaid expenses   189    940 
Shares receivable from the Amendment of the Buffalo Agreement (see note 4J)   500    510 
Deferred debt issuance costs (see note 4F)   638    
-
 
Other   213    9 
    2,154    2,144 

 

F-71

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 – OTHER RECEIVABLES AND LOANS TO OTHERS: (continued)

 

  b. Loans to others – composition:

 

   December 31 
   2024   2023 
   USD in thousands 
Loan to Safee   
-
    126 
Loan to Metagramm (note 4O)   276    250 
    276    376 

 

NOTE 8 – INVENTORY:

 

   December 31 
   2024   2023 
   USD in thousands 
Goods in transit   
-
    219 
Finished goods   
-
    2,167 
    
-
    2,386 

 

As of December 31, 2023, all inventory derived from Jeffs’ Brands.

 

F-72

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9 – GOODWILL AND INATANGIBLE ASSETS:

 

  A. Composition and movements:

 

   Technology   Software
License
   Patent   Brand
Name
   Customer
Relations
   Goodwill   Total 
   USD in thousands 
Cost:                            
Balance as of January 1, 2024   12,908    
         -
    100    8,030    6,234    8,550    35,822 
Deconsolidation of Jeffs’ Brands (see section B below)   
-
    
-
    
-
    (8,030)   
-
    (563)   (8,593)
Currency translation   (10)   
-
    
-
    
-
    
-
    
-
    (10)
Impairment loss (see section C below)   
-
    
-
    
-
    
-
    
-
    (2,919)   (2,919)
Balance as of December 31, 2024   12,898    
-
    100    
-
    6,234    5,068    24,300 
Accumulated Amortization:                                   
Balance as of January 1, 2024   (4,866)   
-
    
-
    (1,987)   (1,633)   
-
    (8,486)
Deconsolidation of Jeffs’ Brands (see note 4E))   
-
    
-
    
-
    2,061    
-
    
-
    2,061 
Additions   (2,031)   
-
    (100)   (74)   (893)   
-
    (3,098)
Currency translation   (7)   
-
                   
-
    (7)
Balance as of December 31, 2024   (6,904)   
-
    (100)   
 
    (2,526)   
-
    (9,531)
Intangible assets, net, as of December 31, 2024   5,994    
-
    
-
    
-
    3,708    5,068    14,770 

 

   Technology   Software
License
   Patent   Brand
Name
   Customer
Relations
   Goodwill   Total 
   USD in thousands 
Cost:                            
Balance as of January 1, 2023   12,921    1,366    75    6,039    6,234    9,068    35,703 
Additions (see section B below)   
-
    
-
    25    1,991    
-
    
-
    2,016 
Currency translation   (13)   (62)   
-
    
-
    
-
    (10)   (85)
Impairment loss (see section C below)   
-
    (1,304)   
-
    
-
    
-
    (508)   (1,812)
Balance as of December 31, 2023   12,908    
-
    100    8,030    6,234    8,550    35,822 
Accumulated Amortization:                                   
Balance as of January 1, 2023   (2,869)   
-
    
-
    (1,230)   (742)   
-
    (4,841)
Additions   (2,026)   
-
    
-
    (757)   (891)   
-
    (3,674)
Currency translation   29    
-
    
-
    
-
    
-
    
-
    29 
Balance as of December 31, 2023   (4,866)   
-
    
-
    (1,987)   (1,633)   
-
    (8,486)
Intangible assets, net, as of December 31, 2023   8,042    
-
    100    6,043    4,601    8,550    27,336 

 

F-73

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9 – GOODWILL AND INATANGIBLE ASSETS: (continued)

 

  B. Additions and disposals during 2024 and 2023:

 

  1. Following the Fort Acquisition on March 9, 2023, an amount of USD 1,991 thousand was recorded as additional Brand name. For additional information, see note 4E.

 

  2. On January 25, 2024, Jeffs’ Brands entered into a private placement transaction with certain institutional investors for aggregate gross proceeds of approximately USD 7,275 thousand. The Company did not participate in the private placement and as a result its holdings in Jeffs’ Brands decreased to 13.37% of Jeffs’ Brands issued and outstanding share capital, which resulted deconsolidation and resulted loss of control in Jeffs’ Brands as of January 28, 2024. As a result, the brand name and the goodwill related to Jeffs’ Brands were deconsolidated as of such date.

 

  C. Impairments during 2024 and 2023:

 

  1. As of December 31, 2024, and 2023, the Group identified indicators of impairment of the online advertising and internet traffic routing reporting unit. As a result, the Group performed an impairment test which included a quantitative analysis of the fair value of the reporting unit. The fair value was estimated using the income approach, which is based on the present value of the future cash flows attributable to the reporting unit. The Group compared the fair value of the reporting unit to its carrying amount. As the carrying amount exceeded the fair value, the Group recognized an impairment loss of USD 2,919 thousand and USD 508 thousand in the consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2024 and 2023, respectively, which was driven mainly due to a decrease in the cash flow projections.

 

  2. On February 4, 2021, Eventer received an exclusive license for using the broadcasting system of Screenz with respect to the field of virtual conferences and development services (“Software License”). As of December 31, 2023, the management of Eventer reviewed the carrying amount of the Software License and determined that it was not recoverable as no cashflows are expected to be generated by the Software License in the foreseeable future. As such, the Group recognized an impairment loss of USD 1,304 thousand in the consolidated statements of income/loss and other comprehensive income/loss.

 

F-74

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 10 – LEASES:

  

Xylo

 

On January 5, 2023, the Company entered into a new lease agreement for its offices for a period of 21 months effective as of February 1, 2023, with an option by the Company to extend the lease period for two additional terms of 12 months each. On August 21,2024, the company extended the lease agreement until November 1, 2025. According to the agreement, the Company will pay NIS 8.3 thousand plus VAT per month. The Company uses its incremental borrowing rate of 10% as the discount rate for its leases, as the implicit rate in the lease is not readily determinable.

 

Jeffs’ Brands

 

Jeffs’ Brands leases office space and a warehouse with a remaining useful life of less than 3 years and uses its incremental borrowing rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2023, Jeffs’ Brands leases had a weighted average remaining lease term of 3 years and a weighted average borrowing rate of 10%.

 

Gix Internet

 

On February 25, 2021, Gix Media entered into a lease agreement for a new corporate office of 479 square meters in Ramat Gan, Israel, for a monthly rent fee of USD 10 thousand. The lease period is for 36 months (the “initial lease period”) with an option to extend the lease period for two additional terms of 24 months each. In accordance with the lease agreement, Gix Media made leasehold improvements in exchange for a rent fee discount of USD 67 thousand which will be spread over the initial lease period.

 

In December 2023, Gix Media exercised the option to extend the lease period for an additional term of 24 months (from March 1, 2024, to February 28, 2026).

 

As of December 31, 2023, Gix’s Media leases had a weighted average remaining lease term of 4 years and a weighted average borrowing rate of 3.10%.

 

On June 20, 2024, Gix Media and the lessor of its offices entered into a lease termination agreement. According to the agreement, the lease terminated on June 30, 2024. In compensation for the lessor’s consent to early termination, Gix Media paid the lessor USD 7 thousand in cash and USD 62 thousand in office furniture and equipment, as per the carrying values of such assets as of the early termination date. As a result of the early termination of the agreement, the Group recorded a capital loss of USD 46 thousand in other expenses in its consolidated statements of income/loss and other comprehensive income/loss for the year ended December 31, 2024.

 

F-75

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 10 – LEASES: (continued)

 

Right-of-use assets

 

   Buildings 
   USD in
thousands
 
Cost:     
As of December 31, 2022   771 
Additions   104 
As of December 31, 2023   875 
Deconsolidation of Jeffs’ Brands   (115)
Derecognition upon early termination   (315)
As of December 31, 2024   445 
      
Accumulated Depreciation:     
As of December 31, 2022   (180)
Depreciation for the year   (199)
As of December 31, 2023   (379)
Depreciation for the year   (20)
Deconsolidation of Jeffs’ Brands   
-
 
Derecognition upon early termination   (46)
As of December 31, 2024   (445)
      
Carrying amount:     
As of December 31, 2024   
-
 
As of December 31, 2023   496 

 

Amounts recognized in profit and loss:

 

   2024   2023 
   USD in thousands 
Depreciation expense on right-of-use assets   20    199 
Interest expense on lease liabilities   56    82 

 

For the year ended December 31, 2024, the total cash outflows for leases amounted to USD 118 thousand (2023: USD 150 thousand).

 

F-76

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 10 – LEASES: (continued)

 

Lease liabilities

 

Maturities of lease liabilities as of December 31, 2024 and 2023 are as follows:

 

   2024   2023 
   USD in thousands 
Year 1   
-
    102 
Year 2   
-
    162 
Year 3   
-
    143 
Year 4   
-
    148 
Year 5   
-
    19 
Onwards   
-
    
-
 
Less: unearned interest   
-
    (4)
    
-
    570 
Analyzed as:          
Non-current   
-
    468 
Current   
-
    102 
    
-
    570 

 

NOTE 11 - TAXES ON INCOME:

 

  a. Tax rates applicable to the Company and subsidiaries:

 

The Company and all subsidiaries based in Israel - Gix Internet, Eventer and Viewbix Ltd. are taxed according to Israeli tax law, where the corporate tax rate is 23% for the years 2024, 2023 and 2022.

 

Gix Media and Cortex are recognized as a “Preferred-Technology Enterprise” in accordance with Section 51 of the Encouragement of Capital Investments Law, 1959 and are taxed at a reduced corporate tax rate of 12% for the years 2024, 2023 and 2022.

 

Viewbix Inc. is taxed according to U.S. tax laws. On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which among other provisions, reduced the U.S. corporate tax rate from 35% to 21%, effective January 1, 2018.

  

  b. Final tax assessments:

 

As of December 31, 2024, the Company had a final tax assessment for all tax year up to the year ended December 31, 2021.

 

As of December 31, 2024, Gix Internet had a final tax assessment for all tax year up to the year ended December 31, 2018. Gix Media had a final tax assessment for all tax year up to the year ended December 31, 2020. Cortex had a final tax assessment for all tax year up to the year ended December 31, 2018. Viewbix Ltd. had a final tax assessment for all the tax years up to the year ended December 31, 2018.

 

As of December 31, 2024, Eventer had a final tax assessment for all tax year up to the year ended December 31, 2018.

 

F-77

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 – TAXES ON INCOME: (continued)

 

  c. Deferred taxes are comprised of the following components:

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

Deferred taxes are comprised of the following components:

 

   As of
December 31
   As of
December 31
 
   2024   2023 
   USD in thousands 
Deferred tax assets        
Deferred research and development expenses   61    77 
Intangible assets   
-
    168 
Employee compensation and benefits   7    28 
Operating loss carryforward   102    
-
 
           
Total deferred tax assets   170    273 
           
Deferred tax liabilities:          
Intangible assets associated with business combinations   1,024    1,465 
Total deferred tax liabilities   1,024    1,465 

 

  d. Tax expense (benefit) included in the consolidated statements of income/loss and other comprehensive income/loss for the periods presented:

 

   Year ended December 31, 
   2024   2023   2022 
   USD in thousands 
Current tax expenses   171    319    813 
Tax benefit in respect of prior years   9    (160)   (82)
Deferred tax expenses (income)   (437)   (233)   (620)
Tax expense (benefit)   (257)   (74)   111 

 

  e. Available carryforward tax losses:

 

   December 31,
2024
   December 31,
2023
 
   USD in thousands 
Xylo Technologies   55,000    65,000 
Eventer   2,791    2,945 
Charging Robotics Inc.   1,599    905 
GERD IP   4,030    3,089 
Gix Internet   19,604    18,971 

 

The Group has not recorded deferred taxes asset in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future.

 

F-78

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 – TAXES ON INCOME: (continued)

 

  f. Reconciliation of the theoretical tax expenses to the actual tax expenses:

 

The following is reconciliation between the “theoretical” tax, which would apply to the Group if all of its income were taxed at the regular rate applicable to the Company in Israel and the amount of tax reflected in the consolidated statements of loss and other comprehensive loss for the reported year:

 

   2024   2023   2022 
   USD in thousands 
Loss before taxes on income   (12,262)   (21,806)   (10,097)
Theoretical tax rate   23%   23%   23%
Theoretical tax benefit   (2,820)   (5,015)   (2,322)
Disallowed deductions (tax exempt income):               
Change in fair value of assets and liabilities measured at fair value through profit or loss   (833)   862    (38)
Share-based compensation   80    178    183 
Profit recognized upon first time consolidation   
-
    
-
    (529)
Non-deductible expenses   873    547    723 
Equity losses   84    945    611 
Net loss (gain) from derecognition of investments accounted for using the equity method upon loss of significant influence   (34)   513    
-
 
Different tax rates applicable to subsidiaries   92    (46)   (360)
Tax benefits in respect of prior years   9    29    (84)
Other   10    95    17 
Tax losses and timing differences incurred in the reporting year for which deferred taxes were not created   2,282    1,818    1,910 
Tax expense (benefit)   (257)   (74)   111 

 

F-79

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 – TRADE ACCOUNTS PAYABLE, ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

 

  a. Trade accounts payable are denominated in the following currencies:

 

   December 31, 
   2024   2023 
   USD in thousands 
NIS   79    1,953 
USD   5,901    10,756 
Other Currencies   
-
    539 
    5,980    13,248 

  

  b. Accrued expenses and other current liabilities:

 

   December 31, 
   2024   2023 
   USD in thousands 
Employees and related institutions   569    980 
Government authorities   335    684 
Accrued expenses   464    894 
Liability to sellers of intangible assets   
-
    430 
Other   178    175 
    1,546    3,163 

 

F-80

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 – EQUITY:

 

  a. Share capital:

 

  1) Composed as follows:

 

   Number of shares   Amount 
   Authorized   Issued and paid   Authorized   Issued and paid 
   December 31,   December 31,   December 31,   December 31, 
   2024   2023   2024   2023   2024   2023   2024   2023 
   In thousands   NIS in thousands   USD in thousands 
Ordinary shares of no-par value as of December 31, 2024, and 2023
   200,000    200,000    32,259    27,989    
-
    
-
    
-
    
-
 

 

  2) The ordinary shares confer upon their holders’ voting rights and the right to participate in shareholders’ meetings, the right to receive dividends and the right to participate in surplus assets in the event of liquidation of the Company.

 

  3) On June 9, 2023, the Company issued 863,100 ordinary shares to Metagramm as part of the share purchase agreement. See note 4O.

 

  4) On July 3, 2023, the Company issued 169,920 ordinary shares to Polyrizon as part of the share purchase agreement. See note 4H.

 

  5) On August 8, 2023, the Company issued 328,506 ordinary shares to Pure Capital as part of the stock transfer agreement of Odysight.ai with a fair value of USD 105 thousand. See note 4C.

 

  6) On November 6, 2023, the Company issued 1,293,450 ordinary shares in relation to RSUs grants.

 

  7) On December 26, 2023, the Company issued 673,019 ordinary shares to Gix Internet. See note 4F.

 

  8) On October 7,2024 the Company issued 2,544,600 ordinary shares to Keshet. See note 4D.  

 

  9) During 2024, the Company issued 1,293,446 Ordinary Shares in relation to RSUs grants.

 

  10) On November 15, 2024 the Company entered into a definitive warrants purchase agreement with Pure Capital, pursuant to which Xylo agreed to issue and sell to such investor in a registered direct offering, or the Offering, pre-funded warrants, (the “Pre-Funded Warrants”), to purchase up to 454,752 ADSs. The Pre-Funded Warrants have an exercise price of USD 0.001 and may be exercised at any time until exercised in full. Pure Capital (together with its affiliates) may not exercise any portion of the Pre-Funded Warrants to the extent that it would own more than 4.99% of Xylo’s issued and outstanding share capital immediately after such exercise.

 

F-81

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 – EQUITY: (continued)

 

  b. Share based payments:

 

  1) In August 2013, the Company’s board of directors approved and adopted the Company’s 2013 Share Option and Incentive Plan, or the 2013 Plan, which expires in August 2023. The 2013 Plan provides for the issuance of shares and the granting of options, restricted shares, restricted share units and other share-based awards to employees, directors, officers, consultants, advisors, and service providers of us and the Company U.S. Subsidiary. The Plan provides for awards to be issued at the determination of The Company board of directors in accordance with applicable law.

 

  2) The following are the grants of options to employees and other service providers:

 

Date of grant  Number of
options granted
   exercise
price per
option to ordinary shares
   Exercise currency   Fair value
on grant date
(USD in thousands)
   Number of
options outstanding-
December 31,
2024
   Number of
options
exercisable at
December 31,
2024
   Expiration
date
January 2019(*)   150,000    11.8    NIS    257    112,500    112,500   January 9, 2025
July 2019(*)   62,500    11.8    NIS    92    62,500    62,500   July 25, 2025
June 2020   62,500    11.8    NIS    82    62,500    62,500   May 31, 2026
July 2020(*)   37,500    8.96    NIS    36    37,500    37,500   July 8, 2026
June 2021(*)   900,000    1.783    USD    1,221    900,000    900,000   June 29, 2027
June 2021   280,000    1.783    USD    380    262,500    262,500   June 29, 2027
June 2021   100,000    1.783    USD    136    100,000    100,000   June 1, 2027
October 2021   90,000    1.783    USD    91    75,000    75,000   October 12, 2027
Total   1,682,500                   1,612,500    1,612,500    

 

(*) Granted to related parties.

 

F-82

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 – EQUITY: (continued)

 

  b. Share based payments: (continued)

 

The fair value of all of the options was calculated using the Black and Scholes options pricing model, and based on the following assumptions:

 

Date of grant   Fair
value on
grant date-
in thousands
  Share
price on
date of
grant
  Expected
dividend
  Expected
volatility
    Risk
free
interest
    Vesting conditions   Expected
term
January 2019   947 NIS   10.12 NIS   None     74 %     1.45 %   will vest in 12 equals quarterly instalments over a three-year period commencing October 1, 2018   6 years
July 2019   325 NIS   8.72 NIS   None     75 %     1.12 %   25% will vest on the first anniversary of the grant date and 75% will vest on a quarterly basis over a period of three years thereafter   6 years
June 2020   282 NIS   7.94 NIS   None     74 %     0.53 %   will vest in 12 equals quarterly instalments over a three-year period commencing June 1, 2020   6 years
July 2020   124 NIS   5.8 NIS   None     74 %     0.37 %   will vest in 12 equals quarterly instalments over a three-year period commencing July 9, 2020   6 years
June 2021   1,737 USD   1.8 USD   None     87 %     0.69 %   will vest over a period of 3 years commencing on April 1, 2021(except for 2,000,000 options commencing on June 1, 2021), with 1/12 of such options vesting at the end of each subsequent three-month period following the grant   6 years
October 2021   91 USD   1.4 USD   None     85 %     0.47 %   will vest over a period of 3 years commencing on October 12, 2021, with 1/12 of such options vesting at the end of each subsequent three-month period following the grant   6 years

 

F-83

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 – EQUITY: (continued)

 

  b. Share based payments: (continued)

 

  3) The changes in the number of share options and the weighted averages of their exercise prices are as follows:

 

   For the year ended December 31, 
   2024   2023   2022 
   Number
of options
   Weighted
average of
exercise
price per
1 ordinary
share-(NIS)
   Number
of options
   Weighted
average of
exercise
price per
1 ordinary
share-(NIS)
   Number
of options
   Weighted
average of
exercise
price per
1 ordinary
share-(NIS)
 
Outstanding at the beginning of year   1,627,500    6.81    1,673,850    7.00    1,674,950    7.02 
Granted   
 
    
 
    
-
    
-
    
-
    
-
 
Forfeited   (15,000)   11.8    (32,500)   5.78    (1,100)   32.4 
Expired             (13,850)   32.4    
-
    
-
 
Outstanding at year end   1,612,500    6.77    1,627,500    6.81    1,673,850    7.00 
Exercisable at year end   1,612,500    6.77    1,488,958    6.91    1,039,579    7.57 

 

  4) The amounts of expenses that were recorded for options to employees and other service providers are USD 17 thousand, USD 198 thousand and USD 624 thousand for the years ended December 31, 2024, 2023 and 2022, respectively.

 

  5)

The plans are intended to be governed by the terms stipulated by Section 102 to the Israeli Income Tax Ordinance (except for the options to controlling shareholders and directors).

 

In accordance with these general rules and the track chosen by the Company pursuant to the terms thereof, in respect of options granted to employees under the option allotment plan, the Company is not allowed to claim as an expense for tax purposes the amounts credited to employees as a benefit, including amounts recorded as salary benefits in the Company’s books, with the exception of the salary-benefit component, if exists, determined on the grant date.

 

F-84

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 – EQUITY: (continued)

 

  c. Restricted Share Units

 

On June 15, 2023, the Board approved a grant of restricted share units (RSUs) to the Company’s Directors, Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), employees and to an advisor of the Company, subject to the approval of shareholders at the general meeting of the shareholders.

 

On August 8, 2023, the Company’s shareholders approved the RSUs grants at the Company’s annual general meeting. The RSUs shall vest over a period of three years commencing on January 1, 2023, with 1/12 of such options vesting at the end of each subsequent three-month period following the grant.

 

The RSUs grant will be in accordance and pursuant to Section 102 of the Income Tax Ordinance [New Version] (“Tax Ordinance”), if applicable, and the RSUs will be accelerated upon the closing of a material transaction, resulting in change of control of the Company.

 

During the year ended December 31, 2024, the Company recognized an expense in the aggregated amount of USD 331 thousand in relation to these RSUs (2023: USD 472 thousand).

 

NOTE 14 – EXPENSES BY NATURE

 

   Year ended December 31, 
   2024   2023   2022 
   USD in thousands 
Payroll and related expenses   5,703    8,638    7,647 
Professional fees   3,580    5,197    7,421 
Traffic-acquisition, materials used and subcontracted work   23,670    76,613    75,455 
Preparation of patents   63    72    153 
Rent and office maintenance   118    187    139 
Depreciation and amortization   3,221    3,979    3,188 
Advertising and participation in exhibitions   338    1,233    1,616 
Amazon Fees   469    4,381    2,558 
Other   1,190    2,239    2,262 
TOTAL COST OF REVENUES, RESEARCH AND DEVELOPMENT, SELLING AND MARKETING AND GENERAL AND ADMINISTRATIVE EXPENSES   38,352    102,539    100,439 

 

F-85

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 15 – LOSS PER SHARE:

 

Basic net loss per share is computed by dividing net loss attributable to ordinary shareholders of Xylo Technologies by the weighted average number of ordinary shares outstanding for the reporting periods.

 

Diluted net loss per share is computed by dividing the basic net loss per share including adjustment of the dilutive effect of the Company’s revaluation of warrants, by the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period. Diluted shares outstanding include the dilutive effect of in-the-money options using the treasury stock method.

 

The following table presents the numerator and denominator of the basic and diluted net loss per share computations:

 

   Year ended December 31, 
   2024   2023   2022 
Numerator (USD in thousands):            
Net loss for the year attributable to Xylo Technologies   (6,027)   (16,025)   (9,815)
                
Denominator (in thousands):               
Weighted average number of ordinary shares used for basic and diluted loss per share calculation   29,756    25,292    24,385 
                
Net loss per share attributable to Xylo Technologies (USD):               
Basic   (0.20)   (0.63)   (0.40)
Diluted   (0.20)   (0.63)   (0.40)

 

F-86

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 – TRANSACTIONS AND BALANCES WITH RELATED PARTIES:

  

  a. Transactions with related parties:  
     
  1) Composed as follows:

 

   Year ended on December 31, 
   2024   2023   2022 
   USD in thousands 
             
Compensations to key officers (1)   1,216    1,746    1,784 
Compensations to directors (2)   1,010    1,525    837 
Directors’ and officers’ insurance   327    771    846 
Consultant services (3)   16    180    218 
Interest and discount amortizations of loans from Jeffs’ Brands related parties (4)   
-
    
-
    42 
Finance expense on Screenz payable balance (note 4D)   
-
    
-
    212 
Compensation to member of senior management of Gix Internet (5)   175    188    34 
Eventer sales and marketing expenses to Keshet (note 4D)   
-
    
-
    165 
Eventer general and administrative expenses to Screenz   
-
    
-
    41 
Jeffs’ Brands cost of revenues from related parties (6)   36    545    
-
 
Jeffs’ Brands income from related parties (7)   10    255    
-
 
Jeffs’ Brands other revenues payment (8)   2    17    
-
 
Management fees from Parazero included in revenues (9)   120    50    
-
 
Other income from credit line to Parazero (note 4L)   
-
    40    
-
 
Royalties from Jeffs’ Brands (10)   24    
-
    
-
 
Management fees from Jeffs’ Brands included in revenues (11)   220    
-
    
-
 
Gix - Other finance expenses from related parties   45    
-
    
-
 
Gix - amortization of deferred debt of issuance cost from related parties   113    
-
    
-
 
Gix - profit from changes in fair value of financial assets from related parties   9    
-
    
-
 

 

(1)Includes granted options benefit in the aggregated amount of USD 15 thousand, USD 80 thousand and USD 263 thousand for the years ended December 31, 2024, 2023 and 2022, respectively and provision of bonus of approximately USD 92 thousand, USD 145 thousand and USD 308 thousand, for each of the years ended December 31, 2024 ,2023, and 2022, respectively. Also, includes grant of restricted share units (RSUs) in the aggregated amount of USD 94 thousand and USD 112 thousand for the year ended December 31, 2024 and 2023, respectively.

 

(2)Includes granted options benefit in the aggregated amount of USD 18 thousand, USD 165 thousand and USD 81 thousand for the years ended December 31, 2024, 2023 and 2022, respectively and provision and payments of bonus of approximately USD 44 thousand, USD 119 thousand and USD 77 thousand for the years ended December 31, 2024, 2023 and 2022, respectively. Also, includes grant of restricted share units (RSUs) in the aggregated amount of USD 161 thousand and USD 193 thousand for the year ended December 31, 2024 and 2023, respectively.

 

(3)Includes consulting fees to Pure Capital who is a related party of Jeffs’ Brands.

 

(4)Includes interest and discount amortizations of loans to related parties of Jeffs’ Brands.

 

(5)Compensation to Cortex’s CTO, a related party of Gix Internet.

 

(6)Includes inventory storage expenses to Pure NJ Logistics LLC who is a related party of Jeffs’ Brands. See note 4E.

 

(7)Includes consulting income and a one-time signing bonus from SciSparc Nutraceuticals who is a related party of Jeffs’ Brands.

 

(8) Includes other revenues payment to Pure Capital who is a related party Jeffs’ Brands.

 

F-87

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 – TRANSACTIONS AND BALANCES WITH RELATED PARTIES: (continued)

 

  a. Transactions with related parties: (continued)

 

(9)On August 1, 2024, the Company and Parazero signed a consulting agreement pursuant to which, the Company will provide Parazero with business consulting services in exchange of monthly management fees of USD 10 thousand.

 

(10)Includes royalties the Company received from Jeffs’ Brands.

 

(11)On April 30, 2024, the Company and Jeffs’ Brands signed a consulting agreement according to which, the Company will provide Jeffs’ Brands with business consulting services in exchange of monthly management fees of USD 20 thousand for 36 months.  On April 8, 2025, the Company’ and Jeffs’ Brands amended the consulting agreement, such that (i) as of January 2025 the monthly consulting fee would be reduced to USD 10 thousand; (ii) the consulting agreement would be extended for an additional 24 months; and (iii) a portion of the consulting fees to which the Company is entitled, and which are supposed to be paid in the last 9 and a half months of the consulting agreement, meaning a portion from March 2028, as well as April through December of 2028, will be paid in shares of Jeffs’ Brands, at a share price of $1.23 per share. In total, the Company was allocated 76,126 shares valued at $93,635, representing 3.51% of Jeffs’ Brands share capital. As of today, the Company holds approximately 4.99% of Jeffs’ Brands share capital.

 

  2) Indemnification, exemption and insurance for directors and officers of the Company

 

a.The Company provides its directors and officers with an obligation for indemnification and exemption.

 

b.The Company has a D&O liability insurance policy covering all the Company’s directors and officers. The current policy provides limits of USD 4,000,000 in the total aggregate for all loss. The policy was placed for a period of 17 months at a premium of USD 191 thousand (for the period). It includes a deductible of USD 300,000 for each claim, other than securities related claims filed in the United States or Canada, for which the deductible is USD 1,000,000.

 

F-88

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 – TRANSACTIONS AND BALANCES WITH RELATED PARTIES: (continued)

 

b.Balances with related parties:

 

(1)Current assets under related parties section:

 

   December 31,   December 31, 
   2024   2023 
   USD in thousands 
         
Other receivables (a related party of Gix Internet) (note 4F)   53    53 
Other receivables - Paraziro   10    
-
 
Other receivables (a related party of Eventer) (note 4D)   
-
    6 
    63    59 

 

(2)Current assets under loans to associates section:

 

   December 31,   December 31, 
   2024   2023 
   USD in thousands 
         
Loan to Zig Miami 54 (note 4G)   1,756    1,545 
Loan to Polyrizon   
-
    77 
Loan to Revoltz   64    62 
    1,820    1,684 

 

(3)Current assets under loans to others section:

 

   December 31,   December 31, 
   2024   2023 
   USD in thousands 
         
Loan to Metagramm (note 4O)   276    250 
    276    250 

 

(4)Current assets under other receivables section:

 

   December 31,   December 31, 
   2024   2023 
   USD in thousands 
         
Deferred debt issuance costs (note 4F)   617    
   -
 
    617    
-
 

 

F-89

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 – TRANSACTIONS AND BALANCES WITH RELATED PARTIES: (continued)

 

b.Balances with related parties: (continued)

 

(5)Current Liabilities:

 

   December 31, 
   2024   2023 
   USD in thousands 
         
Compensation to key management personnel (*)   902    681 
Other accrued expenses to related parties of Jeffs’ Brands   
-
    216 
Other accrued expenses to related parties of Gix Internet   5    6 
Other accrued expenses to related parties of Eventer   
-
    6 
    907    909 

 

* Compensation to key management:

 

   December 31, 
   2024   2023 
   USD in thousands 
     
Directors’ fees   583    322 
Payroll, provision for bonus and for termination of employment   319    359 
    902    681 

 

(6)Non-Current Liabilities:

 

   December 31, 
   2024   2023 
   USD in thousands 
     
Loans from related parties of Viewbix Ltd. (note 4F)   144    187 
Derivative warrant liability   290    
-
 
Short-term convertible loans   179    
-
 
Derivative liabilities   38    
-
 
    651    187 

 

c.As to options and RSUs granted to related parties, see note 13.

 

F-90

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 – REVENUES:

 

The following table present the Group’s revenues disaggregated by revenue type:

 

   Year ended on December 31, 
   2024   2023   2022 
   USD in thousands 
             
Revenues from commissions (from Eventer)   1,551    2,103    2,465 
Revenues from sale of products (from Jeffs’ Brands)   (**) 1,002    10,008    5,861 
Management fees and others (from Xylo Technologies) (***)   364    
-
    
-
 
Revenues from internet services (from Gix Internet)   26,941    79,613    (*) 83,532 
    29,858    91,724    91,858 

 

(*)The revenues from Gix Internet are presented for the period from February 28, 2022, to December 31, 2022.

 

(**)The revenues from Jeffs’ Brands are presented for the period from January 1, 2024, to January 28, 2024.

 

(***)Revenues from consulting services to Jeffs’ Brands and Parazero.

 

F-91

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 – SEGMENTS:

 

The Group identified four operating segments as follows: corporate, online advertising & internet traffic routing, online event management, real-estate and electronics.

 

The Company concluded that the real-estate and electronics segments are not “reportable segments” as defined in IFRS 8, Operating Segments. As such, these segments were combined and disclosed under “Others”.

 

The CODM measures and evaluates the operating performance of the Group’s segments based on operating loss (income), assets and liabilities.

 

The table set forth other information of the Group:

 

   December 31, 2024 
   Corporate   Online
Advertising
& Internet
Traffic
Routing
   Online
Event
Management
   Others   Adjustments
and
eliminations
   Total 
   USD in thousands 
                         
Total segments’ assets   13,133    18,335    1,729    
(*)2,986
    1,366    37,549 
                               
Total segments’ liabilities   399    17,076    1,354    1,131    
-
    19,960 

 

(*)Includes investments accounted for using the equity method of USD 268 thousand in relation to Zig Miami 54. In addition, includes loan to Zig Miami 54 in an amount of USD 1,756 thousand.

 

   December 31, 2023 
   Corporate   E-commerce   Online
Advertising
& Internet
Traffic
Routing
   Online
Event
Management
   Others   Adjustments and eliminations   Total 
   USD in thousands 
                             
Total segments’ assets   10,708    13,122    35,178    1,874    (*)3,444    (430)   63,896 
                                    
Total segments’ liabilities   (867)   (4,483)   (25,723)   (2,015)   (605)   2,232    (31,461)

 

(*) Includes investments accounted for using the equity method of USD 498 thousand and USD 370 thousand in relation to Polyrizon and Zig Miami 54, respectively. In addition, includes loan to Zig Miami 54 in an amount of USD 1,545 thousand.

 

F-92

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 – SEGMENTS: (continued)

 

The table set forth the operating results of the Group:

 

   Year ended December 31, 2024 
   Corporate   Online
Advertising
& Internet
Traffic
Routing
   Online
Event
Management
   Others   Adjustments and eliminations   Total 
   USD in thousands 
                         
External revenues   364    26,941    1,551    1,002    
-
    29,858 
                               
Cost of revenues   
-
    (21,988)   (260)   (927)   
-
    (23,175)
                               
Segment results – operating profit (loss)   4,352    (7,304)   (356)   
(*) (1,753
)   (2,956)   (8,017)
                               
Non-operating income (loss)   34    (1,920)   
-
    10    (1,318)   (3,194)
                               
Finance income (loss)   249    (1,111)   (34)   (60)   (95)   (1,051)
                               
Profit (Loss) before taxes on income   4,635    (10,335)   (390)   (1,803)   (4,369)   (12,262)
                               
Tax benefit   
-
    221    11    25    
-
    257 
                               
Segment results – net profit (loss)   4,635    (10,114)   (379)   (1,778)   (4,369)   (12.005)

 

(*)Includes equity losses of USD 102 thousand in relation to Zig Miami 54.

 

The table set forth the operating results of the Group:

 

   Year ended December 31, 2023 
   Corporate   E-commerce   Online
Advertising
& Internet
Traffic
Routing
   Online
Event
Management
   Others   Adjustments and eliminations   Total 
   USD in thousands 
                             
External revenues   
-
    10,008    79,613    2,103    
-
    
-
    91,724 
                                    
Cost of revenues        (9,032)   (70,452)   (399)   
-
    
-
    (79,883)
                                    
Segment results – operating loss   (4,295)   (5,614)   (3,548)   (651)   (*) (3,446)   (5,767)   (23,321)
                                    
Non-operating income (loss)   446    2,739    
-
    
-
    
-
    (138)   3,047 
                                    
Finance income (loss)   83    (110)   (1,605)   (82)   (25)   207    (1,532)
                                    
Loss before taxes on income   (3,766)   (2,985)   (5,153)   (733)   (3,471)   (5,698)   (21,806)
                                    
Tax benefit (expense) on income   3    (7)   66    12    
-
    
-
    74 
                                    
Segment results – net loss   (3,763)   (2,992)   (5,087)   (721)   (3,471)   (5,698)   (21,732)

 

(*)Includes equity losses of USD 209 thousand in relation to Polyrizon, of USD 85 thousand in relation to Zig Miami 54, of USD 543 thousand in relation to Parazero, of USD 1,176 thousand in relation to Laminera and USD 660 thousand in relation to Odysight.ai.

 

F-93

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 19 – ENTITY LEVEL DISCLOSURES:

 

a.Revenues by geographical area (based on the location of customers):

 

   Year ended on December 31, 
   2024   2023   2022 
   USD in thousands 
USA   15,785    49,954    52,129 
Europe   8,419    19,285    21,731 
Great Britain   662    5,628    166 
Israel   4,864    15,653    15,266 
Canada   117    944    385 
Asia   10    254    2,108 
Other   1    6    73 
    29,858    91,724    91,858 

 

b.Major customers

 

Set forth below is a breakdown of Company’s revenue by major customers (major customer –revenues from these customers constitute at least 10% of total revenues in a certain year):

 

   Year ended on December 31, 
   2024   2023   2022 
   USD in thousands 
             
Customer A   4,336    14,471    16,919 
                
Customer B   5,473    11,334    16,468 

 

F-94

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 20 – COMMITMENTS AND CONTINGENCIES:

 

1.On April 1, 2024, a lawsuit seeking declaratory judgement was filed in the District Court of Tel Aviv-Jaffa in Israel by minority shareholders of Eventer against Eventer and the Company (together, the “Defendants”). The minority shareholders of Eventer (the “Plaintiffs”), hold in aggregate 31.86% of the outstanding ordinary shares of Eventer.

 

The Plaintiffs allege, among others, that the Defendants violated the agreement whereby the Company acquired control of Eventer (the “Purchase Agreement”), which established a “separation” mechanism, pursuant to which certain Plaintiffs were granted an option to convert their shares in Eventer into shares of the Company. The claim alleges that the Company has violated the terms of the Purchase Agreement by refusing to negotiate Eventer’s valuation to enable certain of the Plaintiffs to exercise their option to convert their shares of Eventer into shares of the Company. The Plaintiffs seek an aggregate of NIS 8,602 thousand from the Company as consideration for the Plaintiffs’ shares in Eventer or as an alternative remedy, to convert Eventer’s shares into the Company shares for an aggregate value of NIS 8,602 thousand (approximately USD 2,348 thousand) following which all the Plaintiffs shares in Eventer would be transferred to the Company.

 

In addition, the Plaintiffs seek an aggregate of NIS 2,259 thousand from Eventer due to claims of breach of agreements (approximately USD 600 thousand).  

 

The Company submitted its response to the District Court of Tel Aviv – Jaffa and it intends to defend its position vigorously. The Company estimates the chances of a court ruling or a settlement in which the Plaintiffs will be awarded a consideration for their Eventer shares that is materially in excess of their fair value is remote. Accordingly, no loss contingency has been recorded as of December 31, 2024.

 

2.On December 2024, L.I.A Pure Capital Ltd. (“Pure Capital”), which held at that time 4.76% of the Company’s issued and outstanding share capital, has filed a request in the Tel Aviv District Court (Economic Division) to convene a special general meeting of the Company’s shareholders (the “Court Request” and the “Meeting” respectively), to approve an arrangement between the Company and its shareholders in accordance with Section 350 of the Israeli Companies Law, 5799-1999 (the “Companies Law”).

 

The purpose of the Meeting is to deliberate and discuss Pure Capital’s acquisition of the remaining 95.24% of the Company’s issued and outstanding share capital at a purchase price of USD 0.0925 per ordinary share of the Company (or USD 3.70 per American Depositary Share (“ADS”)), resulting in the privatization of the Company, delisting of the Company’s ADSs from the Nasdaq Stock Exchange, and terminating its obligations as a public company.

 

The Court Request also seeks that the Company undertake all necessary legal procedures, reports, and publications at its own expense, and seeks to establish instructions and timetables for approving the Meeting, including the convention, submitting applications, and addressing potential objections from ADS holders, in accordance with the Companies Law and the regulations promulgated thereunder.

 

On March 4, 2025, Pure Capital submitted an amendment to the Request (the “Amended Request”). The Amended Request increased Pure Capital’s proposal for the acquisition of the remaining issued and outstanding share capital of the Company to an updated purchase price of $0.13125 per Ordinary Share (or $5.25 per ADS) as opposed to the previous proposed purchase price of $0.0925 per Ordinary Share (or $3.70 per ADS). The Amended Request further clarified, subject to shareholder approval of the Arrangement, that (i) Pure Capital commits to purchase RSUs granted to the Company’s employees, officers and directors that are subject to acceleration upon a change of control; and (ii) the Company will purchase customary “run-off” insurance as of the date the Arrangement becomes effective.

 

On March 27, 2025, the Company, in agreement with Pure Capital, submitted a request to the court to order the convening of two shareholders meetings, in accordance with Section 350 of the Israeli Companies Law, as follows: the first meeting shall include all of the Company’s shareholders and ADS holders; the second meeting shall be considered a “pure” meeting, including the Company’s shareholders and ADS holders, except for (i) Pure Capital; (ii) Pure Capital’s controlling shareholder; and (iii) holders of Ordinary Shares or ADSs who have an ongoing business relationship with Pure Capital or its controlling shareholder. The court has approved the joint request as submitted.

 

On April 21, 2025, the Company published Proxy materials in preparation for the upcoming shareholder meetings. These materials included detailed information about the proposed Arrangement, the Amended Request, and the rationale behind the Company’s board of directors’ decision not to oppose the Arrangement. The Proxy materials also provided instructions for shareholders and ADS holders on how to participate in the meetings, vote on the proposed Arrangement, and submit any questions or comments they may have.

 

F-95

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 21 – EVENT SUBSEQUENT TO DECEMBER 31, 2024:

 

1.On January 5, 2025, Gix Internet entered into an agreement with Delivers.AI Ltd. (“Delivers.AI”), and with all of Delivers.AI’s shareholders (the “Sellers”) (the “Delivers.AI Transaction”), pursuant to which Gix Interent will acquire all (100%) of the share capital of Delivers.AI from the Sellers, in exchange for the allocation of 25% of Gix Internet’s share capital to the Sellers and the allocation of 5% of Gix Internet’s share capital to the entrepreneur upon completion. Also, within the framework of the agreement, a number of milestones were determined as follows:

 

(a)If, after 18 months from the completion date, Delivers.AI successfully completes commercial transactions for the supply of 20 autonomous robots providing delivery services (“Robots”), A “Commercial Transaction” means a binding transaction for the supply of robots to a customer who undertakes to pay a monthly payment for the use of each of the Robots supplied to it at a monthly consideration per robot that is not less than $1,000 per month and for a period of not less than 24 months for each Robot, or alternatively, a sale transaction of each of the Robots in exchange for not less than $10,000 per Robot and a service contract of not less than $400 per month for a period of not less than 24 months. In such a case, Gix Internet will allocate to the Sellers an additional 7.5% of its share capital and additional shares to the entrepreneur up to 5% of its share capital.

 

(b)If, after 48 months from the completion date, Delivers.AI completes Commercial Transactions as stated above, for the supply of 200 Robots, in such a case, Gix Internet will allocate to the Sellers an additional 7.5% of its share capital and additional shares to the entrepreneur up to 5% of its share capital.

 

The completion of the Delivers.AI Transaction will be subject to the approval of Gix Internet’s shareholders and obtaining a tax ruling from the Israel Tax Authority, which were not received as of the signing date of these financial statements, as well as the net cash amount after deducting liabilities and after deducting the Delivers.AI Transaction expenses of the Company on the completion date will be in an amount not less than NIS 4.5 million.

 

2.On January 15, 2025, Charging Robotics Inc issued 30,303 common stock to an investor for USD 50 thousand.

 

3.On January 26, 2025, the Company and Gix Internet signed an addendum to the loan agreement, effective as of December 31, 2024. Pursuant to the addendum, the loan repayment will be postponed until April 30, 2025, and the loan amount will increase in an additional NIS 150 thousand.

 

4.On February 4, 2025, Gix Media and Bank Leumi entered into a fifth addendum to the Financing Agreement, which was effective from January 29, 2025, according to which, inter alia: (i) the Gix Media Credit Line will be extended until March 31, 2025, (ii) Viewbix Inc. is required to deposit a cash amount into Gix Media’s bank account at Bank Leumi (“Investment Amount”) equal to the total of the long-term loan payments that have been and will be deferred until the actual deposit date, no later than March 31, 2025 (“Deferred Amounts”), (iii) if the Investment Amount is less than the Deferred Amounts, the bank reserves the right to fully repay the Deferred Amounts from any other source, (iv) from April 1, 2025, all due payments will be repaid as schedule until the end of the term of the long term bank loans.

 

5.On February 28, 2025, Cortex and Bank Leumi entered into an additional amendment to Cortex’s Loan Agreement, pursuant to which: (i) the credit line of USD 1,000 thousand for Cortex will be extended until December 12, 2025; (ii) Cortex will establish a first-ranking fixed pledge over the cash deposit held in Cortex’s Bank Leumi account, up to a maximum of USD 100 thousand, no later than April 15, 2025, or three days following Cortex’s receipt of its expected tax refund, whichever occurs first. This deposit may be released upon Cortex’s submission of a financial report demonstrating two consecutive quarters of positive EBITDA, with a minimum of USD 75 thousand per quarter.

 

6.On March 19, 2025, the Company converted Metagramm loan into 37,869 ordinary shares.

 

F-96

 

 

XYLO TECHNOLOGIES LTD.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 21 – EVENT SUBSEQUENT TO DECEMBER 31, 2024: (continued)

 

7.On March 23, 2025, Charging Robotics Inc issued 124,604 common stock to an investors for USD 206 thousand. Charging Robotics Inc also issued 111,689 shares to consultants in respect of finders’ fees related to previous private placements.

 

8.On March 24, 2025, Viewbix Inc. entered into a securities exchange agreement (the “Securities Exchange Agreement”) with Metagramm, pursuant to which Viewbix Inc. issued to Metagram’s shareholders (the “Metagramm Shareholders”) capital stock constituting 19.99% of Viewbix’s Inc. issued share capital (upon completion of the transaction), in exchange for Metagramm shares constituting 100% of Metagramm’s issued share capital (upon completion of the transaction). In addition, Viewbix Inc. undertook to pay Metagramm’s shareholders contingent cash consideration in a total amount of up to USD 2 million, subject to the completion of certain milestones in connection with financing and revenues, during a period of three years following the completion of the Securities Exchange Agreement. As part of the Securities Exchange Agreement, Viewbix Inc. and Metagramm canceled the securities exchange agreement signed between them in July 2024. Following the securities exchange agreement between Metagramm and Viewbix Inc., the Company received 171,112 ordinary shares of Viewbix Inc. in exchange for its shares in Metaagramm.

 

9.On March 27, 2025, a primary traffic provider of Gix Media filed a petition against it in the District Court of Tel Aviv for an order to commence insolvency proceedings under the Insolvency and Economic Rehabilitation Law, 5778 – 2018. The petition claims that Gix Media owes it approximately USD 260 thousand (excluding linkage differentials and interest) and that Gix Media is unable to repay its debts. As of the date of the petition, Gix Media has outstanding loans from the banking corporation (see Note 4F)). Due to the filing of the petition and in accordance with the loan terms, the banking corporation may demand immediate repayment of these loans. A hearing on the matter is scheduled for April 24, 2025. As of the date of publication of these financial statements, Gix Media's response has not yet been filed. Given the preliminary stage of the petition, the likelihood of its success cannot be assessed.

 

10.On March 30, 2025, Gix Media and Bank Leumi entered into an additional addendum to the loan agreement, according to which the agreement will be extended from February 4, 2025 to April 30, 2025, with all other conditions remaining unchanged.

 

11.On April 8, 2025, the Company’ and Jeffs’ Brands amended the consulting agreement, such that (i) as of January 2025 the monthly consulting fee would be reduced to USD 10 thousand; (ii) the consulting agreement would be extended for an additional 24 months; and (iii) a portion of the consulting fees to which the Company is entitled, and which are supposed to be paid in the last 9 and a half months of the consulting agreement, meaning a portion from March 2028, as well as April through December of 2028, will be paid in shares of Jeffs’ Brands, at a share price of $1.23 per share. In total, the Company was allocated 76,126 shares valued at $93,635, representing 3.51% of Jeffs’ Brands share capital. As of today, the Company holds approximately 4.99% of Jeffs’ Brands share capital.

 

12.On April 9, 2025, Pure Capital completed the sale of Warrants to certain purchasers, resulting in the right to purchase 454,752 ADSs, which were subsequently exercised in accordance with the terms under the Warrant Purchase Agreement, on April 16, 2025, resulting in the issuance of 18,190,080 of the Company's Ordinary Shares.

 

F-97

 

3-689-9124 +972 International Financial Reporting Standards 0001618500 false FY 0001618500 2024-01-01 2024-12-31 0001618500 dei:BusinessContactMember 2024-01-01 2024-12-31 0001618500 xylo:AmericanDepositarySharesEachRepresentingForty40OrdinarySharesMember 2024-01-01 2024-12-31 0001618500 xylo:OrdinarySharesNoparValueMember 2024-01-01 2024-12-31 0001618500 2024-12-31 0001618500 2023-12-31 0001618500 xylo:ProductsMember 2024-01-01 2024-12-31 0001618500 xylo:ProductsMember 2023-01-01 2023-12-31 0001618500 xylo:ProductsMember 2022-01-01 2022-12-31 0001618500 xylo:ServicesMember 2024-01-01 2024-12-31 0001618500 xylo:ServicesMember 2023-01-01 2023-12-31 0001618500 xylo:ServicesMember 2022-01-01 2022-12-31 0001618500 2023-01-01 2023-12-31 0001618500 2022-01-01 2022-12-31 0001618500 ifrs-full:OrdinarySharesMember 2023-12-31 0001618500 ifrs-full:SharePremiumMember 2023-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2023-12-31 0001618500 ifrs-full:OtherReservesMember 2023-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2023-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001618500 ifrs-full:WarrantsMember 2023-12-31 0001618500 ifrs-full:RetainedEarningsMember 2023-12-31 0001618500 ifrs-full:ParentMember 2023-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2023-12-31 0001618500 ifrs-full:RetainedEarningsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:ParentMember 2024-01-01 2024-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember 2024-01-01 2024-12-31 0001618500 ifrs-full:SharePremiumMember 2024-01-01 2024-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2024-01-01 2024-12-31 0001618500 ifrs-full:OtherReservesMember 2024-01-01 2024-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2024-01-01 2024-12-31 0001618500 ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 ifrs-full:SharePremiumMember 2024-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2024-12-31 0001618500 ifrs-full:OtherReservesMember 2024-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2024-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-12-31 0001618500 ifrs-full:WarrantsMember 2024-12-31 0001618500 ifrs-full:RetainedEarningsMember 2024-12-31 0001618500 ifrs-full:ParentMember 2024-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember 2022-12-31 0001618500 ifrs-full:SharePremiumMember 2022-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2022-12-31 0001618500 ifrs-full:OtherReservesMember 2022-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2022-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001618500 ifrs-full:WarrantsMember 2022-12-31 0001618500 ifrs-full:RetainedEarningsMember 2022-12-31 0001618500 ifrs-full:ParentMember 2022-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001618500 2022-12-31 0001618500 ifrs-full:OrdinarySharesMember 2023-01-01 2023-12-31 0001618500 ifrs-full:SharePremiumMember 2023-01-01 2023-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2023-01-01 2023-12-31 0001618500 ifrs-full:OtherReservesMember 2023-01-01 2023-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2023-01-01 2023-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-12-31 0001618500 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:ParentMember 2023-01-01 2023-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:OrdinarySharesMember 2021-12-31 0001618500 ifrs-full:SharePremiumMember 2021-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2021-12-31 0001618500 ifrs-full:OtherReservesMember 2021-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2021-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-12-31 0001618500 ifrs-full:WarrantsMember 2021-12-31 0001618500 ifrs-full:RetainedEarningsMember 2021-12-31 0001618500 ifrs-full:ParentMember 2021-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001618500 2021-12-31 0001618500 ifrs-full:OrdinarySharesMember 2022-01-01 2022-12-31 0001618500 ifrs-full:SharePremiumMember 2022-01-01 2022-12-31 0001618500 xylo:CapitalReservesFromOptionsGrantedMember 2022-01-01 2022-12-31 0001618500 ifrs-full:OtherReservesMember 2022-01-01 2022-12-31 0001618500 xylo:CapitalReservesFromTransactionsWithNonControllingInterestMember 2022-01-01 2022-12-31 0001618500 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-01-01 2022-12-31 0001618500 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001618500 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001618500 ifrs-full:ParentMember 2022-01-01 2022-12-31 0001618500 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-12-31 0001618500 xylo:OdysightaiMember 2024-01-28 0001618500 xylo:JeffsBrandsMember 2022-02-28 0001618500 xylo:GERDIPIncMember 2024-12-31 0001618500 xylo:GERDIPIncMember 2023-12-31 0001618500 xylo:EventerTechnologiesLtdMember 2024-12-31 0001618500 xylo:EventerTechnologiesLtdMember 2023-12-31 0001618500 xylo:GixInternetLtdMember 2024-12-31 0001618500 xylo:GixInternetLtdMember 2023-12-31 0001618500 xylo:ChargingRoboticsIncMember 2024-12-31 0001618500 xylo:ChargingRoboticsIncMember 2023-12-31 0001618500 xylo:JeffsBrandsLtdMember 2023-12-31 0001618500 2024-01-25 0001618500 xylo:JeffsBrandsLtdMember 2024-01-28 0001618500 xylo:JeffsBrandsLtdMember 2024-12-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2024-01-01 2024-12-31 0001618500 xylo:LamineraFlowOptimizationLtdMember 2024-01-01 2024-12-31 0001618500 xylo:PolyrizonLtdMember 2024-01-01 2024-12-31 0001618500 xylo:MetagrammSoftwareLtdMember 2024-01-01 2024-12-31 0001618500 xylo:ZigMiamiMember 2024-01-01 2024-12-31 0001618500 ifrs-full:EquityInvestmentsMember 2024-01-01 2024-12-31 0001618500 xylo:MachineryAndEquipmentsMember 2024-01-01 2024-12-31 0001618500 xylo:LeaseholdImprovementsAndFurnitureMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:LeaseholdImprovementsAndFurnitureMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001618500 ifrs-full:ComputerEquipmentMember 2024-01-01 2024-12-31 0001618500 xylo:OdysightaiMember 2022-01-01 2022-12-31 0001618500 xylo:PrivatePlacementsMember 2023-03-21 2023-03-21 0001618500 2023-03-21 2023-03-21 0001618500 xylo:OdysightaiMember 2023-03-21 2023-03-21 0001618500 ifrs-full:WarrantsMember 2023-03-21 2023-03-21 0001618500 2023-05-17 2023-05-17 0001618500 xylo:EventerMember 2023-01-01 2023-12-31 0001618500 2024-08-27 2024-08-27 0001618500 2023-12-06 2023-12-06 0001618500 xylo:GixInternetMember 2024-01-01 2024-12-31 0001618500 2020-10-14 2020-10-14 0001618500 2020-10-14 0001618500 2022-10-30 2022-10-30 0001618500 2024-04-01 2024-04-01 0001618500 xylo:JeffsBrandMember 2024-01-01 2024-12-31 0001618500 xylo:JeffsBrandsMember 2024-12-31 0001618500 2023-03-22 2023-03-22 0001618500 2023-03-22 0001618500 xylo:JeffsBrandsMember 2023-01-01 2023-12-31 0001618500 2023-03-09 2023-03-09 0001618500 xylo:NonadjustingEventAfterReportingPeriodMember 2024-02-29 2024-02-29 0001618500 xylo:ScoutCamIncMember xylo:WarrantsAMember 2022-08-30 2022-08-30 0001618500 2022-08-30 2022-08-30 0001618500 2022-11-01 2022-11-28 0001618500 xylo:ViewBixIncMember 2024-12-31 0001618500 xylo:GixInternetMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-01-05 0001618500 xylo:DeliversAILtdMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-01-05 0001618500 xylo:EntrepreneurMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-01-05 0001618500 2021-10-13 0001618500 xylo:GixMediaAndBankLeumiMember 2022-07-25 0001618500 2023-01-23 0001618500 ifrs-full:BottomOfRangeMember 2023-01-23 0001618500 ifrs-full:TopOfRangeMember 2023-01-23 0001618500 2023-01-17 0001618500 2023-01-17 2023-01-17 0001618500 2023-10-10 2023-10-10 0001618500 2024-06-13 2024-06-13 0001618500 2024-06-13 0001618500 2024-08-30 2024-08-30 0001618500 2024-09-16 0001618500 xylo:GixMediaMember 2022-09-14 0001618500 xylo:SubsequentEventsMember 2025-01-02 2025-01-02 0001618500 2024-09-19 0001618500 2024-09-19 2024-09-19 0001618500 2022-09-21 2022-09-21 0001618500 2023-04-27 2023-04-27 0001618500 xylo:BankLeumiMember 2023-09-30 2023-09-30 0001618500 2023-09-30 2023-09-30 0001618500 2024-05-27 2024-05-27 0001618500 2024-05-27 0001618500 2024-08-15 2024-08-15 0001618500 xylo:GixInternetMember 2021-10-13 2021-10-13 0001618500 2021-10-13 2021-10-13 0001618500 2022-08-25 2022-08-25 0001618500 2024-10-06 0001618500 2022-11-15 2022-11-15 0001618500 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:WarrantsMember 2023-12-31 0001618500 2024-06-18 2024-06-18 0001618500 2024-06-18 0001618500 xylo:JuneTwoThousandAndTwentyFourFacilityAgreementMember 2024-12-31 0001618500 xylo:JuneTwoThousandAndTwentyFourFacilityAgreementMember xylo:ViewbixIncMember 2024-12-31 0001618500 xylo:JuneTwoThousandAndTwentyFourFacilityAgreementMember xylo:ViewbixIncMember ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 xylo:JuneTwoThousandAndTwentyFourFacilityAgreementMember ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001618500 xylo:JuneTwoThousandAndTwentyFourFacilityAgreementMember xylo:ViewbixIncMember ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001618500 xylo:JuneTwoThousandAndTwentyFourFacilityAgreementMember ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember 2024-01-01 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 xylo:ViewBixIncMember ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001618500 xylo:ViewBixIncMember ifrs-full:OrdinarySharesMember 2024-01-01 2024-12-31 0001618500 xylo:June2024LeadLenderFeeWarrantsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember xylo:June2024LeadLenderFeeWarrantsMember 2024-01-01 2024-12-31 0001618500 xylo:June2024LeadLenderFeeWarrantsMember 2024-12-31 0001618500 xylo:June2024LeadLenderFeeWarrantsMember 2024-07-31 0001618500 xylo:June2024LeadLenderFeeWarrantsMember 2024-07-31 2024-07-31 0001618500 xylo:June2024LeadLenderFeeWarrantsMember 2024-06-30 2024-06-30 0001618500 ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001618500 ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:PrivatePlacementsMember 2024-07-03 0001618500 xylo:PrivatePlacementsMember xylo:PIPEWarrantsMember 2024-07-03 2024-07-03 0001618500 xylo:PIPEWarrantsMember 2024-07-03 2024-07-03 0001618500 xylo:PIPEWarrantsMember 2024-07-03 0001618500 2024-06-30 2024-06-30 0001618500 2024-07-31 2024-07-31 0001618500 xylo:LeadInvestorMember ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember 2024-07-31 0001618500 xylo:PrivatePlacementsMember 2024-07-31 2024-07-31 0001618500 2024-07-31 0001618500 xylo:PrivatePlacementsMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:PrivatePlacementsMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001618500 2024-07-22 2024-07-22 0001618500 2024-07-25 2024-07-25 0001618500 xylo:FirstJuly2024FacilityAgreementMember 2024-01-01 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember 2024-01-01 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember xylo:ViewBixIncMember 2024-01-01 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember xylo:ViewbixIncMember 2024-12-31 0001618500 xylo:ViewbixIncMember ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001618500 xylo:ViewbixIncMember ifrs-full:OrdinarySharesMember 2024-01-01 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:FirstJuly2024FacilityTermMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember 2024-07-28 2024-07-28 0001618500 xylo:SecondJuly2024FacilityAgreementMember 2024-01-01 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember ifrs-full:WarrantsMember 2024-01-01 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember ifrs-full:OrdinarySharesMember 2024-01-01 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember ifrs-full:OrdinarySharesMember 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember xylo:ViewBixIncMember 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember ifrs-full:TopOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:SecondJuly2024FacilityAgreementMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-12-31 0001618500 xylo:ShareBasedCompensationGrantsMember 2023-03-22 0001618500 xylo:SecuritiesExchangeAgreementWithMeragrammMember ifrs-full:MajorBusinessCombinationMember 2025-03-24 2025-03-24 0001618500 xylo:SecuritiesExchangeAgreementWithMeragrammMember xylo:ViewbixsCommonStockMember ifrs-full:MajorBusinessCombinationMember 2025-03-24 0001618500 xylo:SecuritiesExchangeAgreementWithMeragrammMember xylo:MetagrammOrdinarySharesMember ifrs-full:MajorBusinessCombinationMember 2025-03-24 0001618500 xylo:ConsultantsAgreementsMember 2024-07-31 0001618500 xylo:ConsultantsAgreementsMember 2024-07-31 2024-07-31 0001618500 xylo:RestrictedShareUnitMember 2023-07-20 2023-07-20 0001618500 xylo:ViewBixIncMember ifrs-full:OrdinarySharesMember xylo:FirstTrancheMember 2023-07-01 0001618500 xylo:ViewBixIncMember ifrs-full:OrdinarySharesMember xylo:SecondTrancheMember 2024-07-01 0001618500 xylo:ShareBasedCompensationExpenseMember 2024-01-01 2024-12-31 0001618500 xylo:ShareBasedCompensationExpenseMember 2023-01-01 2023-12-31 0001618500 xylo:ZigInvestmentGroupMember 2023-12-31 0001618500 xylo:ZigInvestmentGroupMember 2023-01-01 2023-12-31 0001618500 xylo:ZigMiami54Member 2023-12-31 0001618500 xylo:ZigMiami54Member 2023-12-15 2023-12-15 0001618500 xylo:PolyrizonMember 2023-01-01 2023-12-31 0001618500 xylo:PolyrizonMember 2023-12-31 0001618500 xylo:PolyrizonMember 2024-05-12 2024-05-12 0001618500 xylo:PolyrizonMember 2024-07-02 0001618500 xylo:PolyrizonMember 2024-07-02 2024-07-02 0001618500 xylo:PolyrizonMember ifrs-full:TopOfRangeMember 2024-07-02 2024-07-02 0001618500 xylo:PolyrizonMember ifrs-full:BottomOfRangeMember 2024-07-02 2024-07-02 0001618500 xylo:PolyrizonMember 2024-10-30 2024-10-30 0001618500 xylo:PolyrizonMember 2024-01-01 2024-12-31 0001618500 xylo:PolyrizonMember 2020-07-01 2020-07-31 0001618500 xylo:PolyrizonMember 2023-04-23 2023-04-23 0001618500 xylo:PolyrizonMember 2021-12-15 0001618500 xylo:PolyrizonMember 2021-12-01 2021-12-15 0001618500 xylo:PolyrizonMember ifrs-full:OrdinarySharesMember 2024-05-07 0001618500 xylo:RevoltzLtdMember 2024-12-31 0001618500 xylo:RevoltzLtdMember 2024-01-01 2024-12-31 0001618500 xylo:ChargingRoboticsLtdMember 2022-07-28 0001618500 xylo:ParazeroTechnologiesLtdMember 2023-12-31 0001618500 xylo:BuffaloInvestmentsLtdMember 2024-12-31 0001618500 xylo:SciSparcLtdMember 2024-12-31 0001618500 xylo:BuffaloAgreementMember 2021-12-07 0001618500 xylo:BuffaloAgreementMember 2021-12-01 2021-12-07 0001618500 2021-12-07 0001618500 xylo:ChargingRoboticsLtdMember 2021-12-01 2021-12-07 0001618500 2021-12-01 2021-12-07 0001618500 xylo:BuffaloAgreementMember 2022-06-30 0001618500 2022-06-30 0001618500 2022-06-01 2022-06-30 0001618500 xylo:BuffaloAgreementMember 2024-01-01 2024-12-31 0001618500 xylo:HydreightTechnologiesIncMember 2024-12-31 0001618500 xylo:ViewbixIncMember 2024-01-01 2024-12-31 0001618500 xylo:SciSparcMember 2024-01-01 2024-12-31 0001618500 xylo:ColugoSystemsLtdMember 2024-01-01 2024-12-31 0001618500 xylo:BuffaloAgreementMember 2024-12-31 0001618500 2023-03-16 0001618500 2023-03-16 2023-03-16 0001618500 xylo:FuelDoctorHoldingsIncMember 2024-12-31 0001618500 xylo:HydreightTechnologiesIncMember 2024-01-01 2024-12-31 0001618500 xylo:ClearmindMedicineIncMember 2024-01-01 2024-12-31 0001618500 xylo:LoanAgreementMember 2024-01-01 2024-12-31 0001618500 xylo:ChargingRoboticsIncMember 2021-01-21 2021-01-21 0001618500 xylo:ChargingRoboticsIncMember 2023-03-28 0001618500 xylo:ChargingRoboticsIncMember ifrs-full:OrdinarySharesMember 2023-03-28 2023-03-28 0001618500 xylo:ChargingRoboticsIncMember 2023-01-01 2023-12-31 0001618500 xylo:ChargingRoboticsIncMember 2024-01-01 2024-12-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2022-12-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2022-02-01 2022-05-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2023-07-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2023-07-31 2023-07-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2023-01-01 2023-12-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2023-10-30 2023-10-30 0001618500 xylo:ParazeroTechnologiesLtdMember 2024-12-31 0001618500 xylo:ParazeroTechnologiesLtdMember 2022-01-01 2022-12-31 0001618500 xylo:CreditFacilityAgreementMember xylo:ParazeroTechnologiesLtdMember 2022-10-30 2022-10-30 0001618500 xylo:CreditFacilityAgreementMember 2023-06-01 2023-06-30 0001618500 xylo:LamineraFlowOptimizationLtdMember 2023-01-01 2023-12-31 0001618500 xylo:GERDIPIncMember 2021-01-01 2021-12-31 0001618500 xylo:GERDIPIncMember 2022-01-01 2022-12-31 0001618500 xylo:MetagrammMember 2023-04-13 2023-04-13 0001618500 xylo:MetagrammMember 2024-01-01 2024-12-31 0001618500 xylo:MetagrammMember 2023-01-01 2023-12-31 0001618500 xylo:MetagrammMember 2024-12-31 0001618500 xylo:MetagrammMember 2023-12-31 0001618500 xylo:MetagrammMember 2024-07-21 2024-07-21 0001618500 xylo:MetagrammMember ifrs-full:MajorBusinessCombinationMember 2025-03-19 2025-03-19 0001618500 xylo:MetagrammMember 2025-03-19 2025-03-19 0001618500 xylo:SolterraEnergyMember 2023-01-01 2023-12-31 0001618500 xylo:SolterraEnergyMember xylo:UniformOfferToThePublicMember 2024-11-18 0001618500 xylo:SolterraEnergyMember 2024-11-18 2024-11-18 0001618500 xylo:SolterraEnergyMember xylo:PrivatePlacementsMember 2024-01-01 2024-12-31 0001618500 xylo:SolterraEnergyMember 2024-12-31 0001618500 xylo:SolterraEnergyMember 2024-01-01 2024-12-31 0001618500 xylo:SolterraEnergyMember 2024-11-28 2024-11-28 0001618500 xylo:EventerLtdMember 2024-01-01 2024-12-31 0001618500 xylo:GERDIPIncMember 2024-01-01 2024-12-31 0001618500 xylo:JeffsBrandsLtdMember 2023-01-01 2023-12-31 0001618500 xylo:EventerLtdMember 2023-01-01 2023-12-31 0001618500 xylo:GERDIPIncMember 2023-01-01 2023-12-31 0001618500 xylo:GixInternetMember 2023-01-01 2023-12-31 0001618500 xylo:JeffsBrandsLtdMember 2024-01-01 2024-12-31 0001618500 xylo:GerdIPMember 2024-01-01 2024-12-31 0001618500 xylo:GerdIPMember 2023-01-01 2023-12-31 0001618500 xylo:FuelDoctorMember 2024-01-01 2024-12-31 0001618500 xylo:FuelDoctorMember 2023-01-01 2023-12-31 0001618500 xylo:EventerMember 2024-01-01 2024-12-31 0001618500 xylo:EventerMember 2022-01-01 2022-12-31 0001618500 xylo:JeffBrandsMember 2024-01-01 2024-12-31 0001618500 xylo:JeffBrandsMember 2023-01-01 2023-12-31 0001618500 xylo:JeffBrandsMember 2022-01-01 2022-12-31 0001618500 xylo:GixInternetMember 2022-01-01 2022-12-31 0001618500 xylo:GerdIPMember 2022-01-01 2022-12-31 0001618500 xylo:ChargingRoboticsIncMember 2022-01-01 2022-12-31 0001618500 xylo:GixInternetMember 2024-12-31 0001618500 xylo:GixInternetMember 2023-12-31 0001618500 xylo:PolyrizonMember 2024-12-31 0001618500 xylo:SciSparcNutraceuticalsMember 2024-12-31 0001618500 xylo:SciSparcNutraceuticalsMember 2023-12-31 0001618500 xylo:SolterraEnergynote4PMember 2024-12-31 0001618500 xylo:SolterraEnergynote4PMember 2023-12-31 0001618500 xylo:RevoltzMember 2024-12-31 0001618500 xylo:RevoltzMember 2023-12-31 0001618500 xylo:ZigMiami54Member 2024-12-31 0001618500 xylo:OdysightaiMember 2024-01-01 2024-12-31 0001618500 xylo:OdysightaiMember 2023-01-01 2023-12-31 0001618500 xylo:ParazeroMember 2024-01-01 2024-12-31 0001618500 xylo:ParazeroMember 2023-01-01 2023-12-31 0001618500 xylo:ParazeroMember 2022-01-01 2022-12-31 0001618500 xylo:LamineraMember 2024-01-01 2024-12-31 0001618500 xylo:LamineraMember 2023-01-01 2023-12-31 0001618500 xylo:LamineraMember 2022-01-01 2022-12-31 0001618500 xylo:SciSparcNutraceuticalsMember 2024-01-01 2024-12-31 0001618500 xylo:SciSparcNutraceuticalsMember 2023-01-01 2023-12-31 0001618500 xylo:SciSparcNutraceuticalsMember 2022-01-01 2022-12-31 0001618500 xylo:PolyrizonMember 2022-01-01 2022-12-31 0001618500 xylo:ElbitImagingMember 2024-01-01 2024-12-31 0001618500 xylo:ElbitImagingMember 2023-01-01 2023-12-31 0001618500 xylo:ElbitImagingMember 2022-01-01 2022-12-31 0001618500 xylo:SolterraEnergyMember 2022-01-01 2022-12-31 0001618500 xylo:RevoltzMember 2024-01-01 2024-12-31 0001618500 xylo:RevoltzMember 2023-01-01 2023-12-31 0001618500 xylo:RevoltzMember 2022-01-01 2022-12-31 0001618500 xylo:ZigMiami54Member 2024-01-01 2024-12-31 0001618500 xylo:ZigMiami54Member 2023-01-01 2023-12-31 0001618500 xylo:ZigMiami54Member 2022-01-01 2022-12-31 0001618500 xylo:OdysightaiMember 2023-12-31 0001618500 xylo:OdysightaiMember 2024-12-31 0001618500 xylo:ZigMiami54Member 2022-12-31 0001618500 ifrs-full:CapitalisationRateMeasurementInputMember 2024-06-18 0001618500 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2024-06-18 0001618500 ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2024-06-18 0001618500 ifrs-full:InterestRateMeasurementInputMember 2024-06-18 0001618500 xylo:ExpectedLifeMember 2024-06-18 0001618500 ifrs-full:CapitalisationRateMeasurementInputMember 2024-12-31 0001618500 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2024-12-31 0001618500 ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2024-12-31 0001618500 ifrs-full:BottomOfRangeMember ifrs-full:InterestRateMeasurementInputMember 2024-12-31 0001618500 ifrs-full:TopOfRangeMember ifrs-full:InterestRateMeasurementInputMember 2024-12-31 0001618500 ifrs-full:BottomOfRangeMember xylo:ExpectedLifeMember 2024-12-31 0001618500 ifrs-full:TopOfRangeMember xylo:ExpectedLifeMember 2024-12-31 0001618500 ifrs-full:LaterThanOneYearMember ifrs-full:LiquidityRiskMember 2024-12-31 0001618500 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ifrs-full:LiquidityRiskMember 2024-12-31 0001618500 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember ifrs-full:LiquidityRiskMember 2024-12-31 0001618500 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2024-12-31 0001618500 ifrs-full:LiquidityRiskMember 2024-12-31 0001618500 ifrs-full:LaterThanOneYearMember ifrs-full:LiquidityRiskMember 2023-12-31 0001618500 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001618500 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001618500 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember ifrs-full:LiquidityRiskMember 2023-12-31 0001618500 ifrs-full:LiquidityRiskMember 2023-12-31 0001618500 xylo:InvestmentsInSharesMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInSharesMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInSharesMember 2024-12-31 0001618500 xylo:InvestmentsInSharesMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInSharesMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInSharesMember 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember 2023-12-31 0001618500 ifrs-full:EquityInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 ifrs-full:EquityInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 ifrs-full:EquityInvestmentsMember 2024-12-31 0001618500 ifrs-full:EquityInvestmentsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 ifrs-full:EquityInvestmentsMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 ifrs-full:EquityInvestmentsMember 2023-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToRevoltzMember 2024-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToRevoltzMember 2023-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToPolyrizonMember 2024-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToPolyrizonMember 2023-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToZigMiami54Member 2024-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToZigMiami54Member 2023-12-31 0001618500 xylo:LoansToAssociatesAndOthersMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoansToAssociatesAndOthersMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoansToAssociatesAndOthersMember 2024-12-31 0001618500 xylo:LoansToAssociatesAndOthersMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoansToAssociatesAndOthersMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoansToAssociatesAndOthersMember 2023-12-31 0001618500 xylo:SharesReceivableFromTheAmendmentOfTheBuffaloAgreementMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:SharesReceivableFromTheAmendmentOfTheBuffaloAgreementMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:SharesReceivableFromTheAmendmentOfTheBuffaloAgreementMember 2024-12-31 0001618500 xylo:SharesReceivableFromTheAmendmentOfTheBuffaloAgreementMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:SharesReceivableFromTheAmendmentOfTheBuffaloAgreementMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:SharesReceivableFromTheAmendmentOfTheBuffaloAgreementMember 2023-12-31 0001618500 ifrs-full:TradeReceivablesMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 ifrs-full:TradeReceivablesMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 ifrs-full:TradeReceivablesMember 2024-12-31 0001618500 ifrs-full:TradeReceivablesMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 ifrs-full:TradeReceivablesMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 ifrs-full:TradeReceivablesMember 2023-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInMutualFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level1OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInMutualFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInMutualFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level1OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInMutualFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInMutualFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInSharesAndWarrantsRollForwardMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInSAFEsMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInSharesAndWarrantsRollForwardMember ifrs-full:Level1OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInSAFEsMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInSharesAndWarrantsRollForwardMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInSAFEsMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInSharesAndWarrantsRollForwardMember ifrs-full:Level1OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInSAFEsMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:LoansToAssociatesAndOthersRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:SharesReceivableMember xylo:Level1AndLevel3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInSharesAndWarrantsRollForwardMember ifrs-full:Level1OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInShareMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInWarrantsMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInSAFEsMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:InvestmentsInSharesWarrantsAndSAFEsRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:LoanToSolterraEnergyMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:InvestmentsInSharesWarrantsAndSAFEsRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:LoanToSolterraEnergyMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:InvestmentsInSharesWarrantsAndSAFEsRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToSolterraEnergyMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:InvestmentsInSharesWarrantsAndSAFEsRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:LoanToSolterraEnergyMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 xylo:InvestmentsInSharesWarrantsAndSAFEsRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToRevoltzMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToSolterraEnergyMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToPolyrizonMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoanToZigMiami54Member ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:LoansToAssociatesAndOthersRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:SharesReceivableMember xylo:Level1AndLevel3OfFairValueHierarchyMember 2022-12-31 0001618500 xylo:LoansToAssociatesAndOthersRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:SharesReceivableMember xylo:Level1AndLevel3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 xylo:LoansToAssociatesAndOthersRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:SharesReceivableMember xylo:Level1AndLevel3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:LoansToAssociatesAndOthersRollForwardMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:SharesReceivableMember xylo:Level1AndLevel3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:WarrantsAtFairValueIssuedBySubsidiariesMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:WarrantsAtFairValueIssuedBySubsidiariesMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 xylo:EmbeddedDerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 xylo:EmbeddedDerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 ifrs-full:Level3OfFairValueHierarchyMember 2024-12-31 0001618500 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001618500 ifrs-full:Level3OfFairValueHierarchyMember 2024-01-01 2024-12-31 0001618500 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001618500 ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001618500 currency:USD 2024-12-31 0001618500 currency:USD 2023-12-31 0001618500 currency:ILS 2024-12-31 0001618500 currency:ILS 2023-12-31 0001618500 currency:GBP 2024-12-31 0001618500 currency:GBP 2023-12-31 0001618500 srt:OtherCurrencyMember 2024-12-31 0001618500 srt:OtherCurrencyMember 2023-12-31 0001618500 xylo:LoanToSafeeMember 2024-12-31 0001618500 xylo:LoanToSafeeMember 2023-12-31 0001618500 xylo:LoanToMetagrammMember 2024-12-31 0001618500 xylo:LoanToMetagrammMember 2023-12-31 0001618500 xylo:JeffsBrandsMember 2024-01-25 2024-01-25 0001618500 xylo:JeffsBrandsMember 2024-01-28 2024-01-28 0001618500 xylo:SoftwareLicenseMember 2021-02-04 2021-02-04 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:TechnologybasedIntangibleAssetsMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:PatentMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:GoodwilllMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:TechnologybasedIntangibleAssetsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:PatentMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:GoodwilllMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember 2024-01-01 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:TechnologybasedIntangibleAssetsMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:PatentMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:GoodwilllMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:TechnologybasedIntangibleAssetsMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:PatentMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:BrandNamesMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:GoodwilllMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:TechnologybasedIntangibleAssetsMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:ComputerSoftwareMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:PatentMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:BrandNamesMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:GoodwilllMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember 2024-01-01 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:TechnologybasedIntangibleAssetsMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:ComputerSoftwareMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:PatentMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:BrandNamesMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:GoodwilllMember 2024-12-31 0001618500 xylo:AccumulatedAmortizationMember 2024-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:TechnologybasedIntangibleAssetsMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:PatentMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:GoodwilllMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:TechnologybasedIntangibleAssetsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:PatentMember 2023-01-01 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember xylo:GoodwilllMember 2023-01-01 2023-12-31 0001618500 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:TechnologybasedIntangibleAssetsMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:PatentMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:BrandNamesMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:GoodwilllMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember 2022-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:TechnologybasedIntangibleAssetsMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:PatentMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember xylo:GoodwilllMember 2023-01-01 2023-12-31 0001618500 xylo:AccumulatedAmortizationMember 2023-01-01 2023-12-31 0001618500 2023-01-05 2023-01-05 0001618500 2023-02-01 2023-02-01 0001618500 2021-02-25 0001618500 xylo:GixMediaMember 2023-01-01 2023-12-31 0001618500 ifrs-full:BuildingsMember 2022-12-31 0001618500 ifrs-full:BuildingsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:BuildingsMember 2023-12-31 0001618500 ifrs-full:BuildingsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:BuildingsMember 2024-12-31 0001618500 ifrs-full:LaterThanOneYearMember 2024-01-01 2024-12-31 0001618500 ifrs-full:LaterThanOneYearMember 2023-01-01 2023-12-31 0001618500 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2023-01-01 2023-12-31 0001618500 xylo:JeffsBrandsMember 2024-01-01 2024-12-31 0001618500 xylo:JeffsBrandsMember 2022-01-01 2022-12-31 0001618500 xylo:GixMediaAndCortexMediaMember 2024-01-01 2024-12-31 0001618500 xylo:GixMediaAndCortexMediaMember 2023-01-01 2023-12-31 0001618500 xylo:GixMediaAndCortexMediaMember 2022-01-01 2022-12-31 0001618500 ifrs-full:TopOfRangeMember 2017-12-22 2017-12-22 0001618500 ifrs-full:BottomOfRangeMember 2017-12-22 2017-12-22 0001618500 xylo:XyloTechnologiesMember 2024-01-01 2024-12-31 0001618500 xylo:XyloTechnologiesMember 2023-01-01 2023-12-31 0001618500 xylo:NisUnlinkedMember 2024-12-31 0001618500 xylo:NisUnlinkedMember 2023-12-31 0001618500 xylo:UnitedStatesDollarMember 2024-12-31 0001618500 xylo:UnitedStatesDollarMember 2023-12-31 0001618500 xylo:OtherCurrenciesMember 2024-12-31 0001618500 xylo:OtherCurrenciesMember 2023-12-31 0001618500 2023-06-09 0001618500 2023-07-03 0001618500 2023-08-08 0001618500 2023-11-06 0001618500 2023-12-26 0001618500 2024-10-07 0001618500 ifrs-full:RestrictedShareUnitsMember 2024-12-31 0001618500 2024-11-15 0001618500 2024-11-15 2024-11-15 0001618500 2023-01-01 2023-01-01 0001618500 xylo:CommonSharesMember 2024-12-31 0001618500 xylo:CommonSharesMember 2023-12-31 0001618500 xylo:JanuaryTwoZeroOneNineMember 2024-01-01 2024-12-31 0001618500 xylo:JanuaryTwoZeroOneNineMember 2024-12-31 0001618500 xylo:JulyTwentyNineteenMember 2024-01-01 2024-12-31 0001618500 xylo:JulyTwentyNineteenMember 2024-12-31 0001618500 xylo:JuneTwoZeroTwoZeroMember 2024-01-01 2024-12-31 0001618500 xylo:JuneTwoZeroTwoZeroMember 2024-12-31 0001618500 xylo:JulyMember 2024-01-01 2024-12-31 0001618500 xylo:JulyMember 2024-12-31 0001618500 xylo:June2021Member 2024-01-01 2024-12-31 0001618500 xylo:June2021Member 2024-12-31 0001618500 xylo:June2021OneMember 2024-01-01 2024-12-31 0001618500 xylo:June2021OneMember 2024-12-31 0001618500 xylo:June2021TwoMember 2024-01-01 2024-12-31 0001618500 xylo:June2021TwoMember 2024-12-31 0001618500 xylo:October2021Member 2024-01-01 2024-12-31 0001618500 xylo:October2021Member 2024-12-31 0001618500 xylo:JanuaryTwoZeroOneNineMember 2024-12-31 0001618500 xylo:JanuaryTwoZeroOneNineMember 2024-01-01 2024-12-31 0001618500 xylo:JulyTwentyNineteenMember 2024-12-31 0001618500 xylo:JulyTwentyNineteenMember 2024-01-01 2024-12-31 0001618500 xylo:JuneTwoZeroTwoZeroMember 2024-12-31 0001618500 xylo:JuneTwoZeroTwoZeroMember 2024-01-01 2024-12-31 0001618500 xylo:JulyMember 2024-12-31 0001618500 xylo:JulyMember 2024-01-01 2024-12-31 0001618500 xylo:June2021Member 2024-12-31 0001618500 xylo:June2021Member 2024-01-01 2024-12-31 0001618500 xylo:October2021Member 2024-12-31 0001618500 xylo:October2021Member 2024-01-01 2024-12-31 0001618500 xylo:LossPerShareMember 2024-01-01 2024-12-31 0001618500 xylo:LossPerShareMember 2023-01-01 2023-12-31 0001618500 xylo:LossPerShareMember 2022-01-01 2022-12-31 0001618500 ifrs-full:RelatedPartiesMember 2024-01-01 2024-12-31 0001618500 ifrs-full:RelatedPartiesMember 2023-01-01 2023-12-31 0001618500 ifrs-full:RelatedPartiesMember 2022-01-01 2022-12-31 0001618500 2024-08-01 2024-08-01 0001618500 xylo:JeffsBrandsMember 2024-04-30 2024-04-30 0001618500 xylo:JeffsBrandsMember 2024-04-30 0001618500 ifrs-full:OtherRelatedPartiesMember 2024-01-01 2024-12-31 0001618500 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-12-31 0001618500 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001618500 xylo:ParaziroMember 2024-12-31 0001618500 xylo:ParaziroMember 2023-12-31 0001618500 xylo:EventerMember 2024-12-31 0001618500 xylo:EventerMember 2023-12-31 0001618500 ifrs-full:OtherRelatedPartiesMember 2024-12-31 0001618500 ifrs-full:OtherRelatedPartiesMember 2023-12-31 0001618500 xylo:CurrentAssetsUnderLoansMember ifrs-full:OtherRelatedPartiesMember 2024-12-31 0001618500 xylo:CurrentAssetsUnderLoansMember ifrs-full:OtherRelatedPartiesMember 2023-12-31 0001618500 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2024-01-01 2024-12-31 0001618500 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-01-01 2023-12-31 0001618500 xylo:ZigMiamiFiftyFourMember 2024-12-31 0001618500 xylo:AdditionalLoanMember xylo:ZigMiamiFiftyFourMember 2024-12-31 0001618500 xylo:PolyrizonMember 2023-12-31 0001618500 xylo:ZigMiamiFiftyFourMember 2023-12-31 0001618500 xylo:AdditionalLoanMember xylo:ZigMiamiFiftyFourMember 2023-12-31 0001618500 xylo:ZigMiamiFiftyFourMember 2024-01-01 2024-12-31 0001618500 xylo:PolyrizonMember 2023-01-01 2023-12-31 0001618500 xylo:ZigMiamiFiftyFourMember 2023-01-01 2023-12-31 0001618500 xylo:ParazeroMember 2023-01-01 2023-12-31 0001618500 xylo:LamineraMember 2023-01-01 2023-12-31 0001618500 xylo:OdysightaiMember 2023-01-01 2023-12-31 0001618500 xylo:CorporatesMember ifrs-full:AllOtherSegmentsMember 2024-12-31 0001618500 xylo:OnlineAdvertisingInternetTrafficRoutingMember ifrs-full:AllOtherSegmentsMember 2024-12-31 0001618500 xylo:OnlineEventManagementMember ifrs-full:AllOtherSegmentsMember 2024-12-31 0001618500 xylo:OthersMember ifrs-full:AllOtherSegmentsMember 2024-12-31 0001618500 xylo:AdjustmentsAndEliminationsMember ifrs-full:AllOtherSegmentsMember 2024-12-31 0001618500 ifrs-full:AllOtherSegmentsMember 2024-12-31 0001618500 xylo:CorporatesMember ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 xylo:EcommerceMember ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 xylo:OnlineAdvertisingInternetTrafficRoutingMember ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 xylo:OnlineEventManagementMember ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 xylo:OthersMember ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 xylo:AdjustmentsAndEliminationsMember ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 ifrs-full:AllOtherSegmentsMember 2023-12-31 0001618500 xylo:CorporatesMember ifrs-full:AllOtherSegmentsMember 2024-01-01 2024-12-31 0001618500 xylo:OnlineAdvertisingInternetTrafficRoutingMember ifrs-full:AllOtherSegmentsMember 2024-01-01 2024-12-31 0001618500 xylo:OnlineEventManagementMember ifrs-full:AllOtherSegmentsMember 2024-01-01 2024-12-31 0001618500 xylo:OthersMember ifrs-full:AllOtherSegmentsMember 2024-01-01 2024-12-31 0001618500 xylo:AdjustmentsAndEliminationsMember ifrs-full:AllOtherSegmentsMember 2024-01-01 2024-12-31 0001618500 ifrs-full:AllOtherSegmentsMember 2024-01-01 2024-12-31 0001618500 xylo:CorporatesMember ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 xylo:EcommerceMember ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 xylo:OnlineAdvertisingInternetTrafficRoutingMember ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 xylo:OnlineEventManagementMember ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 xylo:OthersMember ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 xylo:AdjustmentsAndEliminationsMember ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 ifrs-full:AllOtherSegmentsMember 2023-01-01 2023-12-31 0001618500 country:US 2024-01-01 2024-12-31 0001618500 country:US 2023-01-01 2023-12-31 0001618500 country:US 2022-01-01 2022-12-31 0001618500 srt:EuropeMember 2024-01-01 2024-12-31 0001618500 srt:EuropeMember 2023-01-01 2023-12-31 0001618500 srt:EuropeMember 2022-01-01 2022-12-31 0001618500 xylo:GreatBritainMember 2024-01-01 2024-12-31 0001618500 xylo:GreatBritainMember 2023-01-01 2023-12-31 0001618500 xylo:GreatBritainMember 2022-01-01 2022-12-31 0001618500 country:IL 2024-01-01 2024-12-31 0001618500 country:IL 2023-01-01 2023-12-31 0001618500 country:IL 2022-01-01 2022-12-31 0001618500 xylo:CAMember 2024-01-01 2024-12-31 0001618500 xylo:CAMember 2023-01-01 2023-12-31 0001618500 xylo:CAMember 2022-01-01 2022-12-31 0001618500 xylo:AsiaCountryMember 2024-01-01 2024-12-31 0001618500 xylo:AsiaCountryMember 2023-01-01 2023-12-31 0001618500 xylo:AsiaCountryMember 2022-01-01 2022-12-31 0001618500 xylo:OtherAreaMember 2024-01-01 2024-12-31 0001618500 xylo:OtherAreaMember 2023-01-01 2023-12-31 0001618500 xylo:OtherAreaMember 2022-01-01 2022-12-31 0001618500 xylo:CustomerMember 2024-01-01 2024-12-31 0001618500 xylo:CustomerMember 2023-01-01 2023-12-31 0001618500 xylo:CustomerMember 2022-01-01 2022-12-31 0001618500 xylo:CustomerBMember 2024-01-01 2024-12-31 0001618500 xylo:CustomerBMember 2023-01-01 2023-12-31 0001618500 xylo:CustomerBMember 2022-01-01 2022-12-31 0001618500 2024-04-01 0001618500 xylo:PlaintiffsMember 2024-04-01 0001618500 xylo:PlaintiffsMember 2024-12-31 0001618500 xylo:PureCapitalMember 2024-12-31 0001618500 xylo:AmericanDepositaryShareMember 2024-12-31 0001618500 ifrs-full:OrdinarySharesMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-04 0001618500 xylo:AmericanDepositaryShareMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-04 0001618500 xylo:RobotsAMember 2024-01-01 2024-12-31 0001618500 xylo:TwoHundredRobotsMember 2024-01-01 2024-12-31 0001618500 xylo:NonadjustingEventAfterReportingPeriodMember 2025-01-15 0001618500 xylo:NonadjustingEventAfterReportingPeriodMember 2025-02-28 2025-02-28 0001618500 xylo:MetagrammLoanMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-19 0001618500 xylo:ChargingRoboticsIncMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-23 0001618500 xylo:PrivatePlacementsMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-23 0001618500 xylo:ViewBixIncMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-24 0001618500 xylo:ViewBixIncMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-24 2025-03-24 0001618500 xylo:GixMediaMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-03-27 0001618500 xylo:NonadjustingEventAfterReportingPeriodMember 2025-04-08 2025-04-08 0001618500 xylo:NonadjustingEventAfterReportingPeriodMember 2025-04-09 2025-04-09 0001618500 ifrs-full:OrdinarySharesMember xylo:NonadjustingEventAfterReportingPeriodMember 2025-04-16 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:ILS iso4217:GBP iso4217:AUD iso4217:EUR iso4217:ILS xbrli:shares